polymorphism, Primary Sclerosing Cholangitis Literature

Primary Sclerosing Cholangitis Literature

Home Page

FAQ

PSC Partners

www Resources

Scientific Literature

Scientific Literature, polymorphism

Aarnisalo J, Treszl A, Svec P, Marttila J, Oling V, Simell O, Knip M, Korner A, Madacsy L, Vasarhelyi B, Ilonen J, Hermann R. Reduced CD4(+)T cell activation in children with type 1 diabetes carrying the PTPN22/Lyp 620Trp variant. J. Autoimmun. 31: 13-21 (2008).
Abanmi A, Al Harthi F, Zouman A, Kudwah A, Jamal MA, Arfin M, Tariq M. Association of interleukin-10 gene promoter polymorphisms in Saudi patients with vitiligo. Dis. Markers 24: 51-57 (2008).
Abanmi A, Harthi FA, Baqami RA, Assaf SA, Zouman A, Arfin M, Tariq M. Association of HLA loci alleles and antigens in Saudi patients with vitiligo. Arch. Dermatol. Res. 298: 347-352 (2006). *
Abate N, Chandalia M, Di Paola R, Foster DW, Grundy SM, Trischitta V. Mechanisms of disease: ectonucleotide pyrophosphatase phosphodiesterase 1 as a 'gatekeeper' of insulin receptors. Nat. Clin. Pract. Endocrinol. Metab. 2: 694-701 (2006). *
Abate N, Chandalia M, Satija P, Adams-Huet B, Grundy SM, Sandeep S, Radha V, Deepa R, Mohan V. ENPP1/PC-1 K121Q polymorphism and genetic susceptibility to type 2 diabetes. Diabetes 54: 1207-1213 (2005). *
Abazis-Stamboulieh D, Oikonomou P, Papadoulis N, Panayiotidis P, Vrakidou E, Tsezou A. Association of interleukin-1A, interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms with multiple myeloma. Leuk. Lymphoma 48: 2196-2203 (2007).
Abbas S, Nieters A, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, Chang-Claude J. Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk. Breast Cancer Res. 10: R31 (2008). *
Abbott DW, Wilkins A, Asara JM, Cantley LC. The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO. Curr. Biol. 14: 2217-2227 (2004). *
Abboud N, Amin H, Ghazouani L, Khalifa SB, Khalafallah AB, Aded F, Almawi WY, Mahjoub T. Polymorphisms of human platelet alloantigens HPA-1 and HPA-2 associated with severe coronary artery disease. Cardiovasc. Pathol. Jun 8 [Epub ahead of print] (2009).
Abdallah A, Sato H, Grutters JC, Veeraraghavan S, Lympany PA, Ruven HJ, van den Bosch JM, Wells AU, du Bois RM, Welsh KI. Inhibitor kappa B-alpha (IkappaB-alpha) promoter polymorphisms in UK and Dutch sarcoidosis. Genes Immun. 4: 450-454 (2003). *
Abdallah AM, Renzoni EA, Anevlavis S, Lagan AL, Munkonge FM, Fonseca C, Black CM, Briggs D, Wells AU, Marshall SE, McHugh N, du Bois RM, Welsh KI. A polymorphism in the promoter region of the CD86 (B7.2) gene is associated with systemic sclerosis. Int. J. Immunogenet. 33: 155-161 (2006). *
Abdelmalik N, Ruhe HG, Barwari K, van den Dool EJ, Meijers JC, Middeldorp S, Buller HR, Schene AH, Kamphuisen PW. Effect of the selective serotonin reuptake inhibitor paroxetine on platelet function is modified by a SLC6A4 serotonin transporter polymorphism. J. Thromb. Haemost. 6: 2168-2174 (2008).
Abdgawad M, Hellmark T, Gunnarsson L, Westman KW, Segelmark M. Increased neutrophil membrane expression and plasma level of proteinase 3 in systemic vasculitis are not a consequence of the - 564 A/G promotor polymorphism. Clin. Exp. Immunol. 145: 63-70 (2006). *
Abe K, Klaften M, Narita A, Kimura T, Imai K, Kimura M, Rubio-Aliaga I, Wagner S, Jakob T, Hrabe de Angelis M. Genome-wide search for genes that modulate inflammatory arthritis caused by Ali18 mutation in mice. Mamm. Genome 20: 152-161 (2009).
Abe T, Iinuma Y, Ando M, Yokoyama T, Yamamoto T, Nakashima K, Takagi N, Baba H, Hasegawa Y, Shimokata K. NRAMP1 polymorphisms, susceptibility and clinical features of tuberculosis. J. Infect. 46: 215-220 (2003).
Abe T, Takino H, Yamasaki H, Ozaki M, Sera Y, Kondo H, Sakamaki H, Kawasaki E, Awata T, Yamaguchi Y, Eguchi K. CTLA4 gene polymorphism correlates with the mode of onset and presence of ICA512 Ab in Japanese type 1 diabetes. Diabetes Res. Clin. Pract. 46: 169-175 (1999).
Abel M, Cellier C, Kumar N, Cerf-Bensussan N, Schmitz J, Caillat-Zucman S. Adulthood-onset celiac disease is associated with intercellular adhesion molecule-1 (ICAM-1) gene polymorphism. Hum. Immunol. 67: 612-617 (2006).
Abelson AK, Johansson CM, Kozyrev SV, Kristjansdottir H, Gunnarsson I, Svenungsson E, Jonsen A, Lima G, Scherbarth HR, Gamron S, Allievi A, Palatnik SA, Alvarellos A, Paira S, Graf C, Guilleron C, Catoggio LJ, Prigione C, Battagliotti CG, et al. No evidence of association between genetic variants of the PDCD1 ligands and SLE. Genes Immun. 8: 69-74 (2007). *
Aberle J, Fedderwitz I, Klages N, George E, Beil FU. Genetic variation in two proteins of the endocannabinoid system and their influence on body mass index and metabolism under low fat diet. Horm. Metab. Res. 39: 395-397 (2007).
Aberle J, Flitsch J, Beck NA, Mann O, Busch P, Peitsmeier P, Beil FU. Genetic variation may influence obesity only under conditions of diet: analysis of three candidate genes. Mol. Genet. Metab. 95: 188-191 (2008). *
Aberle J, Hopfer I, Beil FU, Seedorf U. Association of peroxisome proliferator-activated receptor delta +294T/C with body mass index and interaction with peroxisome proliferator-activated receptor alpha L162V. Int. J. Obes. (Lond.) 30: 1709-1713 (2006).
Abifadel M, Rabes JP, Jambart S, Halaby G, Gannage-Yared MH, Sarkis A, Beaino G, Varret M, Salem N, Corbani S, Aydenian H, Junien C, Munnich A, Boileau C. The molecular basis of familial hypercholesterolemia in Lebanon: spectrum of LDLR mutations and role of PCSK9 as a modifier gene. Hum. Mutat. Mar 24 [Epub ahead of print] (2009). *
Abiru N, Kawasaki E, Eguch K. Current knowledge of Japanese type 1 diabetic syndrome. Diabetes Metab. Res. Rev. 18: 357-366 (2002). *
Ablin JN, Cohen H, Buskila D. Mechanisms of disease: genetics of fibromyalgia. Nat. Clin. Pract. Rheumatol. 2: 671-678 (2006). *
Abraham C, Cho JH. Functional consequences of NOD2 (CARD15) mutations. Inflamm. Bowel Dis. 12: 641-650 (2006). *
Abraham C, Cho JH. IL-23 and autoimmunity: new insights into the pathogenesis of inflammatory bowel disease. Annu. Rev. Med. 60: 97-110 (2009). *
Abraham E. Alterations in cell signaling in sepsis. Clin. Infect. Dis. 41 Suppl. 7: S459-S464 (2005). *
Abraham J, Earl HM, Pharoah PD, Caldas C. Pharmacogenetics of cancer chemotherapy. Biochim. Biophys. Acta 1766: 168-183 (2006). *
Abraham LJ, Kroeger KM. Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J. Leukoc. Biol. 66: 562-566 (1999). *
Abrahamian H, Endler G, Exner M, Mauler H, Raith M, Endler L, Rumpold H, Gerdov M, Mannhalter C, Prager R, Irsigler K, Wagner OF. Association of low-grade inflammation with nephropathy in type 2 diabetic patients: role of elevated CRP-levels and 2 different gene-polymorphisms of proinflammatory cytokines. Exp. Clin. Endocrinol. Diabetes 115: 38-41 (2007).
Abrahamsson A, Gafvels M, Reihner E, Bjorkhem I, Einarsson C, Eggertsen G. Polymorphism in the coding part of the sterol 12alpha-hydroxylase gene does not explain the marked differences in the ratio of cholic acid and chenodeoxycholic acid in human bile. Scand. J. Clin. Lab. Invest. 65: 595-600 (2005). *
Abrahamsson A, Krapivner S, Gustafsson U, Muhrbeck O, Eggertsen G, Johansson I, Persson I, Angelin B, Ingelman-Sundberg M, Bjorkhem I, Einarsson C, Hooft FM. Common polymorphisms in the CYP7A1 gene do not contribute to variation in rates of bile acid synthesis and plasma LDL cholesterol concentration. Atherosclerosis 182: 37-45 (2005).
Abreu MT. The pathogenesis of inflammatory bowel disease: translational implications for clinicians. Curr. Gastroenterol. Rep. 4: 481-489 (2002).
Abreu MT, Arditi M. Innate immunity and Toll-like receptors: clinical implications of basic science research. J. Pediatr. 144: 421-429 (2004). *
Abreu MT, Fukata M, Arditi M. TLR signaling in the gut in health and disease. J. Immunol. 174: 4453-4460 (2005). *
Acevedo F, Hammar H. Complement C3 proteins in psoriasis. Br. J. Dermatol. 121: 329-335 (1989).
Achyut BR, Ghoshal UC, Moorchung N, Mittal B. Association of Toll-like receptor-4 (Asp299Gly and Thr399Ileu) gene polymorphisms with gastritis and precancerous lesions. Hum. Immunol. 68: 901-907 (2007).
Achyut BR, Tripathi P, Ghoshal UC, Moorchung N, Mittal B. Interleukin-10 (-819 C/T) and tumor necrosis factor-alpha (-308 G/A) gene variants influence gastritis and lymphoid follicle development. Dig. Dis. Sci. 53: 622-629 (2008). *
Acioli-Santos B, Segat L, Dhalia R, Brito CA, Braga-Neto UM, Marques ET, Crovella S. MBL2 gene polymorphisms protect against development of thrombocytopenia associated with severe dengue phenotype. Hum. Immunol. 69: 122-128 (2008).
Ackerman HC, Ribas G, Jallow M, Mott R, Neville M, Sisay-Joof F, Pinder M, Campbell RD, Kwiatkowski DP. Complex haplotypic structure of the central MHC region flanking TNF in a West African population. Genes Immun. 4: 476-486 (2003). *
Ackert-Bicknell C, Rosen C. The genetics of PPARG and the skeleton. PPAR Res. 2006: 93258 (2006). *
Actis GC, Pellicano R, Rizzetto M, Ayoubi M, Leone N, Tappero G, Pazienza P, Rosina F. Individually administered or co-prescribed thiopurines and mesalamines for inflammatory bowel disease. World J. Gastroenterol. 15: 1420-1426 (2009). *
Adam B, Liebregts T, Holtmann G. Mechanisms of disease: genetics of functional gastrointestinal disorders - searching the genes that matter. Nat. Clin. Pract. Gastroenterol. Hepatol. 4: 102-110 (2007). *
Adam R, Sturrock RD, Gracie JA. TLR4 mutations (Asp299Gly and Thr399Ile) are not associated with ankylosing spondylitis. Ann. Rheum. Dis. 65: 1099-1101 (2006). *
Adamo KB, Dent R, Langefeld CD, Cox M, Williams K, Carrick KM, Stuart JS, Sundseth SS, Harper ME, McPherson R, Tesson F. Peroxisome proliferator-activated receptor gamma 2 and acyl-CoA synthetase 5 polymorphisms influence diet response. Obesity (Silver Spring) 15: 1068-1075 (2007). *
Adamovic S, Amundsen SS, Lie BA, Gudjonsdottir AH, Ascher H, Ek J, van Heel DA, Nilsson S, Sollid LM, Torinsson Naluai A. Association study of IL2/IL21 and FcgRIIa: significant association with the IL2/IL21 region in Scandinavian coeliac disease families. Genes Immun. 9: 364-367 (2008). *
Adamovic S, Amundsen SS, Lie BA, Hellqvist A, Gudjonsdottir AH, Ek J, Nilsson S, Wahlstrom J, Ascher H, Sollid LM, Naluai AT. Fine mapping study in Scandinavian families suggests association between coeliac disease and haplotypes in chromosome region 5q32. Tissue Antigens 71: 27-34 (2008). *
Adams M, Lucock M, Stuart J, Fardell S, Baker K, Ng X. Preliminary evidence for involvement of the folate gene polymorphism 19bp deletion-DHFR in occurrence of autism. Neurosci. Lett. 422: 24-29 (2007).
Adamson KA, Cheetham TD, Kendall-Taylor P, Seckl JR, Pearce SH. The role of the IDDM2 locus in the susceptibility of UK APS1 subjects to type 1 diabetes mellitus. Int. J. Immunogenet. 34: 17-21 (2007). *
Adamzik M, Frey UH, Bitzer K, Jakob H, Baba HA, Schmieder RE, Schneider MP, Heusch G, Peters J, Siffert W. A novel-1364A/C aquaporin 5 gene promoter polymorphism influences the responses to salt loading of the renin-angiotensin-aldosterone system and of blood pressure in young healthy men. Basic Res. Cardiol. 103: 598-610 (2008).
Adamzik M, Frey UH, Rieman K, Sixt S, Beiderlinden M, Siffert W, Peters J. Insertion/deletion polymorphism in the promoter of NFKB1 influences severity but not mortality of acute respiratory distress syndrome. Intensive Care Med. 33: 1199-1203 (2007).
Adcock K, Hedberg C, Loggins J, Kruger TE, Baier RJ. The TNF-alpha -308, MCP-1 -2518 and TGF-beta1 +915 polymorphisms are not associated with the development of chronic lung disease in very low birth weight infants. Genes Immun. 4: 420-426 (2003). *
Addo A, Le J, Li W, Aksentijevich I, Balow J Jr, Lee A, Gregersen PK, Kastner DL, Remmers EF. Analysis of CARD15/NOD2 haplotypes fails to identify common variants associated with rheumatoid arthritis susceptibility. Scand. J. Rheumatol. 34: 198-203 (2005). *
Adinolfi LE, Ingrosso D, Cesaro G, Cimmino A, D'Anto M, Capasso R, Zappia V, Ruggiero G. Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients. Hepatology 41: 995-1003 (2005). *
Adjers K, Karjalainen J, Pessi T, Eklund C, Hurme M. Epistatic effect of TLR4 and IL4 genes on the risk of asthma in females. Int. Arch. Allergy Immunol. 138: 251-256 (2005).
Adorini L. Vitamin D receptor polymorphisms in primary biliary cirrhosis: a functional connection? J. Hepatol. 50: 1071-1073 (2009).
Afzal S, Jensen SA, Vainer B, Vogel U, Matsen JP, Sorensen JB, Andersen PK, Poulsen HE. MTHFR polymorphisms and 5-FU-based adjuvant chemotherapy in colorectal cancer. Ann. Oncol. May 22 [Epub ahead of print] (2009).
Agalliu I, Suuriniemi M, Prokunina-Olsson L, Johanneson B, Collins FS, Stanford JL, Ostrander EA. Evaluation of a variant in the transcription factor 7-like 2 (TCF7L2) gene and prostate cancer risk in a population-based study. Prostate 68: 740-747 (2008).
Agarwal K, Czaja AJ, Donaldson PT. A functional Fas promoter polymorphism is associated with a severe phenotype in type 1 autoimmune hepatitis characterized by early development of cirrhosis. Tissue Antigens 69: 227-235 (2007). *
Agarwal K, Czaja AJ, Jones DE, Donaldson PT. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis. Hepatology 31: 49-53 (2000). *
Agarwal K, Jones DE, Daly AK, James OF, Vaidya B, Pearce S, Bassendine MF. CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis. J. Hepatol. 32: 538-541 (2000). *
Agnese DM, Calvano JE, Hahm SJ, Coyle SM, Corbett SA, Calvano SE, Lowry SF. Human Toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J. Infect. Dis. 186: 1522-1525 (2002). *
Agrawal AA, Kapley A, Yeltiwar RK, Purohit HJ. Assessment of single nucleotide polymorphism at IL-1A+4845 and IL-1B+3954 as genetic susceptibility test for chronic periodontitis in Maharashtrian ethnicity. J. Periodontol. 77: 1515-1521 (2006).
Agrawal C, Raghav SK, Gupta B, Das RH, Chaturvedi VP, Goswami K, Das HR. Tumor necrosis factor-alpha microsatellite polymorphism association with rheumatoid arthritis in Indian patients. Arch. Med. Res. 36: 555-559 (2005).
Agrawal S, Dimitrova N, Prasthani N, Udayakumar K, Sailakshmi S, Sriram S, Manjusha N, Sengupta U. T2D-Db: an integrated platform to study the molecular basis of type 2 diabetes. BMC Genomics 9: 320 (2008). *
Agrawal S, Khan F, Bharadwaj U. Human genetic variation studies and HLA class II loci. Int. J. Immunogenet. 34: 247-252 (2007). *
Agrawal S, Srivastava R, Sharma B, Pandya S, Misra R, Aggarwal A. IL1RN*2 allele of IL-1receptor antagonist VNTR polymorphism is associated with susceptibility to anklyosing spondylitis in Indian patients. Clin. Rheumatol. 27: 573-576 (2008). *
Agrawal SK, Kumar P, Rathi R, Sharma N, Das R, Prasad R, Narang A. UGT1A1 gene polymorphisms in North Indian neonates presenting with unconjugated hyperbilirubinemia. Pediatr. Res. 65: 675-680 (2009).
Aguilar F, Gonzalez-Escribano MF, Sanchez-Roman J, Nunez-Roldan A. MCP-1 promoter polymorphism in Spanish patients with systemic lupus erythematosus. Tissue Antigens 58: 335-338 (2001). *
Aguilar F, Nunez-Roldan A, Torres B, Wichmann I, Sanchez-Roman J, Gonzalez-Escribano MF. Chemokine receptor CCR2/CCR5 polymorphism in Spanish patients with systemic lupus erythematosus. J. Rheumatol. 30: 1770-1774 (2003).
Aguilar F, Torres B, Sanchez-Roman J, Nunez-Roldan A, Gonzalez-Escribano MF. CTLA4 polymorphism in Spanish patients with systemic lupus erythematosus. Hum. Immunol. 64: 936-940 (2003).
Aguilar-Martinez P, Bismuth M, Picot MC, Thelcide C, Pageaux GP, Blanc F, Blanc P, Schved JF, Larrey D. Variable phenotypic presentation of iron overload in H63D homozygotes: are genetic modifiers the cause? Gut 48: 836-842 (2001). *
Aguillon JC, Cruzat A, Aravena O, Salazar L, Llanos C, Cuchacovich M. Could single-nucleotide polymorphisms (SNPs) affecting the tumour necrosis factor promoter be considered as part of rheumatoid arthritis evolution? Immunobiology 211: 75-84 (2006).
Aguillon JC, Cruzat A, Cuenca J, Cuchacovich M. Tumor necrosis factor alpha genetic polymorphism as a risk factor in disease. Rev. Med. Chil. 130: 1043-1050 (2002).
Agundez JA. Polymorphisms of human N-acetyltransferases and cancer risk. Curr. Drug Metab. 9: 520-531 (2008).
Agundez JA, Martinez C, Garcia-Martin E, Ladero JM. Cytochrome P450 CYP2C9 polymorphism and NSAID-related acute gastrointestinal bleeding. Gastroenterology 133: 2071-2072 (2007). *
Ahadi AM, Sadeghizadeh M, Houshmand M, Gharagoozli K, Banoei MM, Panahai MS. An A8296G mutation in the MT-TK gene of a patient with epilepsy - a disease-causing mutation or rare polymorphism? Neurol. Neurochir. Pol. 42: 263-266 (2008).
Ahern PP, Izcue A, Maloy KJ, Powrie F. The interleukin-23 axis in intestinal inflammation. Immunol. Rev. 226: 147-159 (2008). *
Ahluwalia M, Gotlieb V, Damerla V, Saif MW. Aggressive Burkitt-like lymphoma of colon in a patient with prior celiac disease. Yale J. Biol. Med. 79: 173-175 (2006). *
Ahluwalia TS, Ahuja M, Rai TS, Kohli HS, Bhansali A, Sud K, Khullar M. ACE variants interact with the RAS pathway to confer risk and protection against type 2 diabetic nephropathy. DNA Cell Biol. 28: 141-150 (2009).
Ahluwalia TS, Ahuja M, Rai TS, Kohli HS, Sud K, Bhansali A, Khullar M. Endothelial nitric oxide synthase gene haplotypes and diabetic nephropathy among Asian Indians. Mol. Cell. Biochem. 314: 9-17 (2008). *
Ahmad F, Kannan M, Biswas A, Saxena R. Impact of 789Ala/Ala genotype on quantitative type of von Willebrand disease. Ann. Hematol. 88: 479-483 (2009). *
Ahmad T, Armuzzi A, Bunce M, Mulcahy-Hawes K, Marshall SE, Orchard TR, Crawshaw J, Large O, de Silva A, Cook JT, Barnardo M, Cullen S, Welsh KI, Jewell DP. The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology 122: 854-866 (2002). *
Ahmad T, Armuzzi A, Neville M, Bunce M, Ling KL, Welsh KI, Marshall SE, Jewell DP. The contribution of human leucocyte antigen complex genes to disease phenotype in ulcerative colitis. Tissue Antigens 62: 527-535 (2003). *
Ahmad T, Marshall SE, Jewell D. Genetics of inflammatory bowel disease: the role of the HLA complex. World J. Gastroenterol. 12: 3628-3635 (2006). *
Ahmad T, Marshall SE, Mulcahy-Hawes K, Orchard T, Crawshaw J, Armuzzi A, Neville M, van Heel D, Barnardo M, Welsh KI, Jewell DP, Bunce M. High resolution MIC genotyping: design and application to the investigation of inflammatory bowel disease susceptibility. Tissue Antigens 60: 164-179 (2002). *
Ahmad T, Wallace GR, James T, Neville M, Bunce M, Mulcahy-Hawes K, Armuzzi A, Crawshaw J, Fortune F, Walton R, Stanford MR, Welsh KI, Marshall SE, Jewell DP. Mapping the HLA association in Behcet's disease: a role for tumor necrosis factor polymorphisms? Arthritis Rheum. 48: 807-813 (2003). *
Ahmad T, Zhang L, Gogus F, Verity D, Wallace G, Madanat W, Fayyad F, James T, Neville M, Kanawati C, Fortune F, Celik A, Stanford M, Jewell DP, Marshall SE. CARD15 polymorphisms in Behcet's disease. Scand. J. Rheumatol. 34: 233-237 (2005).
Ahmad-Nejad P, Mrabet-Dahbi S, Breuer K, Klotz M, Werfel T, Herz U, Heeg K, Neumaier M, Renz H. The Toll-like receptor 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype. J. Allergy Clin. Immunol. 113: 565-567 (2004). *
Ahmed FE. Gene-gene, gene-environment and multiple interactions in colorectal cancer. J. Environ. Sci. Health C. Environ. Carcinog. Ecotoxicol. Rev. 24: 1-101 (2006). *
Ahmed FE. Molecular markers that predict response to colon cancer therapy. Expert Rev. Mol. Diagn. 5: 353-375 (2005).
Ahmed N, Majeed AA, Ahmed I, Hussain MA, Alvi A, Devi SM, Rizwan M, Ranjan A, Sechi LA, Megraud F. genoBASE pylori: a genotype search tool and database of the human gastric pathogen Helicobacter pylori. Infect. Genet. Evol. 7: 463-468 (2007).
Ahmed S, Ihara K, Bassuny WM, Kuromaru R, Kohno H, Miyako K, Matsuura N, Iwata I, Nagafuchi S, Hara T. Association study between CD30 and CD30 ligand genes and type 1 diabetes in the Japanese population. Genes Immun. 3: 96-101 (2002). *
Ahmed S, Ihara K, Kanemitsu S, Nakashima H, Otsuka T, Tsuzaka K, Takeuchi T, Hara T. Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population. Rheumatology (Oxford) 40: 662-667 (2001). *
Ahmed SS, Tan FK. Identification of novel targets in scleroderma: update on population studies, cDNA arrays, SNP analysis, and mutations. Curr. Opin. Rheumatol. 15: 766-771 (2003).
Ahmetov II, Mozhayskaya IA, Flavell DM, Astratenkova IV, Komkova AI, Lyubaeva EV, Tarakin PP, Shenkman BS, Vdovina AB, Netreba AI, Popov DV, Vinogradova OL, Montgomery HE, Rogozkin VA. PPARalpha gene variation and physical performance in Russian athletes. Eur. J. Appl. Physiol. 97: 103-108 (2006).
Ahmetov II, Mozhayskaya IA, Lyubaeva EV, Vinogradova OL, Rogozkin VA. PPARG gene polymorphism and locomotor activity in humans. Bull. Exp. Biol. Med. 146: 630-632 (2008).
Ahn J, Gammon MD, Santella RM, Gaudet MM, Britton JA, Teitelbaum SL, Terry MB, Neugut AI, Eng SM, Zhang Y, Garza C, Ambrosone CB. Effects of glutathione S-transferase A1 (GSTA1) genotype and potential modifiers on breast cancer risk. Carcinogenesis 27: 1876-1882 (2006). *
Ahn SH, Kim DY, Chang HY, Hong SP, Shin JS, Kim YS, Kim H, Kim JK, Paik YH, Lee KS, Chon CY, Moon YM, Han KH. Association of genetic variations in CCR5 and its ligand, RANTES with clearance of hepatitis B virus in Korea. J. Med. Virol. 78: 1564-1571 (2006). *
Ahram M, El-Omar A, Baho Y, Lubad MA. Association between human herpesvirus 6 and occurrence of multiple sclerosis among Jordanian patients. Acta Neurol. Scand. Jun 10 [Epub ahead of print] (2009).
Ahuja V, Powers-Lee SG. Human carbamoyl-phosphate synthetase: insight into N-acetylglutamate interaction and the functional effects of a common single nucleotide polymorphism. J. Inherit. Metab. Dis. 31: 481-491 (2008). *
Aird RE, Thomson M, Macpherson JS, Thurston DE, Jodrell DI, Guichard SM. ABCB1 genetic polymorphism influences the pharmacology of the new pyrrolobenzodiazepine derivative SJG-136. Pharmacogenomics J. 8: 289-296 (2008).
Aisenberg J, Legnani PE, Nilubol N, Cobrin GM, Ellozy SH, Hegazi RAF, Yager J, Bodian C, Gorfine SR, Bauer JJ, Plevy SE, Sachar DB. Are pANCA, ASCA, or cytokine gene polymorphisms associated with pouchitis? Long-term follow-up in 102 ulcerative colitis patients. Am. J. Gastroenterol. 99: 432-441 (2004). *
Aithal GP. Dangerous liaisons: drug, host and the environment. J. Hepatol. 46: 995-998 (2007). *
Aithal GP, Craggs A, Day CP, Welfare M, Daly AK, Mansfield JC, Hudson M. Role of polymorphisms in the interleukin-10 gene in determining disease susceptibility and phenotype in inflamatory bowel disease. Dig. Dis. Sci. 46: 1520-1525 (2001). *
Aithal GP, Day CP, Leathart J, Daly AK, Hudson M. Association of single nucleotide polymorphisms in the interleukin-4 gene and interleukin-4 receptor gene with Crohn's disease in a British population. Genes Immun. 2: 44-47 (2001). *
Aithal GP, Ramsay L, Daly AK, Sonchit N, Leathart JBS, Alexander G, Kenna JG, Caldwell J, Day CP. Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity. Hepatology 39: 1430-1440 (2004). *
Aitman TJ, Dong R, Vyse TJ, Norsworthy PJ, Johnson MD, Smith J, Mangion J, Roberton-Lowe C, Marshall AJ, Petretto E, Hodges MD, Bhangal G, Patel SG, Sheehan-Rooney K, Duda M, Cook PR, Evans DJ, Domin J, Flint J, Boyle JJ, Pusey CD, Cook HT. Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature 439: 851-855 (2006). *
Aittoniemi J, Pertovaara M, Hulkkonen J, Pasternack A, Hurme M, Laippala P, Antonen J. The significance of mannan-binding lectin gene alleles in patients with primary Sjogren's syndrome. Scand. J. Rheumatol. 31: 362-365 (2002). *
Aittoniemi J, Soranummi H, Rovio AT, Hurme M, Pessi T, Nieminen M, Karjalainen J. Mannose-binding lectin 2 (MBL2) gene polymorphism in asthma and atopy among adults. Clin. Exp. Immunol. 142: 120-124 (2005). *
Aittoniemi J, Turpeinen H, Tiittanen M, Knip M, Simell O, Ilonen J, Vaarala O. Relation among mannose-binding lectin 2 genotype, beta-cell autoantibodies, and risk for type 1 diabetes in Finnish children. Hum. Immunol. 69: 108-111 (2008).
Aizawa Y, Sutoh S, Matsuoka M, Negishi M, Torii A, Miyakawa Y, Sugisaka H, Nakamura M, Toda G. Association of interleukin-18 gene single-nucleotide polymorphisms with susceptibility to inflammatory bowel disease. Tissue Antigens 65: 88-92 (2005). *
Ajiro J, Narita I, Sato F, Saga D, Hasegawa H, Kuroda T, Nakano M, Gejyo F. SAA1 gene polymorphisms and the risk of AA amyloidosis in Japanese patients with rheumatoid arthritis. Mod. Rheumatol. 16: 294-299 (2006). *
Ak DG, Kahraman H, Dursun E, Duman BS, Erensoy N, Alagol F, Tanakol R, Yilmazer S. Polymorphisms at the ligand binding site of the vitamin D receptor gene and osteomalacia. Dis. Markers 21: 191-197 (2005).
Akahoshi M, Ishihara M, Remus N, Uno K, Miyake K, Hirota T, Nakashima K, Matsuda A, Kanda M, Enomoto T, Ohno S, Nakashima H, Casanova JL, Hopkin JM, Tamari M, Mao XQ, Shirakawa T. Association between IFNA genotype and the risk of sarcoidosis. Hum. Genet. 114: 503-509 (2004). *
Akar A, Orkunoglu FE, Ozata M, Sengul A, Gur AR. Lack of association between vitamin D receptor FokI polymorphism and alopecia areata. Eur. J. Dermatol. 14: 156-158 (2004). *
Akar A, Orkunoglu FE, Tunca M, Tastan HB, Kurumlu Z. Vitamin D receptor gene polymorphisms are not associated with alopecia areata. Int. J. Dermatol. 46: 927-929 (2007). *
Akar N, Hasipek M, Ozturk A, Akar E, Tekin M. Serum amyloid A1 -13 T/C alleles in Turkish familial Mediterranean fever patients with and without amyloidosis. J. Nephrol. 19: 318-321 (2006).
Akar N, Koc Y. Single nucleotide polymorphisms that affect homocysteine levels in Turkish population. Clin. Appl. Thromb. Hemost. Sep 15 [Epub ahead of print] (2008).
Akar N, Ozturk A, Ozel D, Akar E, Ekim M. Is MEFV P706 polymorphism important in familial Mediterranean fever patients? J. Nephrol. 19: 119-120 (2006).
Akashi-Takamura S, Miyake K. Toll-like receptors (TLRs) and immune disorders. J. Infect. Chemother. 12: 233-240 (2006). *
Akatsuka Y, Morishima Y, Kuzushima K, Kodera Y, Takahashi T. Minor histocompatibility antigens as targets for immunotherapy using allogeneic immune reactions. Cancer Sci. 98: 1139-1146 (2007). *
Akbas SH, Bilgen T, Keser I, Tuncer M, Yucetin L, Tosun O, Gultekin M, Luleci G. The effect of MDR1 (ABCB1) polymorphism on the pharmacokinetic of tacrolimus in Turkish renal transplant recipients. Transplant. Proc. 38: 1290-1292 (2006). *
Akcali C, Ozkur M, Erbagci Z, Benlier N, Aynacioglu AS. Association of insertion/deletion polymorphism of the angiotensin-converting enzyme gene with angio-oedema accompanying chronic urticaria but not chronic urticaria without angio-oedema or the autologous serum skin test response. J. Eur. Acad. Dermatol. Venereol. 22: 83-86 (2008). *
Akcay A, Ozdemir FN, Sezer S, Micozkadioglu H, Arat Z, Atac FB, Verdi H, Sahin F, Haberal M. Association of vitamin D receptor gene polymorphisms with hypercalcemia in peritoneal dialysis patients. Perit. Dial. Int. 25 Suppl. 3: S52-S55 (2005).
Aker S, Bantis C, Reis P, Kuhr N, Schwandt C, Grabensee B, Heering P, Ivens K. Influence of interleukin-6 G-174C gene polymorphism on coronary artery disease, cardiovascular complications and mortality in dialysis patients. Nephrol. Dial. Transplant. Apr 6 [Epub ahead of print] (2009).
Akesson LS, Duffy DL, Phelps SC, Thompson PJ, Kedda MA. A polymorphism in the promoter region of the human interleukin-16 gene is not associated with asthma or atopy in an Australian population. Clin. Exp. Allergy 35: 327-331 (2005). *
Akhtar S, Gavalas NG, Gawkrodger DJ, Watson PF, Weetman AP, Kemp EH. An insertion/deletion polymorphism in the gene encoding angiotensin converting enzyme is not associated with generalised vitiligo in an English population. Arch. Dermatol. Res. 297: 94-98 (2005). *
Akkad DA, Arning L, Ibrahim SM, Epplen JT. Sex specifically associated promoter polymorphism in multiple sclerosis affects interleukin 4 expression levels. Genes Immun. 8: 703-706 (2007). *
Akkad DA, Godde R, Epplen JT. No association between synapsin III gene promoter polymorphisms and multiple sclerosis in German patients. J. Neurol. 253: 1365-1366 (2006). *
Akkad DA, Jagiello P, Szyld P, Goedde R, Wieczorek S, Gross WL, Epplen JT. Promoter polymorphism rs3087456 in the MHC class II transactivator gene is not associated with susceptibility for selected autoimmune diseases in German patient groups. Int. J. Immunogenet. 33: 59-61 (2006). *
Akkad DA, Kruse N, Arning L, Gold R, Epplen JT. Genomic NGFB variation and multiple sclerosis in a case control study. BMC Med. Genet. 9: 107 (2008). *
Akkiprik M, Celikel CA, Dusunceli F, Sonmez O, Gulluoglu BM, Sav A, Ozer A. Relationship between overexpression of ras p21 oncoprotein and K-ras codon 12 and 13 mutations in Turkish colorectal cancer patients. Turk. J. Gastroenterol. 19: 22-27 (2008). *
Akkiz H. Hepatocellular carcinoma pathogenesis: does PPAR alpha polymorphism have a role in hepatocarcinogenesis associated with HBV and HCV infections? Turk. J. Gastroenterol. 19: 231-233 (2008). *
Akman A, Sallakci N, Coskun M, Bacanli A, Yavuzer U, Alpsoy E, Yegin O. TNF-alpha gene 1031 T/C polymorphism in Turkish patients with Behcet's disease. Br. J. Dermatol. 155: 350-356 (2006). *
Akman A, Sallakci N, Kacaroglu H, Tosun O, Yavuzer U, Alpsoy E, Yegin O. Relationship between periodontal findings and the TNF-alpha gene 1031T/C polymorphism in Turkish patients with Behcet's disease. J. Eur. Acad. Dermatol. Venereol. 22: 950-957 (2008). *
Akoglu B, Kindl P, Weber N, Trojan J, Caspary WF, Faust D. Polymorphisms in the methylenetetrahydrofolate reductase gene are determinant for vascular complications after liver transplantation. Eur. J. Clin. Nutr. 62: 430-435 (2008). *
Akomolafe A, Lunetta K, Erlich P, Cupples L, Baldwin C, Huyck M, Green R, Farrer L; MIRAGE Study Group. Genetic association between endothelial nitric oxide synthase and Alzheimer disease. Clin. Genet. 70: 49-56 (2006). *
Aksentijevich I, Galon J, Soares M, Mansfield E, Hull K, Oh HH, Goldbach-Mansky R, Dean J, Athreya B, Reginato AJ, Henrickson M, Pons-Estel B, O'Shea JJ, Kastner DL. The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. Am. J. Hum. Genet. 69: 301-314 (2001). *
al Sharif F, Ollier WE, Hajeer AH. A rare polymorphism at position -28 in the human RANTES promoter. Eur. J. Immunogenet. 26: 373-374 (1999). *
Al Taji E, Biebermann H, Limanova Z, Hnikova O, Zikmund J, Dame C, Gruters A, Lebl J, Krude H. Screening for mutations in transcription factors in a Czech cohort of 170 patients with congenital and early-onset hypothyroidism: identification of a novel PAX8 mutation in dominantly inherited early-onset non-autoimmune hypothyroidism. Eur. J. Endocrinol. 156: 521-529 (2007). *
Al-Abdulhadi SA, Al-Rabia MW. Association and preferential transmission of the CCR2V64I polymorphism with absence of asthma in high-risk families. Saudi Med. J. 29: 1711-1718 (2008).
Al-Abdulhadi SA, Helms PJ, Main M, Smith O, Christie G. Preferential transmission and association of the -403 G --> A promoter RANTES polymorphism with atopic asthma. Genes Immun. 6: 24-30 (2005). *
Al-Ali AK, Al-Muhana FA, Larbi EB, Abdulmohsen MF, Al-Sultan AI, Al-Maden MS, Al-Ateeq SA. Frequency of methylenetetrahydrofolate reductase C677T polymorphism in patients with cardiovascular disease in Eastern Saudi Arabia. Saudi Med. J. 26: 1886-1888 (2005).
Al-Ansari AS, Ollier WE, Villarreal J, Ordi J, Teh LS, Hajeer AH. Tumor necrosis factor receptor II (TNFRII) exon 6 polymorphism in systemic lupus erythematosus. Tissue Antigens 55: 97-99 (2000). *
Al-Awadhi AM, Haider MZ, Sharma PN, Hasan EA, Botaiban F, Al-Herz A, Nahar I, Al-Enezi H, Al-Saeid K. Angiotensin-converting enzyme gene polymorphism in Kuwaiti patients with systemic lupus erythematosus. Clin. Exp. Rheumatol. 25: 437-442 (2007).
Al-Awadhi AM, Hasan EA, Sharma PN, Haider MZ, Al-Saeid K. Angiotensin-converting enzyme gene polymorphism in patients with psoriatic arthritis. Rheumatol. Int. 27: 1119-1123 (2007). *
Al-Heresh AM, Proctor J, Jones SM, Dixey J, Cox B, Welsh K, McHugh N. Tumour necrosis factor-alpha polymorphism and the HLA-Cw*0602 allele in psoriatic arthritis. Rheumatology (Oxford) 41: 525-530 (2002). *
Al-Kateb H, Mirea L, Xie X, Sun L, Liu M, Chen H, Bull SB, Boright AP, Paterson AD. Multiple variants in vascular endothelial growth factor (VEGF) are risk factors for time to severe retinopathy in type 1 diabetes: the DCCT/EDIC genetics study. Diabetes 56: 2161-2168 (2007). *
Al-Moundhri MS, Al-Nabhani M, Al-Bahrani B, Burney IA, Al-Madhani A, Ganguly SS, Al-Yahyaee SA, Grant CS. Interleukin-1beta gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms and gastric cancer risk in an Omani Arab population. Gastric Cancer 9: 284-290 (2006). *
Al-Muhanna F, Al-Mueilo S, Al-Ali A, Larbi E, Rubaish A, Abdulmohsen MF, Al-Zahrani A, Al-Ateeq S. Polymorphism in methylenetetrahydrofolate reductase, plasminogen activator inhibitor-1, and apolipoprotein E in hemodialysis patients. Saudi J. Kidney Dis. Transpl. 19: 937-941 (2008).
Al-Oanzi ZH, Tuck SP, Mastana SS, Summers GD, Cook DB, Francis RM, Datta HK. Vitamin D-binding protein gene microsatellite polymorphism influences BMD and risk of fractures in men. Osteoporos. Int. 19: 951-960 (2008). *
Al-Tahan J, Sola R, Ruiz JR, Breidenassel C, Garc�a-Fuentes M, Moreno LA, Castillo M, Pietrzik K, Gonzalez-Gross M. Methylenetetrahydrofolate reductase 677CT polymorphism and cobalamin, folate, and homocysteine status in Spanish adolescents. Ann. Nutr. Metab. 52: 315-321 (2008).
Al-Tonbary Y, Abdel-Razek N, Zaghloul H, Metwaly S, El-Deek B, El-Shawaf R. HLA class II polymorphism in Egyptian children with lymphomas. Hematology 9: 139-145 (2004).
Aladzsity I, Kovacs M, Semsei A, Falus A, Szilagyi A, Karadi I, Varga G, Fust G, Varkonyi J. Comparative analysis of IL6 promoter and receptor polymorphisms in myelodysplasia and multiple myeloma. Leuk. Res. Apr 28 [Epub ahead of print] (2009).
Alaez C, Vazquez-Garcia MN, Gorodezky C. DQA1 and DQB1 promoter diversity and linkage disequilibrium with class II haplotypes in Mexican Mestizo population. Genes Immun. 2: 216-221 (2001). *
Alagarasu K, Selvaraj P, Swaminathan S, Narendran G, Narayanan PR. 5' Regulatory and 3' untranslated region polymorphisms of vitamin D receptor gene in South Indian HIV and HIV-TB patients. J. Clin. Immunol. 29: 196-204 (2009).
Alagarasu K, Selvaraj P, Swaminathan S, Raghavan S, Narendran G, Narayanan PR. Mannose binding lectin gene variants and susceptibility to tuberculosis in HIV-1 infected patients of South India. Tuberculosis (Edinb.) 87: 535-543 (2007).
Alam MA, Husain SA, Narang R, Chauhan SS, Kabra M, Vasisht S. Association of polymorphism in the thermolabile 5,10-methylene tetrahydrofolate reductase gene and hyperhomocysteinemia with coronary artery disease. Mol. Cell. Biochem. 310: 111-117 (2008).
Alansari A, Gul A, Inanc M, Ordi J, Teh LS, Ollier WE, Gonzalez-Gay MA, Hajeer AH. Fc receptor gamma subunit polymorphisms and systemic lupus erythematosus. Saudi Med. J. 25: 1445-1448 (2004).
Alansari A, Hajeer A, Teh LS, Bayat A, Mysercough A, Gul A, Inanc M, Ordi-Ros J, Ollier W. Transforming growth factor-12 polymorphism and systemic lupus erythematosus. J. Rheumatol. 29: 1189-1191 (2002).
Alansari A, Hajeer AH, Bayat A, Eyre S, Carthy D, Ollier WE. Two novel polymorphisms in the human transforming growth factor beta 2 gene. Genes Immun. 2: 295-296 (2001). *
Alayli G, Aydin F, Coban AY, Sullu Y, Canturk F, Bek Y, Durupinar B, Canturk T. T helper 1 type cytokines polymorphisms: association with susceptibility to Behcet's disease. Clin. Rheumatol. 26: 1299-1305 (2007). *
Alayli G, Kara N, Tander B, Canturk F, Gunes S, Bagci H. Association of transforming growth factor beta1 gene polymorphism with rheumatoid arthritis in a Turkish population. Joint Bone Spine 76: 20-23 (2009). *
Albala BC, Jimenez RB, Perez B F, Liberman GC. Fatty acid binding protein 2 (FABP-2) polymorphism, obesity and insulin resistance. Rev. Med. Chil. 134: 372-379 (2006).
Albala C, Villarroel A, Santos JL, Angel B, Lera L, Liberman C, Sanchez H, Perez-Bravo F. FABP2 Ala54Thr polymorphism and diabetes in Chilean elders. Diabetes Res. Clin. Pract. 77: 245-250 (2007).
Albani D, Batelli S, Polito L, Prato F, Pesaresi M, Gajo GB, De Angeli S, Zanardo A, Galimberti D, Scarpini E, Gallucci M, Forloni G. Interleukin-6 plasma level increases with age in an Italian elderly population ("The Treviso Longeva"-Trelong-study) with a sex-specific contribution of rs1800795 polymorphism. Age (Dordr.) 31: 155-162 (2009).
Albers CA, Heskes T, Kappen HJ. Haplotype inference in general pedigrees using the cluster variation method. Genetics 177: 1101-1116 (2007). *
Albers CA, Kappen HJ. Modeling linkage disequilibrium in exact linkage computations: a comparison of first-order Markov approaches and the clustered-markers approach. BMC Proc. 1 Suppl. 1: S159 (2007). *
Albert MA, Pare G, Morris A, Rose L, Buring J, Ridker PM, Zee RY. Candidate genetic variants in the fibrinogen, methylenetetrahydrofolate reductase, and intercellular adhesion molecule-1 genes and plasma levels of fibrinogen, homocysteine, and intercellular adhesion molecule-1 among various race/ethnic groups. Am. Heart J. 157: 777-783.e1 (2009).
Albuquerque RV, Hayden CM, Palmer LJ, Laing IA, Rye PJ, Gibson NA, Burton PR, Goldblatt J, Lesouef PN. Association of polymorphisms within the tumour necrosis factor (TNF) genes and childhood asthma. Clin. Exp. Allergy 28: 578-584 (1998).
Aldersley MA, Hamlin PJ, Jones PF, Markham AF, Robinson PA, Howdle PD. No polymorphism in the tissue transglutaminase gene detected in coeliac disease patients. Scand. J. Gastroenterol. 35: 61-63 (2000). *
Aldred PM, Hollox EJ, Armour JA. Copy number polymorphism and expression level variation of the human alpha-defensin genes DEFA1 and DEFA3. Hum. Mol. Genet. 14: 2045-2052 (2005). *
Alenius GM, Friberg C, Nilsson S, Wahlstrom J, Dahlqvist SR, Samuelsson L. Analysis of 6 genetic loci for disease susceptibility in psoriatic arthritis. J. Rheumatol. 31: 2230-2235 (2004). *
Alessandro R, Seidita G, Flugy AM, Damiani F, Russo A, Corrado C, Colomba P, Gullotti L, Buettner R, Bruno L, Leo GD. Role of S128R polymorphism of E-selectin in colon metastasis formation. Int. J. Cancer 121: 528-535 (2007). *
Alessio AC, Annichino-Bizzacchi JM, Bydlowski SP, Eberlin MN, Vellasco AP, Hoehr NF. Polymorphisms in the methylenetetrahydrofolate reductase and methionine synthase reductase genes and homocysteine levels in Brazilian children. Am. J. Med. Genet. A. 128A: 256-260 (2004).
Alessio AC, Siqueira LH, Bydlowski SP, Hoehr NF, Annichino-Bizzacchi JM. Polymorphisms in the CBS gene and homocysteine, folate and vitamin B12 levels: association with polymorphisms in the MTHFR and MTRR genes in Brazilian children. Am. J. Med. Genet. A. 146A: 2598-2602 (2008).
Alessio AM, Hoehr NF, Siqueira LH, Ozelo MC, de Padua Mansur A, Annichino-Bizzacchi JM. Association between estrogen receptor alpha and beta gene polymorphisms and deep vein thrombosis. Thromb. Res. 120: 639-645 (2007). *
Alevizaki M, Mantzou E, Cimponeriu A, Saltiki K, Philippou G, Wiersinga W. The Pro(12)Ala PPARgamma gene polymorphism: possible modifier of the activity and severity of thyroid associated orbitopathy (TAO). Clin. Endocrinol. (Oxf.) 70: 464-468 (2009).
Alfirevic A, Mills T, Harrington P, Pinel T, Sherwood J, Jawaid A, Smith JC, March RE, Barratt BJ, Chadwick DW, Kevin Park B, Pirmohamed M. Serious carbamazepine-induced hypersensitivity reactions associated with the HSP70 gene cluster. Pharmacogenet. Genomics 16: 287-296 (2006).
Ali AA, Moatter T, Baig JA, Iqbal A, Hussain A, Iqbal MP. Polymorphism of HLA-DR and HLA-DQ in rheumatoid arthritis patients and clinical response to methotrexate - a hospital-based study. J. Pak. Med. Assoc. 56: 452-456 (2006).
Ali M, Kim H, Cleary S, Cupples C, Gallinger S, Bristow R. Characterization of mutant MUTYH proteins associated with familial colorectal cancer. Gastroenterology 135: 499-507.e1 (2008). *
Ali ME, Ahmed MU, Alam S, Rahman MH. HLA-A, -B and -DRB1 allele frequencies in the Bangladeshi population. Tissue Antigens 72: 115-119 (2008). *
Ali MF, Meza JL, Rogan EG, Chakravarti D. Prevalence of BER gene polymorphisms in sporadic breast cancer. Oncol. Rep. 19: 1033-1038 (2008). *
Ali S, Vollaard AM, Kremer D, de Visser AW, Martina CA, Widjaja S, Surjadi C, Slagboom E, van de Vosse E, van Dissel JT. Polymorphisms in proinflammatory genes and susceptibility to typhoid fever and paratyphoid fever. J. Interferon Cytokine Res. 27: 271-280 (2007).
Alia P, Mana J, Capdevila O, Alvarez A, Navarro MA. Association between ACE gene I/D polymorphism and clinical presentation and prognosis of sarcoidosis. Scand. J. Clin. Lab. Invest. 65: 691-698 (2005). *
Alibakhshi R, Kianishirazi R, Cassiman JJ, Zamani M, Cuppens H. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations. J. Cyst. Fibros. 7: 102-109 (2008).
Alibakhshi R, Zamani M. Mutation analysis of CFTR gene in 70 Iranian cystic fibrosis patients. Iran. J. Allergy Asthma Immunol. 5: 3-8 (2006).
Alidoust L, Zafarghandi M, Agah M, Sendi H, Alavian SM, Zali MR. Glutathione-S-transferase M1, T1 and P1 gene polymorphisms in type I autoimmune hepatitis: a case-control study. Indian J. Gastroenterol. 26: 97-99 (2007). *
Alifirova VM, Orlova IuIu, Babenko SA, Rudko AA, Puzyrev VP. The 1188 A/C ILI2B gene polymorphism in patients with multiple sclerosis and in healthy subjects of Tomsk region. Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova 2006 Spec. No 3: 130-135 (2006).
Alkassab F, Gourh P, Tan F, Arnett F, Mayes M. Comment on: an allograft inflammatory factor 1 (AIF1) single nucleotide polymorphism (SNP) is associated with anticentromere antibody positive systemic sclerosis: reply. Rheumatology (Oxford) 47: 557 (2008).
Alkassab F, Gourh P, Tan FK, McNearney T, Fischbach M, Ahn C, Arnett FC, Mayes MD. An allograft inflammatory factor 1 (AIF1) single nucleotide polymorphism (SNP) is associated with anticentromere antibody positive systemic sclerosis. Rheumatology (Oxford) 46: 1248-1251 (2007). *
Allahabadia A, Heward JM, Mijovic C, Carr-Smith J, Daykin J, Cockram C, Barnett AH, Sheppard MC, Franklyn JA, Gough SC. Lack of association between polymorphism of the thyrotropin receptor gene and Graves' disease in United Kingdom and Hong Kong Chinese patients: case control and family-based studies. Thyroid 8: 777-780 (1998).
Allan JM, Shorto J, Adlard J, Bury J, Coggins R, George R, Katory M, Quirke P, Richman S, Scott D, Scott K, Seymour M, Travis LB, Worrillow LJ, Bishop DT, Cox A. MLH1 -93G>A promoter polymorphism and risk of mismatch repair deficient colorectal cancer. Int. J. Cancer 123: 2456-2459 (2008). *
Allanore Y, Borderie D, Lemarechal H, Ekindjian OG, Kahan A. Lack of association of eNOS (G894T) and p22phox NADPH oxidase subunit (C242T) polymorphisms with systemic sclerosis in a cohort of French Caucasian patients. Clin. Chim. Acta 350: 51-55 (2004). *
Allayee H, Baylin A, Hartiala J, Wijesuriya H, Mehrabian M, Lusis AJ, Campos H. Nutrigenetic association of the 5-lipoxygenase gene with myocardial infarction. Am. J. Clin. Nutr. 88: 934-940 (2008). *
Allcock R, Dolecki KJ, Boodhoo A, Abdul Khalil A, Wong AM, Price P. Genomic sequence and expression profile of murine Bat1a and Nfkbil1. DNA Seq. 17: 292-299 (2006).
Allcock RJ, Baluchova K, Cheong KY, Price P. Haplotypic single nucleotide polymorphisms in the central MHC gene IKBL, a potential regulator of NF-kappaB function. Immunogenetics 52: 289-293 (2001).
Allcock RJ, Christiansen FT, Price P. The central MHC gene IKBL carries a structural polymorphism that is associated with HLA-A3,B7,DR15. Immunogenetics 49: 660-665 (1999). *
Allcock RJ, de la Concha EG, Fernandez-Arquero M, Vigil P, Conejero L, Arroyo R, Price P. Susceptibility to multiple sclerosis mediated by HLA-DRB1 is influenced by a second gene telomeric of the TNF cluster. Hum. Immunol. 60: 1266-1273 (1999).
Allcock RJ, Price P, Gaudieri S, Leelayuwat C, Witt CS, Dawkins RL. Characterisation of the human central MHC gene, BAT1: genomic structure and expression. Exp. Clin. Immunogenet. 16: 98-106 (1999).
Allen AS, Satten GA. Association mapping via a class of haplotype-sharing statistics. BMC Proc. 1 Suppl. 1: S123 (2007). *
Allen KJ, Cheah DM, Wright PF, Gazeas S, Pettigrew-Buck NE, Deal YH, Mercer JF, Williamson R. Liver cell transplantation leads to repopulation and functional correction in a mouse model of Wilson's disease. J. Gastroenterol. Hepatol. 19: 1283-1290 (2004). *
Allen M, Ameen H, Veal C, Evans J, Ramrakha-Jones VS, Marsland AM, Burden AD, Griffiths CE, Trembath R, Barker JW. The major psoriasis susceptibility locus PSORS1 is not a risk factor for late-onset psoriasis. J. Invest. Dermatol. 124: 103-106 (2005). *
Allen M, Heinzmann A, Noguchi E, Abecasis G, Broxholme J, Ponting CP, Bhattacharyya S, Tinsley J, Zhang Y, Holt R, Jones EY, Lench N, Carey A, Jones H, Dickens NJ, Dimon C, Nicholls R, Baker C, Xue L, Townsend E, Kabesch M, Weiland SK, Carr D et al. Positional cloning of a novel gene influencing asthma from chromosome 2q14. Nat. Genet. 35: 258-263 (2003). *
Allen ML, Hoschtitzky JA, Peters MJ, Elliott M, Goldman A, James I, Klein NJ. Interleukin-10 and its role in clinical immunoparalysis following pediatric cardiac surgery. Crit. Care Med. 34: 2658-2665 (2006).
Allen-Brady K, Horne BD, Malhotra A, Teerlink C, Camp NJ, Thomas A. Analysis of high-density single-nucleotide polymorphism data: three novel methods that control for linkage disequilibrium between markers in a linkage analysis. BMC Proc. 1 Suppl. 1: S160 (2007). *
Allen-Brady K, Miller J, Matsunami N, Stevens J, Block H, Farley M, Krasny L, Pingree C, Lainhart J, Leppert M, McMahon WM, Coon H. A high-density SNP genome-wide linkage scan in a large autism extended pedigree. Mol. Psychiatry 14: 590-600 (2009).
Allen-Brady K, Robison R, Cannon D, Varvil T, Villalobos M, Pingree C, Leppert MF, Miller J, McMahon WM, Coon H. Genome-wide linkage in Utah autism pedigrees. Mol. Psychiatry May 19 [Epub ahead of print] (2009).
Alm JS, Sanjeevi CB, Miller EN, Dabadghao P, Lilja G, Pershagen G, Blackwell JM, Scheynius A. Atopy in children in relation to BCG vaccination and genetic polymorphisms at SLC11A1 (formerly NRAMP1) and D2S1471. Genes Immun. 3: 71-77 (2002). *
Almani M, Raffaeli S, Vider-Shalit T, Tsaban L, Fishbain V, Louzoun Y. Human self-protein CD8(+) T-cell epitopes are both positively and negatively selected. Eur. J. Immunol. 39: 1056-1065 (2009). *
Almasi S, Erfani N, Mojtahedi Z, Rajaee A, Ghaderi A. Association of CTLA-4 gene promoter polymorphisms with systemic sclerosis in Iranian population. Genes Immun. 7: 401-406 (2006). *
Alonso MJ, Heine-Suner D, Calvo M, Rosell J, Gimenez J, Ramos MD, Telleria JJ, Palacio A, Estivill X, Casals T. Spectrum of mutations in the CFTR gene in cystic fibrosis patients of Spanish ancestry. Ann. Hum. Genet. 71: 194-201 (2007). *
Alonso-Navarro H, Jimenez-Jimenez FJ, Garcia-Agundez JA. The role of CYP2C19 polymorphism in the development of adverse effects to drugs and the risk for diseases. Med. Clin. (Barc.) 126: 697-706 (2006).
Alpay HC, Etem EO, Kaygusuz I, Y�ce H, Karlidag T, Keles E, Orhan I, Yalcin S. Evaluation of the polymorphism in the Toll-like receptor 4 (TLR4) genes of tympanosclerosis patients. Auris. Nasus. Larynx Apr 25 [Epub ahead of print] (2009).
Alper CA, Larsen CE, Dubey DP, Awdeh ZL, Fici DA, Yunis EJ. The haplotype structure of the human major histocompatibility complex. Hum. Immunol. 67: 73-84 (2006).
Alper SL. Molecular physiology and genetics of Na+-independent SLC4 anion exchangers. J. Exp. Biol. 212: 1672-1683 (2009). *
Alper SL. Molecular physiology of SLC4 anion exchangers. Exp. Physiol. 91: 153-161 (2006). *
Alsaeid K, Haider MZ, Ayoub EM. Angiotensin converting enzyme gene insertion-deletion polymorphism is associated with juvenile rheumatoid arthritis. J. Rheumatol. 30: 2705-2709 (2003).
Alsmadi O, Al-Rubeaan K, Wakil SM, Imtiaz F, Mohamed G, Al-Saud H, Al-Saud NA, Aldaghri N, Mohammad S, Meyer BF. Genetic Study of Saudi Diabetes (GSSD): significant association of the KCNJ11 E23K polymorphism with type 2 diabetes. Diabetes Metab. Res. Rev. 24: 137-140 (2008).
Altamura C, Squitti R, Pasqualetti P, Tibuzzi F, Silvestrini M, Ventriglia MC, Cassetta E, Rossini PM, Vernieri F. What is the relationship among atherosclerosis markers, apolipoprotein E polymorphism and dementia? Eur. J. Neurol. 14: 679-682 (2007).
Altes A, Bach V, Ruiz A, Esteve A, Felez J, Remacha AF, Sarda MP, Baiget M. Mutations in HAMP and HJV genes and their impact on expression of clinical hemochromatosis in a cohort of 100 Spanish patients homozygous for the C282Y mutation of HFE gene. Ann. Hematol. Feb 13 [Epub ahead of print] (2009).
Altomare DF, Guanti G, Hoch J, Vician M, Krivokapic Z, Bergamaschi R; for the Colorectal Micrometastases Study Group. Non-colonic cancer stem cells in bone marrow of colorectal cancer patients. Colorectal Dis. Jan 27 [Epub ahead of print] (2009). *
Altshuler D, Brooks LD, Chakravarti A, Collins FS, Daly MJ, Donnelly P; International HapMap Consortium. A haplotype map of the human genome. Nature 437: 1299-1320 (2005). *
Alvarado-Guerri R, Cabrera CM, Garrido F, Lopez-Nevot MA. TAP1 and TAP2 polymorphisms and their linkage disequilibrium with HLA-DR, -DP, and -DQ in an Eastern Andalusian population. Hum. Immunol. 66: 921-930 (2005).
Alvarado-Navarro A, Montoya-Buelna M, Munoz-Valle JF, Lopez-Roa RI, Guillen-Vargas C, Fafutis-Morris M. The 3'UTR 1188 A/C polymorphism in the interleukin-12p40 gene (IL-12B) is associated with lepromatous leprosy in the west of Mexico. Immunol. Lett. 118: 148-151 (2008).
Alvarez I, Lopez de Castro JA. HLA-B27 and immunogenetics of spondyloarthropathies. Curr. Opin. Rheumatol. 12: 248-253 (2000).
Alvarez-Blasco F, Martinez-Garcia MA, Luque-Ram�rez M, Parraza N, San Millan JL, Escobar-Morreale HF. Role of haptoglobin in polycystic ovary syndrome (PCOS), obesity and disorders of glucose tolerance in premenopausal women. PLoS ONE 4: e5606 (2009). *
Alvarez-Hernandez D, Naves-Diaz M, Gomez-Alonso C, Coto E, Cannata-Andia JB. Tissue-specific effect of VDR gene polymorphisms on the response to calcitriol. J. Nephrol. 21: 843-849 (2008).
Alvarez-Rodriguez L, Carrasco E, Lopez-Hoyos M, Mata C, Fernandez-Prieto L, Ruiz-Soto M, Calvo J, Rodriguez-Valverde V, Ruiz T, Blanco R, Corrales A, Martinez-Taboada VM. Interleukin-1RN gene polymorphisms in elderly patients with rheumatic inflammatory chronic conditions: association of IL-1RN*2/2 genotype with polymyalgia rheumatica. Hum. Immunol. 70: 49-54 (2009).
Alves C, Meyer I, Toralles MB, Marback RL. Association of human histocompatibility antigens with ophthalmological disorders. Arq. Bras. Oftalmol. 69: 273-278 (2006).
Alves C, Veiga S, Souza T, Toralles MB, da Silva-Bacellar AL. The role of the human histocompatibility antigens in the pathogenesis of neurological disorders. Rev. Neurol. 44: 298-302 (2007).
Alves Correa SA, Ribeiro de Noronha SM, Nogueira-de-Souza NC, Valleta de Carvalho C, Massad Costa AM, Juvenal Linhares J, Vieira Gomes MT, Guerreiro da Silva ID. Association between the angiotensin-converting enzyme (insertion/deletion) and angiotensin II type 1 receptor (A1166C) polymorphisms and breast cancer among Brazilian women. J. Renin Angiotensin Aldosterone Syst. 10: 51-58 (2009).
Alves G, Ogurtsov AY, Yu YK. RAId_DbS: mass-spectrometry based peptide identification web server with knowledge integration. BMC Genomics 9: 505 (2008). *
Alves Pedroso ML, Boldt AB, Pereira-Ferrari L, Steffensen R, Strauss E, Jensenius JC, Ioshii SO, Messias-Reason I. Mannan-binding lectin MBL2 gene polymorphism in chronic hepatitis C: association with the severity of liver fibrosis and response to interferon therapy. Clin. Exp. Immunol. 152: 258-264 (2008). *
Alvim-Pereira F, Montes CC, Thome G, Olandoski M, Trevilatto PC. Analysis of association of clinical aspects and vitamin D receptor gene polymorphism with dental implant loss. Clin. Oral Implants Res. 19: 786-795 (2008).
Aly HH, Shimotohno K, Hijikata M. 3D cultured immortalized human hepatocytes useful to develop drugs for blood-borne HCV. Biochem. Biophys. Res. Commun. 379: 330-334 (2009). *
Aly TA, Baschal EE, Jahromi MM, Fernando MS, Babu SR, Fingerlin TE, Kretowski A, Erlich HA, Fain PR, Rewers MJ, Eisenbarth GS. Analysis of single nucleotide polymorphisms identifies major type 1A diabetes locus telomeric of the major histocompatibility complex. Diabetes 57: 770-776 (2008). *
Aly TA, Eller E, Ide A, Gowan K, Babu SR, Erlich HA, Rewers MJ, Eisenbarth GS, Fain PR. Multi-SNP analysis of MHC region: remarkable conservation of HLA-A1-B8-DR3 haplotype. Diabetes 55: 1265-1269 (2006). *
Aly TA, Ide A, Humphrey K, Barker JM, Steck A, Erlich HA, Yu L, Miao D, Redondo MJ, McFann K, Roberts CM, Babu SR, Norris JM, Eisenbarth GS, Rewers MJ. Genetic prediction of autoimmunity: initial oligogenic prediction of anti-islet autoimmunity amongst DR3/DR4-DQ8 relatives of patients with type 1A diabetes. J. Autoimmun. 25: S40-S45 (2005).
Amanatidou V, Sourvinos G, Apostolakis S, Neonaki P, Tsilimigaki A, Krambovitis E, Spandidos DA. RANTES promoter gene polymorphisms and susceptibility to severe respiratory syncytial virus-induced bronchiolitis. Pediatr. Infect. Dis. J. 27: 38-42 (2008).
Amani D, Farjadian S, Ghaderi A. The frequency of transforming growth factor-beta1 gene polymorphisms in a normal southern Iranian population. Int. J. Immunogenet. 35: 145-151 (2008). *
Amann-Zalcenstein D, Avidan N, Kanyas K, Ebstein RP, Kohn Y, Hamdan A, Ben-Asher E, Karni O, Mujaheed M, Segman RH, Maier W, Macciardi F, Beckmann JS, Lancet D, Lerer B. AHI1, a pivotal neurodevelopmental gene, and C6orf217 are associated with susceptibility to schizophrenia. Eur. J. Hum. Genet. 14: 1111-1119 (2006). *
Amano Y, Komiyama K, Makishima M. Vitamin D and periodontal disease. J. Oral Sci. 51: 11-20 (2009). *
Ambrugger P, Stoeva I, Biebermann H, Torresani T, Leitner C, Gruters A. Novel mutations of the thyroid peroxidase gene in patients with permanent congenital hypothyroidism. Eur. J. Endocrinol. 145: 19-24 (2001). *
Ambruzova Z, Mrazek F, Raida L, Stahelova A, Faber E, Indrak K, Petrek M. Possible impact of MAdCAM1 gene single nucleotide polymorphisms to the outcome of allogeneic haematopoietic stem cell transplantation. Hum. Immunol. 70: 457-460 (2009).
Ambye L, Rasmussen S, Fenger M, Jorgensen T, Borch-Johnsen K, Madsbad S, Urhammer SA. Studies of the Gly482Ser polymorphism of the peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC-1alpha) gene in Danish subjects with the metabolic syndrome. Diabetes Res. Clin. Pract. 67: 175-179 (2005).
Amcheslavsky A, Zou W, Bar-Shavit Z. Toll-like receptor 9 regulates tumor necrosis factor-alpha expression by different mechanisms: implications for osteoclastogenesis. J. Biol. Chem. 279: 54039-54045 (2004). *
Ameen M, Allen MH, Fisher SA, Lewis CM, Cuthbert A, Kondeatis E, Vaughan RW, Murakami H, Nakagawa H, Barker JN. Corneodesmosin (CDSN) gene association with psoriasis vulgaris in Caucasian but not in Japanese populations. Clin. Exp. Dermatol. 30: 414-418 (2005). *
Amengual O, Atsumi T, Komano Y, Kataoka H, Horita T, Yasuda S, Koike T. A polymorphism in human platelet antigen 6b and risk of thrombocytopenia in patients with systemic lupus erythematosus. Arthritis Rheum. 56: 2803-2805 (2007). *
Aminkeng F, Van Autreve JE, Koeleman BP, Quartier E, Van Schravendijk C, Gorus FK, Van der Auwera BJ; Belgian Diabetes Registry. TNFa microsatellite polymorphism modulates the risk of type 1 diabetes in the Belgian population, independent of HLA-DQ. Hum. Immunol. 68: 690-697 (2007).
Amirghofran Z, Jalali SA, Ghaderi A, Hosseini SV. Genetic polymorphism in the transforming growth factor beta1 gene (-509 C/T and -800 G/A) and colorectal cancer. Cancer Genet. Cytogenet. 190: 21-25 (2009).
Amirzargar A, Mytilineos J, Yousefipour A, Farjadian S, Scherer S, Opelz G, Ghaderi A. HLA class II (DRB1, DQA1 and DQB1) associated genetic susceptibility in Iranian multiple sclerosis (MS) patients. Eur. J. Immunogenet. 25: 297-301 (1998). *
Amirzargar AA, Naroueynejad M, Khosravi F, Dianat S, Rezaei N, Mytilineos J, Nikbin B. Cytokine single nucleotide polymorphisms in Iranian populations. Eur. Cytokine Netw. 19: 104-112 (2008).
Amirzargar M, Yavangi M, Basiri A, Moghadam SH, Khosravi F, Solgi G, Gholiaf M, Khoshkho F, Dadaras F, Mahmmodi M, Ansaripour B, Amirzargar A, Nikbin B. Genetic association of interleukin-4, interleukin-10, and transforming growth factor-beta gene polymorphism with allograft function in renal transplant patients. Transplant. Proc. 39: 954-957 (2007). *
Amlie-Lefond C, Paz DA, Connelly MP, Huffnagle GB, Dunn KS, Whelan NT, Whelan HT. Innate immunity for biodefense: a strategy whose time has come. J. Allergy Clin. Immunol. 116: 1334-1342 (2005). *
Ammendola M, Pietropolli A, Saccucci P, Piccione E, Bottini E, Gloria-Bottini F. Acid phosphatase locus 1 genetic polymorphism, endometriosis, and allergy. Fertil. Steril. 90: 1203-1205 (2008).
Amoli MM, Garcia-Porrua C, Ollier WE, Gonzalez-Gay MA. Lack of association between macrophage migration inhibitory factor gene polymorphism and giant cell arteritis. J. Rheumatol. 32: 74-76 (2005).
Amoli MM, Gonzalez-Gay MA, Zeggini E, Salway F, Garcia-Porrua C, Ollier WE. Epistatic interactions between HLA-DRB1 and interleukin 4, but not interferon-gamma, increase susceptibility to giant cell arteritis. J. Rheumatol. 31: 2413-2417 (2004). *
Amoli MM, Hand S, Hajeer AH, Jones KP, Rolf S, Sting C, Davies BH, Ollier WE. Polymorphism in the STAT6 gene encodes risk for nut allergy. Genes Immun. 3: 220-224 (2002). *
Amoli MM, Salway F, Ollier WE, Gonzalez-Gay MA. MCP-1 gene haplotype association in biopsy proven giant cell arteritis. J. Rheumatol. 32: 507-510 (2005).
Amos CI, Chen WV, Lee A, Li W, Kern M, Lundsten R, Batliwalla F, Wener M, Remmers E, Kastner DA, Criswell LA, Seldin MF, Gregersen PK. High-density SNP analysis of 642 Caucasian families with rheumatoid arthritis identifies two new linkage regions on 11p12 and 2q33. Genes Immun. 7: 277-286 (2006). *
Amos CI, Chen WV, Remmers E, Siminovitch KA, Seldin MF, Criswell LA, Lee AT, John S, Shephard ND, Worthington J, Cornelis F, Plenge RM, Begovich AB, Dyer TD, Kastner DL, Gregersen PK. Data for Genetic Analysis Workshop (GAW) 15 Problem 2, genetic causes of rheumatoid arthritis and associated traits. BMC Proc. 1 Suppl. 1: S3 (2007). *
Amre DK, Mack D, Israel D, Morgan K, Lambrette P, Law L, Grimard G, Deslandres C, Krupoves A, Bucionis V, Costea I, Bissonauth V, Feguery H, D'Souza S, Levy E, Seidman EG. Association between genetic variants in the IL-23R gene and early-onset Crohn's disease: results from a case-control and family-based study among Canadian children. Am. J. Gastroenterol. 103: 615-620 (2008). *
Amre DK, Mack DR, Israel D, Morgan K, Krupoves A, Costea I, Lambrette P, Grimard G, Deslandres C, Levy E, Seidman EG. Investigation of associations between the pregnane X receptor gene (NR1I2) and Crohn's disease in Canadian children using a gene-wide haplotype-based approach. Inflamm. Bowel Dis. 14: 1214-1218 (2008). *
Amre DK, Mack DR, Morgan K, Israel D, Lambrette P, Costea I, Krupoves A, Fegury H, Dong J, Grimard G, Deslandres C, Levy E, Seidman EG. Interleukin 10 (IL-10) gene variants and susceptibility for pediatric onset Crohn's disease. Aliment. Pharmacol. Ther. 29: 1025-1031 (2009). *
Amre DK, Mack DR, Morgan K, Krupoves A, Costea I, Lambrette P, Grimard G, Dong J, Feguery H, Bucionis V, Deslandres C, Levy E, Seidman EG. Autophagy gene ATG16L1 but not IRGM is associated with Crohn's disease in Canadian children. Inflamm. Bowel Dis. 15: 501-507 (2009). *
Amroun H, Djoudi H, Busson M, Allat R, El Sherbini SM, Sloma I, Ramasawmy R, Brun M, Dulphy N, Krishnamoorthy R, Toubert A, Charron D, Abbadi MC, Tamouza R. Early-onset ankylosing spondylitis is associated with a functional MICA polymorphism. Hum. Immunol. 66: 1057-1061 (2005).
Amundsen SS, Adamovic S, Hellqvist A, Nilsson S, Gudj�nsd�ttir AH, Ascher H, Ek J, Larsson K, Wahlstrom J, Lie BA, Sollid LM, Naluai AT. A comprehensive screen for SNP associations on chromosome region 5q31-33 in Swedish/Norwegian celiac disease families. Eur. J. Hum. Genet. 15: 980-987 (2007). *
Amundsen SS, Monsuur AJ, Wapenaar MC, Lie BA, Ek J, Gudjonsdottir AH, Ascher H, Wijmenga C, Sollid LM. Association analysis of MYO9B gene polymorphisms with celiac disease in a Swedish/Norwegian cohort. Hum. Immunol. 67: 341-345 (2006).
Amundsen SS, Naluai AT, Ascher H, Ek J, Gudjonsdottir AH, Wahlstrom J, Lie BA, Sollid LM. Genetic analysis of the CD28/CTLA4/ICOS (CELIAC3) region in coeliac disease. Tissue Antigens 64: 593-599 (2004). *
Amundsen SS, Vatn M; the IBSEN study group; Wijmenga C, Sollid LM, Lie BA. Association analysis of MYO9B gene polymorphisms and inflammatory bowel disease in a Norwegian cohort. Tissue Antigens 68: 249-252 (2006). *
An P, Thio CL, Kirk GD, Donfield S, Goedert JJ, Winkler CA. Regulatory polymorphisms in the interleukin-18 promoter are associated with hepatitis C virus clearance. J. Infect. Dis. 198: 1159-1165 (2008). *
Anasetti C. What are the most important donor and recipient factors affecting the outcome of related and unrelated allogeneic transplantation? Best Pract. Res. Clin. Haematol. 21: 691-697 (2008).
Anastassopoulou CG, Kostrikis LG. The impact of human allelic variation on HIV-1 disease. Curr. HIV Res. 1: 185-203 (2003).
Anaya JM, Correa PA, Herrera M, Eskdale J, Gallagher G. Interleukin 10 (IL-10) influences autoimmune response in primary Sjogren's syndrome and is linked to IL-10 gene polymorphism. J. Rheumatol. 29: 1874-1876 (2002). *
Anaya JM, Correa PA, Mantilla RD, Arcos-Burgos M. TAP, HLA-DQB1, and HLA-DRB1 polymorphism in Colombian patients with primary Sjogren's syndrome. Semin. Arthritis Rheum. 31: 396-405 (2002). *
Anaya JM, Mantilla RD, Correa PA. Immunogenetics of primary Sjogren's syndrome in Colombians. Semin. Arthritis Rheum. 34: 735-743 (2005). *
Andersen G, Burgdorf KS, Sparso T, Borch-Johnsen K, Jorgensen T, Hansen T, Pedersen O. AHSG tagSNPs associate with type 2 diabetes and dyslipidemia: studies of metabolic traits in 7,683 Danish whites. Diabetes 57: 1427-1432 (2008). *
Andersen G, Overgaard J, Albrechtsen A, Glumer C, Borch-Johnsen K, Jorgensen T, Hansen T, Pedersen O. Studies of the association of the GNB3 825C>T polymorphism with components of the metabolic syndrome in white Danes. Diabetologia 49: 75-82 (2006). *
Andersen V, Agerstjerne L, Jensen D, Ostergaard M, Saebo M, Hamfjord J, Kure E, Vogel U. The multidrug resistance 1 (MDR1) gene polymorphism G-rs3789243-A is not associated with disease susceptibility in Norwegian patients with colorectal adenoma and colorectal cancer; a case control study. BMC Med. Genet. 10: 18 (2009). *
Anderson AC, Anderson DE. TIM-3 in autoimmunity. Curr. Opin. Immunol. 18: 665-669 (2006).
Anderson CA, Massey DC, Barrett JC, Prescott NJ, Tremelling M, Fisher SA, Gwilliam R, Jacob J, Nimmo ER, Drummond H, Lees CW, Onnie CM, Hanson C, Blaszczyk K, Ravindrarajah R, Hunt S, Varma D, Hammond N, Lewis G, Attlesey H, Watkins N, et al. Investigation of Crohn�s disease risk loci in ulcerative colitis further defines their molecular relationship. Gastroenterology 136: 523-529.e3 (2009). *
Anderson JE, Hansen LL, Mooren FC, Post M, Hug H, Zuse A, Los M. Methods and biomarkers for the diagnosis and prognosis of cancer and other diseases: towards personalized medicine. Drug Resist. Updat. 9: 198-210 (2006).
Andersson P, Varenhorst E, Soderkvist P. Androgen receptor and vitamin D receptor gene polymorphisms and prostate cancer risk. Eur. J. Cancer 42: 2833-2837 (2006). *
Ando T, El-Omar EM, Goto Y, Nobata K, Watanabe O, Maeda O, Ishiguro K, Minami M, Hamajima N, Goto H. Interleukin 1B proinflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy. Gut 55: 158-164 (2006). *
Ando T, Goto Y, Ishiguro K, Maeda O, Watanabe O, Ohmiya N, Niwa Y, Hamajima N, El-Omar E, Goto H. The interaction of host genetic factors and Helicobacter pylori infection. Inflammopharmacology 15: 10-14 (2007).
Andoh A, Sakata S, Koizumi Y, Mitsuyama K, Fujiyama Y, Benno Y. Terminal restriction fragment length polymorphism analysis of the diversity of fecal microbiota in patients with ulcerative colitis. Inflamm. Bowel Dis. 13: 955-962 (2007). *
Andoh A, Tsujikawa T, Sasaki M, Mitsuyama K, Suzuki Y, Matsui T, Matsumoto T, Benno Y, Fujiyama Y. Fecal microbiota profile of Crohn's disease determined by terminal restriction fragment length polymorphism analysis. Aliment. Pharmacol. Ther. 29: 75-82 (2009). *
Andre MF, Aumaitre O, Piette JC, Grateau G, Cardoso MC, Ouchchane L, Kemeny JL, Dastugue B, Delpech M, Creveaux I. Analysis of the NOD2/CARD15 gene in patients affected with the aseptic abscesses syndrome with or without inflammatory bowel disease. Dig. Dis. Sci. 53: 490-499 (2008). *
Andreevskii TV, Sudomoina MA, Gusev EI, Boiko AN, Alekseenkov AD, Favorova OO. Polymorphism A/G in position +49 of CTLA4 exon 1 in multiple sclerosis in Russians. Mol. Biol. (Mosk.) 36: 643-648 (2002).
Andren M, Johanneson B, Alarcon-Riquelme ME, Kleinau S. IgG Fc receptor polymorphisms and association with autoimmune disease. Eur. J. Immunol. 35: 3020-3029 (2005). *
Andreoli V, Cittadella R, Valentino P, Condino F, La Russa A, Liguori M, Manna I, Spadafora P, Nistico R, Pirritano D, Clodomiro A, Quattrone A. The role of VLA4 polymorphisms in multiple sclerosis: an association study. J. Neuroimmunol. 189: 125-128 (2007).
Andrulionyte L, Kuulasmaa T, Chiasson JL, Laakso M. Single nucleotide polymorphisms of the peroxisome proliferator-activated receptor-alpha gene (PPARA) influence the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial. Diabetes 56: 1181-1186 (2007). *
Andrulionyte L, Peltola P, Chiasson JL, Laakso M. Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial. Diabetes 55: 2148-2152 (2006). *
Andrulionyte L, Zacharova J, Chiasson JL, Laakso M; for the STOP-NIDDM Study Group. Common polymorphisms of the PPAR-gamma2 (Pro12Ala) and PGC-1alpha (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial. Diabetologia 47: 2176-2184 (2004). *
Angel B, Santos JL, Carrasco E, Albala C, Perez-Bravo F. Vitamin D receptor polymorphism and susceptibility to type 1 diabetes in Chilean subjects: a case-parent study. Eur. J. Epidemiol. 19: 1085-1087 (2004). *
Angeline T, Jeyaraj N, Tsongalis GJ. MTHFR Gene polymorphisms, B-vitamins and hyperhomocystinemia in young and middle-aged acute myocardial infarction patients. Exp. Mol. Pathol. 82: 227-233 (2007). *
Anger T, Ekici AB, Daniel WG, Garlichs CD. Gene polymorphisms leading to calcified and stenotic aortic valves. Herz. 31: 635-643 (2006).
Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramirez C, Cavallari U, Trabetti E, Sabate M, Hernandez R, Moreno R, Escaned J, Alfonso F, Banuelos C, Costa MA, Bass TA, Pignatti PF, Macaya C. Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrel. Arterioscler. Thromb. Vasc. Biol. 26: 1895-1900 (2006).
Anglicheau D, Legendre C, Beaune P, Thervet E. Cytochrome P450 3A polymorphisms and immunosuppressive drugs: an update. Pharmacogenomics 8: 835-849 (2007).
Anglicheau D, Legendre C, Thervet E. Pharmacogenetics in solid organ transplantation: present knowledge and future perspectives. Transplantation 78: 311-315 (2004).
Anglicheau D, Thervet E, Etienne I, Hurault De Ligny B, Le Meur Y, Touchard G, Buchler M, Laurent-Puig P, Tregouet D, Beaune P, Daly A, Legendre C, Marquet P. CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation. Clin. Pharmacol. Ther. 75: 422-433 (2004). *
Anjos S, Polychronakos C. Mechanisms of genetic susceptibility to type I diabetes: beyond HLA. Mol. Genet. Metab. 81: 187-195 (2004). *
Anjos SM, Shao W, Marchand L, Polychronakos C. Allelic effects on gene regulation at the autoimmunity-predisposing CTLA4 locus: a re-evaluation of the 3' +6230G>A polymorphism. Genes Immun. 6: 305-311 (2005). *
Anjos SM, Tessier MC, Polychronakos C. Association of the cytotoxic T lymphocyte-associated antigen 4 gene with type 1 diabetes: evidence for independent effects of two polymorphisms on the same haplotype block. J. Clin. Endocrinol. Metab. 89: 6257-6265 (2004). *
Annese V, Latiano A, Palmieri O, Lombardi G, Andriulli A; Italian Group of Inflammatory Bowel Disease. NOD2/CARD15 in healthy relatives of IBD patients. Eur. Rev. Med. Pharmacol. Sci. 10: 33-36 (2006).
Annese V, Latiano A, Rossi L, Bossa F, Damonte G, Dallapiccola B, Serafini S, Pierige F, Andriulli A, Magnani M. The polymorphism of multi-drug resistance 1 gene (MDR1) does not influence the pharmacokinetics of dexamethasone loaded into autologous erythrocytes of patients with inflammatory bowel disease. Eur. Rev. Med. Pharmacol. Sci. 10: 27-31 (2006).
Annese V, Lombardi G, Perri F, D'Inca R, Ardizzone S, Riegler G, Giaccari S, Vecchi M, Castiglione F, Gionchetti P, Cocchiara E, Vigneri S, Latiano A, Palmieri O, Andriulli A. Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease - an IG-IBD study. Am. J. Gastroenterol. 100: 84-92 (2005). *
Annese V, Palmieri O, Latiano A, Ardizzone S, Castiglione F, Cottone M, D'Inca R, Gionchetti P, Papi C, Riegler G, Vecchi M, Andriulli A; Italian Group for Inflammatory Bowel Disease. Frequency of NOD2/CARD15 variants in both sporadic and familial cases of Crohn's disease across Italy. An Italian Group for Inflammatory Bowel Disease Study. Dig. Liver Dis. 36: 121-124 (2004).
Annese V, Piepoli A, Andriulli A, Napolitano G, Bisceglia L, Zelante L, Gasparini P. Polymorphism of motilin gene in patients with Crohn's disease. Dig. Dis. Sci. 43: 715-719 (1998). *
Annese V, Valvano MR, Palmieri O, Latiano A, Bossa F, Andriulli A. Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis. World J. Gastroenterol. 12: 3636-3644 (2006). *
Ano H, Matsumoto T, Suetake T, Nagai T, Tamura Y, Takamatsu I, Iwasaki T, Matsuoka H, Sasada S, Tetsumoto S, Tsuyuguchi I, Kusunoki Y, Takashima T. Relationship between the isoniazid-resistant mutation katGS315T and the prevalence of MDR-/XDR-TB in Osaka, Japan. Int. J. Tuberc. Lung Dis. 12: 1300-1305 (2008).
Anstey A, Lear JT. Azathioprine: clinical pharmacology and current indications in autoimmune disorders. BioDrugs 9: 33-47 (1998).
Antoine HJ, Pall M, Trader BC, Chen YD, Azziz R, Goodarzi MO. Genetic variants in peroxisome proliferator-activated receptor gamma influence insulin resistance and testosterone levels in normal women, but not those with polycystic ovary syndrome. Fertil. Steril. 87: 862-869 (2007). *
Antoniades C, Shirodaria C, Leeson P, Baarholm OA, Van-Assche T, Cunnington C, Pillai R, Ratnatunga C, Tousoulis D, Stefanadis C, Refsum H, Channon KM. MTHFR 677 C>T polymorphism reveals functional importance for 5-methyltetrahydrofolate, not homocysteine, in regulation of vascular redox state and endothelial function in human atherosclerosis. Circulation 119: 2507-2515 (2009).
Antonicelli R, Olivieri F, Cavallone L, Spazzafumo L, Bonafe M, Marchegiani F, Cardelli M, Galeazzi R, Giovagnetti S, Perna GP, Franceschi C. Tumor necrosis factor-alpha gene -308G>A polymorphism is associated with ST-elevation myocardial infarction and with high plasma levels of biochemical ischemia markers. Coron. Artery Dis. 16: 489-493 (2005).
Antoniou AN, Powis SJ. Pathogen evasion strategies for the major histocompatibility complex class I assembly pathway. Immunology 124: 1-12 (2008). *
Antoun A, Jobson S, Cook M, Moss P, Briggs D. Ethnic variability in human leukocyte antigen-E haplotypes. Tissue Antigens 73: 39-45 (2009). *
Anuradha S, Radha V, Deepa R, Hansen T, Carstensen B, Pedersen O, Mohan V. A prevalent amino acid polymorphism at codon 98 (Ala98Val) of the hepatocyte nuclear factor-1alpha is associated with maturity-onset diabetes of the young and younger age at onset of type 2 diabetes in Asian Indians. Diabetes Care 28: 2430-2435 (2005). *
Anzai C, Morokawa N, Okada H, Kamidono S, Eto Y, Yoshimura K. CFTR gene mutations in Japanese individuals with congenital bilateral absence of the vas deferens. J. Cyst. Fibros. 2: 14-18 (2003).
Aoki CA, Bowlus CL, Gershwin ME. The immunobiology of primary sclerosing cholangitis. Autoimmun. Rev. 4: 137-143 (2005).
Aoki T, Hirota T, Tamari M, Ichikawa K, Takeda K, Arinami T, Shibasaki M, Noguchi E. An association between asthma and TNF-308G/A polymorphism: meta-analysis. J. Hum. Genet. 51: 677-685 (2006). *
Aouacheria A, Navratil V, Lopez-Perez R, Gutierrez NC, Churkin A, Barash D, Mouchiroud D, Gautier C. In silico whole-genome screening for cancer-related single-nucleotide polymorphisms located in human mRNA untranslated regions. BMC Genomics 8: 2 (2007). *
Aoyagi H, Okada T, Hasatani K, Mibayashi H, Hayashi Y, Tsuji S, Kaneko Y, Yamagishi M. Impact of cystic fibrosis transmembrane conductance regulator gene mutation on the occurrence of chronic pancreatitis in Japanese patients. J. Int. Med. Res. 37: 378-384 (2009).
Aoyama N, Takahashi N, Kitaichi K, Ishihara R, Saito S, Maeno N, Ji X, Takagi K, Sekine Y, Iyo M, Harano M, Komiyama T, Yamada M, Sora I, Ujike H, Iwata N, Inada T, Ozaki N. Association between gene polymorphisms of SLC22A3 and methamphetamine use disorder. Alcohol Clin. Exp. Res. 30: 1644-1649 (2006). *
Apetoh L, Ghiringhelli F, Tesniere A, Criollo A, Ortiz C, Lidereau R, Mariette C, Chaput N, Mira JP, Delaloge S, Andre F, Tursz T, Kroemer G, Zitvogel L. The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy. Immunol. Rev. 220: 47-59 (2007). *
Apostolakis S, Baritaki S, Krambovitis E, Spandidos DA. Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population. J. Clin. Virol. 34: 310-314 (2005).
Apps R, Murphy SP, Fernando R, Gardner L, Ahad T, Moffett A. Human leucocyte antigen (HLA) expression of primary trophoblast cells and placental cell lines, determined using single antigen beads to characterize allotype specificities of anti-HLA antibodies. Immunology 127: 26-39 (2009). *
Apte MV, Pirola RC, Wilson JS. Individual susceptibility to alcoholic pancreatitis. J. Gastroenterol. Hepatol. 23 Suppl. 1: S63-S68 (2008). *
Arai T, Michalski JP, McCombs CC, Elston RC, McCarthy CF, Stevens FM. T cell receptor gamma gene polymorphisms and class II human lymphocyte antigen genotypes in patients with celiac disease from the west of Ireland. Am. J. Med. Sci. 309: 171-178 (1995).
Arakawa T, Kita Y, Niikura T. A rescue factor for Alzheimer's diseases: discovery, activity, structure, and mechanism. Curr. Med. Chem. 15: 2086-2098 (2008).
Araki A, Hazama S, Oka M, Hinoda Y. Polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 in colorectal cancer. Nippon Rinsho 61 Suppl. 7: 229-232 (2003).
Araki E, Igata M, Motoshima H, Tsuruzoe K. Polymorphisms of PPARs and metabolic disorders. Nippon Rinsho 63: 617-622 (2005).
Aranyi T, Ratajewski M, Bardoczy V, Pulaski L, Bors A, Tordai A, Varadi A. Identification of a DNA methylation-dependent activator sequence in the pseudoxanthoma elasticum gene, ABCC6. J. Biol. Chem. 280: 18643-18550 (2005). *
Arason GJ, Kramer J, Blasko B, Kolka R, Thorbjornsdottir P, Einarsdottir K, Sigfusdottir A, Siguretharson ST, Sigurethsson G, Ronai Z, Prohaszka Z, Sasvari-Szekely M, Boethvarsson S, Thorgeirsson G, Fust G. Smoking and a complement gene polymorphism interact in promoting cardiovascular disease morbidity and mortality. Clin. Exp. Immunol. 149: 132-138 (2007). *
Araujo J, Brandao LA, Guimaraes RL, Santos S, Falcao EA, Milanese M, Segat L, Souza PR, de Lima-Filho JL, Crovella S. Mannose binding lectin gene polymorphisms are associated with type 1 diabetes in Brazilian children and adolescents. Hum. Immunol. 68: 739-743 (2007).
Araujo J, Segat L, Guimaraes RL, Brandao LA, Souza PE, Santos S, Soares TS, Falcao EA, Rodrigues F, Carvalho R Jr, de Lima-Filho JL, Arraes LC, Crovella S. Mannose binding lectin gene polymorphisms and associated auto-immune diseases in type 1 diabetes Brazilian patients. Clin. Immunol. 131: 254-259 (2009). *
Arayssi T, Hamdan A. New insights into the pathogenesis and therapy of Behcet's disease. Curr. Opin. Pharmacol. 4: 183-188 (2004).
Arayssi TK, Hamdan AR, Touma Z, Shamseddeen W, Uthman IW, Hourani HB, Farra CG. TNF polymorphisms in Lebanese patients with Behcet's disease. Clin. Exp. Rheumatol. 26: S130-S131 (2008).
Arcaroli J, Fessler MB, Abraham E. Genetic polymorphisms and sepsis. Shock 24: 300-312 (2005). *
Archbold JK, Macdonald WA, Gras S, Ely LK, Miles JJ, Bell MJ, Brennan RM, Beddoe T, Wilce MC, Clements CS, Purcell AW, McCluskey J, Burrows SR, Rossjohn J. Natural micropolymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognition. J. Exp. Med. 206: 209-219 (2009). *
Arcos-Burgos M, Parodi E, Salgar M, Bedoya E, Builes J, Jaramillo D, Ceballos G, Uribe A, Rivera N, Rivera D, Fonseca I, Camargo M, Palacio G. Vitiligo: complex segregation and linkage disequilibrium analyses with respect to microsatellite loci spanning the HLA. Hum. Genet. 110: 334-342 (2002). *
Ardaillou R. Genetic polymorphisms linked to myocardial ischemia in a Japanese population. Med. Sci. (Paris) 19: 413-414 (2003).
Ardaillou R, Le Gall JY. Mass neonatal screening using biological testing. Gynecol. Obstet. Fertil. 35: 367-374 (2007).
Ardeniz O, Avci CB, Sin A, Ozgen G, Gunsar F, Mete N, Gulbahar O, Kokuludag A. Vitamin D deficiency in the absence of enteropathy in three cases with common variable immunodeficiency. Int. Arch. Allergy Immunol. 147: 74-83 (2008).
Ardizzone S. Ulcerative colitis. Orphanet encyclopedia [http://www.orpha.net/data/patho/GB/uk-UC.pdf] (2003). *
Ardizzone S, Maconi G, Bianchi V, Russo A, Colombo E, Cassinotti A, Penati C, Tenchini ML, Bianchi Porro G. Multidrug resistance 1 gene polymorphism and susceptibility to inflammatory bowel disease. Inflamm. Bowel Dis. 13: 516-523 (2007). *
Ardoin SP, Pisetsky DS. Developments in the scientific understanding of lupus. Arthritis Res. Ther. 10: 218 (2008). *
Arfa I, Abid A, Nouira S, Elloumi-Zghal H, Malouche D, Mannai I, Zorgati MM, Ben Alaya N, Rebai A, Zouari B, Ben Ammar S, Ben Rayana MC, Hmida S, Blousa-Chabchoub S, Abdelhak S. Lack of association between the angiotensin-converting enzyme gene (I/D) polymorphism and diabetic nephropathy in Tunisian type 2 diabetic patients. J. Renin Angiotensin Aldosterone Syst. 9: 32-36 (2008).
Argano C, Duro G, Corrao S, Di Chiara T, Nuzzo D, Colomba D, Scaglione R, Licata G. Transforming growth factor beta1 T29C gene polymorphism and hypertension: relationship with cardiovascular and renal damage. Blood Press. 17: 220-226 (2008).
Arias AI, Giles B, Eiermann TH, Sterry W, Pandey JP. Tumor necrosis factor-alpha gene polymorphism in psoriasis. Exp. Clin. Immunogenet. 14: 118-122 (1997).
Arias-Vasquez A, Isaacs A, Aulchenko YS, Hofman A, Oostra BA, Breteler M, van Duijn CM. The cholesteryl ester transfer protein (CETP) gene and the risk of Alzheimer's disease. Neurogenetics 8: 189-193 (2007).
Arico M. Langerhans cell histiocytosis in adults: more questions than answers? Eur. J. Cancer 40: 1467-1473 (2004). *
Arikan C, Berdeli A, Kilic M, Tumgor G, Yagci RV, Aydogdu S. Polymorphisms of the ICAM-1 gene are associated with biliary atresia. Dig. Dis. Sci. 53: 2000-2004 (2008). *
Arikan C, Berdeli A, Ozgenc F, Tumgor G, Yagci RV, Aydogdu S. Positive association of macrophage migration inhibitory factor gene-173G/C polymorphism with biliary atresia. J. Pediatr. Gastroenterol. Nutr. 42: 77-82 (2006). *
Arikan H, Koc M, Sari H, Tuglular S, Ozener C, Akoglu E. Associations between apolipoprotein E gene polymorphism and plasminogen activator inhibitor-1 and atherogenic lipid profile in dialysis patients. Ren. Fail. 29: 713-719 (2007).
Arinami T, Ohtsuki T, Ishiguro H, Ujike H, Tanaka Y, Morita Y, Mineta M, Takeichi M, Yamada S, Imamura A, Ohara K, Shibuya H, Ohara K, Suzuki Y, Muratake T, Kaneko N, Someya T, Inada T, Yoshikawa T, Toyota T, Yamada K, Kojima T, Takahashi S, et al. Genomewide high-density SNP linkage analysis of 236 Japanese families supports the existence of schizophrenia susceptibility loci on chromosomes 1p, 14q, and 20p. Am. J. Hum. Genet. 77: 937-944 (2005). *
Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, Fujita H, Hasegawa S, Takagi T, Wang FY, Hirata I, Nakano H. The relationship between Helicobacter pylori infection and promoter polymorphism of the Nrf2 gene in chronic gastritis. Int. J. Mol. Med. 19: 143-148 (2007). *
Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, Fujita H, Nakamura M, Yoshioka D, Arima Y, Okubo M, Hirata I, Nakano H. The influence of polymorphisms of interleukin-17A and interleukin-17F genes on the susceptibility to ulcerative colitis. J. Clin. Immunol. 28: 44-49 (2008). *
Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, Fujita H, Yoshioka D, Arima Y, Okubo M, Hirata I, Nakano H. The influence of promoter polymorphism of nuclear factor-erythroid 2-related factor 2 gene on the aberrant DNA methylation in gastric epithelium. Oncol. Rep. 19: 211-216 (2008). *
Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, Fujita H, Yoshioka D, Okubo M, Hirata I, Nakano H. Nrf2 gene promoter polymorphism and gastric carcinogenesis. Hepatogastroenterology 55: 750-754 (2008).
Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, Fujita H, Yoshioka D, Okubo M, Sakata M, Wang FY, Hirata I, Nakano H. Nrf2 gene promoter polymorphism is associated with ulcerative colitis in a Japanese population. Hepatogastroenterology 55: 394-397 (2008).
Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, Fujita H, Yoshioka D, Okubo M, Sakata M, Wang FY, Hirata I, Nakano H. Promoter polymorphism of cyclooxygenase-1 (COX1) is not associated with ulcerative colitis in the Japanese population. Hepatogastroenterology 55: 987-990 (2008).
Arlestig L, Wallberg Jonsson S, Stegmayr B, Rantapaa-Dahlqvist S. Polymorphism of genes related to cardiovascular disease in patients with rheumatoid arthritis. Clin. Exp. Rheumatol. 25: 866-871 (2007).
Arman A, Soylu O, Yildirim A, Furman A, Ercelen N, Aydogan H, Coker A, Tezel T. Interleukin-1 receptor antagonist gene VNTR polymorphism is associated with coronary artery disease. Arq. Bras. Cardiol. 91: 293-298 (2008). *
Arman A, Yilmaz B, Coker A, Inanc N, Direskeneli H. Interleukin-1 receptor antagonist (IL-1RN) and interleukin-1B gene polymorphisms in Turkish patients with rheumatoid arthritis. Clin. Exp. Rheumatol. 24: 643-648 (2006).
Armas JB, Gonzalez S, Martinez-Borra J, Laranjeira F, Ribeiro E, Correia J, Ferreira ML, Toste M, Lopez-Vazquez A, Lopez-Larrea C. Susceptibility to ankylosing spondylitis is independent of the Bw4 and Bw6 epitopes of HLA-B27 alleles. Tissue Antigens 53: 237-243 (1999). *
Armbruster D, Moser DA, Strobel A, Hensch T, Kirschbaum C, Lesch KP, Brocke B. Serotonin transporter gene variation and stressful life events impact processing of fear and anxiety. Int. J. Neuropsychopharmacol. 12: 393-401 (2009).
Armendariz-Borunda J, Rincon AR, Munoz-Valle JF, Bueno-Topete M, Oregon-Romero E, Islas-Carbajal MC, Medina-Preciado D, Gonzalez-Garcia I, Bautista CA, Garcia-Rocha S, Godoy J, Vazquez-Del Mercado M, Troyo-Sanroman R, Arellano-Olivera I, Lucano S, et al. Fibrogenic polymorphisms (TGF-beta, PAI-1, AT) in Mexican patients with established liver fibrosis. Potential correlation with pirfenidone treatment. J. Investig. Med. 56: 944-953 (2008).
Armstrong DL, Reiff A, Myones BL, Quismorio FP Jr, Klein-Gitelman M, McCurdy D, Wagner-Weiner L, Silverman E, Ojwang JO, Kaufman KM, Kelly JA, Merrill JT, Harley JB, Bae SC, Vyse TJ, Gilkeson GS, Gaffney PM, Moser KL, Putterman C, Edberg JC, et al. Identification of new SLE-associated genes with a two-step Bayesian study design. Genes Immun. May 14 [Epub ahead of print] (2009).
Armstrong VW, Shipkova M, von Ahsen N, Oellerich M. Analytic aspects of monitoring therapy with thiopurine medications. Ther. Drug Monit. 26: 220-226 (2004).
Armuzzi A, Ahmad T, Ling KL, De Silva A, Cullen S, van Heel D, Orchard TR, Welsh KI, Marshall SE, Jewell DP. Genotype-phenotype analysis of the Crohn's disease susceptibility haplotype on chromosome 5q31. Gut 52: 1133-1139 (2003). *
Arnaiz-Villena A, Martinez-Laso J, Corell A, Allende L, Rosal M, Gomez-Reino JJ, Vicario JL. Frequencies of HLA-A24 and HLA-DR4-DQ8 are increased and that of HLA-B blank is decreased in chronic toxic oil syndrome. Eur. J. Immunogenet. 23: 211-219 (1996).
Arnaiz-Villena A, Martinez-Laso J, Serrano-Vela JI, Reguera R, Moscoso J. HLA-G polymorphism and evolution. Tissue Antigens 69 Suppl. 1: 156-159 (2007). *
Arnaiz-Villena A, Serrano-Vela JI, Reguera R, Perez-Saborido B, Moreno E, Moscoso J. A novel allele, HLA-G*010114, with a non-coding DNA base change in exon 2. Tissue Antigens 71: 258-259 (2008). *
Arnaiz-Villena A, Vargas-Alarcon G, Serrano-Vela JI, Reguera R, Martinez-Laso J, Silvera-Redondo C, Granados J, Moscoso J. HLA-E polymorphism in Amerindians from Mexico (Mazatecans), Colombia (Wayu) and Chile (Mapuches): evolution of MHC-E gene. Tissue Antigens 69 Suppl. 1: 132-135 (2007). *
Arnaud-Lopez L, Usala G, Ceresini G, Mitchell BD, Pilia MG, Piras MG, Sestu N, Maschio A, Busonero F, Albai G, Dei M, Lai S, Mulas A, Crisponi L, Tanaka T, Bandinelli S, Guralnik JM, Loi A, Balaci L, Sole G, Prinzis A, Mariotti S, Shuldiner AR, et al. Phosphodiesterase 8B gene variants are associated with serum TSH levels and thyroid function. Am. J. Hum. Genet. 82: 1270-1280 (2008). *
Arnedo M, Taffe P, Sahli R, Furrer H, Hirschel B, Elzi L, Weber R, Vernazza P, Bernasconi E, Darioli R, Bergmann S, Beckmann JS, Telenti A, Tarr PE; the Swiss HIV Cohort Study. Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy. Pharmacogenet. Genomics 17: 755-764 (2007).
Arnett FC, Bias WB, McLean RH, Engel M, Duvic M, Goldstein R, Freni-Titulaer L, McKinley TW, Hochberg MC. Connective tissue disease in southeast Georgia. A community based study of immunogenetic markers and autoantibodies. J. Rheumatol. 17: 1029-1035 (1990).
Arnett FC, Bias WB, Reveille JD. Genetic studies in Sjogren's syndrome and systemic lupus erythematosus. J. Autoimmun. 2: 403-413 (1989).
Arnett HA, Escobar SS, Gonzalez-Suarez E, Budelsky AL, Steffen LA, Boiani N, Zhang M, Siu G, Brewer AW, Viney JL. BTNL2, a butyrophilin/B7-like molecule, is a negative costimulatory molecule modulated in intestinal inflammation. J. Immunol. 178: 1523-1533 (2007). *
Arnold S, Pelet A, Amiel J, Borrego S, Hofstra R, Tam P, Ceccherini I, Lyonnet S, Sherman S, Chakravarti A. Interaction between a chromosome 10 RET enhancer and chromosome 21 in the Down syndrome-Hirschsprung disease association. Hum. Mutat. 30: 771-775 (2009). *
Arnott ID, Ho GT, Nimmo ER, Satsangi J, Franchimont D, Vermeire S, Deviere J, Rutgeerts PJ. Toll-like receptor 4 gene in IBD: further evidence for genetic heterogeneity in Europe (Author's reply). Gut 54: 308-309 (2005). *
Aron Y, Polla BS, Bienvenu T, Dall'ava J, Dusser D, Hubert D. HLA class II polymorphism in cystic fibrosis. A possible modifier of pulmonary phenotype. Am. J. Respir. Crit. Care Med. 159: 1464-1468 (1999). *
Aron Y, Swierczewski E, Lockhart A. A simple and rapid micromethod for genomic DNA extraction from jugal epithelial cells. Application to human lymphocyte antigen typing in one large family of atopic/asthmatic probands. Allergy 49: 788-790 (1994).
Arranz Duran J, Arteaga Gonzalez A, Dom�nguez Garc�a D, Calvo Falcon R, Flores C, Gonzalez-Paredes FJ, Sanz Pereda P, Mendez Alvarez S, Garc�a Cobaleda I, Aguirre Jaime A, Arteaga Gonzalez I, Varona Bosque A, Barrera Gomez M, Soriano Benitez de Lugo A. Polymorphisms of interleukin-6 and tumor necrosis factor gene promoters and cardiorespiratory function following liver transplantation: a preliminary study. Transplant. Proc. 41: 1062-1064 (2009).
Arredondo M, Jorquera D, Carrasco E, Albala C, Hertrampf E. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with iron status in persons with type 2 diabetes mellitus. Am. J. Clin. Nutr. 86: 1347-1353 (2007). *
Arrese M, Macias RI, Briz O, Perez MJ, Marin JJ. Molecular pathogenesis of intrahepatic cholestasis of pregnancy. Expert Rev. Mol. Med. 10: e9 (2008).
Arrese M, Reyes H. Intrahepatic cholestasis of pregnancy: a past and present riddle. Ann. Hepatol. 5: 202-205 (2006). *
Arriba-Mendez S, Sanz C, Isidoro-Garcia M, Davild I, Laffond E, Horeno E, Avila C, Lorente F. 927T>C polymorphism of the cysteinyl-leukotriene type-1 receptor (CYSLTR1) gene in children with asthma and atopic dermatitis. Pediatr. Allergy Immunol. 17: 323-328 (2006). *
Arrieta-Aguirre I, Garcia-Etxebarria K, Jugo BM. Optimization of the MhcOvar-DRB1 gene typing. Tissue Antigens 67: 222-228 (2006). *
Arroyo-Espliguero R, Avanzas P, Jeffery S, Kaski JC. CD14 and Toll-like receptor 4: a link between infection and acute coronary events? Heart 90: 983-988 (2004). *
Arshad SH, Karmaus W, Kurukulaaratchy R, Sadeghnejad A, Huebner M, Ewart S. Polymorphisms in the interleukin 13 and GATA binding protein 3 genes and the development of eczema during childhood. Br. J. Dermatol. 158: 1315-1322 (2008). *
Arthur AT, Armati PJ, Bye C, Consortium SM, Heard RN, Stewart GJ, Pollard JD, Booth DR. Genes implicated in multiple sclerosis pathogenesis from consilience of genotyping and expression profiles in relapse and remission. BMC Med. Genet. 9: 17 (2008). *
Artlett CM, Black CM, Briggs DC, Stevens CO, Welsh KI. Telomere reduction in scleroderma patients: a possible cause for chromosomal instability. Br. J. Rheumatol. 35: 732-737 (1996).
Arvanitidis K, Ragia G, Iordanidou M, Kyriaki S, Xanthi A, Tavridou A, Manolopoulos VG. Genetic polymorphisms of drug-metabolizing enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population. Fundam. Clin. Pharmacol. 21: 419-426 (2007).
Asada H, Yagihashi T, Furuya M, Kosaki K, Takahashi T, Yoshimura Y. Association between patient age at the time of surgical treatment for endometriosis and aryl hydrocarbon receptor repressor polymorphism. Fertil. Steril. Jun 5 [Epub ahead of print] (2009).
Asadullah K, Eskdale J, Wiese A, Gallagher G, Friedrich M, Sterry W. Interleukin-10 promoter polymorphism in psoriasis. J. Invest. Dermatol. 116: 975-978 (2001). *
Asano K, Ikegami H, Fujisawa T, Kawabata Y, Noso S, Hiromine Y, Ogihara T. The gene for human IL-21 and genetic susceptibility to type 1 diabetes in the Japanese. Ann. N. Y. Acad. Sci. 1079: 47-50 (2006). *
Asano K, Ikegami H, Fujisawa T, Nishino M, Nojima K, Kawabata Y, Noso S, Hiromine Y, Fukai A, Ogihara T. Molecular scanning of interleukin-21 gene and genetic susceptibility to type 1 diabetes. Hum. Immunol. 68: 384-391 (2007).
Aschard H, Bouzigon E, Corda E, Ulgen A, Dizier MH, Gormand F, Lathrop M, Kauffmann F, Demenais F. Sex-specific effect of IL9 polymorphisms on lung function and polysensitization. Genes Immun. Jun 18 [Epub ahead of print] (2009).
Asensi V, Montes AH, Valle E, Ocana MG, Astudillo A, Alvarez V, Lopez-Anglada E, Solis A, Coto E, Meana A, Gonzalez P, Carton JA, Paz J, Fierer J, Celada A. The NOS3 (27-bp repeat, intron 4) polymorphism is associated with susceptibility to osteomyelitis. Nitric Oxide 16: 44-53 (2007). *
Asghar T, Yoshida S, Kennedy S, Negoro K, Zhuo W, Hamana S, Motoyama S, Nakago S, Barlow D, Maruo T. The tumor necrosis factor-alpha promoter -1031C polymorphism is associated with decreased risk of endometriosis in a Japanese population. Hum. Reprod. 19: 2509-2514 (2004). *
Ashavaid TF, Kondkar AA, Dherai AJ, Raghavan R, Udani SV, Udwadia ZF, Desai D. Application of multiplex ARMS and SSCP/HD analysis in molecular diagnosis of cystic fibrosis in Indian patients. Mol. Diagn. 9: 59-66 (2005).
Ashktorab H, Begum R, Akhgar A, Smoot DT, Elbedawi M, Daremipouran M, Zhao A, Momen B, Giardiello FM. Folate status and risk of colorectal polyps in African Americans. Dig. Dis. Sci. 52: 1462-1470 (2007). *
Askar E, Bregadze R, Mertens J, Schweyer S, Rosenberger A, Ramadori G, Mihm S. TLR3 gene polymorphisms and liver disease manifestations in chronic hepatitis C. J. Med. Virol. 81: 1204-1211 (2009). *
Asleh R, Levy AP. In vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular disease. Vasc. Health Risk Manag. 1: 19-28 (2005). *
Assassi S, Mayes MD, McNearney T, Fischbach M, Reveille JD, Arnett FC, Tan FK. Polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in systemic sclerosis. Am. J. Med. 118: 907-911 (2005). *
Assassi S, Tan FK. Genetics of scleroderma: update on single nucleotide polymorphism analysis and microarrays. Curr. Opin. Rheumatol. 17: 761-767 (2005).
Astermark J, Oldenburg J, Pavlova A, Berntorp E, Lefvert AK. Polymorphisms in the IL-10 but not in the IL-1beta and IL-4 genes are associated with inhibitor development in patients with hemophilia A. Blood 107: 3167-3172 (2006). *
Astermark J, Wang X, Oldenburg J, Berntorp E, Lefvert AK; THE MIBS STUDY GROUP. Polymorphisms in the CTLA-4 gene and inhibitor development in patients with severe hemophilia A. J. Thromb. Haemost. 5: 263-265 (2007). *
Asthana S, Roytberg M, Stamatoyannopoulos J, Sunyaev S. Analysis of sequence conservation at nucleotide resolution. PLoS Comput. Biol. 3: e254 (2007). *
Astolfi CM, Shinohara AL, da Silva RA, Santos MC, Line SR, de Souza AP. Genetic polymorphisms in the MMP-1 and MMP-3 gene may contribute to chronic periodontitis in a Brazilian population. J. Clin. Periodontol. 33: 699-703 (2006). *
Asumalahti K, Laitinen T, Itkonen-Vatjus R, Lokki ML, Suomela S, Snellman E, Saarialho-Kere U, Kere J. A candidate gene for psoriasis near HLA-C, HCR (Pg8), is highly polymorphic with a disease-associated susceptibility allele. Hum. Mol. Genet. 9: 1533-1542 (2000). *
Asumalahti K, Veal C, Laitinen T, Suomela S, Allen M, Elomaa O, Moser M, de Cid R, Ripatti S, Vorechovsky I, Marcusson JA, Nakagawa H, Lazaro C, Estivill X, Capon F, Novelli G, Saarialho-Kere U, Barker J, Trembath R, Kere J; Psoriasis Consortium. Coding haplotype analysis supports HCR as the putative susceptibility gene for psoriasis at the MHC PSORS1 locus. Hum. Mol. Genet. 11: 589-597 (2002). *
Asuni C, Stochino ME, Cherchi A, Manchia M, Congiu D, Manconi F, Squassina A, Piccardi MP, Del Zompo M. Migraine and tumour necrosis factor gene polymorphism: an association study in a Sardinian sample. J. Neurol. 256: 194-197 (2009).
Atabani SF, Thio CL, Divanovic S, Trompette A, Belkaid Y, Thomas DL, Karp CL. Association of CTLA4 polymorphism with regulatory T cell frequency. Eur. J. Immunol. 35: 2157-2162 (2005). *
Atalay A, Yildiz-Demirtepe S, Tatlipinar S, Sanli-Erdogan B, Cobankara V, Yildirim C, Bagci H, Atalay EO. HLA-B51 gene and its expression in association with Behcet's disease in Denizli province of Turkey. Mol. Biol. Rep. 35: 345-349 (2008). *
Atan D, Turner SJ, Kilmartin DJ, Forrester JV, Bidwell J, Dick AD, Churchill AJ. Cytokine gene polymorphism in sympathetic ophthalmia. Invest. Ophthalmol. Vis. Sci. 46: 4245-4250 (2005). *
Ates O, Dalyan L, Hatemi G, Hamuryudan V, Topal-Sarikaya A. Genetic susceptibility to Behcet's syndrome is associated with NRAMP1 (SLC11A1) polymorphism in Turkish patients. Rheumatol. Int. 29: 787-791 (2009). *
Ates O, Dalyan L, Musellim B, Hatemi G, Turker H, Ongen G, Hamuryudan V, Topal-Sarikaya A. NRAMP1 (SLC11A1) gene polymorphisms that correlate with autoimmune versus infectious disease susceptibility in tuberculosis and rheumatoid arthritis. Int. J. Immunogenet. 36: 15-19 (2009). *
Ates O, Hatemi G, Hamuryudan V, Topal-Sarikaya A. Tumor necrosis factor-alpha and interleukin-10 gene promoter polymorphisms in Turkish rheumatoid arthritis patients. Clin. Rheumatol. 27: 1243-1248 (2008). *
Ates O, Musellim B, Ongen G, Topal-Sarikaya A. NRAMP1 (SLC11A1): a plausible candidate gene for systemic sclerosis (SSc) with interstitial lung involvement. J. Clin. Immunol. 28: 73-77 (2008). *
Ates O, Musellim B, Ongen G, Topal-Sarikaya A. Interleukin-10 and tumor necrosis factor-alpha gene polymorphisms in tuberculosis. J. Clin. Immunol. 28: 232-236 (2008). *
Ates O, Musellim B, Ongen G, Topal-Sarikaya A. Association between 'interleukin' 10 gene (IL10) polymorphisms and systemic sclerosis with interstitial lung involvement. Rheumatol. Int. 28: 1123-1126 (2008). *
Ates O, Musellim B, Ongen G, Topal-Sarikaya A. Analysis of TNF polymorphisms in Turkish systemic sclerosis patients with interstitial lung involvement. Biochem. Genet. 46: 696-701 (2008). *
Atik B, Skwor TA, Kandel RP, Sharma B, Adhikari HK, Steiner L, Erlich H, Dean D. Identification of novel single nucleotide polymorphisms in inflammatory genes as risk factors associated with trachomatous trichiasis. PLoS ONE 3: e3600 (2008). *
Atkinson SH, Rockett KA, Morgan G, Bejon PA, Sirugo G, O'Connell MA, Hanchard N, Kwiatkowski D, Prentice AM. Tumor necrosis factor SNP haplotypes are associated with iron deficiency anemia in West African children. Blood 112: 4276-4283 (2008). *
Atouf O, Benbouazza K, Brick C, Bzami F, Bennani N, Amine B, Hajja-Hassouni N, Essakali M. HLA polymorphism and early rheumatoid arthritis in the Moroccan population. Joint Bone Spine 75: 554-558 (2008). *
Attia J, Ioannidis JP, Thakkinstian A, McEvoy M, Scott RJ, Minelli C, Thompson J, Infante-Rivard C, Guyatt G. How to use an article about genetic association. A: Background concepts. JAMA 301: 74-81 (2009). *
Atug O, Tahan V, Eren F, Tiftikci A, Imeryuz N, Hamzaoglu HO, Tozun N. Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma (PPARgamma) gene in inflammatory bowel disease. J. Gastrointestin. Liver Dis. 17: 433-437 (2008). *
Atzeni F, Boiardi L, Casali B, Farnetti E, Sarzi-Puttini P, Pipitone N, Olivieri I, Cantini F, Salvi F, La Corte R, Triolo G, Filippini D, Paolazzi G, Salvarani C. Lack of association of the 463 G/A myeloperoxidase promoter polymorphism with Behcet's disease in Italian patients. Rheumatology (Oxford) 46: 1547-1550 (2007). *
Audrezet MP, Dabricot A, Le Marechal C, Ferec C. Validation of high-resolution DNA melting analysis for mutation scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. J. Mol. Diagn. 10: 424-434 (2008).
Auguet T, Vidal F, Lopez-Dupla M, Broch M, Gutierrez C, Olona M, Oltra C, Aguilar C, Gonzalez E, Quer JC, Sirvent JJ, Richart C. A study on the TNF-alpha system in Caucasian Spanish patients with alcoholic liver disease. Drug Alcohol Depend. 92: 91-99 (2008).
Aulisa L, Papaleo P, Pola E, Angelini F, Aulisa AG, Tamburrelli FC, Pola P, Logroscino CA. Association between IL-6 and MMP-3 gene polymorphisms and adolescent idiopathic scoliosis: a case-control study. Spine 32: 2700-2702 (2007).
Avbelj M, Tahirovic H, Debeljak M, Kusekova M, Toromanovic A, Krzisnik C, Battelino T. High prevalence of thyroid peroxidase gene mutations in patients with thyroid dyshormonogenesis. Eur. J. Endocrinol. 156: 511-519 (2007). *
Averdam A, Kuhl H, Sontag M, Becker T, Hughes AL, Reinhardt R, Walter L. Genomics and diversity of the common marmoset monkey NK complex. J. Immunol. 178: 7151-7161 (2007). *
Avila JJ, Lympany PA, Pantelidis P, Welsh KI, Black CM, du Bois RM. Fibronectin gene polymorphisms associated with fibrosing alveolitis in systemic sclerosis. Am. J. Respir. Cell. Mol. Biol. 20: 106-112 (1999). *
Awadallah S, Hamad M. The prevalence of type II diabetes mellitus is haptoglobin phenotype-independent. Cytobios. 101: 145-150 (2000).
Awadallah S, Hamad M. A study of haptoglobin phenotypes in patients with chronic renal failure. Ann. Clin. Biochem. 40: 680-683 (2003).
Awakura Y, Ito N, Nakamura E, Takahashi T, Kotani H, Mikami Y, Manabe T, Kamoto T, Habuchi T, Ogawa O. Matrix metalloproteinase-9 polymorphisms and renal cell carcinoma in a Japanese population. Cancer Lett. 241: 59-63 (2006). *
Awata T, Kanazawa Y. Genetic markers for insulin-dependent diabetes mellitus in Japanese. Diabetes Res. Clin. Pract. 24: S83-S87 (1994).
Awata T, Kurihara S, Iitaka M, Takei S, Inoue I, Ishii C, Negishi K, Izumida T, Yoshida Y, Hagura R, Kuzuya N, Kanazawa Y, Katayama S. Association of CTLA-4 gene A-G polymorphism (IDDM12 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves' disease and Hashimoto's thyroiditis) in the Japanese population. Diabetes 47: 128-129 (1998).
Awomoyi A, Sirugo G, Newport MJ, Tishkoff S. Global distribution of a novel trinucleotide microsatellite polymorphism (ATA) in intron 8 of the SLC11A1 gene and susceptibility to pulmonary tuberculosis. Int. J. Immunogenet. 33: 11-15 (2006). *
Awomoyi AA, Marchant A, Howson JM, McAdam KP, Blackwell JM, Newport MJ. Interleukin-10, polymorphism in SLC11A1 (formerly NRAMP1), and susceptibility to tuberculosis. J. Infect. Dis. 186: 1808-1814 (2002). *
Axtner J, Sommer S. Gene duplication, allelic diversity, selection processes and adaptive value of MHC class II DRB genes of the bank vole, Clethrionomys glareolus. Immunogenetics 59: 417-426 (2007). *
Ay C, Bencur P, Vormittag R, Sailer T, Jungbauer C, Vukovich T, Mannhalter C, Pabinger I. The angiotensin-converting enzyme insertion/deletion polymorphism and serum levels of angiotensin-converting enzyme in venous thromboembolism. Data from a case control study. Thromb. Haemost. 98: 777-782 (2007).
Ayala YM, Pagani F, Baralle FE. TDP43 depletion rescues aberrant CFTR exon 9 skipping. FEBS Lett. 580: 1339-1344 (2006). *
Aydin F, Kara N, Senturk N, Gunes S, Canturk M, Bagci H, Bek Y, Turanli A. Lack of association between leptin G2548A gene polymorphism and Behcet's disease. J. Eur. Acad. Dermatol. Venereol. 21: 68-71 (2007).
Ayed K, Ayed-Jendoubi S, Ben Abdallah T, Bardi R, Gorgi Y, Sfar I, Dhrif B, Abderrahim E, Kheder A. Polymorphism of the renin-angiotensin-aldosterone system in patients with chronic allograft dysfunction. Transpl. Immunol. 15: 303-309 (2006).
Ayesh S, Abu-Rmaileh H, Nassar S, Al-Shareef W, Abu-Libdeh B, Muhanna A, Al-Kafri F. Molecular analysis of MEFV gene mutations among Palestinian patients with Behcet's disease. Scand. J. Rheumatol. 37: 370-374 (2008).
Aytekin C, Dogu F, Ikinciogullari A, Egin Y, Yuksek M, Bozdogan G, Akar N, Babacan E. TGF-beta1-915G/C and TNF-alpha-308G/A polymorphisms in children with asthma. Tuberk. Toraks. 57: 62-67 (2009).
Azad AK, Rauh R, Vermeulen F, Jaspers M, Korbmacher J, Boissier B, Bassinet L, Fichou Y, Georges MD, Stanke F, De Boeck K, Dupont L, Balascakova M, Hjelte L, Lebecque P, Radojkovic D, Castellani C, Schwartz M, Stuhrmann M, Schwarz M, Skalicka V, et al. Mutations in the amiloride-sensitive epithelial sodium channel in patients with cystic fibrosis-like disease. Hum. Mutat. Mar 3 [Epub ahead of print] (2009).
Azarian M, Busson M, Rocha V, Ribaud P, Peffault de Latour R, Bleux H, Lepage V, Charron D, Toubert A, Socie G, Loiseau P. The PTPN22 R620W polymorphism is associated with severe bacterial infections after human leukocyte antigen geno-identical haematopoietic stem-cell transplantations. Transplantation 85: 1859-1862 (2008).
Azarpira N, Aghdai MH, Raisjalali GA, Darai M, Tarahi MJ. Influence of recipient and donor IL-10, TNFA and INFG genotypes on the incidence of acute renal allograft rejection. Mol. Biol. Rep. 36: 1621-1626 (2009). *
Azarpira N, Aghdaie MH, Behzad-Behbahanie A, Geramizadeh B, Behzadi S, Malekhoseinie SA, Raisjalal GH, Rahsaz M, Pourgholami A, Sagheb F. Association between cyclosporine concentration and genetic polymorphisms of CYP3A5 and MDR1 during the early stage after renal transplantation. Exp. Clin. Transplant. 4: 416-419 (2006).
Azarpira N, Dehghani M, Aghdaie MH, Darai M. Interleukin-7 receptor-alpha gene polymorphisms in bone marrow transplant recipients. Mol. Biol. Rep. Mar 1 [Epub ahead of print] (2009).
Azarpira N, Nikeghbalian S, Geramizadeh B, Darai M. Influence of glutathione S-transferase M1 and T1 polymorphisms with acute rejection in Iranian liver transplant recipients. Mol. Biol. Rep. Feb 28 [Epub ahead of print] (2009). *
Azarpira N, Raisjalali G, Darai M. Polymorphism of the methylenetetrahydrofolate reductase C677T gene with chronic allograft nephropathy in renal transplant recipients. Exp. Clin. Transplant. 6: 54-58 (2008).
Azarpira N, Ramzi M, Aghdaie MH, Darai M, Geramizadeh B. Interleukin-10 gene polymorphism in bone marrow transplant recipients. Exp. Clin. Transplant. 6: 74-79 (2008).
Azarpira N, Ramzi M, Aghdaie MH, Daraie M, Geramizadeh B. Methylenetetrahydrofolate reductase C677T genotypes and clinical outcome following hematopoietic cell transplant. Exp. Clin. Transplant. 5: 693-697 (2007).
Azarpira N, Sagheb MM, Geramizadeh B, Darai M. Vitamin D receptor genotypes and kidney allograft rejection. Mol. Biol. Rep. Mar 19 [Epub ahead of print] (2009). *
Azim K, McManus R, Brophy K, Ryan A, Kelleher D, Reynolds JV. Genetic polymorphisms and the risk of infection following esophagectomy: positive association with TNF-alpha gene -308 genotype. Ann. Surg. 246: 122-128 (2007). *
Azizah MR, Kuak SH, Ainol SS, Rahim MN, Normaznah Y, Norella K. Association of the tumor necrosis factor alpha gene polymorphism with susceptibility and clinical-immunological findings of systemic lupus erythematosus. Asian Pac. J. Allergy Immunol. 22: 159-163 (2004).
Azmy IA, Balasubramanian SP, Wilson AG, Stephenson TJ, Cox A, Brown NJ, Reed MW. Role of tumour necrosis factor gene polymorphisms (-308 and -238) in breast cancer susceptibility and severity. Breast Cancer Res. 6: R395-R400 (2004). *
Baars C, Leeb T, von Klopmann T, Tipold A, Potschka H. Allele-specific polymerase chain reaction diagnostic test for the functional MDR1 polymorphism in dogs. Vet. J. 177: 394-397 (2008).
Babalini C, Tarsi T, Martinez-Labarga C, Scano G, Pepe G, De Stefano GF, Rickards O. COL1A2 (type I collagen) polymorphisms in the Colorado Indians of Ecuador. Ann. Hum. Biol. 32: 666-678 (2005).
Babb C, van der Merwe L, Beyers N, Pheiffer C, Walzl G, Duncan K, van Helden P, Hoal EG. Vitamin D receptor gene polymorphisms and sputum conversion time in pulmonary tuberculosis patients. Tuberculosis (Edinb.) 87: 295-302 (2007).
Babel N, Vergopoulos A, Trappe RU, Oertel S, Hammer MH, Karaivanov S, Schneider N, Riess H, Papp-Vary M, Neuhaus R, Gondek LP, Volk HD, Reinke P. Evidence for genetic susceptibility towards development of posttransplant lymphoproliferative disorder in solid organ recipients. Transplantation 84: 387-391 (2007).
Babula O, Linhares IM, Bongiovanni AM, Ledger WJ, Witkin SS. Association between primary vulvar vestibulitis syndrome, defective induction of tumor necrosis factor-alpha, and carriage of the mannose-binding lectin codon 54 gene polymorphism. Am. J. Obstet. Gynecol. 198: 101.e1-101.e4 (2008). *
Babusukumar U, Wang T, McGuire E, Broeckel U, Kugathasan S. Contribution of OCTN variants within the IBD5 locus to pediatric onset Crohn's disease. Am. J. Gastroenterol. 101: 1354-1361 (2006). *
Baca V, Velazquez-Cruz R, Salas-Martinez G, Espinosa-Rosales F, Saldana-Alvarez Y, Orozco L. Association analysis of the PTPN22 gene in childhood-onset systemic lupus erythematosus in Mexican population. Genes Immun. 7: 693-695 (2006). *
Bacanli A, Sallakci N, Yavuzer U, Alpsoy E, Yegin O. Toll-like receptor 2 Arg753Gln gene polymorphism in Turkish patients with Behcet's disease. Clin. Exp. Dermatol. 31: 699-701 (2006). *
Bach JM, Otto H, Nepom GT, Jung G, Cohen H, Timsit J, Boitard C, van Endert PM. High affinity presentation of an autoantigenic peptide in type I diabetes by an HLA class II protein encoded in a haplotype protecting from disease. J. Autoimmun. 10: 375-386 (1997).
Bachvarov DR, Landry M, Houle S, Pare P, Marceau F. Altered frequency of a promoter polymorphic allele of the kinin B1 receptor gene in inflammatory bowel disease. Gastroenterology 115: 1045-1048 (1998). *
B�ckdahl L, Guo JP, Jagodic M, Becanovic K, Ding B, Olsson T, Lorentzen JC. Definition of arthritis candidate risk genes by combining rat linkage-mapping results with human case control association data. Ann. Rheum. Dis. Dec 9 [Epub ahead of print] (2008). *
Bacolod MD, Schemmann GS, Giardina SF, Paty P, Notterman DA, Barany F. Emerging paradigms in cancer genetics: some important findings from high-density single nucleotide polymorphism array studies. Cancer Res. 69: 723-727 (2009). *
Bacolod MD, Schemmann GS, Wang S, Shattock R, Giardina SF, Zeng Z, Shia J, Stengel RF, Gerry N, Hoh J, Kirchhoff T, Gold B, Christman MF, Offit K, Gerald WL, Notterman DA, Ott J, Paty PB, Barany F. The signatures of autozygosity among patients with colorectal cancer. Cancer Res. 68: 2610-2621 (2008). *
Bacsi K, Hitre E, Kosa JP, Horvath H, Lazary A, Lakatos PL, Balla B, Budai B, Lakatos P, Speer G. Effects of the lactase 13910 C/T and calcium-sensor receptor A986S G/T gene polymorphisms on the incidence and recurrence of colorectal cancer in Hungarian population. BMC Cancer 8: 317 (2008). *
Badenhoop K. Genetic markers in thyroid autoimmune diseases. Z. Arztl. Fortbild. Qualitatssich. 98 Suppl. 5: 13-15 (2004).
Badenhoop K, Donner H, Pani M, Rau H, Siegmund T, Braun J. Genetic susceptibility to type 1 diabetes: clinical and molecular heterogeneity of IDDM1 and IDDM12 in a German population. Exp. Clin. Endocrinol. Diabetes 107 Suppl. 3: S89-S92 (1999).
Badenhoop K, Schwarz G, Schleusener H, Weetman AP, Recks S, Peters H, Bottazzo GF, Usadel KH. Tumor necrosis factor beta gene polymorphisms in Graves' disease. J. Clin. Endocrinol. Metab. 74: 287-291 (1992).
Badenhoop K, Schwarz G, Trowsdale J, Lewis V, Usadel KH, Gale EA, Bottazzo GF. TNF-alpha gene polymorphisms in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 32: 445-448 (1989).
Badenhoop K, Walfish PG, Rau H, Fischer S, Nicolay A, Bogner U, Schleusener H, Usadel KH. Susceptibility and resistance alleles of human leukocyte antigen (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune disease. J. Clin. Endocrinol. Metab. 80: 2112-2117 (1995). *
Badger SA, Soong CV, O' Donnell ME, Mercer C, Young IS, Hughes AE. C-reactive protein (CRP) elevation in patients with abdominal aortic aneurysm is independent of the most important CRP genetic polymorphism. J. Vasc. Surg. 49: 178-184 (2009).
Badii R, Bener A, Zirie M, Al-Rikabi A, Simsek M, Al-Hamaq AO, Ghoussaini M, Froguel P, Wareham NJ. Lack of association between the Pro(12)Ala polymorphism of the PPAR-gamma2 gene and type 2 diabetes mellitus in the Qatari consanguineous population. Acta Diabetol. 45: 15-21 (2008). *
Bae SJ, Kim JW, Kang H, Hwang SG, Oh D, Kim NK. Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936 C>T) gene and colon cancer in Korea. Anticancer Res. 28: 1271-1276 (2008).
Bae SY, Choi SK, Kim KR, Park CS, Lee SK, Roh HK, Shin DW, Pie JE, Woo ZH, Kang JH. Effects of genetic polymorphisms of MDR1, FMO3 and CYP1A2 on susceptibility to colorectal cancer in Koreans. Cancer Sci. 97: 774-779 (2006). *
Baena A, Leung JY, Sullivan AD, Landires I, Vasquez-Luna N, Qui�ones-Berrocal J, Fraser PA, Uko GP, Delgado JC, Clavijo OP, Thim S, Meshnick SR, Nyirenda T, Yunis EJ, Goldfeld AE. TNF-alpha promoter single nucleotide polymorphisms are markers of human ancestry. Genes Immun. 3: 482-487 (2002). *
Baena A, Mootnick AR, Falvo JV, Tsytskova AV, Ligeiro F, Diop OM, Brieva C, Gagneux P, O'Brien SJ, Ryder OA, Goldfeld AE. Primate TNF promoters reveal markers of phylogeny and evolution of innate immunity. PLoS ONE 2: e621 (2007). *
Baerwald CG, Panayi GS, Lanchbury JS. Corticotropin releasing hormone promoter region polymorphisms in rheumatoid arthritis. J. Rheumatol. 24: 215-216 (1997).
Bafna V, Bansal V. Inference about recombination from haplotype data: lower bounds and recombination hotspots. J. Comput. Biol. 13: 501-521 (2006).
Baganz NL, Horton RE, Calderon AS, Owens WA, Munn JL, Watts LT, Koldzic-Zivanovic N, Jeske NA, Koek W, Toney GM, Daws LC. Organic cation transporter 3: keeping the brake on extracellular serotonin in serotonin-transporter-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 105: 18976-18981 (2008). *
Bagarolli RA, Saad MJ, Saad ST. Toll-like receptor 4 and inducible nitric oxide synthase gene polymorphisms are associated with Type 2 diabetes. J. Diabetes Complications Apr 21 [Epub ahead of print] (2009).
Bagnall RD, Roberts RG, Mirza MM, Torigoe T, Prescott NJ, Mathew CG. Novel isoforms of the CARD8 (TUCAN) gene evade a nonsense mutation. Eur. J. Hum. Genet. 16: 619-625 (2008). *
Bagnoli S, Cellini E, Tedde A, Nacmias B, Piacentini S, Bessi V, Bracco L, Sorbi S. Association of IL10 promoter polymorphism in Italian Alzheimer's disease. Neurosci. Lett. 418: 262-265 (2007). *
Bagnoli S, Putignano AL, Melean G, Baglioni S, Sestini R, Milla M, d'Albasio G, Genuardi M, Pacini F, Trallori G, Papi L. Susceptibility to refractory ulcerative colitis is associated with polymorphism in the hMLH1 mismatch repair gene. Inflamm. Bowel Dis. 10: 705-708 (2004). *
Bagos PG, Karnaouri AC, Nikolopoulos GK, Hamodrakas SJ. No evidence for association of CTLA-4 gene polymorphisms with the risk of developing multiple sclerosis: a meta-analysis. Mult. Scler. 13: 156-168 (2007).
Bahaoddini A, Farrashbandi H, Saadat M. Genetic polymorphism of glutathione S-transferase T1 (GSTT1) and QT-interval in schizophrenia patients. J. Mol. Neurosci. 38: 173-177 (2009).
Bai C, Matsui E, Ohnishi H, Kimata K, Kasahara K, Kaneko H, Kato Z, Fukao T, Kondo N. A novel polymorphism, E254K, in the 5-lipoxygenase gene associated with bronchial asthma. Int. J. Mol. Med. 21: 139-144 (2008). *
Bai J, Jiang L, Lin M, Zeng X, Wang Z, Chen Q. Association of polymorphisms in the tumor necrosis factor-alpha and interleukin-10 gene with oral lichen planus: a study in a Chinese cohort with Han ethnicity. J. Interferon Cytokine Res. May 18 [Epub ahead of print] (2009).
Bai J, Zhang Y, Lin M, Zeng X, Wang Z, Shen J, Jiang L, Gao F, Chen Q. Interleukin-18 gene polymorphisms and haplotypes in patients with oral lichen planus: a study in an ethnic Chinese cohort. Tissue Antigens 70: 390-397 (2007). *
Bai JL, Zheng MH, Xia X, Ter-Minassian M, Chen YP, Chen F. MTHFR C677T polymorphism contributes to prostate cancer risk among Caucasians: a meta-analysis of 3511 cases and 2762 controls. Eur. J. Cancer 45: 1443-1449 (2009). *
Baier LJ, Permana PA, Traurig M, Dobberfuhl A, Wiedrich C, Sutherland J, Thuillez P, Luczy-Bachman G, Hara M, Horikawa Y, Hinokio Y, Hanson RL, Bogardus C. Mutations in the genes for hepatocyte nuclear factor (HNF)-1alpha, -4alpha, -1beta, and -3beta; the dimerization cofactor of HNF-1; and insulin promoter factor 1 are not common causes of early-onset type 2 diabetes in Pima Indians. Diabetes Care 23: 302-304 (2000). *
Bailey LB. Folate, methyl-related nutrients, alcohol, and the MTHFR 677C-->T polymorphism affect cancer risk: intake recommendations. J. Nutr. 133: 3748S-3753S (2003). *
Bailey SD, Loredo-Osti JC, Lepage P, Faith J, Fontaine J, Desbiens KM, Hudson TJ, Bouchard C, Gaudet D, Perusse L, Vohl MC, Engert JC. Common polymorphisms in the promoter of the visfatin gene (PBEF1) influence plasma insulin levels in a French-Canadian population. Diabetes 55: 2896-2902 (2006). *
Bailey-Wilson JE, Almasy L, de Andrade M, Bailey J, Bickeboller H, Cordell HJ, Daw EW, Goldin L, Goode EL, Gray-McGuire C, Hening W, Jarvik G, Maher BS, Mendell N, Paterson AD, Rice J, Satten G, Suarez B, Vieland V, Wilcox M, Zhang H, Ziegler A, et al. Genetic Analysis Workshop 14: microsatellite and single-nucleotide polymorphism marker loci for genome-wide scans. BMC Genet. 6 Suppl. 1: S1 (2005). *
Baines M, Ebringer A. HLA and disease. Mol. Aspects Med. 13: 263-378 (1992).
Baioni CS, de Souza CM, Ribeiro Braosi AP, Luczyszyn SM, Dias da Silva MA, Ignacio SA, Naval Machado MA, Benato Martins WD, Riella MC, Pecoits-Filho R, Trevilatto PC. Analysis of the association of polymorphism in the osteoprotegerin gene with susceptibility to chronic kidney disease and periodontitis. J. Periodontal Res. 43: 578-584 (2008).
Baird NA, Etter PD, Atwood TS, Currey MC, Shiver AL, Lewis ZA, Selker EU, Cresko WA, Johnson EA. Rapid SNP discovery and genetic mapping using sequenced RAD markers. PLoS ONE 3: e3376 (2008). *
Bairead E, Harmon DL, Curtis AM, Kelly Y, O'Leary C, Gardner M, Leahy DT, Vaughan P, Keegan D, O'Morain C, O'Donoghue D, Shanahan F, Parfrey NA, Quane KA. Association of NOD2 with Crohn's disease in a homogenous Irish population. Eur. J. Hum. Genet. 11: 237-244 (2003). *
Baker BS, Powles A, Fry L. Peptidoglycan: a major aetiological factor for psoriasis? Trends Immunol. 27: 545-551 (2006). *
Baker DE. Pharmacogenomics of azathioprine and 6-mercaptopurine in gastroenterologic therapy. Rev. Gastroenterol. Disord. 3: 150-157 (2003). *
Bakhtadze E, Cervin C, Lindholm E, Borg H, Nilsson P, Arnqvist HJ, Bolinder J, Eriksson JW, Gudbjornsdottir S, Nystrom L, Agardh CD, Landin-Olsson M, Sundkvist G, Groop LC. Common variants in the TCF7L2 gene help to differentiate autoimmune from non-autoimmune diabetes in young (15-34 years) but not in middle-aged (40-59 years) diabetic patients. Diabetologia 51: 2224-2232 (2008). *
Baksh MF, Balding DJ, Vyse TJ, Whittaker JC. Family-based association analysis with ordered categorical phenotypes, covariates and interactions. Genet. Epidemiol. 31: 1-8 (2007).
Balada E, Simeon-Aznar CP, Serrano-Acedo S, Martinez-Lostao L, Selva-O' Callaghan A, Fonollosa-Pla V, Vilardell-Tarres M. Lack of association of the PTPN22 gene polymorphism R620W with systemic sclerosis. Clin. Exp. Rheumatol. 24: 321-324 (2006).
Balada E, Villarreal-Tolchinsky J, Ordi-Ros J, Labrador M, Serrano-Acedo S, Martinez-Lostao L, Vilardell-Tarres M. Multiplex family-based study in systemic lupus erythematosus: association between the R620W polymorphism of PTPN22 and the FcgammaRIIa (CD32A) R131 allele. Tissue Antigens 68: 432-438 (2006). *
Balaguer F, Castellvi-Bel S, Castells A, Andreu M, Munoz J, Gisbert JP, Llor X, Jover R, de Cid R, Gonzalo V, Bessa X, Xicola RM, Pons E, Alenda C, Paya A, Pique JM; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study. Clin. Gastroenterol. Hepatol. 5: 379-387 (2007).
Balas A, Aviles MJ, Alonso-Nieto M, Zarapuz L, Blanco L, Garcia-Sanchez F, Vicario JL. HLA-DQA1 introns 2 and 3 sequencing: DQA1 sequencing-based typing and characterization of a highly polymorphic microsatellite at intron 3 of DQA1*0505. Hum. Immunol. 66: 903-911 (2005).
Balas A, Bustamante L, Garcia-Sanchez F, Vicario JL. The new HLA-C allele, Cw*0220, shows a new polymorphism at amino acid position 169. Tissue Antigens 71: 93 (2008). *
Balas A, Bustamante L, Garcia-Sanchez F, Vicario JL. HLA-A*020115 and HLA-Cw*030203 show new synonymous mutations in exon 4. Tissue Antigens 70: 340-341 (2007). *
Balas A, Bustamante L, Garcia-Sanchez F, Vicario JL. Sequencing of a novel HLA-DRB1*07 allele with a new polymorphism at amino acid position 21 (DRB1*0715). Tissue Antigens 71: 179-180 (2008). *
Balas A, Garcia-Sanchez F, Vicario JL. Sequencing of a new HLA-C allele, HLA-Cw*0742, with a novel HLA polymorphism at exon 3. Tissue Antigens 68: 530-531 (2006). *
Balas A, Sanchez-Gordo F, Garcia-Sanchez F, Prat I, Vicario JL. HLA-B*9523 increases the extremely high B*15-group polymorphism. Tissue Antigens 69: 620-621 (2007). *
Balbi G, Ferrera F, Rizzi M, Piccioli P, Morabito A, Cardamone L, Ghio M, Palmisano GL, Carrara P, Pedemonte S, Sessarego M, De Angioletti M, Notaro R, Indiveri F, Pistillo MP. Association of -318 C/T and +49 A/G cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms with a clinical subset of Italian patients with systemic sclerosis. Clin. Exp. Immunol. 149: 40-47 (2007). *
Balcerzyk A, Zak I, Krauze J. Synergistic effects between Q192R polymorphism of paraoxonase 1 gene and some conventional risk factors in premature coronary artery disease. Arch. Med. Res. 38: 545-550 (2007).
Balcerzyk A, Zak I, Krauze J. Synergistic effect between polymorphisms of PPARA and ABCA1 genes on the premature coronary artery disease. Acta Cardiol. 62: 233-238 (2007).
Balci-Peynircioglu B, Taskiran ZE, T�rel B, Arici M, Bakkaloglu A, Ozen S, Yilmaz E. The analysis of interleukin-1 receptor antagonist and interleukin-1beta gene polymorphisms in Turkish FMF patients: do they predispose to secondary amyloidosis? Clin. Exp. Rheumatol. 26: S99-S102 (2008).
Baldassano RN, Bradfield JP, Monos DS, Kim CE, Glessner JT, Casalunovo T, Frackelton EC, Otieno FG, Kanterakis S, Shaner JL, Smith RM, Eckert AW, Robinson LJ, Onyiah CC, Abrams DJ, Chiavacci RM, Skraban R, Devoto M, Grant SF, Hakonarson H. Association of variants of the interleukin-23 receptor gene with susceptibility to pediatric Crohn's disease. Clin. Gastroenterol. Hepatol. 5: 972-976 (2007).
Balding J, Healy CM, Livingstone WJ, White B, Mynett-Johnson L, Cafferkey M, Smith OP. Genomic polymorphic profiles in an Irish population with meningococcaemia: is it possible to predict severity and outcome of disease? Genes Immun. 4: 533-540 (2003). *
Balding J, Kane D, Livingstone W, Mynett-Johnson L, Bresnihan B, Smith O, FitzGerald O. Cytokine gene polymorphisms: association with psoriatic arthritis susceptibility and severity. Arthritis Rheum. 48: 1408-1413 (2003). *
Balding J, Livingstone WJ, Conroy J, Mynett-Johnson L, Weir DG, Mahmud N, Smith OP. Inflammatory bowel disease: the role of inflammatory cytokine gene polymorphisms. Mediators Inflamm.13: 181-187 (2004). *
Balic I, Angel B, Codner E, Carrasco E, Perez-Bravo F. Association of CTLA-4 polymorphisms and clinical-immunologic characteristics at onset of type 1 diabetes mellitus in children. Hum. Immunol. 70: 116-120 (2009).
Balistreri CR, Grimaldi MP, Chiappelli M, Licastro F, Castiglia L, List� F, Vasto S, Lio D, Caruso C, Candore G. Association between the polymorphisms of TLR4 and CD14 genes and Alzheimer's disease. Curr. Pharm. Des. 14: 2672-2677 (2008).
Balistreri CR, Grimaldi MP, Chiappelli M, Licastro F, Castiglia L, List� F, Vasto S, Lio D, Caruso C, Candore G. Association between the polymorphisms of TLR4 and CD14 genes and Alzheimer's disease. Curr. Pharm. Des. 14: 2672-2677 (2008).
Balistreri CR, Grimaldi MP, Vasto S, Listi F, Chiappelli M, Licastro F, Lio D, Caruso C, Candore G. Association between the polymorphism of CCR5 and Alzheimer's disease: results of a study performed on male and female patients from northern Italy. Ann. N. Y. Acad. Sci. 1089: 454-461 (2006). *
Balistreri WF. Genetic liver disease. 54th Annual Meeting of the American Association for the Study of Liver Diseases (2003).
Balladares S, Alaez C, Pujol J, Duran C, Navarro JL, Gorodezky C. Distribution of TAP gene polymorphisms and extended MHC haplotypes in Mexican Mestizos and in Seri Indians from northwest Mexico. Genes Immun. 3: 78-85 (2002). *
Balog A, Gal J, Gyulai Z, Zsilak S, Mandi Y. Tumour necrosis factor-alpha and heat-shock protein 70-2 gene polymorphisms in a family with rheumatoid arthritis. Acta Microbiol. Immunol. Hung. 51: 263-269 (2004).
Balog A, Gyulai Z, Boros LG, Farkas G, Takacs T, Lonovics J, Mandi Y. Polymorphism of the TNF-alpha, HSP70-2, and CD14 genes increases susceptibility to severe acute pancreatitis. Pancreas 30: e46-e50 (2005).
Balog A, Klausz G, Gal J, Molnar T, Nagy F, Ocsovszky I, Gyulai Z, Mandi Y. Investigation of the prognostic value of TNF-alpha gene polymorphism among patients treated with infliximab, and the effects of infliximab therapy on TNF-alpha production and apoptosis. Pathobiology 71: 274-280 (2004).
Bamm VV, Tsemakhovich VA, Shaklai M, Shaklai N. Haptoglobin phenotypes differ in their ability to inhibit heme transfer from hemoglobin to LDL. Biochemistry 43: 3899-3906 (2004). *
Bamoulid J, Courivaud C, Deschamps M, Mercier P, Ferrand C, Penfornis A, Tiberghien P, Chalopin JM, Saas P, Ducloux D. IL-6 promoter polymorphism -174 is associated with new-onset diabetes after transplantation. J. Am. Soc. Nephrol. 17: 2333-2340 (2006). *
Bamshad MJ, Mummidi S, Gonzalez E, Ahuja SS, Dunn DM, Watkins WS, Wooding S, Stone AC, Jorde LB, Weiss RB, Ahuja SK. A strong signature of balancing selection in the 5' cis-regulatory region of CCR5. Proc. Natl. Acad. Sci. U.S.A. 99: 10539-10544 (2002). *
Ban H, Andoh A, Tanaka A, Tsujikawa T, Sasaki M, Saito Y, Fujiyama Y. Analysis of thiopurine S-methyltransferase genotypes in Japanese patients with inflammatory bowel disease. Intern. Med. 47: 1645-1648 (2008). *
Ban JY, Yoon KL, Kim SK, Kang S, Chung JH. Promoter polymorphism (rs3755724, -55C/T) of tissue inhibitor of metalloproteinase 4 (TIMP4) as a risk factor for Kawasaki disease with coronary artery lesions in a Korean population. Pediatr. Cardiol. 30: 331-335 (2009).
Ban M, Goris A, Lorentzen AR, Baker A, Mihalova T, Ingram G, Booth DR, Heard RN, Stewart GJ, Bogaert E, Dubois B, Harbo HF, Celius EG, Spurkland A, Strange R, Hawkins C, Robertson NP, Dudbridge F, Wason J, De Jager PL, Hafler D, Rioux JD, et al. Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor. Eur. J. Hum. Genet. Mar 18 [Epub ahead of print] (2009).
Ban M, Walton A, Goris A, Gray J, Compston A, Sawcer S. Polymorphisms in the neuromyelitis optica auto-antigen AQP4 and susceptibility to multiple sclerosis. J. Neurol. 254: 398-399 (2007).
Ban Y, Ban Y, Taniyama M, Katagiri T. Vitamin D receptor initiation codon polymorphism in Japanese patients with Graves' disease. Thyroid 10: 375-380 (2000).
Ban Y, Ban Y, Taniyama M, Katagiri T. Vitamin D receptor initiation codon polymorphism in Japanese patients with Graves' disease. Thyroid 10: 475-480 (2000).
Ban Y, Concepcion ES, Villanueva R, Greenberg DA, Davies TF, Tomer Y. Analysis of immune regulatory genes in familial and sporadic Graves' disease. J. Clin. Endocrinol. Metab. 89: 4562-4568 (2004). *
Ban Y, Davies TF, Greenberg DA, Kissin A, Marder B, Murphy B, Concepcion ES, Villanueva RB, Barbesino G, Ling V, Tomer Y. Analysis of the CTLA-4, CD28, and inducible costimulator (ICOS) genes in autoimmune thyroid disease. Genes Immun. 4: 586-593 (2003). *
Ban Y, Greenberg DA, Concepcion E, Skrabanek L, Villanueva R, Tomer Y. Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease. Proc. Natl. Acad. Sci. U.S.A. 100: 15119-15124 (2003). *
Ban Y, Greenberg DA, Concepcion ES, Tomer Y. A germline single nucleotide polymorphism at the intracellular domain of the human thyrotropin receptor does not have a major effect on the development of Graves' disease. Thyroid 12: 1079-1083 (2002).
Ban Y, Taniyama M, Ban Y. Vitamin D receptor gene polymorphism is associated with Graves' disease in the Japanese population. J. Clin. Endocrinol. Metab. 85: 4639-4643 (2000). *
Ban Y, Taniyama M, Tozaki T, Tomita M, Ban Y. Estrogen receptor alpha dinucleotide repeat polymorphism in Japanese patients with autoimmune thyroid diseases. BMC Med. Genet. 1: 1 (2000). *
Ban Y, Taniyama M, Tozaki T, Yanagawa T, Tomita M, Ban Y. SEL1L microsatellite polymorphism in Japanese patients with autoimmune thyroid diseases. Thyroid 11: 335-338 (2001).
Ban Y, Taniyama M, Tozaki T, Yanagawa T, Yamada S, Maruyama T, Kasuga A, Tomita M, Ban Y. No association of type 1 diabetes with a microsatellite marker for CTLA-4 in a Japanese population. Autoimmunity 34: 39-43 (2001).
Ban Y, Tozaki T, Taniyama M, Nakano Y, Yoneyama KI, Ban Y, Hirano T. Association studies of the IL-23R gene in autoimmune thyroid disease in the Japanese population. Autoimmunity 42: 126-130 (2009).
Ban Y, Tozaki T, Taniyama M, Tomita M, Ban Y. Association of a thyroglobulin gene polymorphism with Hashimoto's thyroiditis in the Japanese population. Clin. Endocrinol. (Oxf.) 61: 263-268 (2004). *
Ban Y, Tozaki T, Taniyama M, Tomita M, Ban Y. Association of a CTLA-4 3' untranslated region (CT60) single nucleotide polymorphism with autoimmune thyroid disease in the Japanese population. Autoimmunity 38: 151-153 (2005).
Ban Y, Tozaki T, Taniyama M, Tomita M, Ban Y. Lack of association between estrogen receptor beta dinucleotide repeat polymorphism and autoimmune thyroid diseases in Japanese patients. BMC Med. Genet. 2: 1 (2001). *
Ban Y, Tozaki T, Taniyama M, Tomita M, Ban Y. The codon 620 single nucleotide polymorphism of the protein tyrosine phosphatase-22 gene does not contribute to autoimmune thyroid disease susceptibility in the Japanese. Thyroid 15: 1115-1118 (2005).
Ban Y, Tozaki T, Tobe T, Ban Y, Jacobson EM, Concepcion ES, Tomer Y. The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: an association analysis in Caucasian and Japanese cohorts. J. Autoimmun. 28: 201-207 (2007).
Bandelow B, Saleh K, Pauls J, Domschke K, Wedekind D, Falkai P. Insertion/deletion polymorphism in the gene for angiotensin converting enzyme (ACE) in panic disorder: a gender-specific effect? World J. Biol. Psychiatry Jul 10 [Epub ahead of print] (2007).
Banerjee I, Gupta V, Ahmed T, Faizaan M, Agarwal P, Ganesh S. Inflammatory system gene polymorphism and the risk of stroke: a case-control study in an Indian population. Brain Res. Bull. 75: 158-165 (2008).
Banerjee I, Gupta V, Ganesh S. Association of gene polymorphism with genetic susceptibility to stroke in Asian populations: a meta-analysis. J. Hum. Genet. 52: 205-219 (2007). *
Banerjee S, Oneda B, Yap LM, Jewell DP, Matters GL, Fitzpatrick LR, Seibold F, Sterchi EE, Ahmad T, Lottaz D, Bond JS. MEP1A allele for meprin A metalloprotease is a susceptibility gene for inflammatory bowel disease. Mucosal Immunol. 2: 220-231 (2009). *
Bangel N, Dahlhoff C, Sobczak K, Weber WM, Kusche-Vihrog K. Upregulated expression of ENaC in human CF nasal epithelium. J. Cyst. Fibros. 7: 197-205 (2008).
Baniasadi V, Narain N, Goswami R, Das SN. Promoter region -318 C/ T and -1661 A/G CTLA-4 single nucleotide polymorphisms and type 1 diabetes in North Indians. Tissue Antigens 67: 383-389 (2006). *
Banoei MM, Chaleshtori MH, Sanati MH, Panahi MS, Majidizadeh T, Rostami M, Manshadi MD, Golalipour M. Diversity and relationship between Iranian ethnic groups: human dopamine transporter gene (DAT1) VNTR genotyping. Am. J. Hum. Biol. 19: 821-826 (2007).
Bantis C, Heering PJ, Aker S, Schwandt C, Grabensee B, Ivens K. Influence of interleukin-10 gene G-1082A polymorphism on recurrent IgA nephropathy. J. Nephrol. 21: 941-946 (2008).
Bantis C, Heering PJ, Aker S, Siekierka M, Kuhr N, Grabensee B, Ivens K. Tumor necrosis factor-alpha gene G-308A polymorphism is a risk factor for the development of membranous glomerulonephritis. Am. J. Nephrol. 26: 12-15 (2006).
Banus S, Bottema RW, Siezen CL, Vandebriel RJ, Reimerink J, Mommers M, Koppelman GH, Hoebee B, Thijs C, Postma DS, Kimman TG, Stelma FF. A Toll-like receptor 4 polymorphism is associated with the response to whole-cell pertussis vaccination in children from the KOALA study. Clin. Vaccine Immunol. 14: 1377-1380 (2007).
Bao F, Babu SR, Roberts CM, Martin AK, Gowan K, Eisenbarth GS, Fain PR. Single nucleotide polymorphism study of IDDM 17 in a Bedouin Arab family. Ann. N. Y. Acad. Sci. 1005: 348-351 (2003). *
Bao L, Zhou M, Wu L, Lu L, Goldowitz D, Williams RW, Cui Y. PolymiRTS database: linking polymorphisms in microRNA target sites with complex traits. Nucleic Acids Res. 35: D51-D54 (2007). *
Baragiotta A, Floreani A, Agarwal K, Venturi C, Craggs A, Jones DEJ, Donaldson PT, Bassendine MF. Chemokine receptor 5 and primary biliary cirrhosis: a two-centre genetic association study. Liver Int. 24: 646-650 (2004). *
Barahmani N, de Andrade M, Slusser JP, Zhang Q, Duvic M. Major histocompatibility complex class I chain-related gene a polymorphisms and extended haplotypes are associated with familial alopecia areata. J. Invest. Dermatol. 126: 74-78 (2006). *
Baran W, Szepietowski JC, Mazur G, Baran E. A - 308 promoter polymorphism of tumor necrosis factor alpha gene does not associate with the susceptibility to psoriasis vulgaris. No difference either between psoriasis type I and type II patients. Acta Dermatovenerol. Alp. Panonica Adriat. 15: 113-118 (2006). *
Baran W, Szepietowski JC, Mazur G, Baran E. IFN-gamma promoter gene polymorphism in psoriasis vulgaris. Biomarkers 13: 52-58 (2008).
Baran W, Szepietowski JC, Mazur G, Baran E. TGF-beta(1) gene polymorphism in psoriasis vulgaris. Cytokine 38: 8-11 (2007).
Baran W, Szepietowski JC, Mazur G, Baran E. IL-6 and IL-10 promoter gene polymorphisms in psoriasis vulgaris. Acta Derm. Venereol. 88: 113-116 (2008). *
Baranathan V, Stanford MR, Vaughan RW, Kondeatis E, Graham EM, Fortune F, Madanat W, Kanawati C, Ghabra M, Murray PI, Wallace GR. The association of the PTPN22 620W polymorphism with Behcet's disease. Ann. Rheum. Dis. 66: 1531-1533 (2007). *
Barbaux S, Poirier O, Godefroy T, Kleinert H, Blankenberg S, Cambien F, Tiret L. Differential haplotypic expression of the interleukin-18 gene. Eur. J. Hum. Genet. 15: 856-863 (2007). *
Barbaux S, Tregouet DA, Nicaud V, Poirier O, Perret C, Godefroy T, Francomme C, Combadiere C, Arveiler D, Luc G, Ruidavets JB, Evans AE, Kee F, Morrison C, Tiret L, Brand-Herrmann SM, Cambien F. Polymorphisms in 33 inflammatory genes and risk of myocardial infarction - a system genetics approach. J. Mol. Med. 85: 1271-1280 (2007). *
Barber RC, Aragaki CC, Chang LY, Purdue GF, Hunt JL, Arnoldo BD, Horton JW. CD14-159 C allele is associated with increased risk of mortality after burn injury. Shock 27: 232-237 (2007). *
Barber RC, Chang LY, Arnoldo BD, Purdue GF, Hunt JL, Horton JW, Aragaki CC. Innate immunity SNPs are associated with risk for severe sepsis after burn injury. Clin. Med. Res. 4: 250-255 (2006). *
Barbieri M, Marfella R, Rizzo MR, Boccardi V, Siniscalchi M, Schiattarella C, Siciliano S, Lemme P, Paolisso G. The -8 UTR C/G polymorphism of PSMA6 gene is associated with susceptibility to myocardial infarction in type 2 diabetic patients. Atherosclerosis Mar 19 [Epub ahead of print] (2008).
Barbosa FA, de Labio RW, de Oliveira S Rigolin V, Minett T, Bertolucci PH, de Arruda Cardoso Smith M, Payao SL. Apolipoprotein A-V gene polymorphism -1131T>C and Alzheimer's disease. J. Alzheimers Dis. 10: 365-369 (2006).
Barbosa PR, Stabler SP, Machado AL, Braga RC, Hirata RD, Hirata MH, Sampaio-Neto LF, Allen RH, Guerra-Shinohara EM. Association between decreased vitamin levels and MTHFR, MTR and MTRR gene polymorphisms as determinants for elevated total homocysteine concentrations in pregnant women. Eur. J. Clin. Nutr. 62: 1010-1021 (2008). *
Barbosa PR, Stabler SP, Trentin R, Carvalho FR, Luchessi AD, Hirata RD, Hirata MH, Allen RH, Guerra-Shinohara EM. Evaluation of nutritional and genetic determinants of total homocysteine, methylmalonic acid and S-adenosylmethionine/S-adenosylhomocysteine values in Brazilian childbearing-age women. Clin. Chim. Acta 388: 139-147 (2008). *
Barcellos LF, Begovich AB, Reynolds RL, Caillier SJ, Brassat D, Schmidt S, Grams SE, Walker K, Steiner LL, Cree BA, Stillman A, Lincoln RR, Pericak-Vance MA, Haines JL, Erlich HA, Hauser SL, Oksenberg JR. Linkage and association with the NOS2A locus on chromosome 17q11 in multiple sclerosis. Ann. Neurol. 55: 793-800 (2004).
Barcellos LF, Ramsay PP, Caillier SJ, Sawcer S, Haines J, Schmidt S, Pericak-Vance M, Compston DA, Gabatto P, Hauser SL, Oksenberg JR. Genetic variation in nitric oxide synthase 2A (NOS2A) and risk for multiple sclerosis. Genes Immun. 9: 493-500 (2008). *
Barcellos LF, Schito AM, Rimmler JB, Vittinghoff E, Shih A, Lincoln R, Callier S, Elkins MK, Goodkin DE, Haines JL, Pericak-Vance MA, Hauser SL, Oksenberg JR. CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis. Multiple Sclerosis Genetics Group. Immunogenetics 51: 281-288 (2000).
Barclay AN. Signal regulatory protein alpha (SIRPalpha)/CD47 interaction and function. Curr. Opin. Immunol. 21: 47-52 (2009).
Bardon S, Benelli C, Bernard-Gallon D, Blottiere H, Demarquoy J, Duee PH, Forest C. Dietary fatty acids and cancer: potential cellular and molecular mechanisms. Bull. Cancer 92: 697-707 (2005).
Baricordi OR, Govoni M, Rizzo R, Trotta F. In rheumatoid arthritis, a polymorphism in the HLA-G gene concurs in the clinical response to methotrexate treatment. Ann. Rheum. Dis. 66: 1125-1126 (2007). *
Baricordi OR, Stignani M, Melchiorri L, Rizzo R. HLA-G and inflammatory diseases. Inflamm. Allergy Drug Targets 7: 67-74 (2008).
Barile S, Medda E, Nistico L, Bordignon V, Cordiali-Fei P, Carducci M, Rainaldi A, Marinelli R, Bonifati C. Vascular endothelial growth factor gene polymorphisms increase the risk to develop psoriasis. Exp. Dermatol. 15: 368-376 (2006).
Baris N, Akdeniz B, Ozerkan F, Onder RM, Akarca U, Guneri S. The relationship between hypertensive retinopathy and angiotensin converting enzyme gene polymorphism. Cardiovasc. Hematol. Disord. Drug Targets 6: 57-61 (2006).
Barisani D, Ceroni S, Meneveri R, Cesana BM, Bardella MT. IL-10 polymorphisms are associated with early-onset celiac disease and severe mucosal damage in patients of Caucasian origin. Genet. Med. 8: 169-174 (2006).
Barker DF, Husain A, Neale JR, Martini BD, Zhang X, Doll MA, Christopher States J, Hein DW. Functional properties of an alternative, tissue-specific promoter for human arylamine N-acetyltransferase 1. Pharmacogenet. Genomics 16: 515-525 (2006). *
Barker JM, Triolo TM, Aly TA, Baschal EE, Babu SR, Kretowski A, Rewers MJ, Eisenbarth GS. Two single nucleotide polymorphisms identify highest-risk diabetes human leukocyte antigen genotype: potential for rapid screening. Diabetes 57: 3152-3155 (2008).
Barker JM, Triolo TM, Eisenbarth GS. Response to Comment on: Barker et al. (2008) Two Single Nucleotide Polymorphisms Identify the Highest-Risk Diabetes HLA Genotype: Diabetes 57:3152-3155, 2008. Diabetes 58: e2 (2009).
Barnard ND, Noble EP, Ritchie T, Cohen J, Jenkins DJ, Turner-McGrievy G, Gloede L, Green AA, Ferdowsian H. D2 dopamine receptor Taq1A polymorphism, body weight, and dietary intake in type 2 diabetes. Nutrition 25: 58-65 (2009).
Barnby G, Abbott A, Sykes N, Morris A, Weeks DE, Mott R, Lamb J, Bailey AJ, Monaco AP; International Molecular Genetics Study of Autism Consortium. Candidate-gene screening and association analysis at the autism-susceptibility locus on chromosome 16p: evidence of association at GRIN2A and ABAT. Am. J. Hum. Genet. 76: 950-966 (2005). *
Barnes KC, Caraballo L, Munoz M, Zambelli-Weiner A, Ehrlich E, Burki M, Jimenez S, Mathias RA, Stockton ML, Deindl P, Mendoza L, Hershey GK, Nickel R, Wills-Karp M. A novel promoter polymorphism in the gene encoding complement component 5 receptor 1 on chromosome 19q13.3 is not associated with asthma and atopy in three independent populations. Clin. Exp. Allergy 34: 736-744 (2004). *
Barnes KC, Grant A, Gao P, Baltadjieva D, Berg T, Chi P, Zhang S, Zambelli-Weiner A, Ehrlich E, Zardkoohi O, Brummet ME, Stockton M, Watkins T, Gao L, Gittens M, Wills-Karp M, Cheadle C, Beck LA, Beaty TH, Becker KG, Garcia JG, Mathias RA. Polymorphisms in the novel gene acyloxyacyl hydroxylase (AOAH) are associated with asthma and associated phenotypes. J. Allergy Clin. Immunol. 118: 70-77 (2006). *
Barnes KC, Grant AV, Baltadzhieva D, Zhang S, Berg T, Shao L, Zambelli-Weiner A, Anderson W, Nelsen A, Pillai S, Yarnall DP, Dienger K, Ingersoll RG, Scott AF, Fallin MD, Mathias RA, Beaty TH, Garcia JG, Wills-Karp M. Variants in the gene encoding C3 are associated with asthma and related phenotypes among African Caribbean families. Genes Immun. 7: 27-35 (2006). *
Barnes MR. SNP and mutation data on the web - hidden treasures for uncovering. Comp. Funct. Genomics 3: 67-74 (2002). *
Barnetche T, Constantin A, Gourraud PA, Abbal M, Garnier JG, Cantagrel A, Cambon-Thomsen A. Microsatellite typing of the human leucocyte antigen region: analytical approach and contribution to rheumatoid arthritis immunogenetic studies. Tissue Antigens 68: 390-398 (2006). *
Baron M. The search for complex disease genes: fault by linkage or fault by association? Mol. Psychiatry 6: 143-149 (2001).
Baroncelli GI, Bereket A, El Kholy M, Audi L, Cesur Y, Ozkan B, Rashad M, Fernandez-Cancio M, Weisman Y, Saggese G, Hochberg Z. Rickets in the Middle East: role of environment and genetic predisposition. J. Clin. Endocrinol. Metab. 93: 1743-1750 (2008). *
Baroudi Ouederni T, Sanchez-Corona J, Flores Martinez SE, Ben Maiz H, Aounallah Skhiri H, Kammoun Abid H, Benammar-Elgaaied A. The G1057D polymorphism of IRS-2 gene is not associated with type 2 diabetes and obese patients among ethnic groups in Tunisian population. Clin. Biochem. Mar 27 [Epub ahead of print] (2009). *
Baroudi T, Bouhaha R, Moran-Moguel C, Sanchez-Corona J, Ben Maiz H, Kammoun Abid H, Benammar-Elgaaied A. Association of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene with type 2 diabetes in two ethnic groups of Jerba Island in Tunisia. J. Renin Angiotensin Aldosterone Syst. 10: 35-40 (2009).
Barr M, Mackenzie SM, Wilkinson DM, Holloway CD, Friel EC, Miller S, Macdonald T, Fraser R, Connell JM, Davies E. Functional effects of genetic variants in the 11beta-hydroxylase (CYP11B1) gene. Clin. Endocrinol. (Oxf.) 65: 816-825 (2006). *
Barral S, Haynes C, Levenstien MA, Gordon D. Precision and type I error rate in the presence of genotype errors and missing parental data: a comparison between the original transmission disequilibrium test (TDT) and TDTae statistics. BMC Genet. 6 Suppl. 1: S150 (2005). *
Barreiro LB, Laval G, Quach H, Patin E, Quintana-Murci L. Natural selection has driven population differentiation in modern humans. Nat. Genet. 40: 340-345 (2008). *
Barreto M, Santos E, Ferreira R, Fesel C, Fontes MF, Pereira C, Martins B, Andreia R, Viana JF, Crespo F, Vasconcelos C, Ferreira C, Vicente AM. Evidence for CTLA4 as a susceptibility gene for systemic lupus erythematosus. Eur. J. Hum. Genet. 12: 620-626 (2004). *
Barroso I, Luan J, Sandhu MS, Franks PW, Crowley V, Schafer AJ, O'rahilly S, Wareham NJ. Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes. Diabetologia 49: 501-505 (2006). *
Barry E, Derhammer T, Elsea SH. Prevalence of three hereditary hemochromatosis mutant alleles in the Michigan Caucasian population. Community Genet. 8: 173-179 (2005).
Barshes NR, Lee TR, Goss JA, Goodpastor SE, Huls MH, Rooney CM, Karpen SJ, Wyllie S. Slc11a1 (formerly Nramp1) polymorphisms and susceptibility to post-transplant lymphoproliferative disease following pediatric liver transplantation. Transpl. Infect. Dis. 8: 108-112 (2006). *
Bartels AL, van Berckel BN, Lubberink M, Luurtsema G, Lammertsma AA, Leenders KL. Blood-brain barrier P-glycoprotein function is not impaired in early Parkinson's disease. Parkinsonism Relat. Disord. 14: 505-508 (2008).
Bartfai Z, Gaede KI, Russell KA, Murakozy G, Muller-Quernheim J, Specks U. Different gender-associated genotype risks of Wegener's granulomatosis and microscopic polyangiitis. Clin. Immunol. 109: 330-337 (2003). *
Bartnicka L, Kurzawski M, Drozdzik A, Plonska-Gosciniak E, Gornik W, Drozdzik M. Effect of ABCB1 (MDR1) 3435C >T and 2677G >A,T polymorphisms and P-glycoprotein inhibitors on salivary digoxin secretion in congestive heart failure patients. Pharmacol. Rep. 59: 323-329 (2007). *
Bartoli F, Angotti C, Fatini C, Conforti ML, Guiducci S, Blagojevic J, Melchiorre D, Fiori G, Generini S, Damjanov N, Rednic S, Pignone A, Castellani S, Abbate R, Matucci Cerinic M. Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosis. Rheumatology (Oxford) 46: 772-775 (2007). *
Barton A, Bowes J, Eyre S, Spreckley K, Hinks A, John S, Worthington J. A functional haplotype of the PADI4 gene associated with rheumatoid arthritis in a Japanese population is not associated in a United Kingdom population. Arthritis Rheum. 50: 1117-1121 (2004). *
Barton A, Bowes J, Eyre S, Symmons D, Worthington J, Silman A. Investigation of polymorphisms in the PADI4 gene in determining severity of inflammatory polyarthritis. Ann. Rheum. Dis. 64: 1311-1315 (2005). *
Barton A, Eyre S, Bowes J, Ho P, John S, Worthington J. Investigation of the SLC22A4 gene (associated with rheumatoid arthritis in a Japanese population) in a United Kingdom population of rheumatoid arthritis patients. Arthritis Rheum. 52: 752-758 (2005). *
Barton A, Jury F, Eyre S, Bowes J, Hinks A, Ward D, Worthington J. Haplotype analysis in simplex families and novel analytic approaches in a case-control cohort reveal no evidence of association of the CTLA-4 gene with rheumatoid arthritis. Arthritis Rheum. 50: 748-752 (2004). *
Barton A, Lamb R, Symmons D, Silman A, Thomson W, Worthington J, Donn R. Macrophage migration inhibitory factor (MIF) gene polymorphism is associated with susceptibility to but not severity of inflammatory polyarthritis. Genes Immun. 4: 487-491 (2003). *
Barton A, Myerscough A, John S, Gonzalez-Gay M, Ollier W, Worthington J. A single nucleotide polymorphism in exon 1 of cytotoxic T-lymphocyte-associated-4 (CTLA-4) is not associated with rheumatoid arthritis. Rheumatology (Oxford) 39: 63-66 (2000). *
Barton A, Platt H, Salway F, Symmons D, Barrett E, Bukhari M, Lunt M, Zeggini E, Eyre S, Hinks A, Tellam D, Brintnell B, Ollier W, Worthington J, Silman A. Polymorphisms in the tumour necrosis factor gene are not associated with severity of inflammatory polyarthritis. Ann. Rheum. Dis. 63: 280-284 (2004). *
Barton A, Platt H, Salway F, Symmons D, Lunt M, Worthington J, Silman A. Polymorphisms in the mannose binding lectin (MBL) gene are not associated with radiographic erosions in rheumatoid or inflammatory polyarthritis. J. Rheumatol. 31: 442-447 (2004). *
Barton A, Woolmore JA, Ward D, Eyre S, Hinks A, Ollier WE, Strange RC, Fryer AA, John S, Hawkins CP, Worthington J. Association of protein kinase C alpha (PRKCA) gene with multiple sclerosis in a UK population. Brain 127: 1717-1722 (2004). *
Barton JC, Rivers CA, Niyongere S, Bohannon SB, Acton RT. Allele frequencies of hemojuvelin gene (HJV) I222N and G320V missense mutations in white and African American subjects from the general Alabama population. BMC Med. Genet. 5: 29 (2004). *
Bartunkova J, Kayserova J, Shoenfeld Y. Allergy and autoimmunity: parallels and dissimilarity. The Yin and Yang of immunopathology. Autoimmun. Rev. 8: 302-308 (2009).
Basar Y, Salmayenli N, Aksoy M, Seckin S, Aydin M, Ozkok E. ACE gene polymorphism in peripheral vascular disease. Horm. Metab. Res. 39: 534-537 (2007).
Baschal EE, Aly TA, Jasinski JM, Steck AK, Johnson KN, Noble JA, Erlich HA, Eisenbarth GS; Diabetes Genetics Consortium. The frequent and conserved DR3-B8-A1 extended haplotype confers less diabetes risk than other DR3 haplotypes. Diabetes Obes. Metab. 11 Suppl. 1: 25-30 (2009). *
Baseggio L, Bartholin L, Chantome A, Charlot C, Rimokh R, Salles G. Allele-specific binding to the -308 single nucleotide polymorphism site in the tumour necrosis factor-alpha promoter. Eur. J. Immunogenet. 31: 15-19 (2004). *
Basehore MJ, Howard TD, Lange LA, Moore WC, Hawkins GA, Marshik PL, Harkins MS, Meyers DA, Bleecker ER. A comprehensive evaluation of IL4 variants in ethnically diverse populations: association of total serum IgE levels and asthma in white subjects. J. Allergy Clin. Immunol. 114: 80-87 (2004).
Basic S, Hajnsek S, Bozina N, Filipcic I, Sporis D, Mislov D, Posavec A. The influence of C3435T polymorphism of ABCB1 gene on penetration of phenobarbital across the blood-brain barrier in patients with generalized epilepsy. Seizure 17: 524-530 (2008).
Basic S, Hajnsek S, Poljakovic Z, Basic M. Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment. Epilepsia 47: 449 (2006). *
Baslund B, Gregers J, Nielsen CH. Reduced folate carrier polymorphism determines methotrexate uptake by B cells and CD4+ T cells. Rheumatology (Oxford) 47: 451-453 (2008). *
Basset C, Holton J, Gatta L, Ricci C, Bernabucci V, Liuzzi G, Vaira D. Helicobacter pylori infection: anything new should we know? Aliment. Pharmacol. Ther. 20 Suppl. 2: 31-41 (2004).
Bassi C, Xavier Dj, Palomino G, Nicolucci P, Soares C, Sakamoto-Hojo E, Donadi E. Efficiency of the DNA repair and polymorphisms of the XRCC1, XRCC3 and XRCC4 DNA repair genes in systemic lupus erythematosus. Lupus 17: 988-995 (2008).
Bassuny WM, Ihara K, Matsuura N, Ahmed S, Kohno H, Kuromaru R, Miyako K, Hara T. Association study of the NRAMP1 gene promoter polymorphism and early-onset type 1 diabetes. Immunogenetics 54: 282-285 (2002). *
Basta-Kaim A, Budziszewska B, Lason W. Effects of antiepileptic drugs on immune system. Przegl. Lek. 65: 799-802 (2008).
Bastian HM, Alarcon GS, Roseman JM, McGwin G Jr, Vila LM, Fessler BJ, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XL II: factors predictive of new or worsening proteinuria. Rheumatology (Oxford) 46: 683-689 (2007). *
Bastone L, Reilly M, Rader DJ, Foulkes AS. MDR and PRP: a comparison of methods for high-order genotype-phenotype associations. Hum. Hered. 58: 82-92 (2004).
Basturk B, Karasu Z, Kilic M, Ulukaya S, Boyacioglu S, Oral B. Association of TNF-alpha -308 polymorphism with the outcome of hepatitis B virus infection in Turkey. Infect. Genet. Evol. 8: 20-25 (2008).
Basu D, Lopez I, Kulkarni A, Sellin JH. Impact of race and ethnicity on inflammatory bowel disease. Am. J. Gastroenterol. 100: 2254-2261 (2005). *
Bataller R, North KE, Brenner DA. Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal. Hepatology 37: 493-503 (2003). *
Bates JS, Lessard CJ, Leon JM, Nguyen T, Battiest LJ, Rodgers J, Kaufman KM, James JA, Gilkeson GS, Kelly JA, Humphrey MB, Harley JB, Gray-McGuire C, Moser KL, Gaffney PM. Meta-analysis and imputation identifies a 109 kb risk haplotype spanning TNFAIP3 associated with lupus nephritis and hematologic manifestations. Genes Immun. Apr 23 [Epub ahead of print] (2009).
Bathgate AJ, Pravica V, Perrey C, Hayes PC, Hutchinson IV. Polymorphisms in tumour necrosis factor alpha, interleukin-10 and transforming growth factor beta1 genes and end-stage liver disease. Eur. J. Gastroenterol. Hepatol. 12: 1329-1333 (2000).
Bathum L, Hansen H, Teisner B, Koch C, Garred P, Rasmussen K, Wang P. Association between combined properdin and mannose-binding lectin deficiency and infection with Neisseria meningitidis. Mol. Immunol. 43: 473-479 (2006). *
Batley J, Jewell E, Edwards D. Automated discovery of single nucleotide polymorphism and simple sequence repeat molecular genetic markers. Methods Mol. Biol. 406: 473-494 (2007).
Battelino T, Ursic-Bratina N, Dolzan V, Stopar-Obreza M, Pozzilli P, Krzisnik C, Vidan-Jeras B. The HLA-DRB, -DQB polymorphism and anti-insulin antibody response in Slovenian patients with type 1 diabetes. Eur. J. Immunogenet. 30: 223-227 (2003). *
Battistelli S, Vittoria A, Stefanoni M, Bing C, Roviello F. Total plasma homocysteine and methylenetetrahydrofolate reductase C677T polymorphism in patients with colorectal carcinoma. World J. Gastroenterol. 12: 6128-6132 (2006). *
Bauduer F, Scribans C, Degioanni A, Renoux M, Dutour O. Distribution of the C282Y and H63D polymorphisms in hereditary hemochromatosis patients from the French Basque Country. Ann. Hematol. 84: 99-102 (2005). *
Bauer K, Yu X, Wernhoff P, Koczan D, Thiesen HJ, Ibrahim SM. Identification of new quantitative trait loci in mice with collagen-induced arthritis. Arthritis Rheum. 50: 3721-3728 (2004). *
Baugh JA, Chitnis S, Donnelly SC, Monteiro J, Lin X, Plant BJ, Wolfe F, Gregersen PK, Bucala R. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun. 3: 170-176 (2002). *
Baughman RP, Lower EE, du Bois RM. Sarcoidosis. Lancet 361: 1111-1118 (2003). *
Baumert TF. Novel vaccine strategies. Falk Symposium 138. XII FALK LIVER WEEK 2003 (Part III) In Honour of Hans Popper�s 100th Birthday. State-of-the-art of hepatology: Molecular and Cell Biology. Freiburg (Germany). p. 58-59. October 20 - 21 (2003). *
Baumgart DC, Buning C, Geerdts L, Schmidt HH, Genschel J, Fiedler T, Gentz E, Molnar T, Nagy F, Lonovics J, Lochs H, Wiedenmann B, Nickel R, Witt H, Dignass A. The c.1-260C>T promoter variant of CD14 but not the c.896A>G (p.D299G) variant of Toll-like receptor 4 (TLR4) genes is associated with inflammatory bowel disease. Digestion 76: 196-202 (2007). *
Baune BT, Hohoff C, Mortensen LS, Deckert J, Arolt V, Domschke K. Serotonin transporter polymorphism (5-HTTLPR) association with melancholic depression: a female specific effect? Depress. Anxiety 25: 920-925 (2007).
Baune BT, Ponath G, Rothermundt M, Riess O, Funke H, Berger K. Association between genetic variants of IL-1beta, IL-6 and TNF-alpha cytokines and cognitive performance in the elderly general population of the MEMO-study. Psychoneuroendocrinology 33: 68-76 (2008).
Baurecht H, Irvine AD, Novak N, Illig T, B�hler B, Ring J, Wagenpfeil S, Weidinger S. Toward a major risk factor for atopic eczema: meta-analysis of filaggrin polymorphism data. J. Allergy Clin. Immunol. 120: 1406-1412 (2007). *
Bay JT, Garred P. Rapid bead-based immunoassay for measurement of mannose-binding lectin. Scand. J. Immunol. 69: 570-575 (2009). *
Bayat A, Stanley JK, Watson JS, Ferguson MW, Ollier WE. Genetic susceptibility to Dupuytren's disease: transforming growth factor beta receptor (TGFbetaR) gene polymorphisms and Dupuytren's disease. Br. J. Plast. Surg. 56: 328-333 (2003).
Bayat A, Watson JS, Stanley JK, Alansari A, Shah M, Ferguson MW, Ollier WE. Genetic susceptibility in Dupuytren's disease. TGF-beta1 polymorphisms and Dupuytren's disease. J. Bone Joint Surg. Br. 84: 211-215 (2002).
Bayat A, Watson JS, Stanley JK, Ferguson MW, Ollier WE. Genetic susceptibility to Dupuytren disease: association of Zf9 transcription factor gene. Plast. Reconstr. Surg. 111: 2133-2139 (2003).
Bayazit YA. Genetics of headache and catechol-O-methyltransferase gene polymorphism. J. Headache Pain 7: 60 (2006). *
Bayazit YA, Yilmaz M. An overview of hereditary hearing loss. ORL J. Otorhinolaryngol. Relat. Spec. 68: 57-63 (2006).
Bayley JP, Baggen JM, van der Pouw-Kraan T, Crusius JB, Huizinga TW, Verweij CL. Association between polymorphisms in the human chemokine receptor genes CCR2 and CX3CR1 and rheumatoid arthritis. Tissue Antigens 62: 170-174 (2003). *
Bayley JP, Bakker AM, Kaijzel EL, Huizinga TW, Verweij CL. Association of polymorphisms of the tumour necrosis factor receptors I and II and rheumatoid arthritis. Rheumatology (Oxford) 42: 969-971 (2003). *
Bayley JP, Ottenhoff TH, Verweij CL. Is there a future for TNF promoter polymorphisms? Genes Immun. 5: 315-329 (2004). *
Baylin A, Ruiz-Narvaez E, Kraft P, Campos H. alpha-Linolenic acid, Delta6-desaturase gene polymorphism, and the risk of nonfatal myocardial infarction. Am. J. Clin. Nutr. 85: 554-560 (2007). *
Bayou N, M'rad R, Ahlem B, Bechir Helayem M, Chaabouni H. Autism: an overview of genetic aetiology. Tunis. Med. 86: 573-578 (2008).
Bayoumi RA, Simsek M, Yahya TM, Bendict S, Al-Hinai A, Al-Barwani H, Hassan MO. Insertion-deletion polymorphism in the angiotensin-converting enzyme (ACE) gene among Sudanese, Somalis, Emiratis, and Omanis. Hum. Biol. 78: 103-108 (2006).
Baz K, Emin Erdal M, Yazici AC, Soylemez F, Guvenc U, Tasdelen B, Ikizoglu G. Association between tumor necrosis factor-alpha gene promoter polymorphism at position -308 and acne in Turkish patients. Arch. Dermatol. Res. 300: 371-376 (2008). *
Bazilio AP, Viana VS, Toledo R, Woronik V, Bonfa E, Monteiro RC. Fc gamma RIIa polymorphism: a susceptibility factor for immune complex-mediated lupus nephritis in Brazilian patients. Nephrol. Dial. Transplant. 19: 1427-1431 (2004). *
Bazrafshani MR, Hajeer AH, Ollier WE, Thornhill MH. IL-1B and IL-6 gene polymorphisms encode significant risk for the development of recurrent aphthous stomatitis (RAS). Genes Immun. 3: 302-305 (2002). *
Beagle B, Yang TL, Hung J, Cogger EA, Moriarty DJ, Caudill MA. The glycine N-methyltransferase (GNMT) 1289 C->T variant influences plasma total homocysteine concentrations in young women after restricting folate intake. J. Nutr. 135: 2780-2785 (2005). *
Beasley WD, Beynon J, Jenkins GJ, Parry JM. Reprimo 824 G>C and p53R2 4696 C>G single nucleotide polymorphisms and colorectal cancer: a case-control disease association study. Int. J. Colorectal Dis. 23: 375-381 (2008). *
Becanovic K, Jagodic M, Sheng JR, Dahlman I, Aboul-Enein F, Wallstrom E, Olofsson P, Holmdahl R, Lassmann H, Olsson T. Advanced intercross line mapping of Eae5 reveals Ncf-1 and CLDN4 as candidate genes for experimental autoimmune encephalomyelitis. J. Immunol. 176: 6055-6064 (2006). *
Beck KE, Blansfield JA, Tran KQ, Feldman AL, Hughes MS, Royal RE, Kammula US, Topalian SL, Sherry RM, Kleiner D, Quezado M, Lowy I, Yellin M, Rosenberg SA, Yang JC. Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4. J. Clin. Oncol. 24: 2283-2289 (2006). *
Beck S, Trowsdale J. The human major histocompatability complex: lessons from the DNA sequence. Annu. Rev. Genomics Hum. Genet. 1: 117-137 (2000). *
Becker ML, Visser LE, van Schaik RH, Hofman A, Uitterlinden AG, Stricker BH. Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus. Pharmacogenomics J. Apr 21 [Epub ahead of print] (2009).
Becker T, Jansen S, Tamm S, Wienker TF, Tummler B, Stanke F. Transmission ratio distortion and maternal effects confound the analysis of modulators of cystic fibrosis disease severity on 19q13. Eur. J. Hum. Genet. 15: 774-778 (2007). *
Beckly JB, Hancock L, Geremia A, Cummings JR, Morris A, Cooney R, Pathan S, Guo C, Jewell DP. Two-stage candidate gene study of chromosome 3p demonstrates an association between nonsynonymous variants in the MST1R gene and Crohn's disease. Inflamm. Bowel Dis. 14: 500-507 (2008). *
Beckman L, Beckman G, Frolander N. Population studies in northern Sweden. XII. The haptoglobin polymorphism. Hum. Hered. 33: 371-376 (1983).
Beckmann L, Ziegler A, Duggal P, Bailey-Wilson JE. Haplotypes and haplotype-tagging single-nucleotide polymorphism: Presentation Group 8 of Genetic Analysis Workshop 14. Genet. Epidemiol. 29: S59-S71 (2005).
Bednarczuk T, Hiromatsu Y, Fukutani T, Jazdzewski K, Miskiewicz P, Osikowska M, Nauman J. Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors with Graves' ophthalmopathy in European and Japanese populations. Eur. J. Endocrinol. 148: 13-18 (2003). *
Bednarczuk T, Hiromatsu Y, Seki N, Ploski R, Fukutani T, Kurylowicz A, Jazdzewski K, Chojnowski K, Itoh K, Nauman J. Association of tumor necrosis factor and human leukocyte antigen DRB1 alleles with Graves' ophthalmopathy. Hum. Immunol. 65: 632-639 (2004).
Bednarczuk T, Placha G, Jazdzewski K, Kurylowicz A, Kloza M, Makowska U, Hiromatsu Y, Nauman J. Interleukin-13 gene polymorphisms in patients with Graves' disease. Clin. Endocrinol. (Oxf.) 59: 519-525 (2003). *
Beetstra S, Suthers G, Dhillon V, Salisbury C, Turner J, Altree M, McKinnon R, Fenech M. Methionine-dependence phenotype in the de novo pathway in BRCA1 and BRCA2 mutation carriers with and without breast cancer. Cancer Epidemiol. Biomarkers Prev. 17: 2565-2571 (2008). *
Beghe B, Barton S, Rorke S, Peng Q, Sayers I, Gaunt T, Keith TP, Clough JB, Holgate ST, Holloway JW. Polymorphisms in the interleukin-4 and interleukin-4 receptor alpha chain genes confer susceptibility to asthma and atopy in a Caucasian population. Clin. Exp. Allergy 33: 1111-1117 (2003). *
Begleiter A, Hewitt D, Maksymiuk AW, Ross DA, Bird RP. A NAD(P)H:quinone oxidoreductase 1 polymorphism is a risk factor for human colon cancer. Cancer Epidemiol. Biomarkers Prev. 15: 2422-2426 (2006). *
Begovich AB, Caillier SJ, Alexander HC, Penko JM, Hauser SL, Barcellos LF, Oksenberg JR. The R620W polymorphism of the protein tyrosine phosphatase PTPN22 is not associated with multiple sclerosis. Am. J. Hum. Genet. 76: 184-187 (2005). *
Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, Alexander HC, Ardlie KG, Huang Q, Smith AM, Spoerke JM, Conn MT, Chang M, Chang SY, Saiki RK, Catanese JJ, Leong DU, Garcia VE, McAllister LB, Jeffery DA, Lee AT, Batliwalla F, et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet. 75: 330-337 (2004). *
Begovich AB, Chang M, Caillier SJ, Lew D, Catanese JJ, Wang J, Hauser SL, Oksenberg JR. The autoimmune disease-associated IL12B and IL23R polymorphisms in multiple sclerosis. Hum. Immunol. 68: 934-937 (2007).
Begovich AB, Chang M, Schrodi SJ. Meta-analysis evidence of a differential risk of the FCRL3 -169T-->C polymorphism in white and East Asian rheumatoid arthritis patients. Arthritis Rheum. 56: 3168-3171 (2007). *
Behrens TW, Graham RR, Kyogoku C, Baechler EC, Ramos PS, Gillett C, Bauer J, Ortmann WA, Hippen KL, Peterson E, Langefeld CD, Moser KL, Gaffney PM, Gregersen PK. Progress towards understanding the genetic pathogenesis of systemic lupus erythematosus. Novartis Found. Symp. 267: 145-160 (2005).
Bei T, Tilkeridis C, Garantziotis S, Boikos S, Kazakos K, Simopoulos C, Stratakis C. A novel, non-functional, COL1A1 polymorphism is not associated with lumbar disk disease in young male Greek subjects unlike that of the Sp1 site. Hormones (Athens) 7: 251-254 (2008).
Bekker V, O'Brien TR, Chanock S. Population genetics and comparative genetics of CLDN1, a gene involved in hepatitis C virus entry. Hum. Hered. 67: 206-216 (2008).
Bekris LM, Shephard C, Janer M, Graham J, McNeney B, Shin J, Zarghami M, Griffith W, Farin F, Kavanagh TJ, Lernmark A. Glutamate cysteine ligase catalytic subunit promoter polymorphisms and associations with type 1 diabetes age-at-onset and GAD65 autoantibody levels. Exp. Clin. Endocrinol. Diabetes 115: 221-228 (2007).
Bekris LM, Shephard C, Peterson M, Hoehna J, Yserloo BV, Rutledge E, Farin F, Kavanagh TJ, Lernmark A. Glutathione-S-transferase M1 and T1 polymorphisms and associations with type 1 diabetes age-at-onset. Autoimmunity 38: 567-575 (2005).
Bel Hadj Jrad B, Chatti A, Laatiri A, Ahmed SB, Romdhane A, Ajimi S, Chouchane L. Tumor necrosis factor promoter gene polymorphism associated with increased susceptibility to non-Hodgkin's lymphomas. Eur. J. Haematol. 78: 117-122 (2007). *
Bel Hadj Jrad B, Mahfouth W, Bouaouina N, Gabbouj S, Ahmed SB, Ltaief M, Jalbout M, Chouchane L. A polymorphism in FAS gene promoter associated with increased risk of nasopharyngeal carcinoma and correlated with anti-nuclear autoantibodies induction. Cancer Lett. 233: 21-27 (2006). *
Belcastro V, Gaetano G, Italiano D, Oteri G, Caccamo D, Pisani LR, Striano P, Striano S, Ientile R, Pisani F. Antiepileptic drugs and MTHFR polymorphisms influence hyper-homocysteinemia recurrence in epileptic patients. Epilepsia 48: 1990-1994 (2007).
Belfer I, Buzas B, Hipp H, Dean M, Evans C, Lorincz I, Max MB, Goldman D. Haplotype structure of inflammatory cytokines genes (IL1B, IL6 and TNF/LTA) in US Caucasians and African Americans. Genes Immun. 5: 505-512 (2004). *
Belguith-Maalej S, Hadj Kacem H, Rebai A, Mnif M, Abid M, Ayadi H. Thyroglobulin polymorphisms in Tunisian patients with autoimmune thyroid diseases (AITD). Immunobiology 213: 577-583 (2008).
Belguith-Maalej S, Hadj-Kacem H, Kaddour N, Bahloul Z, Ayadi H. DNase1 exon2 analysis in Tunisian patients with rheumatoid arthritis, systemic lupus erythematosus and Sjogren syndrome and healthy subjects. Rheumatol. Int. Apr 10 [Epub ahead of print] (2009). *
Belitsky GA, Yakubovskaya MG. Genetic polymorphism and variability of chemical carcinogenesis. Biochemistry (Mosc.) 73: 543-554 (2008).
Belkahla R, Omezzine A, Kchok K, Rebhi L, Ben Hadj Mbarek I, Rejeb J, Ben Rejeb N, Slimane N, Nabli N, Ben Abdelaziz A, Boughzala E, Bouslama A. Effect of polymorphisms on key enzymes in homocysteine metabolism, on plasma homocysteine level and on coronary artery-disease risk in a Tunisian population. Ann. Cardiol. Angeiol. (Paris) 57: 219-224 (2008).
Bell J, Rassenti L, Smoot S, Smith K, Newby C, Hohlfeld R, Toyka K, McDevitt H, Steinman L. HLA-DQ beta-chain polymorphism linked to myasthenia gravis. Lancet 1: 1058-1060 (1986).
Bell JI. The molecular genetics of HLA-related disorders. Ciba Found. Symp. 130: 197-214 (1987).
Bell JJ, Divekar RD, Ellis JS, Cascio JA, Haymaker CL, Jain R, Tartar DM, Hoeman CM, Hardaway JC, Zaghouani H. In trans T cell tolerance diminishes autoantibody responses and exacerbates experimental allergic encephalomyelitis. J. Immunol. 180: 1508-1516 (2008). *
Bell JT. A two-dimensional genome scan for rheumatoid arthritis susceptibility loci. BMC Proc. 1 Suppl. 1: S63 (2007). *
Belpomme D, Irigaray P, Sasco AJ, Newby JA, Howard V, Clapp R, Hardell L. The growing incidence of cancer: role of lifestyle and screening detection (review). Int. J. Oncol. 30: 1037-1049 (2007). *
Belshaw R, Dawson AL, Woolven-Allen J, Redding J, Burt A, Tristem M. Genomewide screening reveals high levels of insertional polymorphism in the human endogenous retrovirus family HERV-K(HML2): implications for present-day activity. J. Virol. 79: 12507-12514 (2005). *
Ben Ali S, Kallel A, Ftouhi B, Sediri Y, Feki M, Slimane H, Jemaa R, Kaabachi N. The -2548G/A LEP polymorphism is associated with blood pressure in Tunisian obese patients. Blood Press. 17: 278-283 (2008).
Ben Assayag E, Shenhar-Tsarfaty S, Bova I, Berliner S, Usher S, Peretz H, Shapira I, Bornstein NM. Association of the -757T>C polymorphism in the CRP gene with circulating C-reactive protein levels and carotid atherosclerosis. Thromb. Res. May 8 [Epub ahead of print] (2009). *
Ben Dhifallah I, Chelbi H, Braham A, Hamzaoui K, Houman MH. CTLA-4 +49A/G polymorphism is associated with Behcet's disease in a Tunisian population. Tissue Antigens 73: 213-217 (2009). *
Ben-Ali M, Barbouche MR, Bousnina S, Chabbou A, Dellagi K. Toll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients. Clin. Diagn. Lab. Immunol. 11: 625-626 (2004). *
Bendicho MT, Guedes JC, Silva NN, Santana GO, dos Santos RR, Lyra AC, Lyra LG, Meyer R, Lemaire DC. Polymorphism of cytokine genes (TGF-beta1, IFN-gamma, IL-6, IL-10, and TNF-alpha) in patients with chronic pancreatitis. Pancreas 30: 333-336 (2005).
Bendlova B, Vejralkova D, Vcelak J, Lukalova P, Burkonova D, Kunelova M, Vrbikova J, Dvorakova K, Vondra K, Vankova M. PPARgamma2 Pro12Ala polymorphism in relation to free fatty acids concentration and composition in lean healthy Czech individuals with and without family history of diabetes type 2. Physiol. Res. 57 Suppl. 1: S77-S90 (2008). *
Bene J, Magyari L, Talian G, Komlosi K, Gasztonyi B, Tari B, Varkonyi A, Mozsik G, Melegh B. Prevalence of SLC22A4, SLC22A5 and CARD15 gene mutations in Hungarian pediatric patients with Crohn's disease. World J. Gastroenterol. 12: 5550-5553 (2006). *
Benedek G, Brautbar C, Vardi P, Sharon N, Weintrob N, Zung A, Israel S. Effect of polymorphism in insulin locus and HLA on type 1 diabetes in four ethnic groups in Israel. Tissue Antigens 73: 33-38 (2009). *
Benesova Y, Vasku A, Stourac P, Hladikova M, Beranek M, Kadanka Z, Novotna H, Bednarik J. Matrix metalloproteinase-9 and matrix metalloproteinase-2 gene polymorphisms in multiple sclerosis. J. Neuroimmunol. 205: 105-109 (2008).
Benhamla T, Tirouche YD, Abaoub-Germain A, Theodore F. The onset of psychiatric disorders and Wilson's disease. Encephale 33: 924-932 (2007).
Benito JM. New insights into the mechanisms driving immune activation in HIV. AIDS Rev. 10: 254 (2008).
Bennani N, Atouf O, Benseffaj N, Brick C, Essakalli M. HLA polymorphism and Behcet's disease in Moroccan population. Pathol. Biol. (Paris) Nov 25 [Epub ahead of print] (2008).
Bennett AJ, Sovio U, Ruokonen A, Martikainen H, Pouta A, Hartikainen AL, Franks S, Elliott P, Jarvelin MR, McCarthy MI. No evidence that established type 2 diabetes susceptibility variants in the PPARG and KCNJ11 genes have pleiotropic effects on early growth. Diabetologia 51: 82-85 (2008). *
Bennetts BH, Teutsch SM, Buhler MM, Heard RN, Stewart GJ. HLA-DMB gene and HLA-DRA promoter region polymorphisms in Australian multiple sclerosis patients. Hum. Immunol. 60: 886-893 (1999).
Benrick A, Jirholt P, Wernstedt I, Gustafsson M, Scheller J, Eriksson AL, Boren J, Hedner T, Ohlsson C, Hard T, Rose-John S, Jansson JO. A non-conservative polymorphism in the IL-6 signal transducer (IL6ST)/gp130 is associated with myocardial infarction in a hypertensive population. Regul. Pept. 146: 189-196 (2008).
Bento JL, Palmer ND, Mychaleckyj JC, Lange LA, Langefeld CD, Rich SS, Freedman BI, Bowden DW. Association of protein tyrosine phosphatase 1B gene polymorphisms with type 2 diabetes. Diabetes 53: 3007-3012 (2004). *
Benton JL, Ding J, Tsai MY, Shea S, Rotter JI, Burke GL, Post W. Associations between two common polymorphisms in the ABCA1 gene and subclinical atherosclerosis: Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 193: 352-360 (2007).
Bentz EK, Hefler LA, Denschlag D, Pietrowski D, Buerkle B, Tempfer CB. A polymorphism of the interleukin-1 beta gene is associated with sperm pathology in humans. Fertil. Steril. 88: 751-753 (2007).
Beranek H, Teich N, Witt H, Schulz HU, Mossner J, Keim V. Analysis of tumour necrosis factor alpha and interleukin 10 promotor variants in patients with chronic pancreatitis. Eur. J. Gastroenterol. Hepatol. 15: 1223-1227 (2003).
Beranek M, Kolar P, Tschoplova S, Kankova K, Vasku A. Genetic variation and plasma level of the basic fibroblast growth factor in proliferative diabetic retinopathy. Diabetes Res. Clin. Pract. 79: 362-367 (2008).
Berdeli A, Cam FS. Prevalence of the angiotensin I converting enzyme gene insertion/deletion polymorphism in a healthy Turkish population. Biochem. Genet. 47: 412-420 (2009). *
Berdeli A, Celik HA, Ozyurek R, Dogrusoz B, Aydin HH. TLR-2 gene Arg753Gln polymorphism is strongly associated with acute rheumatic fever in children. J. Mol. Med. 83: 535-541 (2005). *
Berdeli A, Gurkan A, Emingil G, Atilla G, Kose T. Endothelial nitric oxide synthase Glu298Asp gene polymorphism in periodontal diseases. J. Periodontol. 77: 1348-1354 (2006).
Berdeli A, Ozyurek AR, Ulger Z, Gurses D, Levent E, Salar K, Gurpinar AR. Association of macrophage migration inhibitory factor gene -173 G/C polymorphism with prognosis in Turkish children with juvenile rheumatoid arthritis. Rheumatol. Int. 26: 726-731 (2006). *
Berdeli A, Tabel Y, Celik HA, Ozyurek R, Dogrusoz B, Aydin HH. Lack of association between TNFalpha gene polymorphism at position -308 and risk of acute rheumatic fever in Turkish patients. Scand. J. Rheumatol. 35: 44-47 (2006). *
Bereket A. Vitamin D receptor polymorphism in nutritional rickets. Pediatr. Endocrinol. Rev. 3 Suppl. 3: 476-479 (2006).
Beretta L, Cappiello F, Barili M, Bertolotti F, Scorza R. T-889C IL-1alpha promoter polymorphism influences the response to oral cyclophosphamide in scleroderma patients with alveolitis. Clin. Rheumatol. 26: 88-91 (2007). *
Beretta L, Cappiello F, Moore JH, Barili M, Greene CS, Scorza R. Ability of epistatic interactions of cytokine single-nucleotide polymorphisms to predict susceptibility to disease subsets in systemic sclerosis patients. Arthritis Rheum. 59: 974-983 (2008). *
Beretta L, Cappiello F, Moore JH, Scorza R. Interleukin-1 gene complex single nucleotide polymorphisms in systemic sclerosis: a further step ahead. Hum. Immunol. 69: 187-192 (2008).
Beretta L, Cossu M, Marchini M, Cappiello F, Artoni A, Motta G, Scorza R. A polymorphism in the human serotonin 5-HT2A receptor gene may protect against systemic sclerosis by reducing platelet aggregation. Arthritis Res. Ther. 10: R103 (2008). *
Beretta L, Santaniello A, Cappiello F, Barili M, Scorza R. No evidence for a role of the proximal IL-6 G/C -174 single nucleotide polymorphism in Italian patients with systemic sclerosis. J. Cell. Mol. Med. 11: 896-898 (2007). *
Beretta L, Scorza R. 5HT2A polymorphism His452Tyr in a German Caucasian systemic sclerosis population - authors' response. Arthritis Res. Ther. 11: 404 (2009).
Berg KK, Madsen HO, Garred P, Wiseth R, Gunnes S, Videm V. The additive contribution from inflammatory genetic markers on the severity of cardiovascular disease. Scand. J. Immunol. 69: 36-42 (2009). *
Bergasa NV. The pruritus of cholestasis. J. Hepatol. 43: 1078-1088 (2005). *
Bergasa NV, Mason A, Floreani A, Heathcote J, Swain MG, Jones DE, Lindor KM, Bassendine MF, Worman HJ. Primary biliary cirrhosis: report of a focus study group. Hepatology 40: 1013-1020 (2004). *
Berge KE, von Bergmann K, Lutjohann D, Guerra R, Grundy SM, Hobbs HH, Cohen JC. Heritability of plasma noncholesterol sterols and relationship to DNA sequence polymorphism in ABCG5 and ABCG8. J. Lipid Res. 43: 486-494 (2002). *
Berge M, Guillemain R, Boussaud V, Pham MH, Chevalier P, Batisse A, Amrein C, Dannaoui E, Loriot MA, Lillo-Le Louet A, Billaud EM. Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients. Transpl. Infect. Dis. Mar 17 [Epub ahead of print] (2009).
Berger BM, Schroy PC 3rd, Rosenberg JL, Lai-Goldman M, Eisenberg M, Brown T, Rochelle RB, Billings PR. Colorectal cancer screening using stool DNA analysis in clinical practice: early clinical experience with respect to patient acceptance and colonoscopic follow-up of abnormal tests. Clin. Colorectal Cancer 5: 338-343 (2006).
Berger K, Stogbauer F, Stoll M, Wellmann J, Huge A, Cheng S, Kessler C, John U, Assmann G, Ringelstein EB, Funke H. The glu298asp polymorphism in the nitric oxide synthase 3 gene is associated with the risk of ischemic stroke in two large independent case-control studies. Hum. Genet. 121: 169-178 (2007). *
Berghofer B, Frommer T, Konig IR, Ziegler A, Chakraborty T, Bein G, Hackstein H. Common human Toll-like receptor 9 polymorphisms and haplotypes: association with atopy and functional relevance. Clin. Exp. Allergy 35: 1147-1154 (2005).
Bergholdt R, Larsen ZM, Andersen NA, Johannesen J, Kristiansen OP, Mandrup-Poulsen T, Nerup J, Pociot F; Danish Study Group of IDDM in Childhood; Danish IDDM Epidemiology and Genetics Group. Characterization of new polymorphisms in the 5' UTR of the human interleukin-1 receptor type 1 (IL1R1) gene: linkage to type 1 diabetes and correlation to IL-1RI plasma level. Genes Immun. 1: 495-500 (2000). *
Bergholdt R, Nerup J, Pociot F. Fine mapping of a region on chromosome 21q21.11-q22.3 showing linkage to type 1 diabetes. J. Med. Genet. 42: 17-25 (2005). *
Bergholdt R, Taxvig C, Eising S, Nerup J, Pociot F. CBLB variants in type 1 diabetes and their genetic interaction with CTLA4. J. Leukoc. 77: 579-585 (2005). *
Berglund J, Pollard KS, Webster MT. Hotspots of biased nucleotide substitutions in human genes. PLoS Biol. 7: e26 (2009). *
Bergman A, Atzmon G, Ye K, Maccarthy T, Barzilai N. Buffering mechanisms in aging: a systems approach toward uncovering the genetic component of aging. PLoS Comput. Biol. 3: e170 (2007). *
Bergmann A, Li J, Selisko T, Reimann M, Fischer S, Grassler J, Schulze J, Bornstein SR, Schwarz PE. The A98V single nucleotide polymorphism (SNP) in hepatic nuclear factor 1 alpha (HNF-1alpha) is associated with insulin sensitivity and beta-cell function. Exp. Clin. Endocrinol. Diabetes 116 Suppl. 1: S50-S55 (2008).
Bergstrom TF, Josefsson A, Erlich HA, Gyllensten U. Recent origin of HLA-DRB1 alleles and implications for human evolution. Nat. Genet. 18: 237-242 (1998). *
Beringer PM, Kriengkauykiat J, Zhang X, Hidayat L, Liu S, Louie S, Synold T, Burckart GJ, Rao PA, Shapiro B, Gill M. Lack of effect of P-glycoprotein inhibition on renal clearance of dicloxacillin in patients with cystic fibrosis. Pharmacotherapy 28: 883-894 (2008).
Beringer PM, Slaughter RL. Transporters and their impact on drug disposition. Ann. Pharmacother. 39: 1097-1108 (2005).
Berka N, Bland GN, Erabhaoui el H, Dunston GM. Heat-shock protein gene is not associated with type-1 diabetes in African Americans. J. Natl. Med. Assoc. 99: 715-717 (2007). *
Berka N, Nunlee-Bland G, Erabhaoui E, Belmamoun M, Dunston GM. IDDM2 and the polymorphism of the human tyrosine hydroxylase (hTH) gene in African Americans with type-1 diabetes. J. Natl. Med. Assoc. 96: 1042-1046 (2004).
Berkovic M, Cacev T, Zjacic-Rotkvic V, Kapitanovic S. TNF-alpha promoter single nucleotide polymorphisms in gastroenteropancreatic neuroendocrine tumors. Neuroendocrinology 84: 346-352 (2006).
Berkun Y, Atta IA, Rubinow A, Orbach H, Levartovsky D, Aamar S, Arbel O, Dresner-Pollak R, Friedman G, Ben-Yehuda A. 2756GG genotype of methionine synthase reductase gene is more prevalent in rheumatoid arthritis patients treated with methotrexate and is associated with methotrexate-induced nodulosis. J. Rheumatol. 34: 1664-1669 (2007).
Berlin D, Chong G, Chertkow H, Bergman H, Phillips NA, Schipper HM. Evaluation of HFE (hemochromatosis) mutations as genetic modifiers in sporadic AD and MCI. Neurobiol. Aging 25: 465-474 (2004).
Bernal W, Donaldson P, Underhill J, Wendon J, Williams R. Tumor necrosis factor genomic polymorphism and outcome of acetaminophen (paracetamol)-induced acute liver failure. J. Hepatol. 29: 53-59 (1998). *
Bernal W, Moloney M, Underhill J, Donaldson PT. Association of tumor necrosis factor polymorphism with primary sclerosing cholangitis. J. Hepatol. 30: 237-241 (1999). *
Bernard D, Christophe A, Delanghe J, Langlois M, De Buyzere M, Comhaire F. The effect of supplementation with an antioxidant preparation on LDL-oxidation is determined by haptoglobin polymorphism. Redox Rep. 8: 41-46 (2003).
Bernardinelli L, Murgia SB, Bitti PP, Foco L, Ferrai R, Musu L, Prokopenko I, Pastorino R, Saddi V, Ticca A, Piras ML, Cox DR, Berzuini C. Association between the ACCN1 gene and multiple sclerosis in Central East Sardinia. PLoS ONE 2: e480 (2007). *
Bernbom N, Norrung B, Saadbye P, Molbak L, Vogensen FK, Licht TR. Comparison of methods and animal models commonly used for investigation of fecal microbiota: effects of time, host and gender. J. Microbiol. Methods 66: 87-95 (2006). *
Berndt SI, Dodson JL, Huang WY, Nicodemus KK. A systematic review of vitamin D receptor gene polymorphisms and prostate cancer risk. J. Urol. 175: 1613-1623 (2006).
Berndt SI, Huang WY, Chatterjee N, Yeager M, Welch R, Chanock SJ, Weissfeld JL, Schoen RE, Hayes RB. Transforming growth factor beta 1 (TGFB1) gene polymorphisms and risk of advanced colorectal adenoma. Carcinogenesis 28: 1965-1970 (2007). *
Berndt SI, Huang WY, Yeager M, Weissfeld JL, Chanock SJ, Hayes RB. Genetic variants in frizzled-related protein (FRZB) and the risk of colorectal neoplasia. Cancer Causes Control 20: 487-490 (2009). *
Bernig T, Chanock SJ. Challenges of SNP genotyping and genetic variation: its future role in diagnosis and treatment of cancer. Expert Rev. Mol. Diagn. 6: 319-331 (2006).
Bernstein JM, Anon JB, Rontal M, Conroy J, Wang C, Sucheston L. Genetic polymorphisms in chronic hyperplastic sinusitis with nasal polyposis. Laryngoscope Apr 29 [Epub ahead of print] (2009).
Berrahmoune H, Herbeth B, Siest G, Visvikis-Siest S. Heritability of serum hs-CRP concentration and 5-year changes in the Stanislas family study: association with apolipoprotein E alleles. Genes Immun. 8: 352-359 (2007). *
Berry A, Tector M, Oaks MK. Lack of association between sCTLA-4 levels in human plasma and common CTLA-4 polymorphisms. J. Negat. Results Biomed. 7: 8 (2008). *
Bertalan R, Patocs A, Nagy B, Derzsy Z, Gullai N, Szappanos A, Rigo J Jr, Racz K. Overrepresentation of BclI polymorphism of the glucocorticoid receptor gene in pregnant women with HELLP syndrome. Clin. Chim. Acta 405: 148-152 (2009). *
Berthold HK, Giannakidou E, Krone W, Mantzoros CS, Gouni-Berthold I. The Leu72Met polymorphism of the ghrelin gene is associated with a decreased risk for type 2 diabetes. Clin. Chim. Acta 399: 112-116 (2009). *
Berthold HK, Laaksonen R, Lehtimaki T, Gylling H, Krone W, Gouni-Berthold I. SREBP-1c gene polymorphism is associated with increased inhibition of cholesterol-absorption in response to ezetimibe treatment. Exp. Clin. Endocrinol. Diabetes 116: 262-267 (2008).
Bertinetto FE, Dall'omo AM, Mazzola GA, Rendine S, Berrino M, Bertola L, Magistroni P, Caropreso P, Falda M, Locatelli F, Busca A, Amoroso A. Role of non-HLA genetic polymorphisms in graft-versus-host disease after haematopoietic stem cell transplantation. Int. J. Immunogenet. 33: 375-384 (2006). *
Bertoli AM, Fernandez M, McGwin G Jr, Alarcon GS, Tan FK, Reveille JD, Vila LM. Systemic lupus erythematosus in a multiethnic US cohort: XXXVI. Influence of mannose-binding lectin exon 1 polymorphisms in disease manifestations, course, and outcome. Arthritis Rheum. 54: 1703-1704 (2006). *
Bertolo F, De Vita S, Dolcetti R, Carbone A, Ferraccioli GF, Bartoli E, Boiocchi M. Lack of Fas and Fas-L mutations in patients with lymphoproliferative disorders associated with Sjogren's syndrome and type II mixed cryoglobulinemia. Clin. Exp. Rheumatol. 17: 339-342 (1999).
Bertram L, Hiltunen M, Parkinson M, Ingelsson M, Lange C, Ramasamy K, Mullin K, Menon R, Sampson AJ, Hsiao MY, Elliott KJ, Velicelebi G, Moscarillo T, Hyman BT, Wagner SL, Becker KD, Blacker D, Tanzi RE. Family-based association between Alzheimer's disease and variants in UBQLN1. N. Engl. J. Med. 352: 884-894 (2005). *
Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat. Genet. 39: 17-23 (2007). *
Bertram L, Mullin K, Parkinson M, Hsiao M, Moscarillo TJ, Wagner SL, Becker KD, Velicelebi G, Blacker D, Tanzi RE. Is alpha-T catenin (VR22) an Alzheimer's disease risk gene? J. Med. Genet. 44: e63 (2007). *
Bertrand-Thiebault C, Berrahmoune H, Thompson A, Marie B, Droesch S, Siest G, Foernzler D, Visvikis-Siest S. Genetic polymorphism of CYP2C19 gene in the Stanislas cohort. A link with inflammation. Ann. Hum. Genet. 72: 178-183 (2008). *
Bertsias GK, Nakou M, Choulaki C, Raptopoulou A, Papadimitraki E, Goulielmos G, Kritikos H, Sidiropoulos P, Tzardi M, Kardassis D, Mamalaki C, Boumpas DT. Genetic, immunologic, and immunohistochemical analysis of the programmed death 1/programmed death ligand 1 pathway in human systemic lupus erythematosus. Arthritis Rheum. 60: 207-218 (2009). *
Besenbacher S, Pedersen CN, Mailund T. A fast algorithm for genome-wide haplotype pattern mining. BMC Bioinformatics 10 Suppl. 1: S74 (2009). *
Bessa SS, Hamdy SM, Ali EM. Haptoglobin gene polymorphism in type 2 diabetic patients with and without nephropathy: an Egyptian study. Eur. J. Intern. Med. 18: 489-495 (2007).
Bessard G, Hardy G, Chartier A, Stanke-Labesque F. Genetic polymorphism and treatment of chronic bowel inflammatory diseases: the example of azathioprine. Therapie 59: 71-75 (2004).
Bessler H, Osovsky M, Beilin B, Alcalay Y, Sirota L. The existence of gender difference in IL-1Ra gene polymorphism. J. Interferon Cytokine Res. 27: 931-935 (2007).
Bethke L, Webb E, Murray A, Schoemaker M, Feychting M, Lonn S, Ahlbom A, Malmer B, Henriksson R, Auvinen A, Kiuru A, Salminen T, Johansen C, Christensen HC, Muir K, McKinney P, Hepworth S, Dimitropoulou P, Lophatananon A, Swerdlow A, Houlston R. Functional polymorphisms in folate metabolism genes influence the risk of meningioma and glioma. Cancer Epidemiol. Biomarkers Prev. 17: 1195-1202 (2008). *
Bettencourt BF, Santos MR, Fialho RN, Couto AR, Peixoto MJ, Pinheiro JP, Spinola H, Mora MG, Santos C, Brehm A, Bruges-Armas J. Evaluation of two methods for computational HLA haplotypes inference using a real dataset. BMC Bioinformatics 9: 68 (2008). *
Bettens F, Nicoloso de Faveri G, Tiercy JM. HLA-B51 and haplotypic diversity of B-Cw associations: implications for matching in unrelated hematopoietic stem cell transplantation. Tissue Antigens 73: 316-325 (2009). *
Bettinotti MP, Hartung K, Deicher H, Messer G, Keller E, Weiss EH, Albert ED. Polymorphism of the tumor necrosis factor beta gene in systemic lupus erythematosus: TNFB-MHC haplotypes. Immunogenetics 37: 449-454 (1993).
Betz RC, Konig K, Flaquer A, Redler S, Eigelshoven S, Kortum AK, Hanneken S, Hillmer A, Tuting T, Lambert J, De Weert J, Kruse R, Lutz G, Blaumeiser B, Nothen MM. The R620W polymorphism in PTPN22 confers general susceptibility for the development of alopecia areata. Br. J. Dermatol. 158: 389-391 (2008). *
Beulens JW, Rimm EB, Hendriks HF, Hu FB, Manson JE, Hunter DJ, Mukamal KJ. Alcohol consumption and type 2 diabetes: influence of genetic variation in alcohol dehydrogenase. Diabetes 56: 2388-2394 (2007). *
Beutler B, Beutler E. Toll-like receptor 4 polymorphisms and atherogenesis. N. Engl. J. Med. 347: 1978-1980 (2002).
Beutler E, Beutler L, Lee PL, Barton JC. The mitochondrial nt 16189 polymorphism and hereditary hemochromatosis. Blood Cells Mol. Dis. 33: 344-345 (2004).
Beutler E, Gelbart T, Lee P. Haptoglobin polymorphism and iron homeostasis. Clin. Chem. 48: 2232-2235 (2002). *
Beutler E, Hoffbrand AV, Cook JD. Iron deficiency and overload. Hematology (Am. Soc. Hematol. Educ. Program) 2003: 40-61 (2003). *
Beyeler C, Armstrong M, Bird HA, Idle JR, Daly AK. Relationship between genotype for the cytochrome P450 CYP2D6 and susceptibility to ankylosing spondylitis and rheumatoid arthritis. Ann. Rheum. Dis. 55: 66-68 (1996). *
Beygo J, Parwez Q, Petrasch-Parwez E, Epplen JT, Hoffjan S. No evidence of an association between polymorphisms in the IRAK-M gene and atopic dermatitis in a German cohort. Mol. Cell. Probes 23: 16-19 (2009).
Beyzade S, Zhang S, Wong YK, Day IN, Eriksson P, Ye S. Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction. J. Am. Coll. Cardiol. 41: 2130-2137 (2003). *
Bezemer ID, Arellano AR, Tong CH, Rowland CM, Ireland HA, Bauer KA, Catanese J, Reitsma PH, Doggen CJ, Devlin JJ, Rosendaal FR, Bare LA. F9 Malmo, factor IX and deep vein thrombosis. Haematologica 94: 693-699 (2009). *
Bezemer ID, Doggen CJ, Vos HL, Rosendaal FR. No association between the common MTHFR 677C->T polymorphism and venous thrombosis: results from the MEGA study. Arch. Intern. Med. 167: 497-501 (2007). *
Bezerra FF, Cabello GM, Mendonca LM, Donangelo CM. Bone mass and breast milk calcium concentration are associated with vitamin D receptor gene polymorphisms in adolescent mothers. J. Nutr. 138: 277-281 (2008). *
Bhaduri N, Mukhopadhyay K. Lack of significant association between -1021C-->T polymorphism in the dopamine beta hydroxylase gene and attention deficit hyperactivity disorder. Neurosci. Lett. 402: 12-16 (2006). *
Bhagwat M. Identification of disease genes: example-driven web-based tutorial. Methods Mol. Biol. 396: 371-394 (2007).
Bhaskar S, Reddy DN, Mahurkar S, Rao GV, Singh L, Chandak GR. Lack of significant association of an insertion/deletion polymorphism in the angiotensin converting enzyme (ACE) gene with tropical calcific pancreatitis. BMC Gastroenterol. 6: 42 (2006). *
Bhat M, Nguyen GC, Pare P, Lahaie R, Deslandres C, Bernard EJ, Aumais G, Jobin G, Wild G, Cohen A, Langelier D, Brant S, Dassopoulos T, McGovern D, Torres E, Duerr R, Regueiro M, Silverberg MS, Steinhart H, Griffiths AM, Elkadri A, Cho J, et al. Phenotypic and genotypic characteristics of inflammatory bowel disease in French Canadians: comparison with a large North American repository. Am. J. Gastroenterol. Jun 9 [Epub ahead of print] (2009). *
Bhat YM, Papachristou GI, Park JS, Lamb J, Slivka A, Whitcomb DC. Gunctional polymorphisms of the GSTT-1 gene do not predict the severity of acute pancreatitis in the United States. Pancreatology 7: 180-186 (2007).
Bhatnagar V, Xu G, Hamilton BA, Truong DM, Eraly SA, Wu W, Nigam SK. Analyses of 5' regulatory region polymorphisms in human SLC22A6 (OAT1) and SLC22A8 (OAT3). J. Hum. Genet. 51: 575-580 (2006). *
Bhattacharya P, Sengupta S. Predisposition to HPV16/18-related cervical cancer because of proline homozygosity at codon 72 of p53 among Indian women is influenced by HLA-B*07 and homozygosity of HLA-DQB1*03. Tissue Antigens 70: 283-293 (2007). *
Biagini MR, Tozzi A, Marcucci R, Paniccia R, Fedi S, Milani S, Galli A, Ceni E, Capanni M, Manta R, Abbate R, Surrenti C. Hyperhomocysteinemia and hypercoagulability in primary biliary cirrhosis. World J. Gastroenterol. 12: 1607-1612 (2006). *
Bialecka M, Hnatyszyn G, Bielicka-Cymerman J, Drozdzik M. The effect of MDR1 gene polymorphism in the pathogenesis and the treatment of drug-resistant epilepsy. Neurol. Neurochir. Pol. 39: 476-481 (2005).
Bialecka M, Klodowska-Duda G, Honczarenko K, Gawronska-Szklarz B, Opala G, Safranow K, Drozdzik M. Polymorphisms of catechol-O-methyltransferase (COMT), monoamine oxidase B (MAOB), N-acetyltransferase 2 (NAT2) and cytochrome P450 2D6 (CYP2D6) gene in patients with early onset of Parkinson's disease. Parkinsonism Relat. Disord. 13: 224-229 (2007).
Bialecka M, Klodowska-Duda G, Kurzawski M, Slawek J, Gorzkowska A, Opala G, Bialecki P, Sagan L, Drozdzik M. Interleukin-10 (IL10) and tumor necrosis factor alpha (TNF) gene polymorphisms in Parkinson's disease patients. Parkinsonism Relat. Disord. 14: 636-640 (2008).
Bialecka M, Klodowska-Duda G, Kurzawski M, Slawek J, Opala G, Bialecki P, Safranow K, Drozdzik M. Interleukin-10 gene polymorphism in Parkinson's disease patients. Arch. Med. Res. 38: 858-863 (2007).
Bialecka M, Kurzawski M, Klodowska-Duda G, Opala G, Juzwiak S, Kurzawski G, Tan EK, Drozdzik M. CARD15 variants in patients with sporadic Parkinson's disease. Neurosci. Res. 57: 473-476 (2007). *
Biasiotto G, Camaschella C, Forni GL, Polotti A, Zecchina G, Arosio P. New TFR2 mutations in young Italian patients with hemochromatosis. Haematologica 93: 309-310 (2008). *
Biasiotto G, Roetto A, Daraio F, Polotti A, Gerardi GM, Girelli D, Cremonesi L, Arosio P, Camaschella C. Identification of new mutations of hepcidin and hemojuvelin in patients with HFE C282Y allele. Blood Cells Mol. Dis. 33: 338-343 (2004).
Biason-Lauber A, Boehm B, Lang-Muritano M, Gauthier BR, Brun T, Wollheim CB, Schoenle EJ. Association of childhood type 1 diabetes mellitus with a variant of PAX4: possible link to beta cell regenerative capacity. Diabetologia 48: 900-905 (2005). *
Bickston SJ, Comerford LW, Cominelli F. Future therapies for inflammatory bowel disease. Curr. Gastroenterol. Rep. 5: 518-523 (2003).
Bid HK, Chaudhary H, Mittal RD. Association of vitamin-D and calcitonin receptor gene polymorphism in paediatric nephrolithiasis. Pediatr. Nephrol. 20: 773-776 (2005). *
Bid HK, Konwar R, Agrawal CG, Banerjee M. Association of IL-4 and IL-1RN (receptor antagonist) gene variants and the risk of type 2 diabetes mellitus: a study in the north Indian population. Indian J. Med. Sci. 62: 259-266 (2008). *
Bidwell J, Keen L, Gallagher G, Kimberly R, Huizinga T, McDermott MF, Oksenberg J, McNicholl J, Pociot F, Hardt C, D'Alfonso S. Cytokine gene polymorphism in human disease: on-line databases, supplement 1. Genes Immun. 2: 61-70 (2001). *
Bielinski SJ, Pankow JS, Boerwinkle E, Bray MS, Kao WH, Folsom AR. Lack of association between uncoupling protein-2 Ala55Val polymorphism and incident diabetes in the atherosclerosis risk in communities study. Acta Diabetol. 45: 179-182 (2008).
Bierbaum S, Nickel R, Zitnik S, Ahlert I, Lau S, Deichmann KA, Wahn U, Heinzmann A. Confirmation of association of IL-15 with pediatric asthma and comparison of different controls. Allergy 61: 576-580 (2006). *
Bierbaum S, Sengler C, Gerhold K, Berner R, Heinzmann A. Polymorphisms within interleukin 15 are associated with juvenile idiopathic arthritis. Clin. Exp. Rheumatol. 24: 219 (2006).
Biernacka JM, Charoen P, Cordell HJ. Joint linkage and association analysis for identification of potentially causal polymorphisms in GAW15 data. BMC Proc. 1 Suppl. 1: S36 (2007). *
Biernacka JM, Cordell HJ. Exploring causality via identification of SNPs or haplotypes responsible for a linkage signal. Genet. Epidemiol. 31: 727-740 (2007).
Biernacka JM, Cordell HJ. A composite-likelihood approach for identifying polymorphisms that are potentially directly associated with disease. Eur. J. Hum. Genet. 17: 644-650 (2009).
Bigatti MP, Santovito A. Glutathione S-transferase T1 (GSTT1) and M1 (GSTM1) polymorphisms in a sample of the population in Northern Italy. Genetika 43: 827-830 (2007).
Bilbao JR, Calvo B, Aransay AM, Martin-Pagola A, Perez de Nanclares G, Aly TA, Rica I, Vitoria JC, Gaztambide S, Noble J, Fain PR, Awdeh ZL, Alper CA, Castano L. Conserved extended haplotypes discriminate HLA-DR3-homozygous Basque patients with type 1 diabetes mellitus and celiac disease. Genes Immun. 7: 550-554 (2006). *
Bilbao JR, Martin-Pagola A, Calvo B, Perez de Nanclares G, Gepv-N, Castano L. Contribution of MIC-A polymorphism to type 1 diabetes mellitus in Basques. Ann. N. Y. Acad. Sci. 958: 321-324 (2002). *
Bilbao JR, Martin-Pagola A, Perez De Nanclares G, Calvo B, Vitoria JC, Vazquez F, Castano L. HLA-DRB1 and MICA in autoimmunity: common associated alleles in autoimmune disorders. Ann. N. Y. Acad. Sci. 1005: 314-318 (2003). *
Bilbao JR, Martin-Pagola A, Vitoria JC, Zubillaga P, Ortiz L, Castano L. HLA-DRB1 and MHC class 1 chain-related A haplotypes in Basque families with celiac disease. Tissue Antigens 60: 71-76 (2002). *
Bilbao JR, Villoslada P, Martin-Pagola A, Castano L. No evidence of pancreatic autoimmunity among patients with multiple sclerosis. Ann. N. Y. Acad. Sci. 1037: 133-137 (2004). *
Bilinska M, Frydecka I, Noga L, Dobosz T, Zoledziewska M, Suwalska K, Tutak A, Pokryszko-Dragan A. Progression of multiple sclerosis is associated with exon 1 CTLA-4 gene polymorphism. Acta Neurol. Scand. 110: 67-71 (2004).
Bilitewski U. DNA microarrays: an introduction to the technology. Methods Mol. Biol. 509: 1-14 (2009).
Billaut-Laden I, Allorge D, Crunelle-Thibaut A, Rat E, Cauffiez C, Chevalier D, Houdret N, Lo-Guidice JM, Broly F. Evidence for a functional genetic polymorphism of the human thiosulfate sulfurtransferase (Rhodanese), a cyanide and H(2)S detoxification enzyme. Toxicology 225: 1-11 (2006). *
Billaut-Laden I, Rat E, Allorge D, Crunelle-Thibaut A, Cauffiez C, Chevalier D, Lo-Guidice JM, Broly F. Evidence for a functional genetic polymorphism of the human mercaptopyruvate sulfurtransferase (MPST), a cyanide detoxification enzyme. Toxicol. Lett. 165: 101-111 (2006).
Biller H, Zissel G, Ruprecht B, Nauck M, Busse Grawitz A, Muller-Quernheim J. Genotype-corrected reference values for serum angiotensin-converting enzyme. Eur. Respir. J. 28: 1085-1091 (2006).
Binder A. Identification of genes for a complex trait: examples from hypertension. Curr. Pharm. Biotechnol. 7: 1-13 (2006).
Binder EB, Holsboer F. Pharmacogenomics. Handb. Exp. Pharmacol. 169: 527-546 (2005).
Binion DG, Kugathasan S, Dwinell MB. Molecular stratification of Crohn's disease by chemokine receptors: fractalkine receptor polymorphisms define a fibrostenosing ileal subgroup. Am. J. Gastroenterol. 101: 107-109 (2006). *
Biondi ML, Turri O, Leviti S, Seminati R, Cecchini F, Bernini M, Ghilardi G, Guagnellini E. MMP1 and MMP3 polymorphisms in promoter regions and cancer. Clin. Chem. 46: 2023-2024 (2000). *
Bioque G, Bouma G, Crusius JB, Koutroubakis I, Kostense PJ, Meuwissen SG, Pena AS. Evidence of genetic heterogeneity in IBD: 1. The interleukin-1 receptor antagonist in the predisposition to suffer from ulcerative colitis. Eur. J. Gastroenterol. Hepatol. 8: 105-110 (1996).
Bioque G, Crusius JB, Koutroubakis I, Bouma G, Kostense PJ, Meuwissen SG, Pena AS. Allelic polymorphism in IL-1 beta and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease. Clin. Exp. Immunol. 102: 379-383 (1995). *
Biral AC, Magalhaes RF, Wastowski IJ, Simoes R, Donadi EA, Simoes AL, Mendes-Junior CT, Tanaka AM, Kraemer MH. Association of HLA-A, -B, -C genes and TNF microsatellite polymorphism with psoriasis vulgaris: a study of genetic risk in Brazilian patients. Eur. J. Dermatol. 16: 523-529 (2006).
Birinci A, Bilgici A, Kuru O, Durupinar B. HLA-B27 polymorphism in Turkish patients with ankylosing spondylitis. Rheumatol. Int. 26: 285-287 (2006). *
Birklein F, Depmeier C, Rolke R, Hansen C, Rautenstrauss B, Prawitt D, Magerl W. A family-based investigation of cold pain tolerance. Pain 138: 111-118 (2008).
Birlea S, Birlea M, Cimponeriu D, Apostol P, Cosgarea R, Gavrila L, Tigan S, Costin G, Das PK. Autoimmune diseases and vitamin D receptor Apa-I polymorphism are associated with vitiligo in a small inbred Romanian community. Acta Derm. Venereol. 86: 209-214 (2006). *
Birlea SA, Laberge GS, Procopciuc LM, Fain PR, Spritz RA. CTLA4 and generalized vitiligo: two genetic association studies and a meta-analysis of published data. Pigment Cell Melanoma Res. 22: 230-234 (2009).
Birmingham DJ, Irshaid F, Gavit KF, Nagaraja HN, Yu CY, Rovin BH, Hebert LA. A polymorphism in the type one complement receptor (CR1) involves an additional cysteine within the C3b/C4b binding domain that inhibits ligand binding. Mol. Immunol. 44: 3510-3516 (2007). *
Birmingham DJ, Nagaraja HN, Rovin BH, Spetie L, Zhao Y, Li X, Hackshaw KV, Yu CY, Malarkey WB, Hebert LA. Fluctuation in self-perceived stress and increased risk of flare in patients with lupus nephritis carrying the serotonin receptor 1A -1019 G allele. Arthritis Rheum. 54: 3291-3299 (2006). *
Biselli JM, Goloni-Bertollo EM, Haddad R, Eberlin MN, Pavarino-Bertelli EC. The MTR A2756G polymorphism is associated with an increase of plasma homocysteine concentration in Brazilian individuals with Down syndrome. Braz. J. Med. Biol. Res. 41: 34-40 (2008). *
Biselli PM, Guerzoni AR, de Godoy MF, Eberlin MN, Haddad R, Carvalho VM, Vannucchi H, Pavarino-Bertelli EC, Goloni-Bertollo EM. Genetic polymorphisms involved in folate metabolism and concentrations of methylmalonic acid and folate on plasma homocysteine and risk of coronary artery disease. J. Thromb. Thrombolysis Mar 13 [Epub ahead of print] (2009).
Biselli PM, Sanches de Alvarenga MP, Abbud-Filho M, Ferreira-Baptista MA, Galbiatti AL, Goto MT, Cardoso MA, Eberlin MN, Haddad R, Goloni-Bertollo EM, Pavarino-Bertelli EC. Effect of folate, vitamin B(6), and vitamin B(12) intake and MTHFR C677T polymorphism on homocysteine concentrations of renal transplant recipients. Transplant. Proc. 39: 3163-3165 (2007). *
Bisgaard H, Bonnelykke K, Sleiman PM, Brasholt M, Chawes B, Kreiner-Moller E, Stage M, Kim C, Tavendale R, Baty F, Pipper CB, Palmer CN, Hakonarsson H. Chromosome 17q21 gene variants are associated with asthma and exacerbations but not atopy in early childhood. Am. J. Respir. Crit. Care Med. 179: 179-185 (2009). *
Bishof NA, Welch TR, Beischel LS, Carson D, Donnelly PA. DP polymorphism in HLA-A1,-B8,-DR3 extended haplotypes associated with membranoproliferative glomerulonephritis and systemic lupus erythematosus. Pediatr. Nephrol. 7: 243-246 (1993).
Bissonnette M, Khare S, von Lintig FC, Wali RK, Nguyen L, Zhang Y, Hart J, Skarosi S, Varki N, Boss GR, Brasitus TA. Mutational and nonmutational activation of p21ras in rat colonic azoxymethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1. Cancer Res. 60: 4602-4609 (2000). *
Bittencourt PL, Farias AQ, Porta G, Cancado EL, Miura I, Pugliese R, Kalil J, Goldberg AC, Carrilho FJ. Frequency of concurrent autoimmune disorders in patients with autoimmune hepatitis: effect of age, gender, and genetic background. J. Clin. Gastroenterol. 42: 300-305 (2008).
Bittencourt PL, Palacios SA, Cancado EL, Carrilho FJ, Porta G, Kalil J, Goldberg AC. Susceptibility to primary sclerosing cholangitis in Brazil is associated with HLA-DRB1*13 but not with tumour necrosis factor alpha -308 promoter polymorphism. Gut 51: 609-610 (2002). *
Bittencourt PL, Palacios SA, Cancado EL, Porta G, Carrilho FJ, Laudanna AA, Kalil J, Goldberg AC. Cytotoxic T lymphocyte antigen-4 gene polymorphisms do not confer susceptibility to autoimmune hepatitis types 1 and 2 in Brazil. Am. J. Gastroenterol. 98: 1616-1620 (2003). *
Bittencourt PL, Palacios SA, Cancado EL, Porta G, Drigo S, Carrilho FJ, Laudanna AA, Kalil J, Goldberg AC. Autoimmune hepatitis in Brazilian patients is not linked to tumor necrosis factor alpha polymorphisms at position -308. J. Hepatol. 35: 24-28 (2001). *
Bittencourt PL, Palacios SA, Farias AQ, Abrantes-Lemos CP, Cancado EL, Carrilho FJ, Laudanna AA, Kalil J, Goldberg AC. Analysis of major histocompatibility complex and CTLA-4 alleles in Brazilian patients with primary biliary cirrhosis. J. Gastroenterol. Hepatol. 18: 1061-1066 (2003). *
Bjerregaard LT, Nederby NJ, Fredholm L, Brandslund I, Munkholm P, Hey H. Hyperhomocysteinaemia, coagulation pathway activation and thrombophilia in patients with inflammatory bowel disease. Scand. J. Gastroenterol. 37: 62-67 (2002). *
Bjornvold M, Amundsen SS, Stene LC, Joner G, Dahl-Jorgensen K, Njolstad PR, Ek J, Ascher H, Gudjonsdottir AH, Lie BA, Skinningsrud B, Akselsen HE, Ronningen KS, Sollid LM, Undlien DE. FOXP3 polymorphisms in type 1 diabetes and coeliac disease. J. Autoimmun. 27: 140-144 (2006).
Bjornvold M, Munthe-Kaas MC, Egeland T, Joner G, Dahl-Jorgensen K, Njolstad PR, Akselsen HE, Gervin K, Carlsen KC, Carlsen KH, Undlien DE. A TLR2 polymorphism is associated with type 1 diabetes and allergic asthma. Genes Immun. 10: 181-187 (2009).
Bjornvold M, Undlien DE, Joner G, Dahl-Jorgensen K, Njolstad PR, Akselsen HE, Gervin K, Ronningen KS, Stene LC. Joint effects of HLA, INS, PTPN22 and CTLA4 genes on the risk of type 1 diabetes. Diabetologia 51: 589-596 (2008). *
Black S, Teixeira AS, Loh AX, Vinall L, Holloway JW, Hardy R, Swallow DM. Contribution of functional variation in the IL13 gene to allergy, hay fever and asthma in the NSHD longitudinal 1946 birth cohort. Allergy Feb 25 [Epub ahead of print] (2009).
Blackwell JM, Searle S. Genetic regulation of macrophage activation: understanding the function of Nramp1 (=Ity/Lsh/Bcg). Immunol. Lett. 65: 73-80 (1999).
Blackwell JM, Searle S, Mohamed H, White JK. Divalent cation transport and susceptibility to infectious and autoimmune disease: continuation of the Ity/Lsh/Bcg/Nramp1/Slc11a1 gene story. Immunol. Lett. 85: 197-203 (2003).
Blaisdell CJ, Howard TD, Stern A, Bamford P, Bleecker ER, Stine OC. CLC-2 single nucleotide polymorphisms (SNPs) as potential modifiers of cystic fibrosis disease severity. BMC Med. Genet. 5: 26 (2004). *
Blakemore AI, Tarlow JK, Cork MJ, Gordon C, Emery P, Duff GW. Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum. 37: 1380-1385 (1994).
Blanchard C, Wang N, Stringer KF, Mishra A, Fulkerson PC, Abonia JP, Jameson SC, Kirby C, Konikoff MR, Collins MH, Cohen MB, Akers R, Hogan SP, Assa'ad AH, Putnam PE, Aronow BJ, Rothenberg ME. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J. Clin. Invest. 116: 536-547 (2006). *
Blanco Y, Gomez-Choco M, Arostegui JL, Casanova B, Martinez-Rodriguez JE, Bosca I, Munteis E, Yague J, Graus F, Saiz A. No association of the Val66Met polymorphism of brain-derived neurotrophic factor (BDNF) to multiple sclerosis. Neurosci. Lett. 396: 217-219 (2006). *
Blanco-Barca O, Gomez-Lado C, Rodrigo-Saez E, Curros-Novos C, Briones-Godino P, Eiris-Punal J, Castro-Gago M. Pyruvate dehydrogenase deficit associated to the C515T mutation in exon 6 of the E1alpha gene. Rev. Neurol. 43: 341-345 (2006).
Blanco-Gelaz MA, Suarez-Alvarez B, Diaz-Pena R, Lopez-Larrea C. HLA-B27 polymorphism at position 116 critically influences the association with TAP/tapasin, intracellular trafficking and conformational homodimers formation. Mol. Immunol. 46: 1304-1311 (2009). *
Blank MC, Stefanescu RN, Masuda E, Marti F, King PD, Redecha PB, Wurzburger RJ, Peterson MG, Tanaka S, Pricop L. Decreased transcription of the human FCGR2B gene mediated by the -343 G/C promoter polymorphism and association with systemic lupus erythematosus. Hum. Genet. 117: 220-227 (2005). *
Bleiber G, May M, Suarez C, Martinez R, Marzolini C, Egger M, Telenti A; Swiss HIV Cohort Study. MDR1 genetic polymorphism does not modify either cell permissiveness to HIV-1 or disease progression before treatment. J. Infect. Dis. 189: 583-586 (2004). *
Blekhman R, Man O, Herrmann L, Boyko AR, Indap A, Kosiol C, Bustamante CD, Teshima KM, Przeworski M. Natural selection on genes that underlie human disease susceptibility. Curr. Biol. 18: 883-889 (2008).
Bloch MH, Landeros-Weisenberger A, Sen S, Dombrowski P, Kelmendi B, Coric V, Pittenger C, Leckman JF. Association of the serotonin transporter polymorphism and obsessive-compulsive disorder: systematic review. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 147B: 850-858 (2008).
Blokhuis JH, Doxiadis GG, Bontrop RE. A splice site mutation converts an inhibitory killer cell Ig-like receptor into an activating one. Mol. Immunol. 46: 640-648 (2009). *
Blomhoff A, Helen Kemp E, Gawkrodger DJ, Weetman AP, Husebye ES, Akselsen HE, Lie BA, Undlien DE. CTLA4 polymorphisms are associated with vitiligo, in patients with concomitant autoimmune diseases. Pigment Cell Res. 18: 55-58 (2005). *
Blomhoff A, Lie BA, Myhre AG, Kemp EH, Weetman AP, Akselsen HE, Huseby ES, Undlien DE. Polymorphisms in the cytotoxic T lymphocyte antigen-4 gene region confer susceptibility to Addison's disease. J. Clin. Endocrinol. Metab. 89: 3474-3476 (2004). *
Blomhoff A, Olsson M, Johansson S, Akselsen HE, Pociot F, Nerup J, Kockum I, Cambon-Thomsen A, Thorsby E, Undlien DE, Lie BA. Linkage disequilibrium and haplotype blocks in the MHC vary in an HLA haplotype specific manner assessed mainly by DRB1(*)03 and DRB1(*)04 haplotypes. Genes Immun. 7: 130-140 (2006). *
Bloomer J, Wang Y, Singhal A, Risheg H. Molecular studies of liver disease in erythropoietic protoporphyria. J. Clin. Gastroenterol. 39: S167-S175 (2005).
Boccia S, Cadoni G, La Torre G, Arzani D, Volante M, Cattel C, Gianfagna F, Paludetti G, Almadori G, Ricciardi G. A case-control study investigating the role of sulfotransferase 1A1 polymorphism in head and neck cancer. J. Cancer Res. Clin. Oncol. 132: 466-472 (2006). *
Boccia S, Gianfagna F, Persiani R, La Greca A, Arzani D, Rausei S, D'Ugo D, Magistrelli P, Villari P, Van Duijn CM, Ricciardi G. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and susceptibility to gastric adenocarcinoma in an Italian population. Biomarkers 12: 635-644 (2007).
Bochenski J, Placha G, Wanic K, Malecki M, Sieradzki J, Warram JH, Krolewski AS. New polymorphism of ENPP1 (PC-1) is associated with increased risk of type 2 diabetes among obese individuals. Diabetes 55: 2626-2630 (2006). *
Bochud PY, Chien JW, Marr KA, Leisenring WM, Upton A, Janer M, Rodrigues SD, Li S, Hansen JA, Zhao LP, Aderem A, Boeckh M. Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation. N. Engl. J. Med. 359: 1766-1777 (2008). *
Bochud PY, Hawn TR, Aderem A. Cutting edge: a Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling. J. Immunol. 170: 3451-3454 (2003). *
Bock HH, Lammert F. Nuclear xeno-sensors as receptors for cholestatic bile acids: the second line of defense. Hepatology 35: 232-234 (2002). *
Bocko D, Bilinska M, Dobosz T, Zoledziewska M, Suwalska K, Tutak A, Gruszka E, Frydecka I. Lack of association between an exon 1 CTLA-4 gene polymorphism A(49)G and multiple sclerosis in a Polish population of the Lower Silesia region. Arch. Immunol. Ther. Exp. (Warsz.) 51: 201-205 (2003).
Bodamer OA, Mitterer G, Maurer W, Pollak A, Mueller MW, Schmidt WM. Evidence for an association between mannose-binding lectin 2 (MBL2) gene polymorphisms and pre-term birth. Genet. Med. 8: 518-524 (2006).
Bodano A, Gonzalez A, Balada E, Ordi J, Carreira P, Gomez-Reino JJ, Conde C. Study of DNASE I gene polymorphisms in systemic lupus erythematosus susceptibility. Ann. Rheum. Dis. 66: 560-561 (2007). *
Bodano A, Gonzalez A, Ferreiros-Vidal I, Balada E, Ordi J, Carreira P, Gomez-Reino JJ, Conde C. Association of a non-synonymous single-nucleotide polymorphism of DNASEI with SLE susceptibility. Rheumatology (Oxford) 45: 819-823 (2006). *
Bodhini D, Radha V, Deepa R, Ghosh S, Majumder PP, Rao MR, Mohan V. The G1057D polymorphism of IRS-2 gene and its relationship with obesity in conferring susceptibility to type 2 diabetes in Asian Indians. Int. J. Obes. (Lond.) 31: 97-102 (2007). *
Bodhini D, Radha V, Dhar M, Narayani N, Mohan V. The rs12255372(G/T) and rs7903146(C/T) polymorphisms of the TCF7L2 gene are associated with type 2 diabetes mellitus in Asian Indians. Metabolism 56: 1174-1178 (2007). *
Boe Wolff AS, Oftedal B, Johansson S, Bruland O, Lovas K, Meager A, Pedersen C, Husebye ES, Knappskog PM. AIRE variations in Addison's disease and autoimmune polyendocrine syndromes (APS): partial gene deletions contribute to APS I. Genes Immun. 9: 130-136 (2008). *
Boehm BO, Manfras B, Rosak C, Schoffling K, Trucco M. Aspartic acid at position 57 of the HLA-DQ beta chain is protective against future development of insulin-dependent (type 1) diabetes mellitus. Klin. Wochenschr. 69: 146-150 (1991).
Boesgaard TW, Zilinskaite J, Vanttinen M, Laakso M, Jansson PA, Hammarstedt A, Smith U, Stefan N, Fritsche A, H�ring H, Hribal M, Sesti G, Zobel DP, Pedersen O, Hansen T; for the EUGENE 2 Consortium. The common SLC30A8 Arg325Trp variant is associated with reduced first-phase insulin release in 846 non-diabetic offspring of type 2 diabetes patients-the EUGENE2 study. Diabetologia 51: 816-820 (2008). *
Boger CA, Stubanus M, Haak T, Gotz AK, Christ J, Hoffmann U, Riegger GA, Kramer BK. Effect of MTHFR C677T genotype on survival in type 2 diabetes patients with end-stage diabetic nephropathy. Nephrol. Dial. Transplant. 22: 154-162 (2007).
Bogner J, Lutz B, Klein H, Pollerer C, Troendle U, Goebel F. Association of highly active antiretroviral therapy failure with chemokine receptor 5 wild type. HIV Med. 5: 264-272 (2004).
Bogunia-Kubik K, Jaskula E, Lange A. The presence of functional CCR5 and EBV reactivation after allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant. 40: 145-150 (2007).
Bogunia-Kubik K, Koscinska K, Suchnicki K, Lange A. HSP70-hom gene single nucleotide (+2763 G/A and +2437 C/T) polymorphisms in sarcoidosis. Int. J. Immunogenet. 33: 135-140 (2006). *
Bogunia-Kubik K, Middleton P, Norden J, Dickinson A, Lange A. Association of vitamin D receptor polymorphisms with the outcome of allogeneic haematopoietic stem cell transplantation. Int. J. Immunogenet. 35: 207-213 (2008). *
Bogunia-Kubik K, Uklejewska A, Dickinson A, Jarvis M, Lange A. HSP70-hom gene polymorphism as a prognostic marker of graft-versus-host disease. Transplantation 82: 1116-1117 (2006).
Bohan A, Boyer JL. Mechanisms of hepatic transport of drugs: implications for cholestatic drug reactions. Semin. Liver Dis. 22: 123-136 (2002).
Bohanec Grabar P, Logar D, Lestan B, Dolzan V. Genetic determinants of methotrexate toxicity in rheumatoid arthritis patients: a study of polymorphisms affecting methotrexate transport and folate metabolism. Eur. J. Clin. Pharmacol. 64: 1057-1068 (2008). *
Bohanec Grabar P, Logar D, Tomsic M, Rozman B, Dolzan V. Genetic polymorphisms of glutathione S-transferases and disease activity of rheumatoid arthritis. Clin. Exp. Rheumatol. 27: 229-236 (2009).
Bohlouli A, Ebrahimzadeh ME, Kafil HS, Asgharzadeh M. Evaluation mannose-binding lectin gene and promoter polymorphism in renal transplant recipients. J. Pak. Med. Assoc. 58: 294-298 (2008).
Bohme M, Nitz I, Doring F, Klapper M. Analysis of the transcriptional regulation of the FABP2 promoter haplotypes by PPARgamma/RXRalpha and Oct-1. Biochim. Biophys. Acta 1779: 616-621 (2008). *
Bohren KM, Nadkarni V, Song JH, Gabbay KH, Owerbach D. A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus. J. Biol. Chem. 279: 27233-27238 (2004). *
Boiardi L, Casali B, Farnetti E, Pipitone N, Nicoli D, Cantini F, Macchioni P, Bajocchi G, Catanoso MG, Pulsatelli L, Consonni D, Salvarani C. Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica. J. Rheumatol. 33: 703-708 (2006).
Boiardi L, Casali B, Farnetti E, Pipitone N, Nicoli D, Macchioni P, Cimino L, Bajocchi G, Grazia Catanoso M, Pattacini L, Salvarani C. Interleukin-10 promoter polymorphisms in giant cell arteritis. Arthritis Rheum. 54: 4011-4017 (2006). *
Boiardi L, Salvarani C, Casali B, Olivieri I, Ciancio G, Cantini F, Salvi F, Malatesta R, Govoni M, Trotta F, Filippini D, Paolazzi G, Nicoli D, Farnetti E, Macchioni L. Intercellular adhesion molecule-1 gene polymorphisms in Behcet's disease. J. Rheumatol. 28: 1283-1287 (2001).
Boitard C, Debray-Sachs M, Bach JF. Autoimmune disorders in diabetes. Adv. Nephrol. Necker Hosp. 15: 281-305 (1986).
Boke O, Gunes S, Kara N, Aker S, Sahin AR, Basar Y, Bagci H. Association of serotonin 2A receptor and lack of association of CYP1A2 gene polymorphism with tardive dyskinesia in a Turkish population. DNA Cell Biol. 26: 527-531 (2007).
Boki KA, Drosos AA, Tzioufas AG, Lanchbury JS, Panayi GS, Moutsopoulos HM. Examination of HLA-DR4 as a severity marker for rheumatoid arthritis in Greek patients. Ann. Rheum. Dis. 52: 517-519 (1993). *
Boki KA, Panayi GS, Vaughan RW, Drosos AA, Moutsopoulos HM, Lanchbury JS. HLA class II sequence polymorphisms and susceptibility to rheumatoid arthritis in Greeks. The HLA-DR beta shared-epitope hypothesis accounts for the disease in only a minority of Greek patients. Arthritis Rheum. 35: 749-755 (1992).
Bokodi G, Treszl A, Kovacs L, Tulassay T, Vasarhelyi B. Dysplasia: a review. Pediatr. Pulmonol. 42: 954-963 (2007).
Bokor S, Csernus K, Erhardt E, Burus I, Molnar D, Decsi T. Association of n-6 long-chain polyunsaturated fatty acids to -866 G/A genotypes of the human uncoupling protein 2 gene in obese children. Acta Paediatr. 96: 1350-1354 (2007). *
Boldt AB, Culpi L, Tsuneto LT, de Souza IR, Kun JF, Petzl-Erler ML. Diversity of the MBL2 gene in various Brazilian populations and the case of selection at the mannose-binding lectin locus. Hum. Immunol. 67: 722-734 (2006).
Boldt AB, Luty A, Grobusch MP, Dietz K, Dzeing A, Kombila M, Kremsner PG, Kun JF. Association of a new mannose-binding lectin variant with severe malaria in Gabonese children. Genes Immun. 7: 393-400 (2006). *
Bolsover WJ, Hall MA, Vaughan RW, Welsh KI, Ciclitira PJ. A family study confirms that the HLA-DP associations with celiac disease are the result of an extended HLA-DR3 haplotype. Hum. Immunol. 31: 100-108 (1991).
Bolstad AI, Wargelius A, Nakken B, Haga HJ, Jonsson R. Fas and Fas ligand gene polymorphisms in primary Sjogren's syndrome. J. Rheumatol. 27: 2397-2405 (2000).
Bolu SE, Orkunoglu Suer FE, Deniz F, Uckaya G, Imirzalioglu N, Kutlu M. The vitamin D receptor fokI start codon polymorphism and bone mineral density in male hypogonadotrophic hypogonadism. J. Endocrinol. Invest. 28: 810-814 (2005).
Bombell S, McGuire W. Tumour necrosis factor (-308A) polymorphism in pre-eclampsia: meta-analysis of 16 case-control studies. Aust. N. Z. J. Obstet. Gynaecol. 48: 547-551 (2008).
Bombieri C, Giorgi S, Carles S, de Cid R, Belpinati F, Tandoi C, Pallares-Ruiz N, Lazaro C, Ciminelli BM, Romey MC, Casals T, Pompei F, Gandini G, Claustres M, Estivill X, Pignatti PF, Modiano G. A new approach for identifying non-pathogenic mutations. An analysis of the cystic fibrosis transmembrane regulator gene in normal individuals. Hum. Genet. 106: 172-178 (2000). *
Bonafe M, Olivieri F. Genetic polymorphism in long-lived people: cues for the presence of an insulin/IGF-pathway-dependent network affecting human longevity. Mol. Cell. Endocrinol. 299: 118-123 (2009).
Bonanno CT, Cigna D, Danna C, D'Anna RP, Di Sano C, Matranga D, Raffa M, Impeduglia A, Salerno A. HLA class I and class II polymorphism in three Sicilian populations. Hum. Biol. 79: 339-354 (2007).
Bondy B. Common genetic factors for depression and cardiovascular disease. Dialogues Clin. Neurosci. 9: 19-28 (2007).
Bondy B, Spaeth M, Offenbaecher M, Glatzeder K, Stratz T, Schwarz M, de Jonge S, Kruger M, Engel RR, Farber L, Pongratz DE, Ackenheil M. The T102C polymorphism of the 5-HT2A-receptor gene in fibromyalgia. Neurobiol. Dis. 6: 433-439 (1999).
Bonen DK, Cho JH. The genetics of inflammatory bowel disease. Gastroenterology 124: 521-536 (2003). *
Bonetti A, Reunanen K, Finnila S, Koivisto K, Wikstrom J, Sumelahti ML, Pirttila T, Elovaara I, Reunanen M, Saarela J, Peltonen L, Rantamaki T, Tienari PJ. A two-stage study on multiple sclerosis susceptibility and chromosome 2q33. Genes Immun. 5: 142-146 (2004). *
Bongardt F, Schopfer-Wendels A, Huth C, Heid I, Rathmann W, Martin S, Vollmert C, Holle R, Thorand B, Wichmann HE, Koenig W, Kolb H, Herder C. Genetics of type 2 diabetes: impact of interleukin-6 gene variants. Gesundheitswesen 67 Suppl. 1: 122-126 (2005).
Bonhomme-Faivre L, Devocelle A, Saliba F, Chatled S, Maccario J, Farinotti R, Picard V. MDR-1 C3435T polymorphism influences cyclosporine A dose requirement in liver-transplant recipients. Transplantation 78: 21-25 (2004).
Bonifati DM, Willcox N, Vincent A, Beeson D. Lack of association between acetylcholine receptor epsilon polymorphisms and early-onset myasthenia gravis. Muscle Nerve 29: 436-439 (2004). *
Boniotto M, Braida L, Baldas V, Not T, Ventura A, Vatta S, Radillo O, Tedesco F, Percopo S, Montico M, Amoroso A, Crovella S. Evidence of a correlation between mannose binding lectin and celiac disease: a model for other autoimmune diseases. J. Mol. Med. 83: 308-315 (2005). *
Boniotto M, Braida L, Ventura A, Percopo S, Amoroso A, Crovella S. Promoter polymorphisms of the CD14 gene in Italian patients with coeliac disease. J. Med. Genet. 40: e108 (2003). *
Bonne-Tamir B, Bodmer JG, Bodmer WF, Pickbourne P, Brautbar C, Gazit E, Nevo S, Zamir R. HLA polymorphism in Israel. 9. An overall comparative analysis. Tissue Antigens 11: 235-250 (1978).
Bonnefoy A, Moura R, Hoylaerts MF. Thrombospondins: from structure to therapeutics: the evolving role of thrombospondin-1 in hemostasis and vascular biology. Cell. Mol. Life Sci. 65: 713-727 (2008). *
Bonnen PE, Wang PJ, Kimmel M, Chakraborty R, Nelson DL. Haplotype and linkage disequilibrium architecture for human cancer-associated genes. Genome Res. 12: 1846-1853 (2002). *
Bonnet F, Patel S, Laville M, Balkau B, Favuzzi A, Monti LD, Lalic N, Walker M; on behalf of the EGIR-RISC Study group. Influence of the ACE gene I/D polymorphism on insulin sensitivity and impaired glucose tolerance in healthy subjects. Diabetes Care 31: 789-794 (2008). *
Bontrop RE. Comparative genetics of MHC polymorphisms in different primate species: duplications and deletions. Hum. Immunol. 67: 388-397 (2006).
Bontrop RE, Watkins DI. MHC polymorphism: AIDS susceptibility in non-human primates. Trends Immunol. 26: 227-233 (2005). *
Boomgaarden I, Bosy-Westphal A, Muller MJ, Doring F. Influence of a type 2 diabetes associated prostaglandin E synthase 2 polymorphism on blood prostaglandin E2 levels. Prostaglandins Leukot. Essent. Fatty Acids 80: 185-188 (2009). *
Boon M, Nolte IM, De Keyser J, Buys CH, te Meerman GJ. Inheritance mode of multiple sclerosis: the effect of HLA class II alleles is stronger than additive. Hum. Genet. 115: 280-284 (2004). *
Boonsrirat U, Angsuthum S, Vannaprasaht S, Kongpunvijit J, Hirankarn N, Tassaneeyakul W, Avihingsanon Y. Azathioprine-induced fatal myelosuppression in systemic lupus erythematosus patient carrying TPMT*3C polymorphism. Lupus 17: 132-134 (2008).
Boonstra AM, Kooij JJ, Buitelaar JK, Oosterlaan J, Sergeant JA, Heister JG, Franke B. An exploratory study of the relationship between four candidate genes and neurocognitive performance in adult ADHD. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 147B: 397-402 (2007).
Booth DR, Arthur AT, Teutsch SM, Bye C, Rubio J, Armati PJ, Pollard JD, Heard RN, Stewart GJ; The Southern MS Genetics Consortium. Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosis. J. Mol. Med. 83: 822-830 (2005). *
Bora G, Ozkan B, Dayangac-Erden D, Erdem-Yurter H, Coskun T. Vitamin D receptor gene polymorphisms in Turkish children with vitamin D deficient rickets. Turk. J. Pediatr. 50: 30-33 (2008).
Bora NS, Jha P, Bora PS. The role of complement in ocular pathology. Semin. Immunopathol. 30: 85-95 (2008). *
Boraska Jelavic T, Barisic M, Drmic Hofman I, Boraska V, Vrdoljak E, Peruzovic M, Hozo I, Puljiz Z, Terzic J. Microsatelite GT polymorphism in the Toll-like receptor 2 is associated with colorectal cancer. Clin. Genet. 70: 156-160 (2006). *
Boraska V, Skrabic V, Culic VC, Becic K, Kapitanovic S, Zemunik T. Association of TNF promoter polymorphisms with type 1 diabetes in the South Croatian population. Biol. Res. 41: 157-163 (2008). *
Boraska V, Skrabic V, Zeggini E, Groves CJ, Buljubalic M, Peruzovic M, Zemunik T. Family-based analysis of vitamin D receptor gene polymorphisms and type 1 diabetes in the population of South Croatia. J. Hum. Genet. 53: 210-214 (2008). *
Boraska V, Terzic J, Skrabic V, Cacev T, Bucevic-Popovic V, Peruzovic M, Markotic A, Zemunik T. NeuroD1 gene and interleukin-18 gene polymorphisms in type 1 diabetes in Dalmatian population of Southern Croatia. Croat. Med. J. 47: 571-578 (2006). *
Boraska V, Zeggini E, Groves CJ, Rayner NW, Skrabic V, Diakite M, Rockett KA, Kwiatkowski D, McCarthy MI, Zemunik T. Family-based analysis of tumor necrosis factor and lymphotoxin-alpha tag polymorphisms with type 1 diabetes in the population of South Croatia. Hum. Immunol. 70: 195-199 (2009).
Borggreve SE, de Vries R, Dallinga-Thie GM, Wolffenbuttel BH, Groen AK, van Tol A, Dullaart RP. The ability of plasma to stimulate fibroblast cholesterol efflux is associated with the -629C-->A cholesteryl ester transfer protein promoter polymorphism: role of lecithin:cholesterol acyltransferase activity. Biochim. Biophys. Acta 1781: 10-15 (2008). *
Borghaei RC, Gorski G, Javadi M, Chambers M. NF-kappaB and ZBP-89 regulate MMP-3 expression via a polymorphic site in the promoter. Biochem. Biophys. Res. Commun. 382: 269-273 (2009). *
Borghi A, Fogli E, Stignani M, Melchiorri L, Altieri E, Baricordi O, Rizzo R, Virgili A. Soluble human leukocyte antigen-G and interleukin-10 levels in plasma of psoriatic patients: preliminary study on a possible correlation between generalized immune status, treatments and disease. Arch. Dermatol. Res. 300: 551-559 (2008). *
Borgiani P, Vallo L, D'Apice MR, Giardina E, Pucci S, Capon F, Nistico S, Chimenti S, Pallone F, Novelli G. Exclusion of CARD15/NOD2 as a candidate susceptibility gene to psoriasis in the Italian population. Eur. J. Dermatol. 12: 540-542 (2002).
Borglum AD, Flint T, Madsen P, Celis JE, Kruse TA. Refined mapping of the psoriasin gene S100A7 to chromosome 1cen-q21. Hum. Genet. 96: 592-596 (1995).
Borgmann S, Endisch G, Urban S, Sitter T, Fricke H. A linkage disequilibrium between genes at the serine protease inhibitor gene cluster on chromosome 14q32.1 is associated with Wegener's granulomatosis. Clin. Immunol. 98: 244-248 (2001). *
Borgmann S, Haubitz M. Genetic impact of pathogenesis and prognosis of ANCA-associated vasculitides. Clin. Exp. Rheumatol. 22 (6 Suppl. 36): S79-S86 (2004).
Borhani Haghighi A, Ghahramani S, Azarpira N, Pourjafar M, Nikseresht AR. Cytotoxic T lymphocyte associated antigen-4 exon 1 A/G polymorphism in Iranian patients with multiple sclerosis. Eur. J. Neurol. 15: 862-864 (2008).
Borm ME, Bodegraven AA, Mulder CJ, Kraal G, Bouma G. A NFKB1 promoter polymorphism is involved in susceptibility to ulcerative colitis. Int. J. Immunogenet. 32: 401-405 (2005). *
Bornstein SR, Zacharowski P, Schumann RR, Barthel A, Tran N, Papewalis C, Rettori V, McCann SM, Schulze-Osthoff K, Scherbaum WA, Tarnow J, Zacharowski K. Impaired adrenal stress response in Toll-like receptor 2-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 101: 16695-16700 (2004). *
Borowski LC, Lopes RP, Gonzalez TP, Dummer LA, Chies JA, Silveira IG, Keisermann M, Bauer ME. Is steroid resistance related to multidrug resistance-I (MDR-I) in rheumatoid arthritis? Int. Immunopharmacol. 7: 836-844 (2007).
Borzutzky A, Fried A, Chou J, Bonilla FA, Kim S, Dedeoglu F. NOD2-associated diseases: bridging innate immunity and autoinflammation. Clin. Immunol. May 23 [Epub ahead of print] (2009). *
Bos JD. Psoriasis, innate immunity, and gene pools. J. Am. Acad. Dermatol. 56: 468-471 (2007).
Bosch A, Minan A, Vescina C, Degrossi J, Gatti B, Montanaro P, Messina M, Franco M, Vay C, Schmitt J, Naumann D, Yantorno O. Fourier transform infrared spectroscopy for rapid identification of nonfermenting gram-negative bacteria isolated from sputum samples from cystic fibrosis patients. J. Clin. Microbiol. 46: 2535-2546 (2008). *
Bosch TM, Deenen M, Pruntel R, Smits PH, Schellens JH, Beijnen JH, Meijerman I. Screening for polymorphisms in the PXR gene in a Dutch population. Eur. J. Clin. Pharmacol. 62: 395-399 (2006). *
Bosch TM, Huitema AD, Doodeman VD, Jansen R, Witteveen E, Smit WM, Jansen RL, van Herpen CM, Soesan M, Beijnen JH, Schellens JH. Pharmacogenetic screening of CYP3A and ABCB1 in relation to population pharmacokinetics of docetaxel. Clin. Cancer Res. 12: 5786-5793 (2006). *
Bosco P, Gueant-Rodriguez RM, Anello G, Barone C, Namour F, Caraci F, Romano A, Romano C, Gueant JL. Methionine synthase (MTR) 2756 (A --> G) polymorphism, double heterozygosity methionine synthase 2756 AG/methionine synthase reductase (MTRR) 66 AG, and elevated homocysteinemia are three risk factors for having a child with Down syndrome. Am. J. Med. Genet. A. 121A: 219-224 (2003).
Bosco P, Gueant-Rodriguez RM, Anello G, Spada R, Romano A, Fajardo A, Caraci F, Ferri R, Gueant JL. Association of homocysteine (but not of MTHFR 677 C>T, MTR 2756 A>G, MTRR 66 A>G and TCN2 776 C>G) with ischaemic cerebrovascular disease in Sicily. Thromb. Haemost. 96: 154-159 (2006).
Bosse Y, Weisnagel SJ, Bouchard C, Despres JP, Perusse L, Vohl MC. Combined effects of PPARgamma2 P12A and PPARalpha L162V polymorphisms on glucose and insulin homeostasis: the Quebec Family Study. J. Hum. Genet. 48: 614-621 (2003). *
Bossu P, Ciaramella A, Moro ML, Bellincampi L, Bernardini S, Federici G, Trequattrini A, Macciardi F, Spoletini I, Di Iulio F, Caltagirone C, Spalletta G. Interleukin-18 gene polymorphisms predict risk and outcome of Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 78: 807-811 (2007). *
Bossuyt X, Moens L, Van Hoeyveld E, Jeurissen A, Bogaert G, Sauer K, Proesmans M, Raes M, De Boeck K. Coexistence of (partial) immune defects and risk of recurrent respiratory infections. Clin. Chem. 53: 124-130 (2007). *
Bostik P, Kobkitjaroen J, Tang W, Villinger F, Pereira LE, Little DM, Stephenson ST, Bouzyk M, Ansari AA. Decreased NK cell frequency and function is associated with increased risk of KIR3DL allele polymorphism in Simian immunodeficiency virus-infected Rhesus macaques with high viral loads. J. Immunol. 182: 3638-3649 (2009).
Botella C, Marin L, Moya-Quiles R, Miras M, Sanchez-Bueno F, Minguela A, Bermejo J, Parrilla P, Alvarez-Lopez R, Muro M. Lack of association between the -403G/A promoter polymorphism in the human CCL5/RANTES chemokine gene in liver transplant outcome. Transpl. Int. 19: 98-104 (2006). *
Bott C, Lembcke B, Stein J. Colorectal cancer and folate. Z. Gastroenterol. 41: 263-270 (2003).
Bottcher S, Ritgen M, Bruggemann M, Raff T, Luschen S, Humpe A, Kneba M, Pott C. Flow cytometric assay for determination of FcgammaRIIIA-158 V/F polymorphism. J. Immunol. Methods 306: 128-136 (2005). *
Bottiger AK, Hurtig-Wennlof A, Sjostrom M, Yngve A, Nilsson TK. Association of total plasma homocysteine with methylenetetrahydrofolate reductase genotypes 677C>T, 1298A>C, and 1793G>A and the corresponding haplotypes in Swedish children and adolescents. Int. J. Mol. Med. 19: 659-665 (2007). *
Bottini E, Bergamaschi A, Magrini A, Spina C, Ammendola L, Grassi S, Bottini N, Gloria-Bottini F. Allergy and ACP1 genetic polymorphism. Allergy Asthma Proc. 28: 87-92 (2007).
Bottini N, Gloria-Bottini F, Amante A, Saccucci P, Bottini E. Genetic polymorphism and Th1/Th2 orientation. Int. Arch. Allergy Immunol. 138: 328-333 (2005).
Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M, MacMurray J, Meloni GF, Lucarelli P, Pellecchia M, Eisenbarth GS, Comings D, Mustelin T. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat. Genet. 36: 337-338 (2004). *
Bottini N, Stefanini L, Lucarelli P, Bottini E. Adaptation to past malarial endemia and susceptibility to common diseases in modern populations: a study of adenosine deaminase and MN blood group genetic polymorphisms. Am. J. Phys. Anthropol. 128: 194-198 (2005). *
Bottini N, Vang T, Cucca F, Mustelin T. Role of PTPN22 in type 1 diabetes and other autoimmune diseases. Semin. Immunol. 18: 207-213 (2006). *
Botto N, Andreassi MG, Manfredi S, Masetti S, Cocci F, Colombo MG, Storti S, Rizza A, Biagini A. Genetic polymorphisms in folate and homocysteine metabolism as risk factors for DNA damage. Eur. J. Hum. Genet. 11: 671-678 (2003). *
Bouali H, Nietert P, Nowling TM, Pandey J, Dooley MA, Cooper G, Harley J, Kamen DL, Oates J, Gilkeson G. Association of the G-463A myeloperoxidase gene polymorphism with renal disease in African Americans with systemic lupus erythematosus. J. Rheumatol. 34: 2028-2034 (2007).
Bouaziz-Borgi L, Nguyen P, Hezard N, Musharrafieh U, Almawi WY, Mahjoub T. A case control study of deep venous thrombosis in relation to factor V G1691A (Leiden) and A4070G (HR2 haplotype) polymorphisms. Exp. Mol. Pathol. 83: 480-483 (2007).
Bouchard L, Tremblay A, Bouchard C, Perusse L. Contribution of several candidate gene polymorphisms in the determination of adiposity changes: results from the Quebec Family Study. Int. J. Obes. (Lond.) 31: 891-899 (2007).
Bougacha-Elleuch N, Rebai A, Mnif M, Makni H, Bellassouad M, Jouida J, Abid M, Hammadi A. Analysis of MHC genes in a Tunisian isolate with autoimmune thyroid diseases: implication of TNF -308 gene polymorphism. J. Autoimmun. 23: 75-80 (2004).
Bougacha-Elleuch N, Tamouza R, Bellassouad M, Jouida J, Abid M, Maalej A, Makni H, Ayadi H. Analysis of heat shock protein polymorphisms in a large family with autoimmune thyroid diseases. Arch. Inst. Pasteur Tunis. 77: 23-24 (2000).
Boukouvala S, Fakis G. Arylamine N-acetyltransferases: what we learn from genes and genomes. Drug Metab. Rev. 37: 511-564 (2005).
Boulouiz R, Li Y, Abidi O, Bolz H, Chafik A, Kubisch C, Roub H, Wollnik B, Barakat A. Analysis of MYO7A in a Moroccan family with Usher syndrome type 1B: novel loss-of-function mutation and non-pathogenicity of p.Y1719C. Mol. Vis. 13: 1862-1865 (2007). *
Bouma G, Crusius JB, Garcia-Gonzalez MA, Meijer BU, Hellemans HP, Hakvoort RJ, Schreuder GM, Kostense PJ, Meuwissen SG, Pena AS. Genetic markers in clinically well defined patients with ulcerative colitis (UC). Clin. Exp. Immunol. 115: 294-300 (1999). *
Bouma G, Crusius JB, Oudkerk Pool M, Kolkman JJ, von Blomberg BM, Kostense PJ, Giphart MJ, Schreuder GM, Meuwissen SG, Pena AS. Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand. J. Immunol. 43: 456-463 (1996).
Bouma G, Pena AS. Immunology in medical practice. XXVI. Immunogenetics of chronic inflammatory bowel diseases. Ned. Tijdschr. Geneeskd. 143: 2414-2420 (1999).
Bouma G, Poen AC, Garcia-Gonzalez MA, Schreuder GM, Felt-Bersma RJ, Meuwissen SG, Pena AS. HLA-DRB1*03, but not the TNFA -308 promoter gene polymorphism, confers protection against fistulising Crohn's disease. Immunogenetics 47: 451-455 (1998).
Bouma G, Xia B, Crusius JB, Bioque G, Koutroubakis I, Von Blomberg BM, Meuwissen SG, Pena AS. Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD). Clin. Exp. Immunol. 103: 391-396 (1996). *
Bouqbis L, Izaabel H, Akhayat O, Perez-Lezaun A, Calafell F, Bertranpetit J, Comas D. Association of the CTLA4 promoter region (-1661G allele) with type 1 diabetes in the South Moroccan population. Genes Immun. 4: 132-137 (2003). *
Bourdi M, Masubuchi Y, Reilly TP, Amouzadeh HR, Martin JL, George JW, Shah AG, Pohl LR. Protection against acetaminophen-induced liver injury and lethality by interleukin 10: role of inducible nitric oxide synthase. Hepatology 35: 289-298 (2002). *
Bourgey M, Leutenegger AL, Cousin E, Bourgain C, Babron MC, Clerget-Darpoux F. Modeling the effect of a genetic factor for a complex trait in a simulated population. BMC Genet. 6 Suppl. 1: S87 (2005). *
Bournet B, Souque A, Senesse P, Assenat E, Barthet M, Lesavre N, Aubert A, O'Toole D, Hammel P, Levy P, Ruszniewski P, Bouisson M, Escourrou J, Cordelier P, Buscail L. Endoscopic ultrasound-guided fine-needle aspiration biopsy coupled with KRAS mutation assay to distinguish pancreatic cancer from pseudotumoral chronic pancreatitis. Endoscopy 41: 552-557 (2009).
Bournissen FG, Moretti ME, Juurlink DN, Koren G, Walker M, Finkelstein Y. Polymorphism of the MDR1/ABCB1 C3435T drug-transporter and resistance to anticonvulsant drugs: a meta-analysis. Epilepsia 50: 898-903 (2009).
Bouwman LH, Eerligh P, Terpstra OT, Daha MR, de Knijff P, Ballieux BE, Bruining GJ, van der Slik AR, Roos A, Roep BO. Elevated levels of mannose-binding lectin at clinical manifestation of type 1 diabetes in juveniles. Diabetes 54: 3002-3006 (2005). *
Bouwman LH, Roos A, Terpstra OT, de Knijff P, van Hoek B, Verspaget HW, Berger SP, Daha MR, Frolich M, van der Slik AR, Doxiadis II, Roep BO, Schaapherder AF. Mannose binding lectin gene polymorphisms confer a major risk for severe infections after liver transplantation. Gastroenterology 129: 408-414 (2005). *
Bouzigon E, Corda E, Aschard H, Dizier MH, Boland A, Bousquet J, Chateigner N, Gormand F, Just J, Le Moual N, Scheinmann P, Siroux V, Vervloet D, Zelenika D, Pin I, Kauffmann F, Lathrop M, Demenais F. Effect of 17q21 variants and smoking exposure in early-onset asthma. N. Engl. J. Med. 359: 1985-1994 (2008). *
Bowes JD, Potter C, Gibbons LJ, Hyrich K, Plant D, Morgan AW, Wilson AG, Isaacs JD, Worthington J, Barton A; BRAGGSS. Investigation of genetic variants within candidate genes of the TNFRSF1B signalling pathway on the response to anti-TNF agents in a UK cohort of rheumatoid arthritis patients. Pharmacogenet. Genomics 19: 319-323 (2009).
Bowlus CL, Karlsen TH, Broome U, Thorsby E, Vatn M; the IBSEN study group; Schrumpf E, Lie BA, Boberg KM. Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis. J. Hepatol. 45: 704-710 (2006). *
Boxall S, McCormick J, Beverley P, Strobel S, De Filippi P, Dawes R, Klersy C, Clementi R, De Juli E, Ferster A, Wallace D, Arico M, Danesino C, Tchilian E. Abnormal cell surface antigen expression in individuals with variant CD45 splicing and histiocytosis. Pediatr. Res. 55: 478-484 (2004). *
Boxall S, Stanton T, Hirai K, Ward V, Yasui T, Tahara H, Tamori A, Nishiguchi S, Shiomi S, Ishiko O, Inaba M, Nishizawa Y, Dawes R, Bodmer W, Beverley PC, Tchilian EZ. Disease associations and altered immune function in CD45 138G variant carriers. Hum. Mol. Genet. 13: 2377-2384 (2004). *
Boyle B, Koranyi K, Patocs A, Liko I, Szappanos A, Bertalan R, Racz K, Balazs C. Polymorphisms of the glucocorticoid receptor gene in Graves ophthalmopathy. Br. J. Ophthalmol. 92: 131-134 (2008).
Boyles AL, Billups AV, Deak KL, Siegel DG, Mehltretter L, Slifer SH, Bassuk AG, Kessler JA, Reed MC, Nijhout HF, George TM, Enterline DS, Gilbert JR, Speer MC. Neural tube defects and folate pathway genes: family-based association tests of gene-gene and gene-environment interactions. Environ. Health Perspect. 114: 1547-1552 (2006). *
Boyles AL, Wilcox AJ, Taylor JA, Shi M, Weinberg CR, Meyer K, Fredriksen A, Ueland PM, Johansen AM, Drevon CA, Jugessur A, Trung TN, Gjessing HK, Vollset SE, Murray JC, Christensen K, Lie RT. Oral facial clefts and gene polymorphisms in metabolism of folate/one-carbon and vitamin A: a pathway-wide association study. Genet. Epidemiol. 33: 247-255 (2009).
Boyton RJ, Reynolds C, Wahid FN, Jones MG, Ozerovitch L, Ahmad T, Chaudhry A, Jewell DP, Kon OM, Smith J, Rose M, Newman-Taylor AJ, Cole P, Wilson R, Altmann DM. IFNgamma and CXCR-1 gene polymorphisms in idiopathic bronchiectasis. Tissue Antigens 68: 325-330 (2006). *
Bozkurt O, de Boer A, Grobbee DE, Kroon AA, Schiffers P, de Leeuw P, Klungel OH. Renin-angiotensin system polymorphisms and the association between use of angiotensin II receptor blockers or angiotensin-converting enzyme inhibitors and the risk of diabetes. J. Renin Angiotensin Aldosterone Syst. 10: 101-108 (2009).
Bozkurt O, Verschuren WM, van Wieren-de Wijer BM, Knol MJ, de Boer A, Grobbee DE, Geerlings MI, Heerdink ER, Klungel OH. Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives. J. Hum. Hypertens. 22: 774-780 (2008).
Bozzi A, Pereira PP, Reis BS, Goulart MI, Pereira MC, Pedroso EP, Leite MF, Goes AM. Interleukin-10 and tumor necrosis factor-alpha single nucleotide gene polymorphism frequency in paracoccidioidomycosis. Hum. Immunol. 67: 931-939 (2006).
Braat H, Stokkers P, Hommes T, Cohn D, Vogels E, Pronk I, Spek A, van Kampen A, van Deventer S, Peppelenbosch M, Hommes D. Consequence of functional Nod2 and Tlr4 mutations on gene transcription in Crohn's disease patients. J. Mol. Med. 83: 601-609 (2005). *
Brabcova I, Petrasek J, Hribova P, Hyklova K, Bartosova K, Lacha J, Viklicky O. Genetic variability of major inflammatory mediators has no impact on the outcome of kidney transplantation. Transplantation 84: 1037-1044 (2007).
Bradley DS, Nabozny GH, Cheng S, Zhou P, Griffiths MM, Luthra HS, David CS. HLA-DQB1 polymorphism determines incidence, onset, and severity of collagen-induced arthritis in transgenic mice. Implications in human rheumatoid arthritis. J. Clin. Invest. 100: 2227-2234 (1997). *
Braeckman L, De Bacquer D, Delanghe J, Claeys L, De Backer G. Associations between haptoglobin polymorphism, lipids, lipoproteins and inflammatory variables. Atherosclerosis 143: 383-388 (1999).
Brajao de Oliveira K, Vissoci Reiche EM, Kaminami Morimoto H, Pelegrinelli Fungaro MH, Estevao D, Pontello R, Franco Nasser T, Watanabe MA. Analysis of the CC chemokine receptor 5 delta32 polymorphism in a Brazilian population with cutaneous leishmaniasis. J. Cutan. Pathol. 34: 27-32 (2007). *
Brambila-Tapia AJ, Davalos-Rodriguez IP. Fcgamma receptors polymorphisms and systemic lupus erythematosus. Rev. Invest. Clin. 61: 66-72 (2009).
Brand O, Gough S, Heward J. HLA , CTLA-4 and PTPN22: the shared genetic master-key to autoimmunity? Expert Rev. Mol. Med. 7: 1-15 (2005).
Brand OJ, Lowe CE, Heward JM, Franklyn JA, Cooper JD, Todd JA, Gough SC. Association of the interleukin-2 receptor alpha (IL-2Ralpha)/CD25 gene region with Graves' disease using a multilocus test and tag SNPs. Clin. Endocrinol. (Oxf.) 66: 508-512 (2007). *
Brand S, Crispin A. C-reactive protein polymorphism and Crohn's disease: authors' reply. Aliment. Pharmacol. Ther. 25: 520-521 (2007).
Brand S, Hofbauer K, Dambacher J, Schnitzler F, Staudinger T, Pfennig S, Seiderer J, Tillack C, Konrad A, Goke B, Ochsenkuhn T, Lohse P. Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease phenotype. Am. J. Gastroenterol. 101: 99-106 (2006). *
Brand S, Staudinger T, Schnitzler F, Pfennig S, Hofbauer K, Dambacher J, Seiderer J, Tillack C, Konrad A, Crispin A, Goke B, Lohse P, Ochsenkuhn T. The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn's disease. Inflamm. Bowel Dis. 11: 645-652 (2005). *
Brandao LA, Guimaraes RL, Araujo J, Arraes LC, Segat L, Crovella S. Association between MBL2 polymorphism and T1D: does ethnicity play a role in the susceptibility of this multifactorial disease? Hum. Immunol. 69: 577-579 (2008).
Brant SR. Exposed: the genetic underpinnings of ulcerative colitis relative to Crohn's disease. Gastroenterology 136: 396-399 (2009). *
Brant SR, Panhuysen CI, Nicolae D, Reddy DM, Bonen DK, Karaliukas R, Zhang L, Swanson E, Datta LW, Moran T, Ravenhill G, Duerr RH, Achkar JP, Karban AS, Cho JH. MDR1 Ala893 polymorphism is associated with inflammatory bowel disease. Am. J. Hum. Genet.73: 1282-1292 (2003). *
Braun C, Zahn R, Martin K, Albert E, Folwaczny C. Polymorphisms of the ICAM-1 gene are associated with inflammatory bowel disease, regardless of the p-ANCA status. Clin. Immunol. 101: 357-360 (2001). *
Braun J, Donner H, Siegmund T, Walfish PG, Usadel KH, Badenhoop K. CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis. Tissue Antigens 51: 563-566 (1998).
Bravo MJ, Colmenero JD, Martin J, Alonso A, Caballero A. Polymorphism of the transmembrane region of the MICA gene and human brucellosis. Tissue Antigens 69: 358-360 (2007). *
Bravo MJ, Colmenero JD, Queipo-Ortuno MI, Alonso A, Caballero A. TGF-beta1 and IL-6 gene polymorphism in Spanish brucellosis patients. Cytokine 44: 18-21 (2008).
Bravo-Villalta HV, Yamamoto K, Nakamura K, Baya A, Horiuchi R. A novel intronic mutation that may affect genotyping result of CYP2C8 by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) is strongly associated with CYP2C8*3 in a South American population. J. Hum. Genet. 52: 195-199 (2007). *
Bray PF, Mathias RA, Faraday N, Yanek LR, Fallin MD, Wilson AF, Becker LC, Becker DM. Heritability of platelet function in families with premature coronary artery disease. J. Thromb. Haemost. 5: 1617-1623 (2007). *
Brazova J, Sismova K, Vavrova V, Bartosova J, Macek M Jr, Lauschman H, Sediva A. Polymorphisms of TGF-beta1 in cystic fibrosis patients. Clin. Immunol. 121: 350-357 (2006). *
Bream JH, Ping A, Zhang X, Winkler C, Young HA. A single nucleotide polymorphism in the proximal IFN-gamma promoter alters control of gene transcription. Genes Immun. 3: 165-169 (2002). *
Breen DP, Marinaki AM, Arenas M, Hayes PC. Pharmacogenetic association with adverse drug reactions to azathioprine immunosuppressive therapy following liver transplantation. Liver Transpl. 11: 826-833 (2005). *
Bregenzer N, Schaffler A, Gelbmann CM, Steinkamp M, Reinshagen M, Scholmerich J, Andus T. Lack of correlation between the vitamin D receptor Fokl start codon polymorphism and bone mineral density in patients with Crohn's disease. Exp. Clin. Endocrinol. Diabetes 114: 1-5 (2006).
Brenmoehl J, Holler E, Rogler G. Polymorphisms within epithelial receptors: NOD2/CARD15. Methods Mol. Med. 134: 115-122 (2007).
Brennan P, Ollier B, Worthington J, Hajeer A, Silman A. Are both genetic and reproductive associations with rheumatoid arthritis linked to prolactin? Lancet 348: 106-109 (1996). *
Brenner AV, Butler MA, Wang SS, Ruder AM, Rothman N, Schulte PA, Chanock SJ, Fine HA, Linet MS, Inskip PD. Single nucleotide polymorphisms in selected cytokine genes and risk of adult glioma. Carcinogenesis 28: 2543-2547 (2007). *
Brenner M, Meng HC, Yarlett NC, Griffiths MM, Remmers EF, Wilder RL, Gulko PS. The non-major histocompatibility complex quantitative trait locus Cia10 contains a major arthritis gene and regulates disease severity, pannus formation, and joint damage. Arthritis Rheum. 52: 322-332 (2005). *
Brenol CV, Chies JA, Brenol JC, Monticielo OA, Franciscatto P, Birriel F, Neves AG, Xavier RM. Endothelial nitric oxide synthase T-786C polymorphism in rheumatoid arthritis: association with extraarticular manifestations. Clin. Rheumatol. 28: 201-205 (2009).
Breulmann B, Bantis C, Siekierka M, Blume C, Aker S, Kuhr N, Grabensee B, Ivens K. Influence of cytokine genes polymorphisms on long-term outcome in renal transplantation. Clin. Transplant. 21: 615-621 (2007). *
Breunis WB, Tarazona-Santos E, Chen R, Kiley M, Rosenberg SA, Chanock SJ. Influence of cytotoxic T lymphocyte-associated antigen 4 (CTLA4) common polymorphisms on outcome in treatment of melanoma patients with CTLA-4 blockade. J. Immunother. 31: 586-590 (2008).
Breunis WB, van Mirre E, Bruin M, Geissler J, de Boer M, Peters M, Roos D, de Haas M, Koene HR, Kuijpers TW. Copy number variation of the activating FCGR2C gene predisposes to idiopathic thrombocytopenic purpura. Blood 111: 1029-1038 (2008). *
Breunis WB, van Mirre E, Geissler J, Laddach N, Wolbink G, van der Schoot E, de Haas M, de Boer M, Roos D, Kuijpers TW. Copy number variation at the FCGR locus includes FCGR3A, FCGR2C and FCGR3B but not FCGR2A and FCGR2B. Hum. Mutat. 30: E640-E650 (2009). *
Brickner AG. Mechanisms of minor histocompatibility antigen immunogenicity: the role of infinitesimal versus structurally profound polymorphisms. Immunol. Res. 36: 33-42 (2006). *
Bridges SL Jr, Jenq G, Moran M, Kuffner T, Whitworth WC, McNicholl J. Single-nucleotide polymorphisms in tumor necrosis factor receptor genes: definition of novel haplotypes and racial/ethnic differences. Arthritis Rheum. 46: 2045-2050 (2002). *
Briggs D, Stephens C, Vaughan R, Welsh K, Black C. A molecular and serologic analysis of the major histocompatibility complex and complement component C4 in systemic sclerosis. Arthritis Rheum. 36: 943-954 (1993).
Briggs DC, Donaldson PT, Hayes P, Welsh KI, Williams R, Neuberger JM. A major histocompatibility complex class III allotype (C4B 2) associated with primary biliary cirrhosis (PBC). Tissue Antigens 29: 141-145 (1987).
Brinkmann U, Eichelbaum M. Polymorphisms in the ABC drug transporter gene MDR1. Pharmacogenomics J. 1: 59-64 (2001). *
Brintnell W, Zeggini E, Barton A, Thomson W, Eyre S, Hinks A, Silman AJ, Worthington J. Evidence for a novel rheumatoid arthritis susceptibility locus on chromosome 6p. Arthritis Rheum. 50: 3823-3830 (2004). *
Brinza D, Zelikovsky A. Design and validation of methods searching for risk factors in genotype case-control studies. J. Comput. Biol. 15: 81-90 (2008).
Brockton NT. Localized depletion: the key to colorectal cancer risk mediated by MTHFR genotype and folate? Cancer Causes Control 17: 1005-1016 (2006). *
Bronson PG, Criswell LA, Barcellos LF. The MHC2TA -168A/G polymorphism and risk for rheumatoid arthritis: a meta-analysis of 6,861 patients and 9,270 controls reveals no evidence for association. Ann. Rheum. Dis. 67: 933-936 (2008).
Brookes KJ, Chen W, Xu X, Taylor E, Asherson P. Association of fatty acid desaturase genes with attention-deficit/hyperactivity disorder. Biol. Psychiatry 60: 1053-1061 (2006). *
Brooksbank R, Badenhorst D, Sliwa K, Norton G, Woodiwiss A. The G-308A polymorphism of the TNF-alpha gene does not predict changes in cardiac function in response to medical therapy for idiopathic dilated cardiomyopathy. Cardiovasc. J. Afr. 19: 254-258 (2008).
Brophy K, Ryan AW, Thornton JM, Abuzakouk M, Fitzgerald AP, McLoughlin RM, O'Morain C, Kennedy NP, Stevens FM, Feighery C, Kelleher D, McManus R. Haplotypes in the CTLA4 region are associated with coeliac disease in the Irish population. Genes Immun. 7: 19-26 (2006). *
Brorsson C, Hansen NT, Lage K, Bergholdt R, Brunak S, Pociot F; Diabetes Genetics Consortium. Identification of T1D susceptibility genes within the MHC region by combining protein interaction networks and SNP genotyping data. Diabetes Obes. Metab. 11 Suppl. 1: 60-66 (2009). *
Brosbol-Ravnborg A, Hvas CL, Agnholt J, Dahlerup JF, Vind I, Till A, Rosenstiel P, Hollsberg P. Clinical immunology review series: Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2-dependent and -independent pathways. Clin. Exp. Immunol. 155: 487-495 (2009). *
Brosnan JT, da Silva R, Brosnan ME. Amino acids and the regulation of methyl balance in humans. Curr. Opin. Clin. Nutr. Metab. Care 10: 52-57 (2006).
Brouns R, Ursem N, Lindemans J, Hop W, Pluijm S, Steegers E, Steegers-Theunissen R. Polymorphisms in genes related to folate and cobalamin metabolism and the associations with complex birth defects. Prenat. Diagn. 28: 485-493 (2008).
Brouwers A, Langlois M, Delanghe J, Billiet J, De Buyzere M, Vercaemst R, Rietzschel E, Bernard D, Blaton V. Oxidized low-density lipoprotein, iron stores, and haptoglobin polymorphism. Atherosclerosis 176: 189-195 (2004).
Brown EE, Zhang M, Zarin-Pass R, Bernig T, Tseng FC, Xiao N, Yeager M, Edlin BR, Chanock SJ, O'Brien TR. MBL2 and hepatitis C virus infection among injection drug users. BMC Infect. Dis. 8: 57 (2008). *
Brown J, Theisler C, Silberman S, Magnuson D, Gottardi-Littell N, Lee JM, Yager D, Crowley J, Sambamurti K, Rahman MM, Reiss AB, Eckman CB, Wolozin B. Differential expression of cholesterol hydroxylases in Alzheimer's disease. J. Biol. Chem. 279: 34674-34681 (2004). *
Brown KS, Nackos E, Morthala S, Jensen LE, Whitehead AS, VON Feldt JM. Independent role of conventional cardiovascular risk factors as predictors of C-reactive protein concentrations in rheumatoid arthritis. J. Rheumatol. 34: 740-746 (2007).
Brown MA. Genetics and the pathogenesis of ankylosing spondylitis. Curr. Opin. Rheumatol. 21: 318-323 (2009).
Brown RS. Autoimmune thyroid disease: unlocking a complex puzzle. Curr. Opin. Pediatr. May 26 [Epub ahead of print] (2009).
Brown SJ, Abreu MT. Antibodies to tumor necrosis factor-alpha in the treatment of Crohn's disease. Curr. Opin. Drug Discov. Devel. 8: 160-168 (2005).
Brown WM, Pierce J, Hilner JE, Perdue LH, Lohman K, Li L, Venkatesh RB, Hunt S, Mychaleckyj JC, Deloukas P; Diabetes Genetics Consortium. Overview of the MHC fine mapping data. Diabetes Obes. Metab. 11 Suppl. 1: 2-7 (2009). *
Browning BL, Huebner C, Petermann I, Demmers P, McCulloch A, Gearry RB, Barclay ML, Shelling AN, Ferguson LR. Association of DLG5 variants with inflammatory bowel disease in the New Zealand caucasian population and meta-analysis of the DLG5 R30Q variant. Inflamm. Bowel Dis. 13: 1069-1076 (2007). *
Browning BL, Huebner C, Petermann I, Gearry RB, Barclay ML, Shelling AN, Ferguson LR. Has Toll-like receptor 4 been prematurely dismissed as an inflammatory bowel disease gene? Association study combined with meta-analysis shows strong evidence for association. Am. J. Gastroenterol. 102: 2504-2512 (2007). *
Browning SR, Briley JD, Briley LP, Chandra G, Charnecki JH, Ehm MG, Johansson KA, Jones BJ, Karter AJ, Yarnall DP, Wagner MJ. Case-control single-marker and haplotypic association analysis of pedigree data. Genet. Epidemiol. 28: 110-122 (2005). *
Brozek W, Bises G, Fabjani G, Cross HS, Peterlik M. Clone-specific expression, transcriptional regulation, and action of interleukin-6 in human colon carcinoma cells. BMC Cancer 8: 13 (2008). *
Bruck P, Bartsch W, Penna-Martinez M, Kahles H, Seidl C, Bohme A, Badenhoop K, Ramos-Lopez E. Polymorphisms of CXCR3-binding chemokines in type 1 diabetes. Hum. Immunol. Apr 30 [Epub ahead of print] (2009).
Bruck P, Ramos-Lopez E, Bartsch W, Bohme A, Badenhoop K. TIM-3 polymorphisms in type 1 diabetes families. J. Hum. Genet. 53: 559-564 (2008). *
Brugere JF, Gobron S, Baud E, Cailloux F. Single-tube genotyping using a solid-phase method that combines alpha-phosphorothioate-mediated primer extension and ExoIII: Proof of concept with the F508del cystic fibrosis diagnosis. Mol. Cell. Probes 22: 320-323 (2008).
Brumm H, Pfeufer A, Biebermann H, Schnabel D, Deiss D, Gruters A. Congenital central hypothyroidism due to homozygous thyrotropin beta 313 Delta T mutation is caused by a Founder effect. J. Clin. Endocrinol. Metab. 87: 4811-4816 (2002). *
Brun P, Castagliuolo I, Floreani AR, Buda A, Blasone L, Palu G, Martines D. Increased risk of NASH in patients carrying the C(-159)T polymorphism in the CD14 gene promoter region. Gut 55: 1212 (2006). *
Brun T, Gauthier BR. A focus on the role of Pax4 in mature pancreatic islet beta-cell expansion and survival in health and disease. J. Mol. Endocrinol. 40: 37-45 (2008). *
Brune CW, Kim SJ, Salt J, Leventhal BL, Lord C, Cook EH Jr. 5-HTTLPR genotype-specific phenotype in children and adolescents with autism. Am. J. Psychiatry 163: 2148-2156 (2006).
Brune S, Kolsch H, Ptok U, Majores M, Schulz A, Schlosser R, Rao ML, Maier W, Heun R. Polymorphism in the peroxisome proliferator-activated receptor alpha gene influences the risk for Alzheimer's disease. J. Neural. Transm. 110: 1041-1050 (2003). *
Brunham LR, Singaraja RR, Pape TD, Kejariwal A, Thomas PD, Hayden MR. Accurate prediction of the functional significance of single nucleotide polymorphisms and mutations in the ABCA1 gene. PLoS Genet. 1: e83 (2005). *
Bruno F, Damin F, Vincenza C, Galbiati S, Di Carlo G, Seia M, Porcaro L, Ferrari M, Chiari M, Cremonesi L. High-sensitive microarray substrates specifically designed to improve sensitivity for the identification of fetal paternally inherited sequences in maternal plasma. Clin. Chem. Lab. Med. Jun 4 [Epub ahead of print] (2009).
Bryan J, Munoz A, Zhang X, Dufer M, Drews G, Krippeit-Drews P, Aguilar-Bryan L. ABCC8 and ABCC9: ABC transporters that regulate K(+) channels. Pflugers Arch. 453: 703-718 (2007). *
Brynedal B, Duvefelt K, Jonasdottir G, Roos IM, Akesson E, Palmgren J, Hillert J. HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis. PLoS ONE 2: e664 (2007). *
Bu D, Tomlinson G, Lewis CM, Zhang C, Kildebeck E, Euhus DM. An intronic polymorphism associated with increased XRCC1 expression, reduced apoptosis and familial breast cancer. Breast Cancer Res. Treat. 99: 257-265 (2006). *
Bubnova LN, Pavlova IE, Berkos MV, Solovyeva OI, Simanenkov VI. HLA II class polymorphism in patients with ulcerative colitis. Hum. Immunol. 64 (10 Suppl.): S149 (2003).
Bucheton B, Abel L, Kheir MM, Mirgani A, El-Safi SH, Chevillard C, Dessein A. Genetic control of visceral leishmaniasis in a Sudanese population: candidate gene testing indicates a linkage to the NRAMP1 region. Genes Immun. 4: 104-109 (2003). *
Bucheton B, Argiro L, Chevillard C, Marquet S, Kheir MM, Mergani A, El-Safi SH, Dessein AJ. Identification of a novel G245R polymorphism in the IL-2 receptor beta membrane proximal domain associated with human visceral leishmaniasis. Genes Immun. 8: 79-83 (2007). *
Buchs N, di Giovine FS, Silvestri T, Vannier E, Duff GW, Miossec P. IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: interaction with their plasma levels. Genes Immun. 2: 222-228 (2001). *
Buchwald P, Juhasz A, Bell C, Patfalusi M, Kovacs P, Hochhaus G, Howes J, Bodor N. Influence of the N-acetylation polymorphism on the metabolism of talampanel: an investigation in fasted and fed subjects genotyped for NAT2 variants. Pharmazie 61: 125-134 (2006).
Bucin D, Truedsson L, Hammarstrom L, Smith CI, Sjoholm AG. C4 polymorphism and major histocompatibility complex haplotypes in IgA deficiency: association with C4A null haplotypes. Exp. Clin. Immunogenet. 8: 233-241 (1991).
Buck D, Kroner A, Rieckmann P, Maurer M, Wiendl H. Analysis of the C/T(-1)) single nucleotide polymorphism in the CD40 gene in multiple sclerosis. Tissue Antigens 68: 335-338 (2006). *
Buckova D, Holla LI, Znojil V, Vasku A. Polymorphisms of the CD14 gene and atopic phenotypes in Czech patients with IgE-mediated allergy. J. Hum. Genet. 51: 977-983 (2006). *
Bucova M, Bernadic M, Buckingham T. C-reactive protein, cytokines and inflammation in cardiovascular diseases. Bratisl. Lek. Listy. 109: 333-340 (2008).
Buda G, Maggini V, Galimberti S, Martino A, Giuliani N, Morabito F, Genestreti G, Iacopino P, Rizzoli V, Barale R, Rossi AM, Petrini M. MDR1 polymorphism influences the outcome of multiple myeloma patients. Br. J. Haematol. 137: 454-456 (2007). *
Budak F, Goral G, Heper Y, Yilmaz E, Aymak F, Basturk B, Tore O, Ener B, Oral HB. IL-10 and IL-6 gene polymorphisms as potential host susceptibility factors in Brucellosis. Cytokine 38: 32-36 (2007).
Bugawan TL, Angelini G, Larrick J, Auricchio S, Ferrara GB, Erlich HA. A combination of a particular HLA-DP beta allele and an HLA-DQ heterodimer confers susceptibility to coeliac disease. Nature 339: 470-473 (1989). *
Bugawan TL, Horn GT, Long CM, Mickelson E, Hansen JA, Ferrara GB, Angelini G, Erlich HA. Analysis of HLA-DP allelic sequence polymorphism using the in vitro enzymatic DNA amplification of DP-alpha and DP-beta loci. J. Immunol. 141: 4024-4030 (1988).
Bugawan TL, Mirel DB, Valdes AM, Panelo A, Pozzilli P, Erlich HA. Association and interaction of the IL4R, IL4, and IL13 loci with type 1 diabetes among Filipinos. Am. J. Hum. Genet. 72: 1505-1514 (2003). *
Bugeja MJ, Booth D, Bennetts B, Heard R, Rubio J, Stewart G. An investigation of polymorphisms in the 17q11.2-12 CC chemokine gene cluster for association with multiple sclerosis in Australians. BMC Med. Genet. 7: 64 (2006). *
Bugeja MJ, Booth DR, Bennetts BH, Heard RN, Burgner D, Stewart GJ. An investigation of NOS2A promoter polymorphisms in Australian multiple sclerosis patients. Eur. J. Hum. Genet. 13: 815-822 (2005). *
Bugeja MJ, Booth DR, Bennetts BH, Heard RN, Stewart GJ. An investigation of polymorphisms in the 4q1 3.3-21.1 CXC chemokine gene cluster for association with multiple sclerosis in Australians. Mult. Scler. 12: 710-722 (2006).
Buhner S, Buning C, Genschel J, Kling K, Herrmann D, Dignass A, Kuechler I, Krueger S, Schmidt HH, Lochs H. Genetic basis for increased intestinal permeability in families with Crohn�s disease: role of CARD15 3020insC mutation? Gut 55: 342-347 (2006). *
Bui HH, Sidney J, Dinh K, Southwood S, Newman MJ, Sette A. Predicting population coverage of T-cell epitope-based diagnostics and vaccines. BMC Bioinformatics 7: 153 (2006). *
Buijtels PC, van de Sande WW, Parkinson S, Petit PL, van der Sande MA, van Soolingen D, Verbrugh HA, van Belkum A. Polymorphism in CC-chemokine ligand 2 associated with tuberculosis in Zambia. Int. J. Tuberc. Lung Dis. 12: 1485-1488 (2008).
Buis CI, Hoekstra H, Verdonk RC, Porte RJ. Causes and consequences of ischemic-type biliary lesions after liver transplantation. J. Hepatobiliary Pancreat. Surg. 13: 517-524 (2006). *
Buis CI, van der Steege G, Visser DS, Nolte IM, Hepkema BG, Nijsten M, Slooff MJ, Porte RJ. Heme oxygenase-1 genotype of the donor is associated with graft survival after liver transplantation. Am. J. Transplant. 8: 377-385 (2008).
Bukulmez H, Fife M, Tsoras M, Thompson SD, Twine NA, Woo P, Olson JM, Elston RC, Glass DN, Colbert RA. Tapasin gene polymorphism in systemic onset juvenile rheumatoid arthritis: a family-based case-control study. Arthritis Res. Ther. 7: R285-R290 (2005). *
Buning C, Geerdts L, Fiedler T, Gentz E, Pitre G, Reuter W, Luck W, Buhner S, Molnar T, Nagy F, Lonovics J, Dignass A, Landt O, Nickel R, Genschel J, Lochs H, Schmidt HH, Witt H. DLG5 variants in inflammatory bowel disease. Am. J. Gastroenterol. 101: 786-792 (2006). *
Buning C, Genschel J, Weltrich R, Lochs H, Schmidt H. The interleukin-25 gene located in the inflammatory bowel disease (IBD) 4 region: no association with inflammatory bowel disease. Eur. J. Immunogenet. 30: 329-333 (2003). *
Buning C, Molnar T, Nagy F, Lonovics J, Weltrich R, Bochow B, Genschel J, Schmidt H, Lochs H. NOD2/CARD15 gene polymorphism in patients with inflammatory bowel disease: is Hungary different? World J. Gastroenterol. 11: 407-411 (2005). *
Buning C, Schmidt HH, Molnar T, DE Jong DJ, Fiedler T, Buhner S, Sturm A, Baumgart DC, Nagy F, Lonovics J, Drenth JP, Landt O, Nickel R, Buttner J, Lochs H, Witt H. Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn's disease but also ulcerative colitis. Aliment. Pharmacol. Ther. 26: 1025-1033 (2007). *
Buraczynska M, Baranowicz-Gaszczyk I, Borowicz E, Ksiazek A. TGF-beta1 and TSC-22 gene polymorphisms and susceptibility to microvascular complications in type 2 diabetes. Nephron. Physiol. 106: 69-75 (2007).
Buraczynska M, Baranowicz-Gaszczyk I, Tarach J, Ksiazek A. Toll-like receptor 4 gene polymorphism and early onset of diabetic retinopathy in patients with type 2 diabetes. Hum. Immunol. 70: 121-124 (2009).
Buraczynska M, Jozwiak L, Ksiazek P, Borowicz E, Mierzicki P. Interleukin-6 gene polymorphism and faster progression to end-stage renal failure in chronic glomerulonephritis. Transl. Res. 150: 101-105 (2007). *
Buraczynska M, Ksiazek P, Baranowicz-Gaszczyk I, Jozwiak L. Association of the VEGF gene polymorphism with diabetic retinopathy in type 2 diabetes patients. Nephrol. Dial. Transplant. 22: 827-832 (2007).
Buraczynska M, Ksiazek P, Zukowski P, Benedyk-Lorens E, Orlowska-Kowalik G. Complement factor H gene polymorphism and risk of cardiovascular disease in end-stage renal disease patients. Clin. Immunol. May 8 [Epub ahead of print] (2009). *
Buraczynska M, Mierzicki P, Buraczynska K, Dragan M, Ksiazek A. Tumor necrosis factor-alpha gene polymorphism correlates with cardiovascular disease in patients with end-stage renal disease. Mol. Diagn. Ther. 11: 257-263 (2007). *
Buraczynska M, Swatowski A, Buraczynska K, Dragan M, Ksiazek A. Heat-shock protein gene polymorphisms and the risk of nephropathy in type 2 diabetes patients. Clin. Sci. (Lond.) 116: 81-86 (2009).
Burch LR, Zhou K, Donnelly LA, Doney AS, Brady J, Goddard C, Morris AD, Hansen MK, Palmer CN. A single nucleotide polymorphism on exon-4 of the gene encoding PPARdelta is associated with reduced height in adults and children. J. Clin. Endocrinol. Metab. Apr 21 [Epub ahead of print] (2009). *
Burfoot RK, Jensen CJ, Field J, Stankovich J, Varney MD, Johnson LJ, Butzkueven H, Booth D, Bahlo M, Tait BD, Taylor BV, Speed TP, Heard R, Stewart GJ, Foote SJ, Kilpatrick TJ, Rubio JP. SNP mapping and candidate gene sequencing in the class I region of the HLA complex: searching for multiple sclerosis susceptibility genes in Tasmanians. Tissue Antigens 71: 42-50 (2008). *
Burim RV, Canalle R, Martinelli Ad A, Takahashi CS. Polymorphisms in glutathione S-transferases GSTM1, GSTT1 and GSTP1 and cytochromes P450 CYP2E1 and CYP1A1 and susceptibility to cirrhosis or pancreatitis in alcoholics. Mutagenesis 19: 291-298 (2004). *
Burkart KM, Barton SJ, Holloway JW, Yang IA, Cakebread JA, Cruikshank W, Little F, Jin X, Farrer LA, Clough JB, Keith TP, Holgate S, Center DM, O'Connor GT. Association of asthma with a functional promoter polymorphism in the IL16 gene. J. Allergy Clin. Immunol. 117: 86-91 (2006). *
Burke DF, Worth CL, Priego EM, Cheng T, Smink LJ, Todd JA, Blundell TL. Genome bioinformatic analysis of nonsynonymous SNPs. BMC Bioinformatics 8: 301 (2007). *
Burmeister T, Ebert AD, Pritze W, Loddenkemper C, Schwartz S, Thiel E. Insertional polymorphisms of endogenous HERV-K113 and HERV-K115 retroviruses in breast cancer patients and age-matched controls. AIDS Res. Hum. Retroviruses 20: 1223-1229 (2004).
Burmer GC, Crispin DA, Kolli VR, Haggitt RC, Kulander BG, Rubin CE, Rabinovitch PS. Frequent loss of a p53 allele in carcinomas and their precursors in ulcerative colitis. Cancer Commun. 3: 167-172 (1991).
Burns JC, Shimizu C, Gonzalez E, Kulkarni H, Patel S, Shike H, Sundel RS, Newburger JW, Ahuja SK. Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease. J. Infect. Dis. 192: 344-349 (2005). *
Burr ML, Naseem H, Hinks A, Eyre S, Gibbons L, Bowes J, Consortium B, Consortium Y, Wilson AG, Maxwell J, Morgan AW, Emery P, Steer S, Hocking L, Reid DM, Wordsworth BP, Harrison P, Thomson W, Worthington J, Barton A. PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian population. Ann. Rheum. Dis. May 25 [Epub ahead of print] (2009).
Burwick RM, Ramsay PP, Haines JL, Hauser SL, Oksenberg JR, Pericak-Vance MA, Schmidt S, Compston A, Sawcer S, Cittadella R, Savettieri G, Quattrone A, Polman CH, Uitdehaag BM, Zwemmer JN, Hawkins CP, Ollier WE, Weatherby S, Enzinger C, Fazekas F, et al. APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers. Neurology 66: 1373-1383 (2006).
Burzynski M, Duriagin S, Mostowska M, Wudarski M, Chwalinska-Sadowska H, Jagodzinski PP. MTR 2756 A > G polymorphism is associated with the risk of systemic lupus erythematosus in the Polish population. Lupus 16: 450-454 (2007).
Bustamante CD, Fledel-Alon A, Williamson S, Nielsen R, Todd Hubisz M, Glanowski S, Tanenbaum DM, White TJ, Sninsky JJ, Hernandez RD, Civello D, Adams MD, Cargill M, Clark AG. Natural selection on protein-coding genes in the human genome. Nature 437: 1153-1157 (2005). *
Bustamante M, Nogues X, Agueda L, Jurado S, Wesselius A, Caceres E, Carreras R, Ciria M, Mellibovsky L, Balcells S, Diez-Perez A, Grinberg D. Promoter 2 -1025 T/C polymorphism in the RUNX2 gene is associated with femoral neck BMD in Spanish postmenopausal women. Calcif. Tissue Int. 81: 327-332 (2007). *
Bustamante M, Nogues X, Mellibovsky L, Agueda L, Jurado S, Caceres E, Blanch J, Carreras R, Diez-Perez A, Grinberg D, Balcells S. Polymorphisms in the interleukin-6 receptor gene are associated with bone mineral density and body mass index in Spanish postmenopausal women. Eur. J. Endocrinol. 157: 677-684 (2007). *
Buster EH, van Vuuren HJ, Zondervan PE, Metselaar HJ, Tilanus HW, de Man RA. Thiopurine-methyltransferase and inosine triphosphate pyrophosphatase polymorphism in a liver transplant recipient developing nodular regenerative hyperplasia on low-dose azathioprine. Eur. J. Gastroenterol. Hepatol. 20: 68-72 (2008).
Butcher LM, Davis OS, Craig IW, Plomin R. Genome-wide quantitative trait locus association scan of general cognitive ability using pooled DNA and 500K single nucleotide polymorphism microarrays. Genes Brain Behav. 7: 435-446 (2008).
Butland SL, Devon RS, Huang Y, Mead CL, Meynert AM, Neal SJ, Lee SS, Wilkinson A, Yang GS, Yuen MM, Hayden MR, Holt RA, Leavitt BR, Ouellette BF. CAG-encoded polyglutamine length polymorphism in the human genome. BMC Genomics 8: 126 (2007). *
Butler P, McIntyre N, Mistry PK. Molecular diagnosis of Wilson disease. Mol. Genet. Metab. 72: 223-230 (2001). *
Butt C, Gladman D, Rahman P. PPAR-gamma gene polymorphisms and psoriatic arthritis. J. Rheumatol. 33: 1631-1633 (2006). *
Butt C, Lim S, Greenwood CM, Rahman P. VEGF, FGF1, FGF2 and EGF gene polymorphisms and psoriatic arthritis. BMC Musculoskelet. Disord. 8: 1 (2007). *
Butt C, Peddle L, Greenwood C, Hamilton S, Gladman D, Rahman P. Association of functional variants of PTPN22 and tp53 in psoriatic arthritis: a case-control study. Arthritis Res. Ther. 8: R27-R30 (2006). *
Butt C, Rahman P, Siannis F, Farewell VT, Gladman DD. Corneodesmosin polymorphisms in psoriatic arthritis. Rheumatology (Oxford) 44: 684-685 (2005). *
Butt C, Sun S, Peddle L, Greenwood C, Hamilton S, Gladman D, Rahman P. Association of nuclear factor-kappaB in psoriatic arthritis. J. Rheumatol. 32: 1742-1744 (2005).
Buttmann M, Nowak E, Kroner A, Hemmer B, Lesch KP, Rieckmann P. Analysis of the stathmin rs182455 single nucleotide promoter polymorphism in patients with multiple sclerosis. J. Neurogenet. Nov 15 [Epub ahead of print] (2008).
Buxbaum JD, Georgieva L, Young JJ, Plescia C, Kajiwara Y, Jiang Y, Moskvina V, Norton N, Peirce T, Williams H, Craddock NJ, Carroll L, Corfas G, Davis KL, Owen MJ, Harroch S, Sakurai T, O'Donovan MC. Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene. Mol. Psychiatry 13: 162-172 (2008).
Buyukasik Y, Akman U, Buyukasik NS, Goker H, Kilicarslan A, Shorbagi AI, Hascelik G, Haznedaroglu IC. Evidence for higher red blood cell mass in persons with unconjugated hyperbilirubinemia and Gilbert's syndrome. Am. J. Med. Sci. 335: 115-119 (2008).
Buzkova H, Pechandova K, Slanar O, Perlik F. Genetic polymorphism of cytochrome P450 and methods for its determination. Prague Med. Rep. 107: 383-393 (2006).
Buzzetti R, Petrone A, Ribaudo MC, Alemanno I, Zavarella S, Mein CA, Maiani F, Tiberti C, Baroni MG, Vecci E, Arca M, Leonetti F, Mario UD. The common PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity. Eur. J. Hum. Genet. 12: 1050-1054 (2004). *
Bye L, Modi N, Stanford MR, Kondeatis E, Vaughan R, Fortune F, Kanawati C, Ben-Chetrit E, Ghabra M, Murray PI, Wallace GR. CTLA-4 polymorphisms are not associated with ocular inflammatory disease. Tissue Antigens 72: 49-53 (2008). *
Byers J, Sladen RN. Renal function and dysfunction. Curr. Opin. Anaesthesiol. 14: 699-706 (2001).
Byrne JA, Strautnieks SS, Ihrke G, Pagani F, Knisely AS, Linton KJ, Mieli-Vergani G, Thompson RJ. Missense mutations and single nucleotide polymorphisms in ABCB11 impair bile salt export pump processing and function or disrupt pre-messenger RNA splicing. Hepatology 49: 553-567 (2009).
Byth BC, Billingsley GD, Cox DW. Physical and genetic mapping of the serpin gene cluster at 14q32.1: allelic association and a unique haplotype associated with alpha 1-antitrypsin deficiency. Am. J. Hum. Genet. 55: 126-133 (1994). *
Byun E, Caillier SJ, Montalban X, Villoslada P, Fernandez O, Brassat D, Comabella M, Wang J, Barcellos LF, Baranzini SE, Oksenberg JR. Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis. Arch. Neurol. 65: 337-344 (2008).
Caamano JM, Pacheco A, Lanas F, Salazar LA. Single nucleotide polymorphisms in ABCG5 and ABCG8 genes in Chilean subjects with polygenic hypercholesterolemia and controls. Clin. Chem. Lab. Med. 46: 1581-1585 (2008). *
Caballeria J. Current concepts in alcohol metabolism. Ann. Hepatol. 2: 60-68 (2003). *
Caballero A, Bravo MJ, Nieto A, Colmenero JD, Alonso A, Martin J. TNFA promoter polymorphism and susceptibility to brucellosis. Clin. Exp. Immunol. 121: 480-483 (2000). *
Cabello GM, Cabello PH, Lopez-Camelo JS, Llerena JC Jr, Fernandes O. Haplotype distribution of and linkage disequilibrium between four polymorphic markers near the CFTR locus in Brazilian cystic fibrosis patients. Hum. Biol. 77: 853-865 (2005).
Cabello GM, Cabello PH, Otsuki K, Gombarovits ME, Llerena JC Jr, Fernandes O. Molecular analysis of 23 exons of the CFTR gene in Brazilian patients leads to the finding of rare cystic fibrosis mutations. Hum. Biol. 77: 125-135 (2005).
Caca K, Ferenci P, Kuhn HJ, Polli C, Willgerodt H, Kunath B, Hermann W, Mossner J, Berr F. High prevalence of the H1069Q mutation in East German patients with Wilson disease: rapid detection of mutations by limited sequencing and phenotype-genotype analysis. J. Hepatol. 35: 575-581 (2001). *
Cacev T, Radosevic S, Spaventi R, Pavelic K, Kapitanovic S. NF1 gene loss of heterozygosity and expression analysis in sporadic colon cancer. Gut 54: 1129-1135 (2005). *
Cadoni G, Boccia S, Scipione S, Arzani D, Cianfagna F, Ricciardi G, Paludetti G, Agostino S. Glutathione S-transferase gene polymorphisms in Italian patients with sudden sensorineural hearing loss. Otol. Neurotol. 27: 1166-1169 (2006).
Cadwell K, Patel KK, Komatsu M, Virgin HW 4th, Stappenbeck TS. A common role for Atg16L1, Atg5 and Atg7 in small intestinal Paneth cells and Crohn disease. Autophagy 5: 250-252 (2009).
Caffrey C, Hitman GA, Niven MJ, Cassell PG, Kumar P, Fry L, Mackintosh P, Gallagher R, Feighery C, Weir D, et al. HLA-DP and coeliac disease: family and population studies. Gut 31: 663-667 (1990). *
Cagliani R, Fumagalli M, Riva S, Pozzoli U, Comi GP, Menozzi G, Bresolin N, Sironi M. The signature of long-standing balancing selection at the human defensin beta-1 promoter. Genome Biol. 9: R143 (2008). *
Cai M, Yan L, Cheng H, Ding H, Fu Z. Antigen transporter gene polymorphism and predisposition to Graves disease: a preliminary analysis. Zhonghua Nei Ke Za Zhi 41: 758-761 (2002).
Cai PC, Hu LH, Cui TP, Li YR, Chen FH, Wu QW. Association of TIM4 promoter polymorphism -1419G>A with childhood asthma in a Chinese Han population. Tissue Antigens 74: 11-16 (2009). *
Caillat-Zucman S. Molecular mechanisms of HLA association with autoimmune diseases. Tissue Antigens 73: 1-8 (2009). *
Caillat-Zucman S, Daniel S, Djilali-Saiah I, Timsit J, Garchon HJ, Boitard C, Bach JF. Family study of linkage disequilibrium between TAP2 transporter and HLA class II genes. Absence of TAP2 contribution to association with insulin-dependent diabetes mellitus. Hum. Immunol. 44: 80-87 (1995).
Caillier S, Barcellos LF, Baranzini SE, Swerdlin A, Lincoln RR, Steinman L, Martin E, Haines JL, Pericak-Vance M, Hauser SL, Oksenberg JR; Multiple Sclerosis Genetics Group. Osteopontin polymorphisms and disease course in multiple sclerosis. Genes Immun. 4: 312-315 (2003). *
Caillier SJ, Briggs F, Cree BA, Baranzini SE, Fernandez-Vina M, Ramsay PP, Khan O, Royal W 3rd, Hauser SL, Barcellos LF, Oksenberg JR. Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis. J. Immunol. 181: 5473-5480 (2008). *
Calderaro A, Villanacci V, Bommezzadri S, Gorrini C, Piccolo G, Aquilano MC, Incaprera M, Viviani G, Dettori G, Chezzi C. Colonic amoebiasis and spirochetosis: morphological, ultrastructural and microbiological evaluation. J. Gastroenterol. Hepatol. 22: 64-67 (2007). *
Calguneri OM, Ozturk MA, Kiraz S, Ertenli I, Onat AM, Ureten K, Ozbalkan Z, Haznedaroglu IC. Lack of association between familial Mediterranean fever and angiotensin converting enzyme gene polymorphism. Joint Bone Spine 73: 334-336 (2006). *
Caliz R, Atsumi T, Kondeatis E, Amengual O, Khamashta MA, Vaughan RW, Lanchbury JS, Hughes GR. HLA class II gene polymorphisms in antiphospholipid syndrome: haplotype analysis in 83 Caucasoid patients. Rheumatology (Oxford) 40: 31-36 (2001). *
Callaghan MJ, Rockett K, Banner C, Haralambous E, Betts H, Faust S, Maiden MC, Kroll JS, Levin M, Kwiatkowski DP, Pollard AJ. Haplotypic diversity in human CEACAM genes: effects on susceptibility to meningococcal disease. Genes Immun. 9: 30-37 (2008). *
Callejas JL, Sabio JM, Haro MD, Camps M, Ramon ED, Garcia-Hernandez FJ, Koeleman B, Martin J, Gonzalez-Escribano MF. Polymorphisms of the FCRL3 gene in a Spanish population of systemic lupus erythematosus patients. Rheumatology (Oxford) 45: 1044-1046 (2006). *
Calverley DC, Baldermann LV, Moran K, Chen NN, McFann K. Platelet FcgammaRIIA expression is associated with the alpha(2) integrin C807T gene polymorphism in type 2 diabetes. Platelets 17: 78-83 (2006).
Calvo-Alen J, Alarcon GS, Tew MB, Tan FK, McGwin G Jr, Fessler BJ, Vila LM, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort: XXXIV. Deficient mannose-binding lectin exon 1 polymorphisms are associated with cerebrovascular but not with other arterial thrombotic events. Arthritis Rheum. 54: 1940-1945 (2006). *
Camacho JA, Mardach R, Rioseco-Camacho N, Ruiz-Pesini E, Derbeneva O, Andrade D, Zaldivar F, Qu Y, Cederbaum SD. Clinical and functional characterization of a human ORNT1 mutation (T32R) in the hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome. Pediatr. Res. 60: 423-429 (2006). *
Camarena A, Juarez A, Mejia M, Estrada A, Carrillo G, Falfan R, Zuniga J, Navarro C, Granados J, Selman M. Major histocompatibility complex and tumor necrosis factor-alpha polymorphisms in pigeon breeder's disease. Am. J. Respir. Crit. Care Med. 163: 1528-1533 (2001). *
Camargo JF, Correa PA, Castiblanco J, Anaya JM. Interleukin-1beta polymorphisms in Colombian patients with autoimmune rheumatic diseases. Genes Immun. 5: 609-614 (2004). *
Cambien F, Tiret L. Atherosclerosis: from genetic polymorphisms to system genetics. Cardiovasc. Toxicol. 5: 143-152 (2005).
Cambon-Thomsen A, Roth MP. Genetics of autoimmune diseases. Rev. Prat. 44: 43-52 (1994).
Cambra A, Munoz-Saa I, Cresp� C, Serra A, Etxagibel A, Matamoros N, Mila J, Julia MR. MICA-HLA-B haplotype diversity and linkage disequilibrium in a population of Jewish descent from Majorca (Balearic Islands). Hum. Immunol. Apr 10 [Epub ahead of print] (2009).
Cameron EA, Martinez-Marignac VL, Chan A, Valladares A, Simmonds LV, Wacher N, Kumate J, McKeigue P, Shriver MD, Kittles R, Cruz M, Parra EJ. MGEA5-14 polymorphism and type 2 diabetes in Mexico City. Am. J. Hum. Biol. 19: 593-596 (2007).
Cameron L, Webster RB, Strempel JM, Kiesler P, Kabesch M, Ramachandran H, Yu L, Stern DA, Graves PE, Lohman IC, Wright AL, Halonen M, Klimecki WT, Vercelli D. Th2 cell-selective enhancement of human IL13 transcription by IL13-1112C>T, a polymorphism associated with allergic inflammation. J. Immunol. 177: 8633-8642 (2006). *
Camilleri M, Carlson P, McKinzie S, Grudell A, Busciglio I, Burton D, Baxter K, Ryks M, Zinsmeister AR. Genetic variation in endocannabinoid metabolism, gastrointestinal motility and sensation. Am. J. Physiol. Gastrointest. Liver Physiol. 294: G13-G19 (2008). *
Camilleri M, Carlson P, Zinsmeister AR, McKinzie S, Busciglio IA, Burton DD, Zaki EA, Boles RG. Mitochondrial DNA, gastrointestinal motor and sensory functions in health and functional gastrointestinal disorders. Am. J. Physiol. Gastrointest. Liver Physiol. 296: G510-G516 (2009). *
Campa D, Gioia A, Tomei A, Poli P, Barale R. Association of ABCB1/MDR1 and OPRM1 gene polymorphisms with morphine pain relief. Clin. Pharmacol. Ther. 83: 559-566 (2008).
Campa D, Vodicka P, Pardini B, Novotny J, F�rsti A, Hemminki K, Barale R, Canzian F. Could polymorphisms in ATP-binding cassette C3/multidrug resistance associated protein 3 (ABCC3/MRP3) modify colorectal cancer risk? Eur. J. Cancer 44: 854-857 (2008). *
Campagnoli MF, Garbarini L, Quarello P, Garelli E, Carando A, Baravalle V, Doria A, Biava A, Chiocchetti A, Rosolen A, Dufour C, Dianzani U, Ramenghi U. The broad spectrum of autoimmune lymphoproliferative disease: molecular bases, clinical features and long-term follow-up in 31 patients. Haematologica 91: 538-541 (2006). *
Campalani E, Arenas M, Marinaki AM, Lewis CM, Barker JN, Smith CH. Polymorphisms in folate, pyrimidine, and purine metabolism are associated with efficacy and toxicity of methotrexate in psoriasis. J. Invest. Dermatol. 127: 1860-1867 (2007). *
Campana S, Taccetti G, Ravenni N, Favari F, Cariani L, Sciacca A, Savoia D, Collura A, Fiscarelli E, De Intinis G, Busetti M, Cipolloni A, d'Aprile A, Provenzano E, Collebrusco I, Frontini P, Stassi G, Trancassini M, Tovagliari D, et al. Transmission of Burkholderia cepacia complex: evidence for new epidemic clones infecting cystic fibrosis patients in Italy. J. Clin. Microbiol. 43: 5136-5142 (2005). *
Campbell AK, Waud JP, Matthews SB. The molecular basis of lactose intolerance. Sci. Prog. 88: 157-202 (2005).
Campbell DB, Buie TM, Winter H, Bauman M, Sutcliffe JS, Perrin JM, Levitt P. Distinct genetic risk based on association of MET in families with co-occurring autism and gastrointestinal conditions. Pediatrics 123: 1018-1024 (2009). *
Campelo V, Dantas RO, Simoes RT, Mendes-Junior CT, Sousa SM, Simoes AL, Donadi EA. TNF microsatellite alleles in Brazilian Chagasic patients. Dig. Dis. Sci. 52: 3334-3339 (2007). *
Campo DS, Dimitrova Z, Mitchell RJ, Lara J, Khudyakov Y. Coordinated evolution of the hepatitis C virus. Proc. Natl. Acad. Sci. U.S.A. 105: 9685-9690 (2008). *
Campo I, Morbini P, Zorzetto M, Tinelli C, Brunetta E, Villa C, Bombieri C, Cuccia M, Agostini C, Bozzi V, Facoetti A, Ferrarotti I, Mazzola P, Scabini R, Semenzato G, Pignatti PF, Pozzi E, Luisetti M. Expression of receptor for advanced glycation end products in sarcoid granulomas. Am. J. Respir. Crit. Care Med. 175: 498-506 (2007). *
Campos Alberto EJ, Shimojo N, Suzuki Y, Mashimo Y, Arima T, Matsuura T, Inoue Y, Yamaide A, Tomiita M, Fujii K, Hata A, Kohno Y. IL-10 gene polymorphism, but not TGF-beta1 gene polymorphisms, is associated with food allergy in a Japanese population. Pediatr. Allergy Immunol. 19: 716-721 (2008).
Campos E, Shimojo N, Inoue Y, Arima T, Suzuki S, Tomiita M, Matsuura T, Hata A, Suzuki Y, Aoyagi M, Kohno Y. No association of polymorphisms in the 5' region of the CD14 gene and food allergy in a Japanese population. Allergol. Int. 56: 23-27 (2007).
Campos J, Gonzalez-Quintela A, Quinteiro C, Gude F, Perez LF, Torre JA, Vidal C. The -159C/T polymorphism in the promoter region of the CD14 gene is associated with advanced liver disease and higher serum levels of acute-phase proteins in heavy drinkers. Alcohol. Clin. Exp. Res. 29: 1206-1213 (2005). *
Canadas C, Sanchez-de-Abajo A, Fernandez JM, Martin M, Diaz-Rubio E, Caldes T, de la Hoya M. Molecular haplotyping of tandem single nucleotide polymorphisms by allele-specific PCR. Anal. Biochem. 364: 153-158 (2007). *
Canani LH, Capp C, Ng DP, Choo SG, Maia AL, Nabinger GB, Santos K, Crispim D, Roisemberg I, Krolewski AS, Gross JL. The fatty acid-binding protein-2 A54T polymorphism is associated with renal disease in patients with type 2 diabetes. Diabetes 54: 3326-3330 (2005). *
Candore G, Aquino A, Balistreri CR, Bulati M, Di Carlo D, Grimaldi MP, Listi F, Orlando V, Vasto S, Caruso M, Colonna-Romano G, Lio D, Caruso C. Inflammation, longevity, and cardiovascular diseases: role of polymorphisms of TLR4. Ann. N. Y. Acad. Sci. 1067: 282-287 (2006). *
Candore G, Balistreri CR, Colonna-Romano G, Lio D, Caruso C. Major histocompatibility complex and sporadic Alzheimer's disease: a critical reappraisal. Exp. Gerontol. 39: 645-652 (2004). *
Canedo P, Corso G, Pereira F, Lunet N, Suriano G, Figueiredo C, Pedrazzani C, Moreira H, Barros H, Carneiro F, Seruca R, Roviello F, Machado JC. The interferon gamma receptor 1 (IFNGR1) -56C/T gene polymorphism is associated with increased risk of early gastric carcinoma. Gut 57: 1504-1508 (2008).
Canedo P, Duraes C, Pereira F, Regalo G, Lunet N, Barros H, Carneiro F, Seruca R, Rocha J, Machado JC. Tumor necrosis factor alpha extended haplotypes and risk of gastric carcinoma. Cancer Epidemiol. Biomarkers Prev. 17: 2416-2420 (2008). *
Canete JD, Suarez B, Hernandez MV, Sanmarti R, Rego I, Celis R, Moll C, Pinto JA, Blanco FJ, Lozano F. Influence of variants of Fcgamma receptors IIA and IIIA on the ACR and EULAR responses to anti-TNFalpha therapy in rheumatoid arthritis. Ann. Rheum. Dis. Oct 17 [Epub ahead of print] (2008).
Canhao H, Fonseca JE, Caetano-Lopes J, Saldanha C, Queiroz MV. Assessment of laboratory measurements and -308 TNFalpha gene promoter polymorphisms in normal bone mineral density. Clin. Rheumatol. 27: 301-307 (2008). *
Canova C, Hashibe M, Simonato L, Nelis M, Metspalu A, Lagiou P, Trichopoulos D, Ahrens W, Pigeot I, Merletti F, Richiardi L, Talamini R, Barzan L, Macfarlane GJ, Macfarlane TV, Holc�tov� I, Bencko V, Benhamou S, Bouchardy C, Kjaerheim K, Lowry R, et al. Genetic associations of 115 polymorphisms with cancers of the upper aerodigestive tract across 10 European countries: the ARCAGE project. Cancer Res. 69: 2956-2965 (2009). *
Cantaert T, Coucke P, De Rycke L, Veys EM, De Keyser F, Baeten D. Functional haplotypes of PADI4: relevance for rheumatoid arthritis-specific synovial intracellular citrullinated proteins and anti-citrullinated protein antibodies. Ann. Rheum. Dis. 64: 1316-1320 (2005). *
Cantaert T, Stone MA, Terborg M, Mog R, de Vries N, Wilson AG, Tak PP, Baeten D. A functional polymorphism of TIR-domain-containing adaptor protein is not associated with axial spondyloarthritis. Ann. Rheum. Dis. 67: 720-722 (2008).
Cantagrel A, Navaux F, Loubet-Lescoulie P, Nourhashemi F, Enault G, Abbal M, Constantin A, Laroche M, Mazieres B. Interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum. 42: 1093-1100 (1999). *
Canto E, Ricart E, Busquets D, Monfort D, Garcia-Planella E, Gonzalez D, Balanzo J, Rodriguez-Sanchez JL, Vidal S. Influence of a nucleotide oligomerization domain 1 (NOD1) polymorphism and NOD2 mutant alleles on Crohn's disease phenotype. World J. Gastroenterol. 13: 5446-5453 (2007). *
Canton I, Akhtar S, Gavalas NG, Gawkrodger DJ, Blomhoff A, Watson PF, Weetman AP, Kemp EH. A single-nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptibility to generalised vitiligo. Genes Immun. 6: 584-587 (2005). *
Cantor MJ, Nickerson P, Bernstein CN. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease. Am. J. Gastroenterol. 100: 1134-1142 (2005). *
Cao HX, Li M, Nie J, Wang W, Zhou SF, Yu XQ. Human leukocyte antigen DRB1 alleles predict risk and disease progression of immunoglobulin A nephropathy in Han Chinese. Am. J. Nephrol. 28: 684-691 (2008).
Cao HX, Zhao L, Zhou LX. HLA-DRB1 allele polymorphosm associated with susceptibility to leukemia in Han nationality of Gansu. Zhongguo Shi Yan Xue Ye Xue Za Zhi 13: 788-792 (2005).
Cao MY, Thonnard J, Deggouj N, Gersdorff M, Philippe M, Osselaer JC, Tomasi JP. HLA class II-associated genetic susceptibility in idiopathic progressive sensorineural hearing loss. Ann. Otol. Rhinol. Laryngol. 105: 628-633 (1996).
Cao Q, Shen XL, Zhou W, Wang JG. The relationship of nature killer cell 2D gene polymorphisms and ulcerative colitis in the Chinese. Zhonghua Nei Ke Za Zhi 45: 824-826 (2006).
Cao Q, Zhu Q, Shang Y, Gao M, Si J. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease. Digestion 79: 58-63 (2009).
Cao Q, Zhu Q, Wu ML, Hu WL, Gao M, Si JM. Genetic susceptibility to ulcerative colitis in the Chinese Han ethnic population: association with TNF polymorphisms. Chin. Med. J. (Engl.) 119: 1198-1203 (2006). *
Cao TM, Lazzeroni LC, Tsai S, Pang WW, Kao A, Camp NJ, Thomas A, Shizuru JA. Identification of a major susceptibility locus for lethal graft-versus-host disease in MHC-matched mice. J. Immunol. Jun 12 [Epub ahead of print] (2009).
Cao W, Cai L, Rao JY, Pantuck A, Lu ML, Dalbagni G, Reuter V, Scher H, Cordon-Cardo C, Figlin RA, Belldegrun A, Zhang ZF. Tobacco smoking, GSTP1 polymorphism, and bladder carcinoma. Cancer 104: 2400-2408 (2005). *
Cao XB, Qiu Y, Qiu XS, Chen ZJ, Chen HO, Chen WJ. FBN3 gene polymorphisms in adolescent idiopathic scoliosis patients. Stud. Health Technol. Inform. 140: 321 (2008).
Cao Z, Li C, Jin L, Corbet EF. Association of matrix metalloproteinase-1 promoter polymorphism with generalized aggressive periodontitis in a Chinese population. J. Periodontal Res. 40: 427-431 (2005). *
Cao Z, Song JH, Park YK, Maeng EJ, Nam SW, Lee JY, Park WS. The p53 codon 72 polymorphism and susceptibility to colorectal cancer in Korean patients. Neoplasma 56: 114-118 (2009).
Capilla A, Donat E, Planelles D, Espinos C, Ribes-Koninckx C, Palau F. Genetic analyses of celiac disease in a Spanish population confirm association with CELIAC3 but not with CELIAC4. Tissue Antigens 70: 324-329 (2007). *
Capittini C, Pasi A, Bergamaschi P, Tinelli C, De Silvestri A, Mercati MP, Badulli C, Garlaschelli F, Sbarsi I, Guarene M, Martinetti M, Salvaneschi L, Cuccia M. HLA haplotypes and birth weight variation: is your future going to be light or heavy? Tissue Antigens Jun 4 [Epub ahead of print] (2009).
Capoluongo E, Almadori G, Concolino P, Bussu F, Santonocito C, Vendittelli F, Galli J, Zuppi C, Ameglio F, Paludetti G, Giardina B. GSTT1 and GSTM1 allelic polymorphisms in head and neck cancer patients from Italian Lazio region. Clin. Chim. Acta 376: 174-178 (2007). *
Caponi L, Petit-Teixeira E, Sebbag M, Bongiorni F, Moscato S, Pratesi F, Pierlot C, Osorio J, Chapuy-Regaud S, Guerrin M, Cornelis F, Serre G, Migliorini P; ECRAF. A family based study shows no association between rheumatoid arthritis and the PADI4 gene in a white French population. Ann. Rheum. Dis. 64: 587-593 (2005). *
Caporale CM, Papola F, Fioroni MA, Aureli A, Giovannini A, Notturno F, Adorno D, Caporale V, Uncini A. Susceptibility to Guillain-Barre syndrome is associated to polymorphisms of CD1 genes. J. Neuroimmunol. 177: 112-118 (2006).
Caporaso N, Gu F, Chatterjee N, Sheng-Chih J, Yu K, Yeager M, Chen C, Jacobs K, Wheeler W, Landi MT, Ziegler RG, Hunter DJ, Chanock S, Hankinson S, Kraft P, Bergen AW. Genome-wide and candidate gene association study of cigarette smoking behaviors. PLoS ONE 4: e4653 (2009). *
Capron A, Lerut J, Verbaandert C, Mathys J, Ciccarelli O, Vanbinst R, Roggen F, De Reyck C, Lemaire J, Wallemacq PE. Validation of a liquid chromatography-mass spectrometric assay for tacrolimus in liver biopsies after hepatic transplantation: correlation with histopathologic staging of rejection. Ther. Drug Monit. 29: 340-348 (2007).
Capurso C, Solfrizzi V, D'Introno A, Colacicco AM, Capurso SA, Semeraro C, Capurso A, Panza F. Interleukin 6 variable number of tandem repeats (VNTR) gene polymorphism in centenarians. Ann. Hum. Genet. 71: 843-848 (2007). *
Caputo M, Cerrone GE, Lopez AP, Villalba A, Krochik GA, Cedola FN, Targovnik HM, Frechtel GD. Cytotoxic T lymphocyte antigen 4 heterozygous codon 49 A/G dimorphism is associated to latent autoimmune diabetes in adults (LADA). Autoimmunity 38: 277-281 (2005).
Caputo M, Cerrone GE, Mazza C, C�dola N, Targovnik HM, Gustavo DF. No evidence of association of CTLA-4 -318 C/T, 159 C/T, 3' STR and SUMO4 163 AG polymorphism with autoimmune diabetes. Immunol. Invest. 36: 259-270 (2007).
Cara Terribas CJ, Gonzalez Guijarro L. Hypomethylation and multiple sclerosis, the susceptibility factor? Neurologia 17: 132-135 (2002).
Caramori G, Adcock I. Gene-environment interactions in the development of chronic obstructive pulmonary disease. Curr. Opin. Allergy Clin. Immunol. 6: 323-328 (2006).
Carcao MD, Blanchette VS, Wakefield CD, Stephens D, Ellis J, Matheson K, Denomme GA. Fcgamma receptor IIa and IIIa polymorphisms in childhood immune thrombocytopenic purpura. Br. J. Haematol. 120: 135-141 (2003).
Cardelli M, Cavallone L, Marchegiani F, Oliveri F, Dato S, Montesanto A, Lescai F, Lisa R, De Benedictis G, Franceschi C. A genetic-demographic approach reveals male-specific association between survival and tumor necrosis factor (A/G)-308 polymorphism. J. Gerontol. A. Biol. Sci. Med. Sci. 63: 454-460 (2008).
Cardon LR. Genetics. Delivering new disease genes. Science 314: 1403-1405 (2006). *
Cargill EJ, Womack JE. Detection of polymorphisms in bovine Toll-like receptors 3, 7, 8, and 9. Genomics 89: 745-755 (2007). *
Cargill M, Schrodi SJ, Chang M, Garcia VE, Brandon R, Callis KP, Matsunami N, Ardlie KG, Civello D, Catanese JJ, Leong DU, Panko JM, McAllister LB, Hansen CB, Papenfuss J, Prescott SM, White TJ, Leppert MF, Krueger GG, Begovich AB. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am. J. Hum. Genet. 80: 273-390 (2007). *
Carlberg C, Dunlop TW. An integrated biological approach to nuclear receptor signaling in physiological control and disease. Crit. Rev. Eukaryot. Gene Expr. 16: 1-22 (2006).
Carless MA, Kraska T, Lintell N, Neale RE, Green AC, Griffiths LR. Polymorphisms of the VDR gene are associated with presence of solar keratoses on the skin. Br. J. Dermatol. 159: 804-810 (2008). *
Carlson CS, Eberle MA, Kruglyak L, Nickerson DA. Mapping complex disease loci in whole-genome association studies. Nature 429: 446-452 (2004). *
Carlson CS, Heagerty PJ, Nord AS, Pritchard DK, Ranchalis J, Boguch JM, Duan H, Hatsukami TS, Schwartz SM, Rieder MJ, Nickerson DA, Jarvik GP. TagSNP evaluation for the association of 42 inflammation loci and vascular disease: evidence of IL6, FGB, ALOX5, NFKBIA, and IL4R loci effects. Hum. Genet. 121: 65-75 (2007). *
Carlsson M, Sjoholm AG, Eriksson L, Thiel S, Jensenius JC, Segelmark M, Truedsson L. Deficiency of the mannan-binding lectin pathway of complement and poor outcome in cystic fibrosis: bacterial colonization may be decisive for a relationship. Clin. Exp. Immunol. 139: 306-313 (2005). *
Carlton VE, Hu X, Chokkalingam AP, Schrodi SJ, Brandon R, Alexander HC, Chang M, Catanese JJ, Leong DU, Ardlie KG, Kastner DL, Seldin MF, Criswell LA, Gregersen PK, Beasley E, Thomson G, Amos CI, Begovich AB. PTPN22 genetic variation: evidence for multiple variants associated with rheumatoid arthritis. Am. J. Hum. Genet. 77: 567-581 (2005). *
Carlton VE, Ireland JS, Useche F, Faham M. Functional single nucleotide polymorphism-based association studies. Hum. Genomics 2: 391-402 (2006).
Carmichael SL, Shaw GM, Iovannisci DM, Yang W, Finnell RH, Cheng S, Lammer EJ. Risks of human limb deficiency anomalies associated with 29 SNPs of genes involved in homocysteine metabolism, coagulation, cell-cell interactions, inflammatory response, and blood pressure regulation. Am. J. Med. Genet. A. 140: 2433-2440 (2006).
Carney G, Wei S, Rizzo WB. Sjogren-Larsson syndrome: seven novel mutations in the fatty aldehyde dehydrogenase gene ALDH3A2. Hum. Mutat. 24: 186 (2004). *
Carola V, Frazzetto G, Pascucci T, Audero E, Puglisi-Allegra S, Cabib S, Lesch KP, Gross C. Identifying molecular substrates in a mouse model of the serotonin transporter x environment risk factor for anxiety and depression. Biol. Psychiatry 63: 840-846 (2008). *
Carpenter SL, Lieff S, Howard TA, Eggleston B, Ware RE. UGT1A1 promoter polymorphisms and the development of hyperbilirubinemia and gallbladder disease in children with sickle cell anemia. Am. J. Hematol. 83: 800-803 (2008). *
Carr DF, Alfirevic A, Tugwood JD, Barratt BJ, Sherwood J, Smith J, Pirmohamed M, Kevin Park B. Molecular and genetic association of interleukin-6 in tacrine-induced hepatotoxicity. Pharmacogenet. Genomics 17: 961-972 (2007).
Carr WH, Pando MJ, Parham P. KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand. J. Immunol. 175: 5222-5229 (2005). *
Carreira PE, Gonzalez-Crespo MR, Ciruelo E, Pablos JL, Santiago B, Gomez-Camara A, Gomez-Reino JJ. Polymorphism of the interleukin-1 receptor antagonist gene: a factor in susceptibility to rheumatoid arthritis in a Spanish population. Arthritis Rheum. 52: 3015-3019 (2005). *
Carrell DT, De Jonge C, Lamb DJ. The genetics of male infertility: a field of study whose time is now. Arch. Androl. 52: 269-274 (2006).
Carrick DM, Chulada P, Donn R, Fabris M, McNicholl J, Whitworth W, Blackshear PJ. Genetic variations in ZFP36 and their possible relationship to autoimmune diseases. J. Autoimmun. 26: 182-196 (2006).
Carrier CM, Mollen N, Rothman WC, Rodriguez de Cordoba S, Rey-Campos J, Ginsberg-Fellner F, Carpenter C, Rubinstein P. Definition of IDDM-associated HLA DQ and DX RFLPs by segregation analysis of multiplex sibships. Hum. Immunol. 24: 51-63 (1989).
Carrington M, Martin MP. The impact of variation at the KIR gene cluster on human disease. Curr. Top. Microbiol. Immunol. 298: 225-257 (2006).
Carrington M, Martin MP, van Bergen J. KIR-HLA intercourse in HIV disease. Trends Microbiol. 16: 620-627 (2008). *
Carrion F, Figueroa F, Martinez ME, Massardo L, Perez T, Foster C, Mancilla C, Neira O, Guzman L, Valenzuela V, Urrutia R, Carmona S, Figueroa M, Lubiano A, Wainstein E. Study of polymorphism of Fc gamma IIa receptors in Chilean patients with systemic lupus erythematosus. Rev. Med. Chil. 131: 11-18 (2003).
Carroll L, Frazer IH, Turner M, Marwick T, Thomas R. The receptor for advanced glycation end products glycine 82 serine polymorphism and the risk of cardiovascular events in rheumatoid arthritis. Arthritis Res. Ther. 9: R39 (2007). *
Carroll L, Hannawi S, Marwick T, Thomas R. Rheumatoid arthritis: links with cardiovascular disease and the receptor for advanced glycation end products. Wien. Med. Wochenschr. 156: 42-52 (2006).
Carter CJ. Convergence of genes implicated in Alzheimer's disease on the cerebral cholesterol shuttle: APP, cholesterol, lipoproteins, and atherosclerosis. Neurochem. Int. 50: 12-38 (2007).
Carter MJ, Di Giovine FS, Cox A, Goodfellow P, Jones S, Shorthouse AJ, Duff GW, Lobo AJ. The interleukin 1 receptor antagonist gene allele 2 as a predictor of pouchitis following colectomy and IPAA in ulcerative colitis. Gastroenterology 121: 805-811 (2001). *
Carter MJ, di Giovine FS, Jones S, Mee J, Camp NJ, Lobo AJ, Duff GW. Association of the interleukin 1 receptor antagonist gene with ulcerative colitis in Northern European Caucasians. Gut 48: 461-467 (2001). *
Carter MJ, Jones S, Camp NJ, Cox A, Mee J, Warren B, Duff GW, Lobo AJ, Di Giovine FS. Functional correlates of the interleukin-1 receptor antagonist gene polymorphism in the colonic mucosa in ulcerative colitis. Genes Immun. 5: 8-15 (2004). *
Cartier KC, Miscimarra L, Dazard JE, Song Y, Iyengar SK, Rao JS. Studying genetic determinants of natural variation in human gene expression using Bayesian ANOVA. BMC Proc. 1 Suppl. 1: S115 (2007). *
Carulli MT, Spagnolo P, Fonseca C, Welsh KI, Dubois RM, Black CM, Denton CP. Single-nucleotide polymorphisms in CCL2 gene are not associated with susceptibility to systemic sclerosis. J. Rheumatol. 35: 839-844 (2008).
Caruso C, Aquino A, Candore G, Scola L, Colonna-Romano G, Lio D. Looking for immunological risk genotypes. Ann. N. Y. Acad. Sci. 1019: 141-146 (2004). *
Carvalho A, Marques A, Maciel P, Rodrigues F. Study of disease-relevant polymorphisms in the TLR4 and TLR9 genes: a novel method applied to the analysis of the Portuguese population. Mol. Cell. Probes 21: 316-320 (2007).
Carvalho A, Pasqualotto AC, Pitzurra L, Romani L, Denning DW, Rodrigues F. Polymorphisms in Toll-like receptor genes and susceptibility to pulmonary aspergillosis. J. Infect. Dis. 197: 618-621 (2008). *
Carvalho AP, Ventura GM, Pereira CB, Leao RS, Folescu TW, Higa L, Teixeira LM, Plotkowski MC, Merquior VL, Albano RM, Marques EA. Burkholderia cenocepacia, B. multivorans, B. ambifaria and B. vietnamiensis isolates from cystic fibrosis patients have different profiles of exoenzyme production. APMIS 115: 311-318 (2007). *
Casas JP, Cavalleri GL, Bautista LE, Smeeth L, Humphries S, Hingorani AD. Endothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: a HuGE review. Am. J. Epidemiol. 164: 921-935 (2006). *
Cascino I, Paladini F, Belfiore F, Cauli A, Angelini C, Fiorillo MT, Mathieu A, Sorrentino R. Identification of previously unrecognized predisposing factors for ankylosing spondylitis from analysis of HLA-B27 extended haplotypes in Sardinia. Arthritis Rheum. 56: 2640-2651 (2007). *
Caserta TM, Knisley AA, Tan FK, Arnett FC, Brown TL. Genotypic analysis of the TGF beta-509 allele in patients with systemic lupus erythematosus and Sjogren's syndrome. Ann. Genet. 47: 359-363 (2004).
Casey B, Glatt CE, Tottenham N, Soliman F, Bath K, Amso D, Altemus M, Pattwell S, Jones R, Levita L, McEwen B, Magari�os AM, Gunnar M, Thomas KM, Mezey J, Clark AG, Hempstead BL, Lee FS. BDNF as a model system for examining gene by environment interactions across development Neuroscience Apr 6 [Epub ahead of print] (2009).
Castaldo G, Polizzi A, Tomaiuolo R, Cazeneuve C, Girodon E, Santostasi T, Salvatore D, Raia V, Rigillo N, Goossens M, Salvatore F. Comprehensive cystic fibrosis mutation epidemiology and haplotype characterization in a southern Italian population. Ann. Hum. Genet. 69: 15-24 (2005). *
Castano-Rodriguez N, Diaz-Gallo LM, Pineda-Tamayo R, Rojas-Villarraga A, Anaya JM. Meta-analysis of HLA-DRB1 and HLA-DQB1 polymorphisms in Latin American patients with systemic lupus erythematosus. Autoimmun. Rev. 7: 322-330 (2008).
Castellani C, Malerba G, Sangalli A, Delmarco A, Petrelli E, Rossini M, Assael BM, Mottes M. The genetic background of osteoporosis in cystic fibrosis: association analysis with polymorphic markers in four candidate genes. J. Cyst. Fibros. 5: 229-235 (2006).
Castellanos-Rubio A, Martin-Pagola A, Santin I, Hualde I, Aransay AM, Castano L, Vitoria JC, Bilbao JR. Combined functional and positional gene information for the identification of susceptibility variants in celiac disease. Gastroenterology 134: 738-746 (2008). *
Castelli EC, Mendes-Junior CT, Donadi EA. HLA-G alleles and HLA-G 14 bp polymorphisms in a Brazilian population. Tissue Antigens 70: 62-68 (2007). *
Castelli L, Comi C, Chiocchetti A, Nicola S, Mesturini R, Giordano M, D'Alfonso S, Cerutti E, Galimberti D, Fenoglio C, Tesser F, Yagi J, Rojo JM, Perla F, Leone M, Scarpini E, Monaco F, Dianzani U. ICOS gene haplotypes correlate with IL10 secretion and multiple sclerosis evolution. J. Neuroimmunol. 186: 193-198 (2007).
Castellon R, Hamdi HK. Demystifying the ACE polymorphism: from genetics to biology. Curr. Pharm. Des. 13: 1191-1198 (2007).
Castiblanco J, Anaya JM. The IkappaBL gene polymorphism influences risk of acquiring systemic lupus erythematosus and Sjogren's syndrome. Hum. Immunol. 69: 45-51 (2008).
Castiblanco J, Varela DC, Castano-Rodriguez N, Rojas-Villarraga A, Hincapie ME, Anaya JM. TIRAP (MAL) S180L polymorphism is a common protective factor against developing tuberculosis and systemic lupus erythematosus. Infect. Genet. Evol. 8: 541-544 (2008).
Castillejo A, Rothman N, Murta-Nascimento C, Malats N, Garcia-Closas M, Gomez-Martinez A, Lloreta J, Tardon A, Serra C, Garcia-Closas R, Chanock S, Silverman DT, Dosemeci M, Kogevinas M, Carrato A, Soto JL, Real FX. TGFB1 and TGFBR1 polymorphic variants in relationship to bladder cancer risk and prognosis. Int. J. Cancer 124: 608-613 (2008). *
Castro F, Acevedo E, Ciusani E, Angulo JA, Wollheim FA, Sandberg-Wollheim M. Tumour necrosis factor microsatellites and HLA-DRB1*, HLA-DQA1*, and HLA-DQB1* alleles in Peruvian patients with rheumatoid arthritis. Ann. Rheum. Dis. 60: 791-795 (2001). *
Castro-Giner F, Kogevinas M, Machler M, de Cid R, Steen KV, Imboden M, Schindler C, Berger W, Gonzalez JR, Franklin KA, Janson C, Jarvis D, Omenaas E, Burney P, Rochat T, Estivill X, Anto JM, Wjst M, Probst-Hensch NM. TNFA-308 in two international population-based cohorts shows increased risk for asthma. Eur. Respir. J. 32: 350-361 (2008).
Castro-Santos P, Mozo L, Gutierrez C, Suarez A. TNFalpha genotype influences development of IgA-ASCA antibodies in Crohn's disease patients with CARD15 wild type. Clin. Immunol. 121: 305-313 (2006). *
Castro-Santos P, Suarez A, Lopez-Rivas L, Mozo L, Gutierrez C. TNFalpha and IL-10 gene polymorphisms in inflammatory bowel disease. Association of -1082 AA low producer IL-10 genotype with steroid dependency. Am. J. Gastroenterol. 101: 1039-1047 (2006). *
Castro-Santos P, Suarez A, Mozo L, Gutierrez C. Association of IL-10 and TNFalpha genotypes with ANCA appearance in ulcerative colitis. Clin. Immunol. 122: 108-114 (2007). *
Catakoglu AB, Duman BS, Kurtoglu H, Ersoz M, Sener M, Celebi H, Cagatay P, Aytekin V, Aytekin S. Common variants in the ATP-binding cassette transporter 1 gene with decreased HDL-cholesterol levels and coronary artery disease. Arch. Med. Res. 39: 735-742 (2008).
Catalano M, Cortelazzo A, Santi R, Contino L, Demicheli M, Yilmaz Y, Zorzetto M, Campo I, Lanati N, Emanuele E. The Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma2 gene is associated with plasma levels of soluble RAGE (Receptor for Advanced Glycation Endproducts) and the presence of peripheral arterial disease. Clin. Biochem. 41: 981-985 (2008). *
Cataldo F, Lio D, Marino V, Scola L, Crivello A, Mule AM, Corazza GR; Groups of the SIGEP and "Club del Tenue". Cytokine genotyping (TNF and IL-10) in patients with celiac disease and selective IgA deficiency. Am. J. Gastroenterol. 98: 850-856 (2003). *
Catano G, Agan BK, Kulkarni H, Telles V, Marconi VC, Dolan MJ, Ahuja SK. Independent effects of genetic variations in mannose-binding lectin influence the course of HIV disease: the advantage of heterozygosity for coding mutations. J. Infect. Dis. 198: 72-80 (2008). *
Catano G, Kulkarni H, He W, Marconi VC, Agan BK, Landrum M, Anderson S, Delmar J, Telles V, Song L, Castiblanco J, Clark RA, Dolan MJ, Ahuja SK. HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 alleles. PLoS ONE 3: e3636 (2008). *
Cauchi S, El Achhab Y, Choquet H, Dina C, Krempler F, Weitgasser R, Nejjari C, Patsch W, Chikri M, Meyre D, Froguel P. TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. J. Mol. Med. 85: 777-782 (2007). *
Caudill MA, Dellschaft N, Solis C, Hinkis S, Ivanov AA, Nash-Barboza S, Randall KE, Jackson B, Solomita GN, Vermeylen F. Choline intake, plasma riboflavin, and the phosphatidylethanolamine N-methyltransferase G5465A genoref-type predict plasma homocysteine in folate-deplete Mexican-American men with the methylenetetrahydrofolate reductase 677TT genoref-type. J. Nutr. 139: 727-733 (2009).
Cauffiez C, Pottier N, Tournel G, Lo-Guidice JM, Allorge D, Chevalier D, Migot-Nabias F, Kenani A, Broly F. CYP2A13 genetic polymorphism in French Caucasian, Gabonese and Tunisian populations. Xenobiotica 35: 661-669 (2005). *
Cavaco I, Gil JP, Gil-Berglund E, Ribeiro V. CYP3A4 and MDR1 alleles in a Portuguese population. Clin. Chem. Lab. Med. 41: 1345-1350 (2003).
Cavan DA, Jacobs KH, Penny MA, Kelly MA, Mijovic C, Jenkins D, Fletcher JA, Barnett AH. Both DQA1 and DQB1 genes are implicated in HLA-associated protection from type 1 (insulin-dependent) diabetes mellitus in a British Caucasian population. Diabetologia 36: 252-257 (1993).
Cavestro GM, Frulloni L, Neri TM, Seghini P, Nouvenne A, Zanetti A, Bovo P, Di Mario F, Okolicsanyi L, Cavallini G. Association of HLA-DRB1*0401 allele with chronic pancreatitis. Pancreas 26: 388-391 (2003).
Cawood AL, Carroll MP, Wootton SA, Calder PC. Is there a case for n-3 fatty acid supplementation in cystic fibrosis? Curr. Opin. Clin. Nutr. Metab. Care 8: 153-159 (2005).
Cebecauerova D, Jirasek T, Budisova L, Mandys V, Volf V, Novotna Z, Subhanova I, Hrebicek M, Elleder M, Jirsa M. Dual hereditary jaundice: simultaneous occurrence of mutations causing Gilbert's and Dubin-Johnson syndrome. Gastroenterology 129: 315-320 (2005). *
Cecil JE, Watt P, Palmer CN, Hetherington M. Energy balance and food intake: the role of PPARgamma gene polymorphisms. Physiol. Behav. 88: 227-233 (2006). *
Cederholm T, Persson M, Andersson P, Stenvinkel P, Nordfors L, Madden J, Vedin I, Wretlind B, Grimble RF, Palmblad J. Polymorphisms in cytokine genes influence long-term survival differently in elderly male and female patients. J. Intern. Med. 262: 215-223 (2007). *
Ceglia L. Vitamin D and skeletal muscle tissue and function. Mol. Aspects Med. 29: 407-414 (2008).
Cejkova P, Novota P, Cerna M, Kololtova K, Novakova D, Kucera P, Novak J, Andel M, Weber P, Zdarsky E. KCNJ11 E23K polymorphism and diabetes mellitus with adult onset in Czech patients. Folia Biol. (Praha) 53: 173-175 (2007).
Cejkova P, Novota P, Cerna M, Kolostova K, Novakova D, Kucera P, Novak J, Andel M, Weber P, Zdarsky E. HLA DRB1, DQB1 and insulin promoter VNTR polymorphisms: interactions and the association with adult-onset diabetes mellitus in Czech patients. Int. J. Immunogenet. 35: 133-140 (2008). *
Celebi Kobak A, Kobak S, Kabasakal Y, Akarca US. Tumor necrosis factor-alpha gene promoter polymorphism in patients with familial Mediterranean fever. Clin. Rheumatol. 26: 908-910 (2007). *
Celik U, Yildizdas D, Alhan E, Celik T, Attila G, Sertdemir Y, Tepe T. Genetic dilemma: eNOS gene intron 4a/b VNTR polymorphism in sepsis and its clinical features in Turkish children. Turk. J. Pediatr. 50: 114-119 (2008).
Celik Y, Dagli U, Yalin Kilic M, Toruner M, Ceren Ozen S, Ozkan M, Soykan I, Cetinkaya H, Ulker A, Ozden A, Mithat Bozdayi A. Cytokine gene polymorphisms in Turkish patients with inflammatory bowel disease. Scand. J. Gastroenterol. 41: 559-565 (2006). *
Cellini L, Grande R, Di Campli E, Di Bartolomeo S, Capodicasa S, Marzio L. Analysis of genetic variability, antimicrobial susceptibility and virulence markers in Helicobacter pylori identified in Central Italy. Scand. J. Gastroenterol. 41: 280-287 (2006). *
Cereda C, Baiocchi C, Bongioanni P, Cova E, Guareschi S, Metelli MR, Rossi B, Sbalsi I, Cuccia MC, Ceroni M. TNF and sTNFR1/2 plasma levels in ALS patients. J. Neuroimmunol. 194: 123-131 (2008).
Cerhan JR, Liu-Mares W, Fredericksen ZS, Novak AJ, Cunningham JM, Kay NE, Dogan A, Liebow M, Wang AH, Call TG, Habermann TM, Ansell SM, Slager SL. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma. Cancer Epidemiol. Biomarkers Prev. 17: 3161-3169 (2008). *
Cerhan JR, Novak AJ, Fredericksen ZS, Wang AH, Liebow M, Call TG, Dogan A, Witzig TE, Ansell SM, Habermann TM, Kay NE, Slager SL. Risk of non-Hodgkin lymphoma in association with germline variation in complement genes. Br. J. Haematol. 145: 614-623 (2009). *
Cerna M, Kolostova K, Novota P, Romzova M, Cejkova P, Pinterova D, Pruhova S, Treslova L, Andel M. Autoimmune diabetes mellitus with adult onset and type 1 diabetes mellitus in children have different genetic predispositions. Ann. N. Y. Acad. Sci. 1110: 140-150 (2007). *
Cerrone GE, Caputo M, Lopez AP, Gonzalez C, Massa C, Cedola N, Targovnik HM, Frechtel GD. Variable number of tandem repeats of the insulin gene determines susceptibility to latent autoimmune diabetes in adults. Mol. Diagn. 8: 43-49 (2004).
Cerundolo V, Salio M. Harnessing NKT cells for therapeutic applications. Curr. Top. Microbiol. Immunol. 314: 325-340 (2007).
Cervilla JA, Rivera M, Molina E, Torres-Gonzalez F, Bellon JA, Moreno B, de Dios Luna J, Lorente JA, de Diego-Otero Y, King M, Nazareth I, Gutierrez B. The 5-HTTLPR s/s genotype at the serotonin transporter gene (SLC6A4) increases the risk for depression in a large cohort of primary care attendees: the PREDICT-gene study. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 141: 912-917 (2006).
Cervino AC, Gosink M, Fallahi M, Pascal B, Mader C, Tsinoremas NF. A comprehensive mouse IBD database for the efficient localization of quantitative trait loci. Mamm. Genome 17: 565-574 (2006). *
Cha S, Choi CB, Han TU, Kang CP, Kang C, Bae SC. Association of anti-cyclic citrullinated peptide antibody levels with PADI4 haplotypes in early rheumatoid arthritis and with shared epitope alleles in very late rheumatoid arthritis. Arthritis Rheum. 56: 1454-1463 (2007). *
Cha SH, Lee WK, Kwak JO, Hwang JS, Suh CK. Identification and characterization of single nucleotide polymorphisms of SLC22A11 (hOAT4) in Korean women osteoporosis patients. Mol. Cells 25: 265-271 (2008).
Chaar V, Keclard L, Etienne-Julan M, Diara JP, Elion J, Krishnamoorthy R, Romana M. UGT1A1 polymorphism outweighs the modest effect of deletional (-3.7 kb) alpha-thalassemia on cholelithogenesis in sickle cell anemia. Am. J. Hematol. 81: 377-379 (2006). *
Chabchoub G, Maalej A, Petit-Teixeira E, Glikmans E, Rebai A, Farid NR, Cornelis F, Ayadi H. Polymorphisms in the protein tyrosine phosphatase (PTPN22) gene is not associated with autoimmune thyroid in a large affected Tunisian family. Clin. Immunol. 120: 235-236 (2006). *
Chabchoub G, Teixiera EP, Maalej A, Hamad MB, Bahloul Z, Cornelis F, Ayadi H. The R620W polymorphism of the protein tyrosine phosphatase 22 gene in autoimmune thyroid diseases and rheumatoid arthritis in the Tunisian population. Ann. Hum. Biol. 36: 342-349 (2009).
Chadha S, Miller K, Farwell L, Lightstone LB, Daly MJ, Rioux JD, Vyse TJ. Haplotype structure of TNFRSF5-TNFSF5 (CD40-CD40L) and association analysis in systemic lupus erythematosus. Eur. J. Hum. Genet. 13: 669-676 (2005). *
Chadha S, Miller K, Farwell L, Sacks S, Daly MJ, Rioux JD, Vyse TJ. Haplotype analysis of tumour necrosis factor receptor genes in 1p36: no evidence for association with systemic lupus erythematosus. Eur. J. Hum. Genet. 14: 69-78 (2006). *
Chae SC, Lee YC, Park YR, Shin JS, Song JH, Oh GJ, Hong ST, Pae HO, Choi BM, Chung HT. Analysis of the polymorphisms in eotaxin gene family and their association with asthma, IgE, and eosinophil. Biochem. Biophys. Res. Commun. 320: 131-137 (2004). *
Chae SC, Li CS, Kim KM, Yang JY, Zhang Q, Lee YC, Yang YS, Chung HT. Identification of polymorphisms in human interleukin-27 and their association with asthma in a Korean population. J. Hum. Genet. 52: 355-361 (2007). *
Chae SC, Park BL, Park CS, Ryu HJ, Yang YS, Lee SO, Choi YH, Kim EM, Uh ST, Kim YH, Kim KK, Oh B, Chung HT, Kimm K, Shin HD. Putative association of RUNX1 polymorphisms with IgE levels in a Korean population. Exp. Mol. Med. 38: 583-588 (2006). *
Chae SC, Park YR, Lee YC, Lee JH, Chung HT. The association of TIM-3 gene polymorphism with atopic disease in Korean population. Hum. Immunol. 65: 1427-1431 (2004).
Chae SC, Park YR, Li CS, Lee JH, Yang YS, Zhang Q, Kim KS, Chung HT. Analysis of the variations in IL-28RA gene and their association with allergic rhinitis. Exp. Mol. Med. 38: 302-309 (2006). *
Chae SC, Park YR, Shim SC, Lee IK, Chung HT. Eotaxin-3 gene polymorphisms are associated with rheumatoid arthritis in a Korean population. Hum. Immunol. 66: 314-320 (2005).
Chae SC, Park YR, Shim SC, Yoon KS, Chung HT. The polymorphisms of Th1 cell surface gene Tim-3 are associated in a Korean population with rheumatoid arthritis. Immunol. Lett. 95: 91-95 (2004).
Chae SC, Park YR, Song JH, Shim SC, Yoon KS, Chung HT. The polymorphisms of Tim-1 promoter region are associated with rheumatoid arthritis in a Korean population. Immunogenetics 56: 696-701 (2005). *
Chae SC, Shim SC, Chung HT. Association of TBX21 polymorphisms in a Korean population with rheumatoid arthritis. Exp. Mol. Med. 41: 33-41 (2009). *
Chae SJ, Kim H, Jee BC, Suh CS, Kim SH, Kim JG. Tumor necrosis factor (TNF)-TNF receptor gene polymorphisms and their serum levels in Korean women with endometriosis. Am. J. Reprod. Immunol. 60: 432-439 (2008).
Chaganti S, Ma CS, Bell AI, Croom-Carter D, Hislop AD, Tangye SG, Rickinson AB. Epstein-Barr virus persistence in the absence of conventional memory B cells: IgM+IgD+ CD27+ B cells harbour the virus in X-linked lymphoproliferative disease patients. Blood 112: 672-679 (2008). *
Chaimuangraj S, Thammachoti R, Ongphiphadhanakul B, Thammavit W. Lack of association of VDR polymorphisms with Thai prostate cancer as compared with benign prostate hyperplasia and controls. Asian Pac. J. Cancer Prev. 7: 136-139 (2006).
Chamaillard M, Philpott D, Girardin SE, Zouali H, Lesage S, Chareyre F, Bui TH, Giovannini M, Zaehringer U, Penard-Lacronique V, Sansonetti PJ, Hugot JP, Thomas G. Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc. Natl. Acad. Sci. U.S.A. 100: 3455-3460 (2003). *
Chames P, Van Regenmortel M, Weiss E, Baty D. Therapeutic antibodies: successes, limitations and hopes for the future. Br. J. Pharmacol. 157: 220-233 (2009).
Chan A, Newman DL, Shon AM, Schneider DH, Kuldanek S, Ober C. Variation in the type I interferon gene cluster on 9p21 influences susceptibility to asthma and atopy. Genes Immun. 7: 169-178 (2006). *
Chan AO, Chu KM, Huang C, Lam KF, Leung SY, Sun YW, Ko S, Xia HH, Cho CH, Hui WM, Lam SK, Rashid A. Association between Helicobacter pylori infection and interleukin 1beta polymorphism predispose to CpG island methylation in gastric cancer. Gut 56: 595-597 (2007). *
Chan CC, Ross RJ, Shen D, Ding X, Majumdar Z, Bojanowski CM, Zhou M, Salem N Jr, Bonner R, Tuo J. Ccl2/Cx3cr1-deficient mice: an animal model for age-related macular degeneration. Ophthalmic Res. 40: 124-128 (2008).
Chan E, Tan CS, Deurenberg-Yap M, Chia KS, Chew SK, Tai ES. The V227A polymorphism at the PPARA locus is associated with serum lipid concentrations and modulates the association between dietary polyunsaturated fatty acid intake and serum high density lipoprotein concentrations in Chinese women. Atherosclerosis 187: 309-315 (2006).
Chan HL, Tse AM, Chim AM, Wong VW, Choi PC, Yu J, Zhang M, Sung JJ. Association of cytokine gene polymorphisms and liver fibrosis in chronic hepatitis B. J. Gastroenterol. Hepatol. 23: 783-789 (2008). *
Chan IH, Tang NL, Leung TF, Huang W, Lam YY, Wong GW, Chan JC, Chan MH, Wong CK, Zhang YP, Lam CW. Association of early growth response-1 gene polymorphisms with total IgE and atopy in asthmatic children. Pediatr. Allergy Immunol. 20: 142-150 (2009). *
Chan IH, Tang NL, Leung TF, Ma SL, Zhang YP, Wong GW, Wong CK, Lam CW. Association of prostaglandin-endoperoxide synthase 2 gene polymorphisms with asthma and atopy in Chinese children. Allergy 62: 802-809 (2007).
Chanda P, Zhang A, Brazeau D, Sucheston L, Freudenheim JL, Ambrosone C, Ramanathan M. Information-theoretic metrics for visualizing gene-environment interactions. Am. J. Hum. Genet. 81: 939-963 (2007). *
Chang CC, Chen SC, Hsieh YH, Chen YC, Chen TY, Chu YH, Ma HJ, Chou MC, Tsai HT, Yang SF. Stromal cell-derived factor-1 but not its receptor, CXCR4, gene variants increase susceptibility and pathological development of hepatocellular carcinoma. Clin. Chem. Lab. Med. 47: 412-418 (2009).
Chang CC, Lu RB, Ma KH, Chang HA, Chen CL, Huang CC, Lin WW, Huang SY. Association study of the norepinephrine transporter gene polymorphisms and bipolar disorder in Han Chinese population. World J. Biol. Psychiatry 8: 188-195 (2007).
Chang CC, Silvia EA, Ho EK, Vlad G, Suciu-Foca N, Vasilescu ER. Polymorphism and linkage disequilibrium of immunoglobulin-like transcript 3 gene. Hum. Immunol. 69: 284-290 (2008).
Chang CH, Chiu CF, Liang SY, Wu HC, Chang CL, Tsai CW, Wang HC, Lee HZ, Bau DT. Significant association of Ku80 single nucleotide polymorphisms with bladder cancer susceptibility in Taiwan. Anticancer Res. 29: 1275-1279 (2009). *
Chang HK, Jang WC, Park SB, Nam YH, Lee SS, Park YW, Kim SK. The novel -G646A polymorphism of the TNFalpha promoter is associated with the HLA-B51 allele in Korean patients with Behcet's disease. Scand. J. Rheumatol. 36: 216-221 (2007). *
Chang HS, Kim JS, Lee JH, Cho JI, Rhim TY, Uh ST, Park BL, Chung IY, Park CS, Shin HD. A single nucleotide polymorphism on the promoter of eotaxin1 associates with its mRNA expression and asthma phenotypes. J. Immunol. 174: 1525-1531 (2005). *
Chang HW, Yang CH, Chang PL, Cheng YH, Chuang LY. SNP-RFLPing: restriction enzyme mining for SNPs in genomes. BMC Genomics 7: 30 (2006). *
Chang JB, Zhou ZX, Xue R, Zhu GS, Tian YL, Zhao W. The relationship between alpha-IFN anti-virus treatment and HLA-DRB1*11 gene mononucleotide polymorphism. Zhonghua Gan Zang Bing Za Zhi 16: 646-648 (2008).
Chang JH, Hampartzoumian T, Everett B, Lloyd A, McCluskey PJ, Wakefield D. Changes in Toll-like receptor (TLR)-2 and TLR4 expression and function but not polymorphisms are associated with acute anterior uveitis. Invest. Ophthalmol. Vis. Sci. 48: 1711-1717 (2007). *
Chang JL, Bigler J, Schwarz Y, Li SS, Li L, King IB, Potter JD, Lampe JW. UGT1A1 polymorphism is associated with serum bilirubin concentrations in a randomized, controlled, fruit and vegetable feeding trial. J. Nutr. 137: 890-897 (2007). *
Chang LY, Chang IS, Chen WJ, Huang YC, Chen GW, Shih SR, Juang JL, Shih HM, Hsiung CA, Lin TY, Huang LM. HLA-A33 is associated with susceptibility to enterovirus 71 infection. Pediatrics 122: 1271-1276 (2008). *
Chang M, Li Y, Yan C, Callis-Duffin KP, Matsunami N, Garcia VE, Cargill M, Civello D, Bui N, Catanese JJ, Leppert MF, Krueger GG, Begovich AB, Schrodi SJ. Variants in the 5q31 cytokine gene cluster are associated with psoriasis. Genes Immun. 9: 176-181 (2008). *
Chang M, Tsuchiya K, Batchelor RH, Rabinovitch PS, Kulander BG, Haggitt RC, Burmer GC. Deletion mapping of chromosome 8p in colorectal carcinoma and dysplasia arising in ulcerative colitis, prostatic carcinoma, and malignant fibrous histiocytomas. Am. J. Pathol. 144: 1-6 (1994). *
Chang MC, Chang YT, Tien YW, Liang PC, Jan IS, Wei SC, Wong JM. T-cell regulatory gene CTLA-4 polymorphism/haplotype association with autoimmune pancreatitis. Clin. Chem. 53: 1700-1705 (2007). *
Chang MC, Chang YT, Tien YW, Liang PC, Wei SC, Wong JM. Association of tumour necrosis factor-alpha promoter haplotype with chronic pancreatitis. Gut 55: 1674-1676 (2006). *
Chang MC, Chang YT, Wei SC, Kuo CH, Liang PC, Wong JM. Autoimmune pancreatitis associated with high prevalence of gastric ulcer independent of Helicobacter pylori infection status. Pancreas 38: 442-446 (2009).
Chang PM, Tzeng CH, Chen PM, Lin JK, Lin TC, Chen WS, Jiang JK, Wang HS, Wang WS. ERCC1 codon 118 C-->T polymorphism associated with ERCC1 expression and outcome of FOLFOX-4 treatment in Asian patients with metastatic colorectal carcinoma. Cancer Sci. Dec 4 [Epub ahead of print] (2008). *
Chang SC, Lin PC, Lin JK, Yang SH, Wang HS, Fen-Yau Li A. Role of MTHFR polymorphisms and folate levels in different phenotypes of sporadic colorectal cancers. Int. J. Colorectal Dis. 22: 483-489 (2007). *
Chang SC, Rashid A, Gao YT, Andreotti G, Shen MC, Wang BS, Han TQ, Zhang BH, Sakoda LC, Leitzmann MF, Chen BE, Rosenberg P, Chen J, Chanock S, Hsing AW. Polymorphism of genes related to insulin sensitivity and the risk of biliary tract cancer and biliary stone: a population-based case-control study in Shanghai, China. Carcinogenesis 29: 944-948 (2008). *
Chang SJ, Chen CJ, Tsai FC, Lai HM, Tsai PC, Tsai MH, Ko YC. Associations between gout tophus and polymorphisms 869T/C and -509C/T in transforming growth factor beta1 gene. Rheumatology (Oxford) 47: 617-621 (2008). *
Chang SJ, Tsai PC, Chen CJ, Lai HM, Ko YC. The polymorphism -863C/A in tumour necrosis factor-alpha gene contributes an independent association to gout. Rheumatology (Oxford) 46: 1662-1666 (2007). *
Chang X, Yamada R, Suzuki A, Sawada T, Yoshino S, Tokuhiro S, Yamamoto K. Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis. Rheumatology (Oxford) 44: 40-50 (2005). *
Chang YC, Wu WM, Chen CH, Hu CF, Hsu LA. Association between P478S polymorphism of the filaggrin gene and risk of psoriasis in a Chinese population in Taiwan. Arch. Dermatol. Res. 300: 133-137 (2008). *
Chang YC, Wu WM, Chen CH, Lee SH, Hong HS, Hsu LA. Association between the insertion/deletion polymorphism of the angiotensin I-converting enzyme gene and risk for psoriasis in a Chinese population in Taiwan. Br. J. Dermatol. 156: 642-645 (2007).
Chang YH, Huang CN, Wu CY, Shiau MY. Association of Interleukin-10 A-592C and T-819C polymorphisms with type 2 diabetes mellitus. Hum. Immunol. 66: 1258-1263 (2005).
Chang YH, Lee DS, Jo HS, Cho SI, Yoon HJ, Shin S, Yoon JH, Kim HY, Hong YJ, Hong SI, Cho HI. Tumor necrosis factor alpha promoter polymorphism associated with increased susceptibility to secondary hemophagocytic lymphohistiocytosis in the Korean population. Cytokine 36: 45-50 (2006).
Chang YK, Yang W, Zhao M, Mok CC, Chan TM, Wong RW, Lee KW, Mok MY, Wong SN, Ng IO, Lee TL, Ho MH, Lee PP, Wong WH, Lau CS, Sham PC, Lau YL. Association of BANK1 and TNFSF4 with systemic lupus erythematosus in Hong Kong Chinese. Genes Immun. Apr 9 [Epub ahead of print] (2009). *
Chang YT, Chang MC, Su TC, Liang PC, Su YN, Kuo CH, Wei SC, Wong JM. Association of cystic fibrosis transmembrane conductance regulator (CFTR) mutation/variant/haplotype and tumor necrosis factor (TNF) promoter polymorphism in hyperlipidemic pancreatitis. Clin. Chem. 54: 131-138 (2008). *
Chang YT, Chou CT, Shiao YM, Lin MW, Yu CW, Chen CC, Huang CH, Lee DD, Liu HN, Wang WJ, Tsai SF. Psoriasis vulgaris in Chinese individuals is associated with PSORS1C3 and CDSN genes. Br. J. Dermatol. 155: 663-669 (2006). *
Chang YT, Chou CT, Yu CW, Lin MW, Shiao YM, Chen CC, Huang CH, Lee DD, Liu HN, Wang WJ, Tsai SF. Cytokine gene polymorphisms in Chinese patients with psoriasis. Br. J. Dermatol. 156: 899-905 (2007). *
Chang YT, Hsu CY, Chou CT, Lin MW, Shiao YM, Tsai CY, Yu CW, Shiue JJ, Lee YF, Huang CH, Chen CC, Lee DD, Wang WJ, Liu HN, Tsai SF. The genetic polymorphisms of POU5F1 gene are associated with psoriasis vulgaris in Chinese. J. Dermatol. Sci. 46: 153-156 (2007).
Chang YT, Lee WR, Yu CW, Liu HN, Lin MW, Huang CH, Chen CC, Lee DD, Wang WJ, Hu CH, Tsai SF. No association of cytokine gene polymorphisms in Chinese patients with atopic dermatitis. Clin. Exp. Dermatol. 31: 419-423 (2006). *
Chang YT, Liu HN, Shiao YM, Lin MW, Lee DD, Liu MT, Wang WJ, Wu S, Lai CY, Tsai SF. A study of PSORS1C1 gene polymorphisms in Chinese patients with psoriasis. Br. J. Dermatol. 153: 90-96 (2005). *
Chang YT, Liu HN, Yu CW, Lin MW, Huang CH, Chen CC, Liu MT, Lee DD, Wang WJ, Tsai SF. Cytokine gene polymorphisms in bullous pemphigoid in a Chinese population. Br. J. Dermatol. 154: 79-84 (2006).
Chang YT, Shiao YM, Chin PJ, Liu YL, Chou FC, Wu S, Lin YF, Li LH, Lin MW, Liu HN, Tsai SF. Genetic polymorphisms of the HCR gene and a genomic segment in close proximity to HLA-C are associated with patients with psoriasis in Taiwan. Br. J. Dermatol. 150: 1104-1111 (2004). *
Chang YT, Tsai SF, Lee DD, Shiao YM, Huang CY, Liu HN, Wang WJ, Wong CK. A study of candidate genes for psoriasis near HLA-C in Chinese patients with psoriasis. Br. J. Dermatol. 148: 418-423 (2003). *
Chang YT, Tsai SF, Lin MW, Liu HN, Lee DD, Shiao YM, Chin PJ, Wang WJ. SPR1 gene near HLA-C is unlikely to be a psoriasis susceptibility gene. Exp. Dermatol. 12: 307-314 (2003). *
Chang Z, Guo CL, Ahronowitz I, Stemmer-Rachamimov AO, Maccollin M, Nunes FP. A role for the p53 pathway in the pathology of meningiomas with NF2 loss. J. Neurooncol. 91: 265-270 (2009).
Chanson M, Kwak BR. Connexin37: a potential modifier gene of inflammatory disease. J. Mol. Med. 85: 787-795 (2007). *
Chao C, Zhang ZF, Berthiller J, Boffetta P, Hashibe M. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis. Cancer Epidemiol. Biomarkers Prev. 15: 979-987 (2006). *
Chao YC, Chu HC, Chang WK, Huang HH, Hsieh TY. CD14 promoter polymorphism in Chinese alcoholic patients with cirrhosis of liver and acute pancreatitis. World J. Gastroenterol. 11: 6043-6048 (2005). *
Chao YL, Shen YC, Liao DL, Chen JY, Wang YC, Lai IC, Liou YJ, Chen CH. Association study of HLA-A gene and schizophrenia in Han Chinese from Taiwan. Prog. Neuropsychopharmacol. Biol. Psychiatry 32: 1834-1837 (2008).
Chaouni I, Lefranc MP, d'Angeac AD, Zanin C, Pellet F, Clot J, Combe B, Sany J, Reme T. T cell receptor gamma variable gene locus polymorphism in patients with rheumatoid arthritis. Arthritis Rheum. 35: 756-760 (1992).
Chapman K, Takahashi A, Meulenbelt I, Watson C, Rodriguez-Lopez J, Egli R, Tsezou A, Malizos KN, Kloppenburg M, Shi D, Southam L, van der Breggen R, Donn R, Qin J, Doherty M, Slagboom PE, Wallis G, Kamatani N, Jiang Q, Gonzalez A, Loughlin J, Ikegawa S. A meta-analysis of European and Asian cohorts reveals a global role of a functional SNP in the 5' UTR of GDF5 with osteoarthritis susceptibility. Hum. Mol. Genet. 17: 1497-1504 (2008).
Chappell S, Hadzic N, Stockley R, Guetta-Baranes T, Morgan K, Kalsheker N. A polymorphism of the alpha(1)-antitrypsin gene represents a risk factor for liver disease. Hepatology 47: 127-132 (2008). *
Chapuis J, Hot D, Hansmannel F, Kerdraon O, Ferreira S, Hubans C, Maurage CA, Huot L, Bensemain F, Laumet G, Ayral AM, Fievet N, Hauw JJ, Dekosky ST, Lemoine Y, Iwatsubo T, Wavrant-Devrieze F, Dartigues JF, Tzourio C, Buee L, Pasquier F, Berr C, et al. Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease. Mol. Psychiatry Feb 10 [Epub ahead of print] (2009).
Charli-Joseph Y, Cruz-Fuentes C, Orozco-Topete R. Incidence of adverse cutaneous drug reactions in a Mexican sample: an exploratory study on their association to tumour necrosis factor alpha TNF2 allele. J. Eur. Acad. Dermatol. Venereol. Mar 4 [Epub ahead of print] (2009). *
Charmley P, Nelson JL, Hansen JA, Branchaud A, Barrington RA, Templin D, Boyer G, Lanier AP, Concannon P. T-cell receptor polymorphisms in Tlingit Indians with rheumatoid arthritis. Autoimmunity 19: 247-251 (1994).
Charmley P, Nepom BS, Concannon P. HLA and T cell receptor beta-chain DNA polymorphisms identify a distinct subset of patients with pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum. 37: 695-701 (1994).
Charriere S, Bernard S, Aqallal M, Merlin M, Billon S, Perrot L, Le Coquil E, Sassolas A, Moulin P, Marcais C. Association of APOA5 -1131T>C and S19W gene polymorphisms with both mild hypertriglyceridemia and hyperchylomicronemia in type 2 diabetic patients. Clin. Chim. Acta 394: 99-103 (2008). *
Charron D. Immunogenomics of hematopoietic stem cell transplantation. Pathol. Biol. (Paris) 53: 171-173 (2005).
Charron DJ. New aspects of HLA: perspectives for rheumatoid arthritis. Clin. Exp. Rheumatol. 10: 293-296 (1992).
Chatterjee A, Rathore A, Dhole TN. Association of IL-4 589 C/T promoter and IL-4RalphaI50V receptor polymorphism with susceptibility to HIV-1 infection in North Indians. J. Med. Virol. 81: 959-965 (2009). *
Chatterjee A, Rathore A, Sivarama P, Yamamoto N, Dhole TN. Genetic association of IL-10 gene promoter polymorphism and HIV-1 infection in North Indians. J. Clin. Immunol. 29: 71-77 (2009). *
Chatterjee N, Wacholder S. Invited commentary: efficient testing of gene-environment interaction. Am. J. Epidemiol. 169: 231-233 (2009). *
Chatterjee R, Batra J, Das S, Sharma SK, Ghosh B. Genetic association of acidic mammalian chitinase with atopic asthma and serum total IgE levels. J. Allergy Clin. Immunol. 122: 202-208.e7 (2008).
Chatterjee R, Batra J, Ghosh B. A common exonic variant of interleukin-21 confers susceptibility to atopic asthma. Int. Arch. Allergy Immunol. 148: 137-146 (2008).
Chatterjee R, Batra J, Kumar A, Mabalirajan U, Nahid S, Niphadkar PV, Ghosh B. Interleukin-10 promoter polymorphisms and atopic asthma in North Indians. Clin. Exp. Allergy 35: 914-919 (2005).
Chatzikyriakidou A, Georgiou I, Voulgari PV, Georgiadis AN, Argyriou ES, Drosos AA. Glucocorticoid receptor variants may predispose to rheumatoid arthritis susceptibility. Scand. J. Rheumatol. 38: 1-5 (2009). *
Chatzikyriakidou A, Georgiou I, Voulgari PV, Papadopoulos CG, Tzavaras T, Drosos AA. Transcription regulatory polymorphism -43T>C in the 5'-flanking region of SLC19A1 gene could affect rheumatoid arthritis patient response to methotrexate therapy. Rheumatol. Int. 27: 1057-1061 (2007). *
Chatzikyriakidou A, Georgiou I, Voulgari PV, Venetsanopoulou AI, Drosos AA. Combined tumour necrosis factor-alpha and tumour necrosis factor receptor genotypes could predict rheumatoid arthritis patients' response to anti-TNF-alpha therapy and explain controversies of studies based on a single polymorphism. Rheumatology (Oxford) 46: 1034-1035 (2007). *
Chatzikyriakidou A, Vakalis KV, Kolaitis N, Kolios G, Naka KK, Michalis LK, Georgiou I. Distinct association of SLC19A1 polymorphism -43T>C with red cell folate levels and of MTHFR polymorphism 677C>T with plasma folate levels. Clin. Biochem. 41: 174-176 (2008). *
Chatzipapas C, Boikos S, Drosos GI, Kazakos K, Tripsianis G, Serbis A, Stergiopoulos S, Tilkeridis C, Verettas DA, Stratakis CA. Polymorphisms of the vitamin D receptor gene and stress fractures. Horm. Metab. Res. Apr 23 [Epub ahead of print] (2009).
Chauffert M, Cisse A, Chevenne D, Parfait B, Michel S, Trivin F. HLA-DQ beta 1 typing and non-Asp57 alleles in the aborigine population of Senegal. Diabetes Care 18: 677-680 (1995).
Chauhan M, McGuire W. Interleukin-6 (-174C) polymorphism and the risk of sepsis in very-low-birth-weight infants: meta-analysis. Arch. Dis. Child. Fetal Neonatal Ed. 93: F427-F429 (2008).
Checa M, Ruiz V, Montano M, Velazquez-Cruz R, Selman M, Pardo A. MMP-1 polymorphisms and the risk of idiopathic pulmonary fibrosis. Hum. Genet. 124: 465-472 (2008). *
Chen B, Fang J, Zhang W, Jin Z, Yu Z, Cai W. Detection of C1236T, G2677T/A, and C3435T polymorphism of MDR1 by amplification refractory mutation system PCR. J. Clin. Lab. Anal. 23: 110-116 (2009).
Chen B, Zeng Z, Hou J, Chen M, Gao X, Hu P. Association of interleukin-17F 7488 single nucleotide polymorphism and inflammatory bowel disease in the Chinese population. Scand. J. Gastroenterol. 44: 720-726 (2009). *
Chen CC, Huang CY, Huang FY, Dang CW, Lin CL, Lo FS, Lin CH, Tsang CC, Li HJ, Liu HF, Chu CC, Lin M, Lee YJ. The CBLB gene and Graves' disease in children. J. Pediatr. Endocrinol. Metab. 18: 1119-1126 (2005).
Chen CC, Isomoto H, Narumi Y, Sato K, Oishi Y, Kobayashi T, Yanagihara K, Mizuta Y, Kohno S, Tsukamoto K. Haplotypes of PADI4 susceptible to rheumatoid arthritis are also associated with ulcerative colitis in the Japanese population. Clin. Immunol. 126: 165-171 (2008). *
Chen CJ, Yen JH, Tsai WC, Wu CS, Chiang W, Tsai JJ, Liu HW. The TNF2 allele does not contribute towards susceptibility to systemic lupus erythematosus. Immunol. Lett. 55: 1-3 (1997).
Chen CM, Chen IC, Chang KH, Chen YC, Lyu RK, Liu YT, Hu FJ, Chao CY, Lee-Chen GJ, Wu YR. Nuclear receptor NR4A2 IVS6 +18insG and brain derived neurotrophic factor (BDNF) V66M polymorphisms and risk of Taiwanese Parkinson's disease. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 144: 458-462 (2007).
Chen D, Hsieh C, Chen K, Chen Y, Lin F, Lan J. Association of interleukin-18 promoter polymorphisms with WHO pathological classes and serum IL-18 levels in Chinese patients with lupus nephritis. Lupus 18: 29-37 (2009).
Chen D, Jin G, Wang Y, Wang H, Liu H, Liu Y, Fan W, Ma H, Miao R, Hu Z, Sun W, Qian J, Jin L, Wei Q, Shen H, Huang W, Lu D. Genetic variants in peroxisome proliferator-activated receptor-gamma gene are associated with risk of lung cancer in a Chinese population. Carcinogenesis 29: 342-350 (2008). *
Chen D, Tian T, Wang H, Liu H, Hu Z, Wang Y, Liu Y, Ma H, Fan W, Miao R, Sun W, Wang Y, Qian J, Jin L, Wei Q, Shen H, Huang W, Lu D. Association of human aryl hydrocarbon receptor gene polymorphisms with risk of lung cancer among cigarette smokers in a Chinese population. Pharmacogenet. Genomics 19: 25-34 (2009). *
Chen F, Wollmer MA, Hoerndli F, Munch G, Kuhla B, Rogaev EI, Tsolaki M, Papassotiropoulos A, Gotz J. Role for glyoxalase I in Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 101: 7687-7692 (2004). *
Chen FJ, Yu H, Fan F, Lu JX. Mitochondrial D-loop gene polymorphisms in the patients with type 2 diabetes mellitus. Yi Chuan 31: 265-272 (2009).
Chen GG, Ho RL, Wong J, Lee KF, Lai PB. Single nucleotide polymorphism in the promoter region of human alpha-fetoprotein (AFP) gene and its significance in hepatocellular carcinoma (HCC). Eur. J. Surg. Oncol. 33: 882-886 (2007).
Chen H, Cui B, Wang S, Zhao Z, Sun H, Gu X, Zhao Y, Li X, Ning G. The common variants of E-selectin gene in Graves' disease. Genes Immun. 9: 182-186 (2008). *
Chen H, Toh TK, Szeverenyi I, Ong RT, Theng CT, McLean WH, Seielstad M, Lane EB. Association of skin barrier genes within the PSORS4 locus is enriched in Singaporean Chinese with early-onset psoriasis. J. Invest. Dermatol. 129: 606-614 (2009). *
Chen H, Yang Z, Gibbs D, Yang X, Hau V, Zhao P, Ma X, Zeng J, Luo L, Pearson E, Constantine R, Kaminoh Y, Harmon J, Tong Z, Stratton CA, Cameron DJ, Tang S, Zhang K. Association of HTRA1 polymorphism and bilaterality in advanced age-related macular degeneration. Vision Res. 48: 690-694 (2008).
Chen HH, Lee WJ, Fann CS, Bouchard C, Pan WH. Severe obesity is associated with novel single nucleotide polymorphisms of the ESR1 and PPARgamma locus in Han Chinese. Am. J. Clin. Nutr. Jun 2 [Epub ahead of print] (2009).
Chen HL, Liu YJ, Su YN, Wang NY, Wu SH, Ni YH, Hsu HY, Wu TC, Chang MH. Diagnosis of BSEP/ABCB11 mutations in Asian patients with cholestasis using denaturing high performance liquid chromatography. J. Pediatr. 153: 825-832.e2 (2008). *
Chen HL, Su HJ, Wang YJ, Guo YL, Liao PC, Lee CC. Interactive effects between CYP1A1 genotypes and environmental polychlorinated dibenzo-p-dioxins and dibenzofurans exposures on liver function profile. J. Toxicol. Environ. Health A. 69: 269-281 (2006).
Chen HO, Chen ZJ, Qiu Y, Qiu XS, Cao XB, Liu Z, Li WG. Investigation on the association between estrogen beta receptor gene polymorphisms and the susceptibility of adolescent idiopathic scoliosis. Stud. Health Technol. Inform. 140: 322 (2008).
Chen HY, Cui B, Wang S, Zhao ZF, Sun H, Zhao YJ, Li XY, Ning G. L-Selectin gene polymorphisms in Graves' disease. Clin. Endocrinol. (Oxf.) 67: 145-151 (2007). *
Chen J, Compton C, Cheng E, Fromowitz F, Viola MV. c-Ki-ras mutations in dysplastic fields and cancers in ulcerative colitis. Gastroenterology 102: 1983-1987 (1992).
Chen J, Giovannucci E, Kelsey K, Rimm EB, Stampfer MJ, Colditz GA, Spiegelman D, Willett WC, Hunter DJ. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res. 56: 4862-4864 (1996). *
Chen J, Giovannucci EL, Hunter DJ. MTHFR polymorphism, methyl-replete diets and the risk of colorectal carcinoma and adenoma among U.S. men and women: an example of gene-environment interactions in colorectal tumorigenesis. J. Nutr. 129: 560S-564S (1999). *
Chen J, Huang XF. Interleukin-6 promotes carcinogenesis through multiple signal pathways - comment on: clinical significance of interleukin-6 gene polymorphism and IL-6 serum level in pancreatic adenocarcinoma and chronic pancreatitis. Dig. Dis. Sci. 54: 1373-1374 (2009). *
Chen J, Killary AM, Sen S, Amos CI, Evans DB, Abbruzzese JL, Frazier ML. Polymorphisms of p21 and p27 jointly contribute to an earlier age at diagnosis of pancreatic cancer. Cancer Lett. 272: 32-39 (2008).
Chen J, Kyte C, Valcin M, Chan W, Wetmur JG, Selhub J, Hunter DJ, Ma J. Polymorphisms in the one-carbon metabolic pathway, plasma folate levels and colorectal cancer in a prospective study. Int. J. Cancer 110: 617-620 (2004). *
Chen J, Ma J, Stampfer MJ, Palomeque C, Selhub J, Hunter DJ. Linkage disequilibrium between the 677C>T and 1298A>C polymorphisms in human methylenetetrahydrofolate reductase gene and their contributions to risk of colorectal cancer. Pharmacogenetics 12: 339-342 (2002).
Chen J, Xu Z, Ou X, Wang M, Yang X, Li Q. Mannose-binding lectin polymorphisms and recurrent respiratory tract infection in Chinese children. Eur. J. Pediatr. Jan 24 [Epub ahead of print] (2009). *
Chen JY, Wang CM, Lu SC, Chou YH, Luo SF. Association of apoptosis-related microsatellite polymorphisms on chromosome 1q in Taiwanese systemic lupus erythematosus patients. Clin. Exp. Immunol. 143: 281-287 (2006). *
Chen JY, Wang CM, Ma CC, Chow YH, Luo SF. The -844C/T polymorphism in the Fas ligand promoter associates with Taiwanese SLE. Genes Immun. 6: 123-128 (2005). *
Chen JY, Wang CM, Ma CC, Hsu LA, Ho HH, Wu YJ, Kuo SN, Wu J. A transmembrane polymorphism in FcgammaRIIb (FCGR2B) is associated with the production of anti-cyclic citrullinated peptide autoantibodies in Taiwanese RA. Genes Immun. 9: 680-688 (2008). *
Chen JY, Wang CM, Ma CC, Luo SF, Edberg JC, Kimberly RP, Wu J. Association of a transmembrane polymorphism of Fcgamma receptor IIb (FCGR2B) with systemic lupus erythematosus in Taiwanese patients. Arthritis Rheum. 54: 3908-3917 (2006). *
Chen JY, Wang CM, Wu JM, Ho HH, Luo SF. Association of rheumatoid factor production with FcgammaRIIIa polymorphism in Taiwanese rheumatoid arthritis. Clin. Exp. Immunol. 144: 10-16 (2006). *
Chen L, Ambrosone CB, Lee J, Sellers TA, Pow-Sang J, Park JY. Association between polymorphisms in the DNA repair genes XRCC1 and APE1, and the risk of prostate cancer in white and black Americans. J. Urol. 175: 108-112 (2006).
Chen L, Brosnan CF. Regulation of immune response by P2X7 receptor. Crit. Rev. Immunol. 26: 499-513 (2006).
Chen LS, Wei JB, Zhou YC, Zhang S, Liang JL, Cao YF, Tang ZJ, Zhang XL, Gao F. Genetic alterations and expression of inhibitor of growth 1 in human sporadic colorectal cancer. World J. Gastroenterol. 11: 6120-6124 (2005). *
Chen M, Peyrin-Biroulet L, Xia B, Rodriguez-Gueant RM, Bronowicki JP, Bigard MA, Gueant JL. Methionine synthase A2756G polymorphism may predict ulcerative colitis and methylenetetrahydrofolate reductase C677T pancolitis, in Central China. BMC Med. Genet. 9: 78 (2008). *
Chen M, Xia B, Chen B, Guo Q, Li J, Ye M, Hu Z. N-acetyltransferase 2 slow acetylator genotype associated with adverse effects of sulphasalazine in the treatment of inflammatory bowel disease. Can. J. Gastroenterol. 21: 155-158 (2007).
Chen MP, Chung FM, Chang DM, Tsai JC, Huang HF, Shin SJ, Lee YJ. ENPP1 K121Q polymorphism is not related to type 2 diabetes mellitus, features of metabolic syndrome, and diabetic cardiovascular complications in a Chinese population. Rev. Diabet. Stud. 3: 21-30 (2006). *
Chen PJ, Wei CC, Wang C, Chen FW, Hsu YH, Chang MS. Promoter analysis of interleukin 19. Biochem. Biophys. Res. Commun. 344: 713-720 (2006). *
Chen PL, Fann CS, Chang CC, Wu IL, Chiu WY, Lin CY, Yang WS, Chang TC. Linkage of Graves' disease to the human leucocyte antigen region in the Chinese-Han population in Taiwan. Clin. Endocrinol. (Oxf.) 66: 646-651 (2007). *
Chen PL, Fann CS, Chang CC, Wu IL, Chiu WY, Lin CY, Yang WS, Chang TC. Family-based association study of cytotoxic T-lymphocyte antigen-4 with susceptibility to Graves' disease in Han population of Taiwan. Genes Immun. 9: 87-92 (2008). *
Chen Q, Kamboh MI. Complete DNA sequence variation in the apolipoprotein H (beta-glycoprotein I) gene and identification of informative SNPs. Ann. Hum. Genet. 70: 1-11 (2006). *
Chen QB, Fan LY, Zhong RQ, Tu XQ, Yuan Y, Zhu Y, Ye WM, Lu HQ, Han HX. A study on the relationship between interleukin-10 promoter polymorphism and autoimmune liver disease. Zhonghua Gan Zang Bing Za Zhi 12: 356-358 (2004).
Chen QX, Lv C, Huang LX, Cheng BL, Xie GH, Wu SJ, Fang XM. Genomic variations within DEFB1 are associated with the susceptibility to and the fatal outcome of severe sepsis in Chinese Han population. Genes Immun. 8: 439-443 (2007). *
Chen QY, Nadell D, Zhang XY, Kukreja A, Huang YJ, Wise J, Svec F, Richards R, Friday KE, Vargas A, Gomez R, Chalew S, Lan MS, Tomer Y, Maclaren NK. The human leukocyte antigen HLA DRB3*020/DQA1*0501 haplotype is associated with Graves' disease in African Americans. J. Clin. Endocrinol. Metab. 85: 1545-1549 (2000). *
Chen R, Fang M, Cai Q, Duan S, Lv K, Cheng N, Ren D, Shen J, He D, He L, Sun S. Tumor necrosis factor alpha -308 polymorphism is associated with rheumatoid arthritis in Han population of Eastern China. Rheumatol. Int. 28: 121-126 (2007). *
Chen RH, Chang CT, Chen HY, Chen WC, Tsai CH, Tsai FJ. Association between vitamin-D receptor gene FokI polymorphism and Graves' disease among Taiwanese Chinese. J. Clin. Lab. Anal. 21: 173-177 (2007).
Chen RH, Chang CT, Wang TY, Chen CC, Tsai CH, Tsai FJ. Lack of association between interleukin-4 gene polymorphisms and autoimmune thyroid diseases amongst Taiwanese Chinese. Endocrine 32: 170-174 (2007).
Chen RH, Chang CT, Wang TY, Huang WL, Tsai CH, Tsai FJ. p53 codon 72 proline/arginine polymorphism and autoimmune thyroid diseases. J. Clin. Lab. Anal. 22: 321-326 (2008).
Chen RH, Chen WC, Chang CT, Tsai CH, Tsai FJ. Interleukin-1-beta gene, but not the interleukin-1 receptor antagonist gene, is associated with Graves' disease. J. Clin. Lab. Anal. 19: 133-138 (2005).
Chen RH, Chen WC, Chen CC, Tsai CH, Tsai FJ. Association between the TAP1 gene codon 637 polymorphism and Graves' disease. Endocrine 25: 137-140 (2004).
Chen RH, Chen WC, Wang TY, Tsai CH, Tsai FJ. Lack of association between pro-inflammatory cytokine (IL-6, IL-8 and TNF-alpha) gene polymorphisms and Graves' disease. Int. J. Immunogenet. 32: 343-347 (2005). *
Chen RH, Wang TY, Chen WC, Tsai CH, Tsai FJ. Association between the TAP2 gene codon 665 polymorphism and Graves' disease. J. Clin. Lab. Anal. 20: 93-97 (2006).
Chen S, Li W, Hu Q, Liu Z, Xu Y, Xu A. Polymorphism of HLA class I genes in Meizhou Han population of Guangdong, China. Int. J. Immunogenet. 34: 131-136 (2007). *
Chen S, Li Y, Li S, Yu C. A Val227Ala substitution in the peroxisome proliferator activated receptor alpha (PPAR alpha) gene associated with non-alcoholic fatty liver disease and decreased waist circumference and waist-to-hip ratio. J. Gastroenterol. Hepatol. 23: 1415-1418 (2008). *
Chen S, Ren X, Liu Y, Hu Q, Hong W, Xu A. Human leukocyte antigen class I polymorphism in Miao, Bouyei, and Shui ethnic minorities of Guizhou, China. Hum. Immunol. 68: 928-933 (2007).
Chen SF, Lu XF, Yan WL, Huang JF, Gu DF. Variations in the calpain-10 gene are associated with the risk of type 2 diabetes and hypertension in northern Han Chinese population. Chin. Med. J. (Engl.) 120: 2218-2223 (2007).
Chen SH, Li YM, Yu CH, Jiang LL. The association of Val227Ala polymorphism of the peroxisome proliferator activated receptor alpha (PPAR alpha) gene with non-alcoholic fatty liver disease. Zhonghua Gan Zang Bing Za Zhi 15: 64-65 (2007).
Chen SY, Wan L, Huang YC, Sheu JJ, Lan YC, Lai CH, Lin CW, Chang JS, Tsai Y, Liu SP, Lin YJ, Tsai FJ. Interleukin-18 gene 105A/C genetic polymorphism is associated with the susceptibility of Kawasaki disease. J. Clin. Lab. Anal. 23: 71-76 (2009).
Chen TJ, Ji CY, Zheng XY, Hu YH. Association of beta3 adrenergic receptor and peroxisome proliferator-activated receptor gamma 2 polymorphisms with insulin sensitivity: a twin study. Biomed. Environ. Sci. 20: 99-105 (2007).
Chen W, Ye W, Su P, Ding Y, Peng Y, Liang A, Huang D, Li G. The vitamin D receptor gene TruI polymorphisms and its effect on the detection of BsmI polymorphisms in Han nationality. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 24: 338-340 (2007).
Chen WC, Nie JS. Genetic polymorphism of MCP-1-2518, IL-8-251 and susceptibility to acute pancreatitis: a pilot study in population of Suzhou, China. World J. Gastroenterol. 14: 5744-5748 (2008). *
Chen WJ, Qiu Y, Cao XB, Qiu XS, Chen ZJ, Chen HO. Vitamin D receptor gene polymorphisms: no association with low bone mineral density in adolescent idiopathic scoliosis girls. Stud. Health Technol. Inform. 140: 323 (2008).
Chen WJ, Qiu Y, Zhu F, Zhu ZZ, Sun X, Liu Z, Chen ZJ. Vitamin D receptor gene polymorphisms: no association with low bone mineral density in adolescent idiopathic scoliosis girls. Zhonghua Wai Ke Za Zhi 46: 1183-1186 (2008).
Chen WV, Amos CI, Etzel CJ, Shete S, Gregersen PK. Comparison of genome-wide single-nucleotide polymorphism linkage analyses in Caucasian and Hispanic NARAC families. BMC Proc. 1 Suppl. 1: S97 (2007). *
Chen X, Guan J, Song Y, Chen P, Zheng H, Tang C, Wu Q. IGF-I (CA) repeat polymorphisms and risk of cancer: a meta-analysis. J. Hum. Genet. 53: 227-238 (2008). *
Chen X, Katoh Y, Nakamura K, Oyama N, Kaneko F, Endo Y, Fujita T, Nishida T, Mizuki N. Single nucleotide polymorphisms of Ficolin 2 gene in Behcet's disease. J. Dermatol. Sci. 43: 201-205 (2006).
Chen X, Liu CT, Zhang M, Zhang H. A forest-based approach to identifying gene and gene gene interactions. Proc. Natl. Acad. Sci. U.S.A. 104: 19199-19203 (2007). *
Chen X, Wang H, Xie W, Liang R, Wei Z, Zhi L, Zhang X, Hao B, Zhong S, Zhou G, Zhang L, Gao X, Zhu Y, He F. Association of CYP1A2 genetic polymorphisms with hepatocellular carcinoma susceptibility: a case-control study in a high-risk region of China. Pharmacogenet. Genomics 16: 219-227 (2006).
Chen X, Wang L, Zhi L, Zhou G, Wang H, Zhang X, Hao B, Zhu Y, Cheng Z, He F. The G-113A polymorphism in CYP1A2 affects the caffeine metabolic ratio in a Chinese population. Clin. Pharmacol. Ther. 78: 249-259 (2005). *
Chen XQ, Huang HG, Zhou YN, Li Y, Chen YC. The study of the relationship between interleukin gene polymorphism and the morbidity of patients with acute pancreatitis. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 21: 99-102 (2009).
Chen XR, Feng YL, Ma Y, Zhang ZD, Li CY, Wen FQ, Tang XY, Su ZG. Study on the association of two polymorphisms of the vitamin D receptor (VDR) gene with the susceptibility to pulmonary tuberculosis (PTB) in Chinese Tibetans. Sichuan Da Xue Xue Bao Yi Xue Ban 37: 847-851 (2006).
Chen XY, Yan WH, Lin A, Xu HH, Zhang JG, Wang XX. The 14 bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma. Tissue Antigens 72: 335-341 (2008). *
Chen Y, Chen W, Cobb MH, Zhao Y. PTMap - a sequence alignment software for unrestricted, accurate, and full-spectrum identification of post-translational modification sites. Proc. Natl. Acad. Sci. U.S.A. 106: 761-766 (2009). *
Chen Y, Cicciarelli J, Pravica V, Hutchinson IV. Long-range linkage on chromosome 6p of VEGF, FKBP5, HLA and TNF alleles associated with transplant rejection. Mol. Immunol. Feb 20 [Epub ahead of print] (2009). *
Chen Y, Jia L, Wei C, Wang F, Lv H, Jia J. Association between polymorphisms in the apolipoprotein D gene and sporadic Alzheimer's disease. Brain Res. 1233: 196-202 (2008).
Chen Y, Perry D, Boackle SA, Sobel ES, Molina H, Croker BP, Morel L. Several genes contribute to the production of autoreactive B and T cells in the murine lupus susceptibility locus Sle1c. J. Immunol. 175: 1080-1089 (2005). *
Chen Y, Takita J, Choi YL, Kato M, Ohira M, Sanada M, Wang L, Soda M, Kikuchi A, Igarashi T, Nakagawara A, Hayashi Y, Mano H, Ogawa S. Oncogenic mutations of ALK kinase in neuroblastoma. Nature 455: 971-974 (2008). *
Chen Y, Zhou B, Peng Y, Wang Y, Li C, Ding X, He X, Xu J, Huang L, Rao L. Interleukin-23 receptor gene polymorphisms is associated with dilated cardiomyopathy in Chinese Han population. Tissue Antigens 73: 330-334 (2009). *
Chen YC, Giovannucci E, Kraft P, Lazarus R, Hunter DJ. Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer. Cancer Epidemiol. Biomarkers Prev. 16: 1982-1989 (2007). *
Chen YC, Giovannucci E, Lazarus R, Kraft P, Ketkar S, Hunter DJ. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer. Cancer Res. 65: 11771-11778 (2005). *
Chen YJ, Lin CH, Ou TT, Wu CC, Tsai WC, Liu HW, Yen JH. Solute carrier family 11 member A1 gene polymorphisms in reactive arthritis. J. Clin. Immunol. 27: 46-52 (2007). *
Chen YJ, Shen JL, Wu CY, Chang YT, Chen CM, Lee FY. Elevated plasma osteopontin level is associated with occurrence of psoriasis and is an unfavorable cardiovascular risk factor in patients with psoriasis. J. Am. Acad. Dermatol. 60: 225-230 (2009).
Chen YL, Chang YS, Chang JG, Wu SM. Genotyping of K-ras codons 12 and 13 mutations in colorectal cancer by capillary electrophoresis. J. Chromatogr. A. 1216: 5147-5154 (2009).
Chen YP, Pfab T, Slowinski T, Richter CM, Godes M, Hocher B. Impact of genetic variation of tumor necrosis factor-alpha on gestational hypertension. Chin. Med. J. (Engl.) 119: 719-724 (2006). *
Chen Z, Ma G, Qian Q, Yao Y, Feng Y, Tang C. Toll-like receptor 8 polymorphism and coronary artery disease. Mol. Biol. Rep. Nov 5 [Epub ahead of print] (2008). *
Chen Z, Takahashi M, Naruse T, Nakajima T, Chen YW, Inoue Y, Ishikawa I, Iwai T, Kimura A. Synergistic contribution of CD14 and HLA loci in the susceptibility to Buerger disease. Hum. Genet. 122: 367-372 (2007). *
Chen Z, Tang NL, Cao X, Qiao D, Yi L, Cheng JC, Qiu Y. Promoter polymorphism of matrilin-1 gene predisposes to adolescent idiopathic scoliosis in a Chinese population. Eur. J. Hum. Genet. 17: 525-532 (2009).
Chen Z, Zhou Z, Chen X, Xu J, Liu A, Du W, Gu D, Ge J, Guo Z, Wang X, Dong X, Ren Q, Yang R. Single nucleotide polymorphism in DNMT3B promoter and the risk for idiopathic thrombocytopenic purpura in Chinese population. J. Clin. Immunol. 28: 399-404 (2008). *
Chen ZC, Shin SJ, Kuo KK, Lin KD, Yu ML, Hsiao PJ. Significant association of ABCG8:D19H gene polymorphism with hypercholesterolemia and insulin resistance. J. Hum. Genet. 53: 757-763 (2008). *
Chen ZY, Jing D, Bath KG, Ieraci A, Khan T, Siao CJ, Herrera DG, Toth M, Yang C, McEwen BS, Hempstead BL, Lee FS. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 314: 140-143 (2006). *
Cheng CH, Huang YC, Chen FP, Chou MC, Tsai TP. B-vitamins, homocysteine and gene polymorphism in adults with fasting or post-methionine loading hyperhomocysteinemia. Eur. J. Nutr. 47: 491-498 (2008). *
Cheng CW, Yu JC, Huang CS, Shieh JC, Fu YP, Wang HW, Wu PE, Shen CY. Polymorphism of cytosolic serine hydroxymethyltransferase, estrogen and breast cancer risk among Chinese women in Taiwan. Breast Cancer Res. Treat. 111: 145-155 (2008).
Cheng JC, Tang NL, Yeung HY, Miller N. Genetic association of complex traits: using idiopathic scoliosis as an example. Clin. Orthop. Relat. Res. 462: 38-44 (2007).
Cheng L, Enomoto T, Hirota T, Shimizu M, Takahashi N, Akahoshi M, Matsuda A, Dake Y, Doi S, Enomoto K, Yamasaki A, Fukuda S, Mao XQ, Hopkin JM, Tamari M, Shirakawa T. Polymorphisms in ADAM33 are associated with allergic rhinitis due to Japanese cedar pollen. Clin. Exp. Allergy 34: 1192-1201 (2004). *
Cheng L, Zhang SZ, Xiao CY, Hou YP, Li L, Luo HC, Jiang HY, Zuo WQ. The A5.1 allele of the major histocompatibility complex class I chain-related gene A is associated with psoriasis vulgaris in Chinese. Br. J. Dermatol. 143: 324-329 (2000).
Cheng PL, Eng HL, Chou MH, You HL, Lin TM. Genetic polymorphisms of viral infection-associated Toll-like receptors in Chinese population. Transl. Res. 150: 311-318 (2007). *
Cheng S, Afif H, Martel-Pelletier J, Benderdour M, Pelletier JP, Hilal G, Haraoui P, Raynauld JP, Choquette D, Fahmi H. Association of polymorphisms in the peroxisome proliferator-activated receptor gamma gene and osteoarthritis of the knee. Ann. Rheum. Dis. 65: 1394-1397 (2006). *
Cheng SL, Yu CJ, Yang PC. Genetic polymorphisms of cytochrome P450 and matrix metalloproteinase in chronic obstructive pulmonary disease. Biochem. Genet. Jun 9 [Epub ahead of print] (2009).
Cheng X, Xu G. Association between aldosterone synthase CYP11B2 polymorphism and essential hypertension in Chinese: a meta-analysis. Kidney Blood Press. Res. 32: 128-140 (2009).
Cheng XJ, Xu W, Zhang QY, Zhou RL. Relationship between LAPTM4B gene polymorphism and susceptibility of colorectal and esophageal cancers. Ann. Oncol. 19: 527-532 (2008).
Cheng YK, Lin CD, Chang WC, Hwang GY, Tsai SW, Wan L, Tsai MH, Tsai JJ, Tsai FJ. Increased prevalence of interleukin-1 receptor antagonist gene polymorphism in patients with chronic rhinosinusitis. Arch. Otolaryngol. Head Neck Surg. 132: 285-290 (2006).
Cheong HS, Kim LH, Park BL, Choi YH, Park HS, Hong SJ, Choi BW, Park CS, Shin HD. Association analysis of interleukin 5 receptor alpha subunit (IL5RA) polymorphisms and asthma. J. Hum. Genet. 50: 628-634 (2005). *
Cheong HS, Lee SO, Choi CB, Sung YK, Shin HD, Bae SC. MERTK polymorphisms associated with risk of haematological disorders among Korean SLE patients. Rheumatology (Oxford) 46: 209-214 (2007). *
Cheong JY, Cho SW, Chung SG, Lee JA, Yeo M, Wang HJ, Lee JE, Hahm KB, Kim JH. Genetic polymorphism of interferon-gamma, interferon-gamma receptor, and interferon regulatory factor-1 genes in patients with hepatitis B virus infection. Biochem. Genet. 44: 246-255 (2006). *
Cheong JY, Cho SW, Lim SK, Shin do H, Yoon SK, Lee JE, Hahm KB, Kim JH. Lack of association between hepatitis B virus infection and polymorphism of mannose-binding lectin gene in Korean population. J. Korean Med. Sci. 20: 65-69 (2005). *
Cheong KY, Allcock RJ, Eerligh P, Witt CS, Christiansen FT, McCann V, Price P. Localization of central MHC genes influencing type I diabetes. Hum. Immunol. 62: 1363-2370 (2001).
Chermesh I, Azriel A, Alter-Koltunoff M, Eliakim R, Karban A, Levi BZ. Crohn's disease and SLC11A1 promoter polymorphism. Dig. Dis. Sci. 52: 1632-1635 (2007). *
Chernavsky AC, Paez MC, Periolo N, Correa P, Guillen L, Niveloni SI, Maurino E, Bai JC, Anaya JM. The simultaneous presence of IL-1B and TNFA two-positions risk haplotypes enhances the susceptibility for celiac disease. Cytokine 42: 48-54 (2008).
Chessman D, Kostenko L, Lethborg T, Purcell AW, Williamson NA, Chen Z, Kjer-Nielsen L, Mifsud NA, Tait BD, Holdsworth R, Almeida CA, Nolan D, Macdonald WA, Archbold JK, Kellerher AD, Marriott D, Mallal S, Bharadwaj M, Rossjohn J, McCluskey J. Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity. Immunity 28: 822-832 (2008). *
Cheung VG, Spielman RS. Data for Genetic Analysis Workshop (GAW) 15, Problem 1: genetics of gene expression variation in humans. BMC Proc. 1 Suppl. 1: S2 (2007). *
Cheung VG, Spielman RS, Ewens KG, Weber TM, Morley M, Burdick JT. Mapping determinants of human gene expression by regional and genome-wide association. Nature 437: 1365-1369 (2005). *
Cheung YF, Huang GY, Chen SB, Liu XQ, Xi L, Liang XC, Huang MR, Chen S, Huang LS, Liu XQ, Chan KW, Lau YL. Inflammatory gene polymorphisms and susceptibility to Kawasaki disease and its arterial sequelae. Pediatrics 122: e608-e614 (2008). *
Chevalier-Porst F, Souche G, Bozon D. Identification and characterization of three large deletions and a deletion/polymorphism in the CFTR gene. Hum. Mutat. 25: 504 (2005). *
Chiang CH, Tang YC, Lin MW, Chung MY. Association between the IL-4 promoter polymorphisms and asthma or severity of hyperresponsiveness in Taiwanese. Respirology 12: 42-48 (2007).
Chiappelli M, Tumini E, Porcellini E, Licastro F. Impaired regulation of immune responses in cognitive decline and Alzheimer's disease: lessons from genetic association studies. Expert Rev. Neurother. 6: 1327-1336 (2006).
Chien CC, Chen SH, Liu CC, Lee CL, Yang RN, Yang SH, Huang CJ. Correlation of K-ras codon 12 mutations in human feces and ages of patients with colorectal cancer (CRC). Transl. Res. 149: 96-102 (2007). *
Child NJ, Yang IA, Pulletz MC, de Courcy-Golder K, Andrews AL, Pappachan VJ, Holloway JW. Polymorphisms in Toll-like receptor 4 and the systemic inflammatory response syndrome. Biochem. Soc. Trans. 31: 652-653 (2003). *
Chin J. Intestinal microflora: negotiating health outcomes with the warring community within us. Asia Pac. J. Clin. Nutr. 13: S24-S25 (2004).
Chinoy H, Platt H, Lamb JA, Betteridge Z, Gunawardena H, Fertig N, Varsani H, Davidson J, Oddis CV, McHugh NJ, Wedderburn LR, Ollier WE, Cooper RG. The protein tyrosine phosphatase N22 gene is associated with juvenile and adult idiopathic inflammatory myopathy independent of the HLA 8.1 haplotype in British Caucasian patients. Arthritis Rheum. 58: 3247-3254 (2008). *
Chinoy H, Salway F, John S, Fertig N, Tait BD, Oddis CV, Ollier WE, Cooper RG; for the UK Adult Onset Myositis Immunogenetic Collaboration (AOMIC). Tumour necrosis factor-alpha single nucleotide polymorphisms are not independent of HLA class I in UK Caucasians with adult onset idiopathic inflammatory myopathies. Rheumatology (Oxford) 46: 1411-1416 (2007). *
Chiodini RJ, Van Kruiningen HJ, Thayer WR, Coutu JA. Spheroplastic phase of mycobacteria isolated from patients with Crohn's disease. J. Clin. Microbiol. 24: 357-363 (1986). *
Chistiakov D, Zotova E, Savost'anov K, Bursa T, Galeev I, Strokov Ia, Nosikov V. The 262T>C promoter polymorphism of the catalase gene is associated with diabetic neuropathy in type 1 diabetic Russian patients. Diabetes Metab. 32: 63-68 (2006).
Chistiakov DA. Thyroid-stimulating hormone receptor and its role in Graves' disease. Mol. Genet. Metab. 80: 377-388 (2003). *
Chistiakov DA, Potapov VA, Khodirev DC, Shamkhalova MS, Shestakova MV, Nosikov VV. Genetic variations in the pancreatic ATP-sensitive potassium channel, beta-cell dysfunction, and susceptibility to type 2 diabetes. Acta Diabetol. 46: 43-49 (2009).
Chistiakov DA, Savost'anov KV, Nosikov VV. CTLA4 gene polymorphisms are associated with, and linked to, insulin-dependent diabetes mellitus in a Russian population. BMC Genet. 2: 6 (2001). *
Chistiakov DA, Savost'anov KV, Shestakova MV, Chugunova LA, Samkhalova MSh, Dedov II, Nosikov VV. Confirmation of a susceptibility locus for diabetic nephropathy on chromosome 3q23-q24 by association study in Russian type 1 diabetic patients. Diabetes Res. Clin. Pract. 66: 79-86 (2004).
Chistiakov DA, Savost'anov KV, Turakulov RI. Screening of SNPs at 18 positional candidate genes, located within the GD-1 locus on chromosome 14q23-q32, for susceptibility to Graves' disease: a TDT study. Mol. Genet. Metab. 83: 264-270 (2004). *
Chistiakov DA, Savost'anov KV, Turakulov RI, Efremov IA, Demurov LM. Genetic analysis and functional evaluation of the C/T(-318) and A/G(-1661) polymorphisms of the CTLA-4 gene in patients affected with Graves' disease. Clin. Immunol. 118: 233-242 (2006). *
Chistiakov DA, Savost'anov KV, Turakulov RI, Petunina N, Balabolkin MI, Nosikov VV. Further studies of genetic susceptibility to Graves' disease in a Russian population. Med. Sci. Monit. 8: CR180-CR184 (2002). *
Chistiakov DA, Savost'anov KV, Turakulov RI, Titovich EV, Zilberman LI, Kuraeva TL, Dedov II, Nosikov VV. A new type 1 diabetes susceptibility locus containing the catalase gene (chromosome 11p13) in a Russian population. Diabetes Metab. Res. Rev. 20: 219-224 (2004).
Chistiakov DA, Savost'ianov KV, Chugunova LA, Shamkhalova MSh, Shestakova MV, Milen'kaia TM, Nosikov VV, Dedov II, Debabov VG. Associative analysis of the connection between mutation C1167T in the catalase gene and polymorphic marker D6S392 nearby the Mn-dependent superoxide dismutase gene with diabetic microangiopathies. Ter. Arkh. 74: 28-30 (2002).
Chistiakov DA, Seryogin YA, Turakulov RI, Savost'anov KV, Titovich EV, Zilberman LI, Kuraeva TL, Dedov II, Nosikov VV. Evaluation of IDDM8 susceptibility locus in a Russian simplex family data set. J. Autoimmun. 24: 243-250 (2005).
Chistiakov DA, Turakulov RI. CTLA-4 and its role in autoimmune thyroid disease. J. Mol. Endocrinol. 31: 21-36 (2003). *
Chistyakov DA, Savost'anov KV, Turakulov RI, Petunina NA, Trukhina LV, Kudinova AV, Balabolkin MI, Nosikov VV. Complex association analysis of Graves disease using a set of polymorphic markers. Mol. Genet. Metab. 70: 214-218 (2000). *
Chiu YF, Liu SY, Tsai YY. A comparison in association and linkage genome-wide scans for alcoholism susceptibility genes using single-nucleotide polymorphisms. BMC Genet. 6 Suppl. 1: S89 (2005). *
Chmaisse HN, Fakhoury HA, Salti NN, Makki RF. The ICAM-1 469 T/C gene polymorphism but not 241 G/A is associated with Behcets disease in the Lebanese population. Saudi Med. J. 27: 604-607 (2006).
Cho EK, Tchinda J, Freeman JL, Chung YJ, Cai WW, Lee C. Array-based comparative genomic hybridization and copy number variation in cancer research. Cytogenet. Genome Res. 115: 262-272 (2006).
Cho HJ, Chung JH, Kim IS, Kim HJ, Cho SH, Ki CS, Kim JW. Lack of a genetic association between the CTLA-4 gene and Graves' disease in Koreans. Thyroid 16: 237-241 (2006).
Cho J. Genetic advances in inflammatory bowel disease. Curr. Treat. Options Gastroenterol. 9: 191-200 (2006).
Cho J. Update on inflammatory bowel disease genetics. Curr. Gastroenterol. Rep. 2: 434-439 (2000).
Cho JH. Update on the genetics of inflammatory bowel disease. Curr. Gastroenterol. Rep. 3: 458-463 (2001).
Cho JH, Abraham C. Inflammatory bowel disease genetics: Nod2. Annu. Rev. Med. 58: 401-416 (2007). *
Cho JH, Bang S, Park SW, Chung JB, Song SY. BRCA2 mutations as a universal risk factor for pancreatic cancer has a limited role in Korean ethnic group. Pancreas 36: 337-340 (2008).
Cho JH, Huh S, Kwon TG, Choi JY, Hur IK, Lee EY, Park SH, Kim YL, Kim CD. Association of C-509T and T869C polymorphisms of transforming growth factor-beta1 gene with chronic allograft nephropathy and graft survival in Korean renal transplant recipients. Transplant. Proc. 40: 2355-2360 (2008).
Cho JH, Weaver CT. The genetics of inflammatory bowel disease. Gastroenterology 133: 1327-1339 (2007). *
Cho JK, Kim YH, Park IY, Shin JC, Oh MK, Park SJ, Kim NH, Kim IS. Polymorphism of haptoglobin in patients with premature rupture of membrane. Yonsei Med. J. 50: 132-136 (2009). *
Cho SC, Yim SH, Yoo HK, Kim MY, Jung GY, Shin GW, Kim BN, Hwang JW, Kang JJ, Kim TM, Chung YJ. Copy number variations associated with idiopathic autism identified by whole-genome microarray-based comparative genomic hybridization. Psychiatr. Genet. Apr 29 [Epub ahead of print] (2009).
Cho SE, Sook Hong K, Shin GJ, Chung WS. The methylenetetrahydrofolate reductase C677T gene mutation is associated with hyperhomocysteinemia, cardiovascular disease and plasma B-type natriuretic peptide levels in Korea. Clin. Chem. Lab. Med. 44: 1070-1075 (2006). *
Cho SM, Kim J, Ryu HJ, Kim JJ, Kim HH, Park JH, Kim HT, Kim KH, Cho HY, Oh B, Park C, Kimm K, Jo I, Lee JE, Shin HD, Lee JK. Identification of single nucleotide polymorphisms in the tumor necrosis factor (TNF) and TNF receptor superfamily in the Korean population. Hum. Immunol. 65: 710-718 (2004).
Cho YG, Choi BJ, Kim CJ, Song JH, Zhang C, Nam SW, Lee JY, Park WS. Genetic analysis of the DBC2 gene in gastric cancer. Acta Oncol. 47: 366-371 (2008).
Chocano-Bedoya P, Ronnenberg AG. Vitamin D and tuberculosis. Nutr. Rev. 67: 289-293 (2009). *
Choi CB, Kang CP, Seong SS, Bae SC, Kang C. The -169C/T polymorphism in FCRL3 is not associated with susceptibility to rheumatoid arthritis or systemic lupus erythematosus in a case-control study of Koreans. Arthritis Rheum. 54: 3838-3841 (2006). *
Choi HB, Han H, Youn JI, Kim TY, Kim TG. MICA 5.1 allele is a susceptibility marker for psoriasis in the Korean population. Tissue Antigens 56: 548-550 (2000). *
Choi JH, Ahn BM, Yi J, Lee JH, Lee JH, Nam SW, Chon CY, Han KH, Ahn SH, Jang IJ, Cho JY, Suh Y, Cho MO, Lee JE, Kim KH, Lee MG. MRP2 haplotypes confer differential susceptibility to toxic liver injury. Pharmacogenet. Genomics 17: 403-415 (2007).
Choi JH, Kim SH, Cho BY, Lee SK, Kim SH, Suh CH, Park HS. Association of TNF-alpha promoter polymorphisms with aspirin-induced urticaria. J. Clin. Pharm. Ther. 34: 231-238 (2009).
Choi JW, Park CS, Hwang M, Nam HY, Chang HS, Park SG, Han BG, Kimm K, Kim HL, Oh B, Kim Y. A common intronic variant of CXCR3 is functionally associated with gene expression levels and the polymorphic immune cell responses to stimuli. J. Allergy Clin. Immunol. 122: 1119-1126.e7 (2008).
Choi MK, Song IS. Organic cation transporters and their pharmacokinetic and pharmacodynamic consequences. Drug Metab. Pharmacokinet. 23: 243-253 (2008).
Choi SW, Gu BH, Ramakrishna S, Park JM, Baek KH. Association between a single nucleotide polymorphism in MTHFR gene and polycystic ovary syndrome. Eur. J. Obstet. Gynecol. Reprod. Biol. May 6 [Epub ahead of print] (2009).
Choi YS, Hong JM, Lim S, Ko KS, Pak YK. Impaired coactivator activity of the Gly(482) variant of peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha) on mitochondrial transcription factor A (Tfam) promoter. Biochem. Biophys. Res. Commun. 344: 708-712 (2006). *
Chong KK, Chiang SW, Wong GW, Tam PO, Ng TK, Hu YJ, Yam GH, Lam DS, Pang CP. Association of CTLA-4 and IL-13 gene polymorphisms with Graves' disease and ophthalmopathy in Chinese children. Invest. Ophthalmol. Vis. Sci. 49: 2409-2415 (2008). *
Chong KT, Ho WF, Koo SH, Thompson P, Lee EJ. Distribution of the FcgammaRIIIa 176 F/V polymorphism amongst healthy Chinese, Malays and Asian Indians in Singapore. Br. J. Clin. Pharmacol. 63: 328-332 (2007). *
Chong WP, Ip WE, Tso GH, Ng MW, Wong WH, Law HK, Yung RW, Chow EY, Au K, Chan EY, Lim W, Peiris JM, Lau YL. The interferon gamma gene polymorphism +874 A/T is associated with severe acute respiratory syndrome. BMC Infect. Dis. 6: 82 (2006). *
Chong WP, Ip WK, Wong WH, Lau CS, Chan TM, Lau YL. Association of interleukin-10 promoter polymorphisms with systemic lupus erythematosus. Genes Immun. 5: 484-492 (2004). *
Choonhakarn C, Romphruk A, Puapairoj C, Jirarattanapochai K, Romphruk A, Leelayuwat C. Haplotype associations of the major histocompatibility complex with psoriasis in Northeastern Thais. Int. J. Dermatol. 41: 330-334 (2002).
Choquet H, Cavalcanti-Proenca C, Lecoeur C, Dina C, Cauchi S, Vaxillaire M, Hadjadj S, Horber F, Potoczna N, Charpentier G, Ruiz J, Hercberg S, Maimaitiming S, Roussel R, Boenhnke M, Jackson AU, Patsch W, Krempler F, Voight BF, Altshuler D, Groop L, et al. The T-381C SNP in BNP gene may be modestly associated with type 2 diabetes: an updated meta-analysis in 49,279 subjects. Hum. Mol. Genet. 18: 2495-2501 (2009).
Chou LS, Lyon E, Wittwer CT. A comparison of high-resolution melting analysis with denaturing high-performance liquid chromatography for mutation scanning: cystic fibrosis transmembrane conductance regulator gene as a model. Am. J. Clin. Pathol. 124: 330-338 (2005).
Chouchane L, Sfar I, Bousaffara R, El Kamel A, Sfar MT, Ismail A. A repeat polymorphism in interleukin-4 gene is highly associated with specific clinical phenotypes of asthma. Int. Arch. Allergy Immunol. 120: 50-55 (1999).
Choudhry S, Avila PC, Nazario S, Ung N, Kho J, Rodriguez-Santana JR, Casal J, Tsai HJ, Torres A, Ziv E, Toscano M, Sylvia JS, Alioto M, Salazar M, Gomez I, Fagan JK, Salas J, Lilly C, Matallana H, Castro RA, Selman M, Weiss ST, Ford JG, Drazen JM, et al. CD14 tobacco gene-environment interaction modifies asthma severity and immunoglobulin E levels in Latinos with asthma. Am. J. Respir. Crit. Care Med. 172: 173-182 (2005). *
Choudhuri S, Klaassen CD. Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters. Int. J. Toxicol. 25: 231-259 (2006). *
Choudhury K, McQuillin A, Puri V, Pimm J, Datta S, Thirumalai S, Krasucki R, Lawrence J, Bass NJ, Quested D, Crombie C, Fraser G, Walker N, Nadeem H, Johnson S, Curtis D, St Clair D, Gurling HM. A genetic association study of chromosome 11q22-24 in two different samples implicates the FXYD6 gene, encoding phosphohippolin, in susceptibility to schizophrenia. Am. J. Hum. Genet. 80: 664-672 (2007). *
Choukem SP, Boudou P, Sobngwi E, Villette JM, Ibrahim F, Moulin P, Hadjadj S, Eberle D, Foufelle F, Vexiau P, Gautier JF. The polymorphism Arg585Gln in the gene of the sterol regulatory element binding protein-1 (SREBP-1) is not a determinant of ketosis prone type 2 diabetes (KPD) in Africans. Diabetes Metab. 35: 20-24 (2009).
Chow E, Lipton L, Lynch E, D'Souza R, Aragona C, Hodgkin L, Brown G, Winship I, Barker M, Buchanan D, Cowie S, Nasioulas S, du Sart D, Young J, Leggett B, Jass J, Macrae F. Hyperplastic polyposis syndrome: phenotypic presentations and the role of MBD4 and MYH. Gastroenterology 131: 30-39 (2006). *
Chowdhury ZM, McDermott MF, Davey S, Hassan Z, Sinnott PJ, Hemmatpour SK, Sherwin S, Ali L, Aganna E, Allotey RA, North BV, Cassell PG, Azad Khan AK, Hitman GA. Genetic susceptibility to fibrocalculous pancreatic diabetes in Bangladeshi subjects: a family study. Genes Immun. 3: 5-8 (2002). *
Christiani DC, Mehta AJ, Yu CL. Genetic susceptibility to occupational exposures. Occup. Environ. Med. 65: 430-436 (2008).
Chrzanowska M, Kurzawski M, Drozdzik M, Mazik M, Oko A, Czekalski S. Thiopurine S-methyltransferase phenotype-genotype correlation in hemodialyzed patients. Pharmacol. Rep. 58: 973-978 (2006).
Chu CC, Ho HT, Lee HL, Chan YS, Chang FJ, Wang CL, Lin M. Anti-"Mi" immunization is associated with HLA-DRB1*0901. Transfusion 49: 472-478 (2009).
Chu CH, Yang AM, Kao JH, Liu CY, Chang WH, Yang WS. Uridine diphosphate glucuronosyl transferase 1A1 promoter polymorphism is associated with choledocholithiasis in Taiwanese patients. J. Gastroenterol. Hepatol. May 28 [Epub ahead of print] (2009). *
Chu JH, Weiss ST, Carey VJ, Raby BA. A graphical model approach for inferring large-scale networks integrating gene expression and genetic polymorphism. BMC Syst. Biol. 3: 55 (2009). *
Chu LW, Li Y, Li Z, Tang AY, Cheung BM, Leung RY, Yik PY, Jin DY, Song YQ. A novel intronic polymorphism of ABCA1 gene reveals risk for sporadic Alzheimer's disease in Chinese. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 144: 1007-1013 (2007).
Chu NF. Plasma hyperhomocysteinemia, MTHFR polymorphism and thromboembolic disease: an example of gene-nutrition interactions in chronic disease. J. Chin. Med. Assoc. 68: 557-559 (2005).
Chu X, Dong C, Lei R, Sun L, Wang Z, Dong Y, Shen M, Wang Y, Wang B, Zhang K, Yang L, Li Y, Yuan W, Wang Y, Song H, Jin L, Xiong M, Huang W. Polymorphisms in the interleukin 3 gene show strong association with susceptibility to Graves' disease in Chinese population. Genes Immun. 10: 260-266 (2009).
Chu X, Dong Y, Shen M, Sun L, Dong C, Wang Y, Wang B, Zhang K, Hua Q, Xu S, Huang W. Polymorphisms in the ADRB2 gene and Graves disease: a case-control study and a meta-analysis of available evidence. BMC Med. Genet. 10: 26 (2009). *
Chu ZT, Tsuchiya N, Kyogoku C, Ohashi J, Qian YP, Xu SB, Mao CZ, Chu JY, Tokunaga K. Association of Fcgamma receptor IIb polymorphism with susceptibility to systemic lupus erythematosus in Chinese: a common susceptibility gene in the Asian populations. Tissue Antigens 63: 21-27 (2004). *
Chua KH, Hilmi I, Ng CC, Eng TL, Palaniappan S, Lee WS, Goh KL. Identification of NOD2/CARD15 mutations in Malaysian patients with Crohn's disease. J. Dig. Dis. 10: 124-130 (2009). *
Chua KH, Kee BP, Tan SY, Lian LH. Interleukin-6 promoter polymorphisms (-174 G/C) in Malaysian patients with systemic lupus erythematosus. Braz. J. Med. Biol. Res. 42: 551-555 (2009). *
Chuang CZ, Boyles A, Legardeur B, Su J, Japa S, Lopez SA. Effects of riboflavin and folic acid supplementation on plasma homocysteine levels in healthy subjects. Am. J. Med. Sci. 331: 65-71 (2006).
Chuang JH, Chou MH, Wu CL, Du YY. Implication of innate immunity in the pathogenesis of biliary atresia. Chang Gung Med. J. 29: 240-250 (2006). *
Chui MH, Papanikolaou Y, Fontaine-Bisson B, Turcotte J, Wolever TM, El-Sohemy A, Chiasson JL, Rabasa-Lhoret R, Maheux P, Ryan E, Greenwood CE. The TNF-alpha-238A single-nucleotide polymorphism protects against memory decline in older adults with type 2 diabetes. Behav. Neurosci. 121: 619-624 (2007).
Chun JK, Kang DW, Yoo BW, Shin JS, Kim DS. Programmed death-1 (PD-1) gene polymorphisms lodged in the genetic predispositions of Kawasaki disease. Eur. J. Pediatr. May 26 [Epub ahead of print] (2009).
Chung BS, Lee JK, Choi MH, Park MH, Choi D, Hong ST. Single nucleotide polymorphisms of cytokine genes are associated with fibrosis of the intrahepatic bile duct wall in human clonorchiasis. Korean J. Parasitol. 47: 145-151 (2009).
Chung EK, Wu YL, Yang Y, Zhou B, Yu CY. Human complement components C4A and C4B genetic diversities: complex genotypes and phenotypes. Curr. Protoc. Immunol. Chapter 13: Unit 13.8 (2005).
Chung EY, Liu J, Zhang Y, Ma X. Differential expression in lupus-associated IL-10 promoter single-nucleotide polymorphisms is mediated by poly(ADP-ribose) polymerase-1. Genes Immun. 8: 577-589 (2007). *
Chung HT, Kim LH, Park BL, Lee JH, Park HS, Choi BW, Hong SJ, Chae SC, Kim JJ, Park CS, Shin HD. Association analysis of novel TBX21 variants with asthma phenotypes. Hum. Mutat. 22: 257 (2003). *
Chung SA, Criswell LA. PTPN22: its role in SLE and autoimmunity. Autoimmunity 40: 582-590 (2007).
Chung SL, Chiou KR, Charng MJ. 677TT polymorphism of methylenetetrahydrofolate reductase in combination with low serum vitamin B(12) is associated with coronary in-stent restenosis. Catheter Cardiovasc. Interv. 67: 349-355 (2006).
Chung Y, Dong C. Don�t leave home without it: the IL-23 visa to TH-17 cells. Nat. Immunol. 10: 236-238 (2009). *
Chung YS, Cha HE, Kang IG, Hwang YJ, Kim ST. Polymorphism at the glutathione S-transferase P1 locus in Korean patients with perennial allergic rhinitis. Am. J. Rhinol. 20: 648-651 (2006).
Ciccia F, Bombardieri M, Principato A, Giardina A, Tripodo C, Porcasi R, Peralta S, Franco V, Giardina E, Craxi A, Pitzalis C, Triolo G. Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis. Arthritis Rheum. 60: 955-965 (2009). *
Cichoz-Lach H, Celinski K, Slomka M. Alcohol-metabolizing enzyme gene polymorphisms and alcohol chronic pancreatitis among Polish individuals. HPB (Oxford) 10: 138-143 (2008). *
Cichoz-Lach H, Partycka J, Nesina I, Celinski K, Slomka M. The influence of genetic polymorphism of CYP2E1 on the development of alcohol liver cirrhosis. Wiad. Lek. 59: 757-761 (2006).
Cichoz-Lach H, Partycka J, Nesina I, Celinski K, Slomka M, Wojcierowski J. Genetic polymorphism of alcohol dehydrogenase 3 in alcohol liver cirrhosis and in alcohol chronic pancreatitis. Alcohol Alcohol. 41: 14-17 (2006).
Cichy M, Adamek-Guzik T, Uracz D, Uracz W, Czerniawska-Mysik G, Korbut R, Guzik TJ. The functional relevance of Arg16Gly and Gln27Glu-beta2-adrenoreceptor polymorphism in patients with asthma and allergic rhinitis. Folia. Med. Cracov. 46: 33-51 (2005).
Ciernikova S, Tomka M, Kovac M, Stevurkova V, Zajac V. Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families. Neoplasma 53: 97-102 (2006). *
Cimaz R, Cazalis MA, Raynaud C, Gerloni V, Zulian F, Biggioggero M, Martini G, Pontikaki I, Fantini F, Mougin B, Miossec P. IL-1 and TNF gene polymorphisms in patients with juvenile idiopathic arthritis treated with TNF inhibitors. Ann. Rheum. Dis. 66: 900-904 (2007). *
Cinek O, Drevinek P, Sumnik Z, Bendlova B, Vavrinec J. Association of insulin gene variants with type 1 diabetes mellitus in Czech population. Cas. Lek. Cesk. 143: 318-322 (2004).
Cinek O, Hradsky O, Ahmedov G, Slavcev A, Kolouskova S, Kulich M, Sumnik Z. No independent role of the -1123 G>C and+2740 A>G variants in the association of PTPN22 with type 1 diabetes and juvenile idiopathic arthritis in two Caucasian populations. Diabetes Res. Clin. Pract. 76: 297-303 (2007).
Cinek O, Vavrincova P, Striz I, Drevinek P, Sedlakova P, Vavrinec J, Slavcev A. Association of single nucleotide polymorphisms within cytokine genes with juvenile idiopathic arthritis in the Czech population. J. Rheumatol. 31: 1206-1210 (2004).
Cipriano C, Caruso C, Lio D, Giacconi R, Malavolta M, Muti E, Gasparini N, Franceschi C, Mocchegiani E. The -308G/A polymorphism of TNF-alpha influences immunological parameters in old subjects affected by infectious diseases. Int. J. Immunogenet. 32: 13-18 (2005). *
Cirillo G, Di Domenico MR, Corsi I, Gagliardo T, Del Giudice EM, Perrone L, Tolone C. Do MYO9B genetic variants predispose to coeliac disease? An association study in a cohort of South Italian children. Dig. Liver Dis. 39: 228-231 (2007).
Claas FH, Dankers MK, Oudshoorn M, van Rood JJ, Mulder A, Roelen DL, Duquesnoy RJ, Doxiadis II. Differential immunogenicity of HLA mismatches in clinical transplantation. Transpl. Immunol. 14: 187-191 (2005).
Clappers N, van Oijen MG, Sundaresan S, Brouwer MA, Te Morsche RH, Keuper W, Peters WH, Drenth JP, Verheugt FW. The C50T polymorphism of the cyclooxygenase-1 gene and the risk of thrombotic events during low-dose therapy with acetyl salicylic acid. Thromb. Haemost. 100: 70-75 (2008).
Clarizia AD, Bastos-Rodrigues L, Pena HB, Anacleto C, Rossi B, Soares FA, Lopes A, Rocha JC, Caballero O, Camargo A, Simpson AJ, Pena SD. Relationship of the methylenetetrahydrofolate reductase C677T polymorphism with microsatellite instability and promoter hypermethylation in sporadic colorectal cancer. Genet. Mol. Res. 5: 315-322 (2006). *
Clark DW. Genetically determined variability in acetylation and oxidation. Therapeutic implications. Drugs 29: 342-375 (1985).
Clark NM, Marinis JM, Cobb BA, Abbott DW. MEKK4 sequesters RIP2 to dictate NOD2 signal specificity. Curr. Biol. 18: 1402-1408 (2008).
Clark TG, Andrew T, Cooper GM, Marguiles EH, Mullikin JC, Balding DJ. Functional constraint and small insertions and deletions in the ENCODE regions of the human genome. Genome Biol. 8: R180 (2007). *
Clark TG, Diakite M, Auburn S, Campino S, Fry AE, Green A, Richardson A, Small K, Teo YY, Wilson J, Jallow M, Sisay-Joof F, Pinder M, Griffiths MJ, Peshu N, Williams TN, Marsh K, Molyneux ME, Taylor TE, Rockett KA, Kwiatkowski DP. Tumor necrosis factor and lymphotoxin-alpha polymorphisms and severe malaria in African populations. J. Infect. Dis. 199: 569-575 (2009). *
Clark VJ, Dean M. Characterisation of SNP haplotype structure in chemokine and chemokine receptor genes using CEPH pedigrees and statistical estimation. Hum. Genomics 1: 195-207 (2004).
Clark VJ, Dean M. Haplotype structure and linkage disequilibrium in chemokine and chemokine receptor genes. Hum. Genomics 1: 255-273 (2004).
Clarke E, Rahman N, Page N, Rolph MS, Stewart GJ, Jones GJ. Functional characterization of the atopy-associated gene PHF11. J. Allergy Clin. Immunol. 121: 1148-1154.e3 (2008).
Clatworthy MR, Willcocks L, Urban B, Langhorne J, Williams TN, Peshu N, Watkins NA, Floto RA, Smith KG. Systemic lupus erythematosus-associated defects in the inhibitory receptor FcgammaRIIb reduce susceptibility to malaria. Proc. Natl. Acad. Sci. U.S.A. 104: 7169-7174 (2007). *
Clausmeyer S, Hesse V, Clemens PC, Engelbach M, Kreuzer M, Becker-Rose P, Spital H, Schulze E, Raue F. Mutational analysis of the PHEX gene: novel point mutations and detection of large deletions by MLPA in patients with X-linked hypophosphatemic rickets. Calcif. Tissue Int. Jun 10 [Epub ahead of print] (2009).
Claustres M. Molecular pathology of the CFTR locus in male infertility. Reprod. Biomed. Online 10: 14-41 (2005).
Claustres M, Altieri JP, Guittard C, Templin C, Chevalier-Porst F, Des Georges M. Are p.I148T, p.R74W and p.D1270N cystic fibrosis causing mutations? BMC Med. Genet. 5: 19 (2004). *
Clementi M, Gianantonio ED. Genetic susceptibility to infectious diseases. Reprod. Toxicol. 21: 345-349 (2006).
Clendenen TV, Arslan AA, Koenig KL, Enquist K, Wirgin I, Gren S, Lukanova A, Sjodin H, Zeleniuch-Jacquotte A, Shore RE, Hallmans G, Toniolo P, Lundin E. Vitamin D receptor polymorphisms and risk of epithelial ovarian cancer. Cancer Lett. 260: 209-215 (2008).
Clot F, Fulchignoni-Lataud MC, Renoux C, Percopo S, Bouguerra F, Babron MC, Djilali-Saiah I, Caillat-Zucman S, Clerget-Darpoux F, Greco L, Serre JL. Linkage and association study of the CTLA-4 region in coeliac disease for Italian and Tunisian populations. Tissue Antigens 54: 527-530 (1999). *
Cobb JE, White SJ, Harrap SB, Ellis JA. Androgen receptor copy number variation and androgenetic alopecia: a case-control study. PLoS ONE 4: e5081 (2009). *
Cocco E, Murru MR, Melis C, Schirru L, Solla E, Lai M, Rolesu M, Marrosu MG. PTPRC (CD45) C77G mutation does not contribute to multiple sclerosis susceptibility in Sardinian patients. J. Neurol. 251: 1085-1088 (2004). *
Cochery-Nouvellon E, Vitry F, Cornillet-Lefebvre P, Hezard N, Gillot L, Nguyen P. Interleukin-10 promoter polymorphism and venous thrombosis: a case-control study. Thromb. Haemost. 96: 24-28 (2006).
Coelho A, Matos A, Catarino R, Pinto D, Sousa H, Pereira D, Medeiros R. The influence of chemokine receptor CCR2 genotypes in the route to cervical carcinogenesis. Gynecol. Obstet. Invest. 64: 208-212 (2007).
Cohen JC, Kiss RS, Pertsemlidis A, Marcel YL, McPherson R, Hobbs HH. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 305: 869-872 (2004). *
Cohen N, Brautbar C, Font MP, Dausset J, Cohen D. HLA-DR2-associated Dw subtypes correlate with RFLP clusters: most DR2 IDDM patients belong to one of these clusters. Immunogenetics 23: 84-89 (1986).
Cohen R, Metzger S, Nahir M, Chajek-Shaul T. Association of the MIC-A gene and HLA-B51 with Behcet's disease in Arabs and non-Ashkenazi Jews in Israel. Ann. Rheum. Dis. 61: 157-160 (2002). *
Cohn JA, Neoptolemos JP, Feng J, Yan J, Jiang Z, Greenhalf W, McFaul C, Mountford R, Sommer SS. Increased risk of idiopathic chronic pancreatitis in cystic fibrosis carriers. Hum. Mutat. 26: 303-307 (2005).
Cole SM, Long JC. A coalescent simulation of marker selection strategy for candidate gene association studies. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 147: 86-93 (2008).
Coles BF, Kadlubar FF. Human alpha class glutathione S-transferases: genetic polymorphism, expression, and susceptibility to disease. Methods Enzymol. 401: 9-42 (2005).
Colleran G, McInerney N, Rowan A, Barclay E, Jones AM, Curran C, Miller N, Kerin M, Tomlinson I, Sawyer E. The TGFBR1*6A/9A polymorphism is not associated with differential risk of breast cancer. Breast Cancer Res. Treat. Apr 24 [Epub ahead of print] (2009).
Collins JE, Heward JM, Howson JM, Foxall H, Carr-Smith J, Franklyn JA, Gough SC. Common allelic variants of exons 10, 12, and 33 of the thyroglobulin gene are not associated with autoimmune thyroid disease in the United kingdom. J. Clin. Endocrinol. Metab. 89: 6336-6339 (2004). *
Collins JE, Heward JM, Nithiyananthan R, Nejentsev S, Todd JA, Franklyn JA, Gough SC. Lack of association of the vitamin D receptor gene with Graves' disease in UK Caucasians. Clin. Endocrinol. (Oxf.) 60: 618-624 (2004). *
Collins M, Posthumus M, Schwellnus MP. The COL1A1 gene and acute soft tissue ruptures. Br. J. Sports Med. Feb 4 [Epub ahead of print] (2009).
Collins RW, Stephens HA, Clare MA, Vaughan RW. High resolution molecular phototyping of MICA and MICB alleles using sequence specific primers. Hum. Immunol. 63: 783-794 (2002).
Colobran R, Casamitjana N, Roman A, Faner R, Pedrosa E, Arostegui JI, Pujol-Borrell R, Juan M, Palou E. Copy number variation in the CCL4L gene is associated with susceptibility to acute rejection in lung transplantation. Genes Immun. 10: 254-259 (2009).
Colobran R, Comas D, Faner R, Pedrosa E, Anglada R, Pujol-Borrell R, Bertranpetit J, Juan M. Population structure in copy number variation and SNPs in the CCL4L chemokine gene. Genes Immun. 9: 279-288 (2008). *
Colonna M, Bresnahan M, Bahram S, Strominger JL, Spies T. Allelic variants of the human putative peptide transporter involved in antigen processing. Proc. Natl. Acad. Sci. U.S.A. 89: 3932-3936 (1992). *
Colucci R, Blandizzi C, Bellini M, Ghisu N, Tonini M, Del Tacca M. The genetics of the serotonin transporter and irritable bowel syndrome. Trends Mol. Med. 14: 295-304 (2008). *
Comabella M, Altet L, Peris F, Villoslada P, Sanchez A, Montalban X. Genetic analysis of SLC11A1 polymorphisms in multiple sclerosis patients. Mult. Scler. 10: 618-620 (2004). *
Comabella M, Craig DW, Camina-Tato M, Morcillo C, Lopez C, Navarro A, Rio J; BiomarkerMS Study Group, Montalban X, Martin R. Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500,000 single nucleotide polymorphisms. PLoS ONE 3: e3490 (2008). *
Combarros O, Infante J, Rodriguez E, Llorca J, Pena N, Fernandez-Viadero C, Berciano J. CD14 receptor polymorphism and Alzheimer's disease risk. Neurosci. Lett. 380: 193-196 (2005). *
Combarros O, Riancho JA, Infante J, Sanudo C, Llorca J, Zarrabeitia MT, Berciano J. Interaction between CYP19 aromatase and butyrylcholinesterase genes increases Alzheimer's disease risk. Dement. Geriatr. Cogn. Disord. 20: 153-157 (2005).
Comets E, Verstuyft C, Lavielle M, Jaillon P, Becquemont L, Mentre F. Modelling the influence of MDR1 polymorphism on digoxin pharmacokinetic parameters. Eur. J. Clin. Pharmacol. 63: 437-449 (2007). *
Cominelli F, Pizarro TT. Interleukin-1 and interleukin-1 receptor antagonist in inflammatory bowel disease. Aliment. Pharmacol. Ther. 10 Suppl. 2: 49-53 (1996).
Conrad DF, Andrews TD, Carter NP, Hurles ME, Pritchard JK. A high-resolution survey of deletion polymorphism in the human genome. Nat. Genet. 38: 75-81 (2006). *
Conrad DJ, Stenbit AE, Zettner EM, Wick I, Eckhardt C, Hardiman G. Frequency of mitochondrial 12S ribosomal RNA variants in an adult cystic fibrosis population. Pharmacogenet. Genomics 18: 1095-1102 (2008).
Conrad S, Kauffmann HM, Ito K, Deeley RG, Cole SP, Schrenk D. Identification of human multidrug resistance protein 1 (MRP1) mutations and characterization of a G671V substitution. J. Hum. Genet. 46: 656-663 (2001).
Conseil G, Deeley RG, Cole SP. Polymorphisms of MRP1 (ABCC1) and related ATP-dependent drug transporters. Pharmacogenet. Genomics 15: 523-533 (2005).
Constantin A, Dieude P, Lauwers-Cances V, Jamard B, Mazieres B, Cambon-Thomsen A, Cornelis F, Cantagrel A. Tumor necrosis factor receptor II gene polymorphism and severity of rheumatoid arthritis. Arthritis Rheum. 50: 742-747 (2004). *
Constantin A, Lauwers-Cances V, Navaux F, Abbal M, van Meerwijk J, Mazieres B, Cambon-Thomsen A, Cantagrel A. Collagenase-1 (MMP-1) and HLA-DRB1 gene polymorphisms in rheumatoid arthritis: a prospective longitudinal study. J. Rheumatol. 29: 15-20 (2002). *
Constantin A, Lauwers-Cances V, Navaux F, Abbal M, van Meerwijk J, Mazieres B, Cambon-Thomsen A, Cantagrel A. Stromelysin 1 (matrix metalloproteinase 3) and HLA-DRB1 gene polymorphisms: association with severity and progression of rheumatoid arthritis in a prospective study. Arthritis Rheum. 46: 1754-1762 (2002). *
Constantin A, Navaux F, Lauwers-Cances V, Abbal M, van Meerwijk JP, Mazieres B, Cambon-Thomsen A, Cantagrel A. Interferon gamma gene polymorphism and susceptibility to, and severity of, rheumatoid arthritis. Lancet 358: 2051-2052 (2001). *
Contreras J, Hare L, Camarena B, Glahn D, Dassori A, Medina R, Contreras S, Ramirez M, Armas R, Munoz R, Mendoza R, Raventos H, Ontiveros A, Nicolini H, Palmer R, Escamilla M. The serotonin transporter 5-HTTPR polymorphism is associated with current and lifetime depression in persons with chronic psychotic disorders. Acta Psychiatr. Scand. 119: 117-127 (2009).
Contu D, Morelli L, Santoni F, Foster JW, Francalacci P, Cucca F. Y-chromosome based evidence for pre-neolithic origin of the genetically homogeneous but diverse Sardinian population: inference for association scans. PLoS ONE 3: e1430 (2008). *
Conway BR, Savage DA, Brady HR, Maxwell AP. Association between haptoglobin gene variants and diabetic nephropathy: haptoglobin polymorphism in nephropathy susceptibility. Nephron. Exp. Nephrol. 105: e75-e79 (2007).
Cook DN, Pisetsky DS, Schwartz DA. Toll-like receptors in the pathogenesis of human disease. Nat. Immunol. 5: 975-979 (2004). *
Cooke GS, Campbell SJ, Sillah J, Gustafson P, Bah B, Sirugo G, Bennett S, McAdam KP, Sow O, Lienhardt C, Hill AV. Polymorphism within the interferon-gamma/receptor complex is associated with pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 174: 339-343 (2006). *
Cookson S, Constantini PK, Clare M, Underhill JA, Bernal W, Czaja AJ, Donaldson PT. Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis. Hepatology 30: 851-856 (1999). *
Cooley P, Taylor KH, Czika W, Seifer C, Taylor JF. Analysis of a biomarker for Wegener's granulomatosis. Int. J. Immunogenet. 32: 237-243 (2005). *
Coolman M, de Maat M, Van Heerde WL, Felida L, Schoormans S, Steegers EA, Bertina RM, de Groot CJ. Matrix metalloproteinase-9 gene -1562C/T polymorphism mitigates preeclampsia. Placenta 28: 709-713 (2007).
Coon KD, Myers AJ, Craig DW, Webster JA, Pearson JV, Lince DH, Zismann VL, Beach TG, Leung D, Bryden L, Halperin RF, Marlowe L, Kaleem M, Walker DG, Ravid R, Heward CB, Rogers J, Papassotiropoulos A, Reiman EM, Hardy J, Stephan DA. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. J. Clin. Psychiatry 68: 613-618 (2007).
Cooney R, Cummings JR, Pathan S, Beckly J, Geremia A, Hancock L, Guo C, Morris A, Jewell DP. Association between genetic variants in myosin IXB and Crohn's disease. Inflamm. Bowel Dis. 15: 1014-1021 (2009). *
Cooper GS, Miller FW, Pandey JP. The role of genetic factors in autoimmune disease: implications for environmental research. Environ. Health Perspect. 107 Suppl. 5: 693-700 (1999).
Cooper JD, Smyth DJ, Bailey R, Payne F, Downes K, Godfrey LM, Masters J, Zeitels LR, Vella A, Walker NM, Todd JA. The candidate genes TAF5L, TCF7, PDCD1, IL6 and ICAM1 cannot be excluded from having effects in type 1 diabetes. BMC Med. Genet. 8: 71 (2007). *
Cope N, Harold D, Hill G, Moskvina V, Stevenson J, Holmans P, Owen MJ, O'Donovan MC, Williams J. Strong evidence that KIAA0319 on chromosome 6p is a susceptibility gene for developmental dyslexia. Am. J. Hum. Genet. 76: 581-591 (2005). *
Coppede F, Colognato R, Bonelli A, Astrea G, Bargagna S, Siciliano G, Migliore L. Polymorphisms in folate and homocysteine metabolizing genes and chromosome damage in mothers of Down syndrome children. Am. J. Med. Genet. A. 143: 2006-2015 (2007).
Coppola G, Geschwind DH. Technology insight: querying the genome with microarrays-progress and hope for neurological disease. Nat. Clin. Pract. Neurol. 2: 147-158 (2006).
Coppotelli G, Summers A, Chidakel A, Ross JM, Celi FS. Functional characterization of the 258 A/G (D2-ORFa-Gly3Asp) human type-2 deiodinase polymorphism: a naturally occurring variant increases the enzymatic activity by removing a putative repressor site in the 5' UTR of the gene. Thyroid 16: 625-632 (2006).
Corbetta S, Eller-Vainicher C, Frigerio M, Valaperta R, Costa E, Vicentini L, Baccarelli A, Beck-Peccoz P, Spada A. Analysis of the 206M polymorphic variant of the SLC26A6 gene encoding a Cl- oxalate transporter in patients with primary hyperparathyroidism. Eur. J. Endocrinol. 160: 283-288 (2009).
Cordeiro CA, Moreira PR, Costa GC, Dutra WO, Campos WR, Orefice F, Teixeira AL. TNF-alpha gene polymorphism (-308G/A) and toxoplasmic retinochoroiditis. Br. J. Ophthalmol. 92: 986-988 (2008).
Cordell HJ. Genome-wide association studies: detecting gene-gene interactions that underlie human diseases. Nat. Rev. Genet. May 12 [Epub ahead of print] (2009). *
Corder EH, Blennow K, Prince JA. Genetic susceptibility sets for Alzheimer's disease identified from diverse candidate loci. Rejuvenation Res. 11: 667-679 (2008).
Corder EH, Hefler LA. Multilocus genotypes spanning estrogen metabolism associated with breast cancer and fibroadenoma. Rejuvenation Res. 9: 56-60 (2006).
Cordoba-Lanus E, de-Torres JP, Lopez-Aguilar C, Rodriguez-Perez MC, Maca-Meyer N, Montejo-de-Garcini A, Aguirre-Jaime A, Perez-Mendez L, Casanova C. Association of IL-6 gene polymorphisms and COPD in a Spanish Population. Respir. Med. 102: 1805-1811 (2008).
Cordonnier-Pratt MM, Liang C, Wang H, Kolychev DS, Sun F, Freeman R, Sullivan R, Pratt LH. MAGIC database and interfaces: an integrated package for gene discovery and expression. Comp. Funct. Genomics 5: 268-275 (2004). *
Cordovado SK, Hancock LN, Simone AE, Hendrix M, Mueller PW. High-resolution genotyping of HLA-DQA1 in the GoKinD study and identification of novel alleles HLA-DQA1*040102, HLA-DQA1*0402 and HLA-DQA1*0404. Tissue Antigens 65: 448-458 (2005). *